Patent Grant
11786694
The present invention generally relates to the field of neuromodulation and neuroenhancement, and more specifically to systems, methods and applications for improving achievement and/or maintenance of sleep.
Each reference and document cited herein is expressly incorporated herein by reference in its entirety, for all purposes.
Brain Computer Interface (BCI): sometimes called a neural-control interface (NCI), mind-machine interface (MMI), direct neural interface (DNI), or brain-machine interface (BMI), is a communication pathway between a brain and an external computerized device. BCI may allows for bidirectional information flow. BCIs are often directed at researching, mapping, assisting, augmenting, or repairing human cognitive or sensory-motor functions. See, en.wikipedia.org/wiki/Brain-computer_interface. A bidirectional adaptive BCI controlling computer buzzer by an anticipatory brain potential, the Contingent Negative Variation (CNV) potential has been reported. The experiment described how an expectation state of the brain, manifested by CNV, controls in a feedback loop the S2 buzzer in the S1-S2-CNV paradigm. The obtained cognitive wave representing the expectation learning in the brain is named Electroexpectogram (EXG). Electroencephalography (EEG) is the most studied non-invasive interface, mainly due to its fine temporal resolution, ease of use, portability and low set-up cost. See Reference List Table 1.
Time in a biological manner: Almost everything in biology is subject to change over time. These changes occur on many different time scales, which vary greatly. For example, there are evolutionary changes that affect entire populations over time rather than a single organism. Evolutionary changes are often slower than a human time scale that spans many years (usually a human lifetime). Faster variations of the timing and duration of biological activity in living organisms occur, for example, in many essential biological processes in everyday life: in humans and animals, these variations occur, for example, in eating, sleeping, mating, hibernating, migration, cellular regeneration, etc. Other fast changes may include the transmission of a neural signal, for example, through a synapse such as the calyx of held, a particularly large synapse in the auditory central nervous system of mammals that can reach transmission frequencies of up to 50 Hz. With recruitment modulation, the effective frequencies can be higher. A single nerve impulse can reach a speed as high as one hundred meters (0.06 mile) per second (Kraus, David. Concepts in Modern Biology. New York: Globe Book Company, 1969: 170.). Myelination of axons can increase the speed of transmission by segmenting the membrane depolarization process.
Many of these changes over time are repetitive or rhythmic and are described as some frequency or oscillation. The field of chronobiology, for example, examines such periodic (cyclic) phenomena in living organisms and their adaptation, for example, to solar and lunar-related rhythms [DeCoursey et al. (2003).]These cycles are also known as biological rhythms. The related terms chronomics and chronome have been used in some cases to describe either the molecular mechanisms involved in chronobiological phenomena or the more quantitative aspects of chronobiology, particularly where comparison of cycles between organisms is required. Chronobiological studies include, but are not limited to, comparative anatomy, physiology, genetics, molecular biology, and behavior of organisms within biological rhythms mechanics [DeCoursey et al. (2003).]. Other aspects include epigenetics, development, reproduction, ecology, and evolution.
The most important rhythms in chronobiology are the circadian rhythms, roughly 24-hour cycles shown by physiological processes in all these organisms. It is regulated by circadian clocks. The circadian rhythms can be further broken down into routine cycles during the 24-hour day [Nelson R J. 2005. An Introduction to Behavioral Endocrinology. Sinauer Associates, Inc.: Massachusetts. Pg. 587.] All animals can be classified according to their activity cycles: Diurnal, which describes organisms active during daytime; Nocturnal, which describes organisms active in the night; and Crepuscular, which describes animals primarily active during the dawn and dusk hours (ex: white-tailed deer, some bats).
While circadian rhythms are defined as regulated by endogenous processes, other biological cycles may be regulated by exogenous signals. In some cases, multi-trophic systems may exhibit rhythms driven by the circadian clock of one of the members (which may also be influenced or reset by external factors).
Many other important cycles are also studied, including Infradian rhythms, which are cycles longer than a day. Examples include circannual or annual cycles that govern migration or reproduction cycles in many plants and animals, or the human menstrual cycle; Ultradian rhythms, which are cycles shorter than 24 hours, such as the 90-minute REM cycle, the 4-hour nasal cycle, or the 3-hour cycle of growth hormone production; Tidal rhythms, commonly observed in marine life, which follow the roughly 12.4-hour transition from high to low tide and back; Lunar rhythms, which follow the lunar month (29.5 days). They are relevant, for example, to marine life, as the level of the tides is modulated across the lunar cycle; and Gene oscillations—some genes are expressed more during certain hours of the day than during other hours.
Within each cycle, the time period during which the process is more active is called the acrophase [Refinetti, Roberto (2006). Circadian Physiology. CRC Press/Taylor & Francis Group. ISBN 0-8493-2233-2. Lay summary]. When the process is less active, the cycle is in its bathyphase or trough phase. The particular moment of highest activity is the peak or maximum; the lowest point is the nadir. How high (or low) the process gets is measured by the amplitude.
The sleep cycle and the ultradian rhythms: The normal cycle of sleep and wakefulness implies that, at specific times, various neural systems are being activated while others are being turned off. A key to the neurobiology of sleep is, therefore, to understand the various stages of sleep. In 1953, Nathaniel Kleitman and Eugene Aserinksy showed, using electroencephalographic (EEG) recordings from normal human subjects, that sleep comprises different stages that occur in a characteristic sequence.
Humans descend into sleep in stages that succeed each other over the first hour or so after retiring. These characteristic stages are defined primarily by electroencephalographic criteria. Initially, during “drowsiness,” the frequency spectrum of the electroencephalogram (EEG) is shifted toward lower values, and the amplitude of the cortical waves slightly increases. This drowsy period, called stage I sleep, eventually gives way to light or stage II sleep, which is characterized by a further decrease in the frequency of the EEG waves and an increase in their amplitude, together with intermittent high-frequency spike clusters called sleep spindles. Sleep spindles are periodic bursts of activity at about 10-12 Hz that generally last 1 or 2 seconds and arise as a result of interactions between thalamic and cortical neurons. In stage Ill sleep, which represents moderate to deep sleep, the number of spindles decreases, whereas the amplitude of low-frequency waves increases still more. In the deepest level of sleep, stage IV sleep, the predominant EEG activity consists of low-frequency (1-4 Hz), high-amplitude fluctuations called delta waves, the characteristic slow waves for which this phase of sleep is named. The entire sequence from drowsiness to deep stage IV sleep usually takes about an hour.
These four sleep stages are called non-rapid eye movement (non-REM or NREM) sleep, and its most prominent feature is the slow-wave (stage IV) sleep. Sometimes, stages Ill and IV are combined and referred to jointly as the stage Ill sleep. It is most difficult to awaken people from slow-wave sleep; hence, it is considered to be the deepest stage of sleep. Following a period of slow-wave sleep, however, EEG recordings show that the stages of sleep reverse to reach a quite different state called rapid eye movement, or REM, sleep. In REM sleep, the EEG recordings are remarkably similar to that of the awake state. This mode is bizarre: a dreamer's brain becomes highly active while the body's muscles are paralyzed, and breathing and heart rate become erratic. After about 10 minutes in REM sleep, the brain typically cycles back through the non-REM sleep stages. Slow-wave sleep usually occurs again in the second period of this continual cycling, but not during the rest of the night. On average, four additional periods of REM sleep occur, each having longer than the preceding cycle durations.
The sleep cycle is an oscillation between the non-REM (including slow-waves) and REM phases of sleep. It is sometimes called the ultradian sleep cycle, sleep-dream cycle, or REM-NREM cycle, to distinguish it from the circadian alternation between sleep and wakefulness. In humans, this cycle takes on average between 1 and 2 hours (approximately 90 min).
The timing of sleep cycles can be observed on EEG by marked distinction in brainwaves manifested during REM and non-REM sleep. Delta wave activity, correlating with slow-wave (deep) sleep, in particular, shows regular oscillations throughout a night's sleep. Secretions of various hormones, including renin, growth hormone, and prolactin, correlate positively with delta-wave activity, whereas secretion of thyroid stimulating hormone correlates inversely. Heart rate variability, well-known to increase during REM, also correlates inversely with delta-wave oscillations over the ˜90-minute cycle.
Homeostatic functions, especially thermoregulation, normally occur during non-REM sleep, but not during REM sleep. During REM sleep, body temperature tends to drift from its mean level, and during non-REM sleep, to return to normal. The alternation between the stages, therefore, maintains body temperature within an acceptable range.
In humans, the transition between non-REM and REM is abrupt; in other animals, less so.
Different models have been proposed to elucidate the complex rhythm of electrochemical processes that result in the regular alternation of REM and non-REM sleep. Monoamines are active during non-REM stages but not during REM stages, whereas acetylcholine is more active during REM sleep. The reciprocal interaction model proposed in the 1970s suggested a cyclic give and take between these two systems. More recent theories such as the “flip-flop” model proposed in the 2000s include the regulatory role of in inhibitory neurotransmitter gamma-aminobutyric acid (GABA).
The average length of the sleep cycle in an adult man is 90 minutes. N1 (NREM stage 1) is when the person is drowsy or awake to falling asleep. Brain waves and muscle activity start to decrease at this stage. N2 is when the person experiences a light sleep. Eye movement has stopped by this time. Brain wave frequency and muscle tonus is decreased. The heart rate and body temperature go down. N3 or even N4 is the most difficult stages to be awakened. Every part of the body is now relaxed, breathing is slowed, blood pressure and body temperature are reduced. REM sleep is a unique state, in which dreams usually occur. The brain is awake, and body paralyzed. This unique stage is usually when the person is in the deepest stage of sleep and dreams. The average length of a sleep cycle usually thought of as 90 min. Some sources give it 90-110 minutes or an even wider range of 80-120 minutes. A seven-eight-hour sleep usually includes five cycles, the middle two of which tend to be longer. REM takes up more of the cycle as the night goes on.
When falling asleep, a series of highly orchestrated events puts the brain to sleep in the above-mentioned stages. Technically, sleep starts in the brain areas that produce slow-wave sleep (SWS). It has been shown that two groups of cells—the ventrolateral preoptic nucleus in the hypothalamus and the parafacial zone in the brain stem—are involved in prompting SWS. When these cells are activated, it triggers a loss of consciousness. After SWS, REM sleep begins. The purpose of REM sleep remains a biological mystery, despite our growing understanding of its biochemistry and neurobiology. It has been shown that a small group of cells in the brain stem, called the subcoeruleus nucleus, control REM sleep. When these cells become injured or diseased, people do not experience the muscle paralysis associated with REM sleep, which can lead to REM sleep behavior disorder—a serious condition in which the afflicted violently act out their dreams. For reasons that are not clear, the amount of REM sleep each day decreases from about 8 hours at birth to 2 hours at 20 years, to only about 45 minutes at 70 years of age.
Mental State: A mental state is a state of mind that a subject is in. Some mental states are pure and unambiguous, while humans are capable of complex states that are a combination of mental representations, which may have in their pure state contradictory characteristics. There are several paradigmatic states of mind that a subject has: love, hate, pleasure, fear, and pain. Mental states can also include a waking state, a sleeping state, a flow (or being in the “zone”), and a mood (a mental state). A mental state is a hypothetical state that corresponds to thinking and feeling and consists of a conglomeration of mental representations. A mental state is related to an emotion, though it can also relate to cognitive processes. Because the mental state itself is complex and potentially possess inconsistent attributes, clear interpretation of mental state through external analysis (other than self-reporting) is difficult or impossible. However, some studies report that certain attributes of mental state or thought processes may, in fact, be determined through passive monitoring, such as EEG, or fMRI with some degree of statistical reliability. In most studies, the characterization of mental state was an endpoint, and the raw signals, after statistical classification or semantic labeling, are superseded. The remaining signal energy treated as noise. Current technology does not permit a precise abstract encoding or characterization of the full range of mental states based on neural correlates of mental state.
Brain: The brain is a key part of the central nervous system, enclosed in the skull. In humans, and mammals more generally, the brain controls both autonomic processes, as well as cognitive processes. The brain (and to a lesser extent, the spinal cord) controls all volitional functions of the body and interprets information from the outside world. Intelligence, memory, emotions, speech, thoughts, movements, and creativity are controlled by the brain. The central nervous system also controls autonomic functions and many homeostatic and reflex actions, such as breathing, heart rate, etc. The human brain consists of the cerebrum, cerebellum, and brainstem. The brainstem includes the midbrain, the pons, and the medulla oblongata. Sometimes the diencephalon, the caudal part of the forebrain, is included.
The brainstem has many basic functions, including heart rate, breathing, sleeping, and eating. The skull imposes a barrier to electrical access to the brain functions, and in a healthy human, breaching the dura to access the brain is highly disfavored. The result is that electrical readings of brain activity are filtered by the dura, the cerebrospinal fluid, the skull, the scalp, skin appendages (e.g., hair), resulting in a loss of potential spatial resolution and amplitude of signals emanating from the brain. While magnetic fields resulting from brain electrical activity are accessible, the spatial resolution using feasible sensors is also limited.
The brain is composed of neurons, neuroglia (a.k.a., glia), and other cell types in connected networks that integrate sensory inputs, control movements, facilitate learning and memory, activate and express emotions, and control all other behavioral and cognitive functions. A neuron is a fundamental unit of the nervous system, which comprises the autonomic nervous system and the central nervous system. Neurons communicate primarily through electrochemical pulses that transmit signals between connected cells within and between brain areas. Thus, the desire to noninvasively capture and replicate neural activity associated with cognitive states has been a subject of interest to behavioral and cognitive neuroscientists. Nerve electrical activity may be detected through the skull.
Technological advances now allow for the non-invasive recording of large quantities of information from the brain at multiple spatial and temporal scales. Examples include electroencephalogram (“EEG”) data using multi-channel electrode arrays placed on the scalp or inside the brain, magnetoencephalography (“MEG”), magnetic resonance imaging (“MRI”), functional data using functional magnetic resonance imaging (“fMRI”), positron emission tomography (“PET”), near-infrared spectroscopy (“NIRS”), single-photon emission computed tomography (“SPECT”), and others.
Noninvasive neuromodulation technologies have also been developed that can modulate the pattern of neural activity, and thereby cause altered behavior, cognitive states, perception, and motor output. Integration of noninvasive measurement and neuromodulation techniques for identifying and transplanting brain states from neural activity would be very valuable for clinical therapies, such as brain stimulation and related technologies often attempting to treat disorders of cognition.
Mental State: A number of studies report that certain attributes of mental state or thought processes may, in fact, be determined through passive monitoring, such as EEG, with some degree of statistical reliability. In most studies, the characterization of mental state was an endpoint, and the raw signals, after statistical classification or semantic labeling, are superseded and the remaining signal energy treated as noise.
Neural Correlates: A neural correlate of a sleep state is an electro-neuro-biological state or the state assumed by some biophysical subsystem of the brain, whose presence necessarily and regularly correlates with such specific sleep states. All properties credited to the mind, including consciousness, emotion, and desires are thought to have direct neural correlates. Neural correlates of a sleep state can be defined as the minimal set of neuronal oscillations that correspond to the given sleep stage.
Brainwaves: At the root of all our thoughts, emotions, and behaviors is the communication between neurons within our brains, a rhythmic or repetitive neural activity in the central nervous system. The oscillation can be produced by a single neuron or by synchronized electrical pulses from ensembles of neurons communicating with each other. The interaction between neurons can give rise to oscillations at a different frequency than the firing frequency of individual neurons. The synchronized activity of large numbers of neurons produces macroscopic oscillations, which can be observed in an electroencephalogram. They are divided into bandwidths to describe their purported functions or functional relationships. Oscillatory activity in the brain is widely observed at different levels of organization and is thought to play a key role in processing neural information. Numerous experimental studies support a functional role of neural oscillations. A unified interpretation, however, is still not determined. Neural oscillations and synchronization have been linked to many cognitive functions such as information transfer, perception, motor control, and memory. Electroencephalographic (EEG) signals are relatively easy and safe to acquire, have a long history of analysis, and can have high dimensionality, e.g., up to 128 or 256 separate recording electrodes. While the information represented in each electrode is not independent of the others, and the noise in the signals high, there is much information available through such signals that has not been fully characterized to date.
Brainwaves have been widely studied in neural activity generated by large groups of neurons, mostly by EEG. In general, EEG signals reveal oscillatory activity (groups of neurons periodically firing in synchrony), in specific frequency bands: alpha (7.5-12.5 Hz) that can be detected from the occipital lobe during relaxed wakefulness and which increases when the eyes are closed; delta (1-4 Hz), theta (4-8 Hz), beta (13-30 Hz), low gamma (30-70 Hz), and high gamma (70-150 Hz) frequency bands, where faster rhythms such as gamma activity have been linked to cognitive processing. Higher frequencies imply multiple groups of neurons firing in coordination, either in parallel or in series, or both, since individual neurons do not fire at rates of 100 Hz. Neural oscillations of specific characteristics have been linked to cognitive states, such as awareness and consciousness and different sleep stages. See, Chang-Hwan Im, Computational EEG Analysis: Methods and Applications (Biological and Medical Physics, Biomedical Engineering), Sep. 11, 2019.
Nyquist Theorem states that the highest frequency that can be accurately represented is one-half of the sampling rate. Practically, the sampling rate should be ten times higher than the highest frequency of the signal. (See, www.slideshare.net/ertvk/eeg-examples). While EEG signals are largely band limited, the superimposed noise may not be. Further, the EEG signals themselves represent components from a large number of neurons, which fire independently. Therefore, large bandwidth signal acquisition may have utility.
It is a useful analogy to think of brainwaves as musical notes. Like in a symphony, the higher and lower frequencies link and cohere with each other through harmonics, especially when one considers that neurons may be coordinated not only based on transitions, but also on phase delay. Oscillatory activity is observed throughout the central nervous system at all levels of organization. The dominant neuro oscillation frequency is associated with a respective mental state.
The functions of brainwaves are wide-ranging and vary for different types of oscillatory activity. Neural oscillations also play an important role in many neurological disorders.
In standard EEG recording practice, 19 recording electrodes are placed uniformly on the scalp (the International 10-20 System). In addition, one or two reference electrodes (often placed on earlobes) and a ground electrode (often placed on the nose to provide amplifiers with reference voltages) are required.
However, additional electrodes may add minimal useful information unless supplemented by computer algorithms to reduce raw EEG data to a manageable form. When large numbers of electrodes are employed, the potential at each location may be measured with respect to the average of all potentials (the common average reference), which often provides a good estimate of potential at infinity. The common average reference is not appropriate when electrode coverage is sparse (perhaps less than 64 electrodes). See, Paul L. Nunez and Ramesh Srinivasan (2007) Electroencephalogram. Scholarpedia, 2(2):1348, scholarpedia.org/article/Electroencephalogram. Dipole localization algorithms may be useful to determine spatial emission patterns in EEG.
Scalp potential may be expressed as a volume integral of dipole moment per unit volume over the entire brain provided P(r,t) is defined generally rather than in columnar terms. For the important case of dominant cortical sources, scalp potential may be approximated by the following integral over the cortical volume Θ, VS(r,t)=∫∫∫ΘG(r,r′)·P(r′,t)dΘ(r′). If the volume element dΘ(r′) is defined in terms of cortical columns, the volume integral may be reduced to an integral over the folded cortical surface. The time-dependence of scalp potential is the weighted sum of all dipole time variations in the brain, although deep dipole volumes typically make negligible contributions. The vector Green's function G(r,r′) contains all geometric and conductive information about the head volume conductor and weights the integral accordingly. Thus, each scalar component of the Green's function is essentially an inverse electrical distance between each source component and scalp location. For the idealized case of sources in an infinite medium of constant conductivity, the electrical distance equals the geometric distance. The Green's function accounts for the tissue's finite spatial extent and its inhomogeneity and anisotropy. The forward problem in EEG consists of choosing a head model to provide G(r,r′) and carrying out the integral for some assumed source distribution. The inverse problem consists of using the recorded scalp potential distribution VS(r,t) plus some constraints (usual assumptions) on P(r,t) to find the best fit source distribution P(r,t). Since the inverse problem has no unique solution, any inverse solution depends critically on the chosen constraints, for example, only one or two isolated sources, distributed sources confined to the cortex, or spatial and temporal smoothness criteria. High-resolution EEG uses the experimental scalp potential VS(r,t) to predict the potential on the dura surface (the unfolded membrane surrounding the cerebral cortex) VD(r,t). This may be accomplished using a head model Green's function G(r,r′) or by estimating the surface Laplacian with either spherical or 3D splines. These two approaches typically provide very similar dura potentials VD(r,t); the estimates of dura potential distribution are unique subject to head model, electrode density, and noise issues.
In an EEG recording system, each electrode is connected to one input of a differential amplifier (one amplifier per pair of electrodes); a common system reference electrode (or synthesized reference) is connected to the other input of each differential amplifier. These amplifiers amplify the voltage between the active electrode and the reference (typically 1,000-100,000 times, or 60-100 dB of voltage gain). The amplified signal is digitized via an analog-to-digital converter, after being passed through an anti-aliasing filter. Analog-to-digital sampling typically occurs at 256-512 Hz in clinical scalp EEG; sampling rates of up to 20 kHz are used in some research applications. The EEG signals can be captured with open source hardware such as OpenBCI, and the signal can be processed by freely available EEG software such as EEGLAB or the Neurophysiological Biomarker Toolbox. A typical adult human EEG signal is about 10 μV to 100 μV in amplitude when measured from the scalp and is about 10-20 mV when measured from subdural electrodes.
Delta wave (en.wikipedia.org/wiki/Delta_wave) is the frequency range up to 4 Hz. It tends to be the highest in amplitude and the slowest waves. It is normally seen in adults in NREM (en.wikipedia.org/wiki/NREM). It is also seen normally in babies. It may occur focally with subcortical lesions and in general distribution with diffuse lesions, metabolic encephalopathy hydrocephalus or deep midline lesions. It is, usually, most prominent frontally in adults (e.g., FIRDA-frontal intermittent rhythmic delta) and posteriorly in children (e.g., OIRDA-occipital intermittent rhythmic delta).
Theta is the frequency range from 4 Hz to 7 Hz. Theta is normally seen in young children. It may be seen in drowsiness or arousal in older children and adults; it can also be seen in meditation. Excess theta for age represents abnormal activity. It can be seen as a focal disturbance in focal subcortical lesions; it can be seen in the generalized distribution in diffuse disorder or metabolic encephalopathy or deep midline disorders or some instances of hydrocephalus. On the contrary, this range has been associated with reports of relaxed, meditative, and creative states.
Alpha is the frequency range from 7 Hz to 14 Hz. This was the “posterior basic rhythm” (also called the “posterior dominant rhythm” or the “posterior alpha rhythm”), seen in the posterior regions of the head on both sides, higher in amplitude on the dominant side. It emerges with the closing of the eyes and with relaxation and attenuates with eye opening or mental exertion. The posterior basic rhythm is slower than 8 Hz in young children (therefore technically in the theta range). In addition to the posterior basic rhythm, there are other normal alpha rhythms such as the sensorimotor, or mu rhythm (alpha activity in the contralateral sensory and motor cortical areas) that emerges when the hands and arms are idle; and the “third rhythm” (alpha activity in the temporal or frontal lobes). Alpha can be abnormal; for example, an EEG that has diffuse alpha occurring in a coma and is not responsive to external stimuli is referred to as “alpha coma.”
Beta is the frequency range from 15 Hz to about 30 Hz. It is usually seen on both sides in symmetrical distribution and is most evident frontally. Beta activity is closely linked to motor behavior and is generally attenuated during active movements. Low-amplitude beta with multiple and varying frequencies is often associated with active, busy, or anxious thinking and active concentration. Rhythmic beta with a dominant set of frequencies is associated with various pathologies, such as Dup15q syndrome, and drug effects, especially benzodiazepines. It may be absent or reduced in areas of cortical damage. It is the dominant rhythm in patients who are alert or anxious or who have their eyes open.
Gamma is the frequency range of approximately 30-100 Hz. Gamma rhythms are thought to represent binding of different populations of neurons together into a network to carry out a certain cognitive or motor function.
Mu range is 8-13 Hz and partly overlaps with other frequencies. It reflects the synchronous firing of motor neurons in a rest state. Mu suppression is thought to reflect motor mirror neuron systems because when an action is observed, the pattern extinguishes, possibly because of the normal neuronal system and the mirror neuron system “go out of sync” and interfere with each other. (en.wikipedia.org/wiki/Electroencephalography). See Reference List Table 2.
All sleep stages are associated with frequencies below 13 Hz—delta (1-4 Hz), theta (4-8 Hz), and alpha (8-12 Hz). While these frequencies may be reproduced in transcranial electric (or magnetic) stimulation, or via sensory stimulation with light, any attempts to reproduce these frequencies for stimulation via sound ran into problems associated with infrasound, defined as any sound below 20 Hz frequency. Firstly, it is difficult to generate infrasound through acoustic speakers. Earbuds are too small for that and so are most regular speakers. Specialized large subwoofers with circular design or sound guides may be used, but tend to be impractical.
A more serious problem is the effect of the infrasound on human health. While many animals (e.g., elephants and wales) communicate via infrasound, in humans, infrasound causes undesirable effects including send of panic, fear, and anxiety. Prolonged exposure to infrasound could be dangerous to human health. See, for example, Persinger, M. A. Nat Hazards (2014) 70: 501. doi.org/10.1007/s11069-013-0827-3. These problems are addressed using binaural beats.
Binaural beats: (See en.wikipedia.org/wiki/Beat_(acoustics) #Binaural_beats) A binaural beat is an auditory illusion perceived when two different pure-tone sine waves, both with frequencies lower than 1500 Hz, with less than a 40 Hz difference between them, are presented to a listener dichotically (one through each ear).
For example, if a 530 Hz pure tone is presented to a subject's right ear, while a 520 Hz pure tone is presented to the subject's left ear, the listener will perceive the auditory illusion of a third tone, in addition to the two pure-tones presented to each ear. The third sound is called a binaural beat, and in this example would have a perceived pitch correlating to a frequency of 10 Hz, that being the difference between the 530 Hz and 520 Hz pure tones presented to each ear.
Binaural-beat perception originates in the inferior colliculus of the midbrain and the superior olivary complex of the brainstem, where auditory signals from each ear are integrated and precipitate electrical impulses along neural pathways through the reticular formation up the midbrain to the thalamus, auditory cortex, and other cortical regions. Binaural beats are widely used in brain stimulation.
EEG AND qEEG: An EEG electrode will mainly detect the neuronal activity in the brain region just beneath it. However, the electrodes receive the activity from thousands of neurons. One square millimeter of cortex surface, for example, has more than 100,000 neurons. It is only when the input to a region is synchronized with electrical activity occurring at the same time that simple periodic waveforms in the EEG become distinguishable. The temporal pattern associated with specific brainwaves can be digitized and encoded a non-transient memory, and embodied in or referenced by, computer software.
EEG (electroencephalography) and MEG (magnetoencephalography) are available technologies to monitor brain electrical activity. Each generally has sufficient temporal resolution to follow dynamic changes in brain electrical activity. Electroencephalography (EEG) and quantitative electroencephalography (qEEG) are electrophysiological monitoring methods that analyze the electrical activity of the brain to measure and display patterns that correspond to cognitive states and/or diagnostic information. It is typically noninvasive, with the electrodes placed on the scalp, although invasive electrodes are also used in some cases. EEG signals may be captured and analyzed by a mobile device, often referred to as “brain wearables.” There are a variety of “brain wearables” readily available on the market today. EEGs can be obtained with a non-invasive method where the aggregate oscillations of brain electric potentials are recorded with numerous electrodes attached to the scalp of a person. Most EEG signals originate in the brain's outer layer (the cerebral cortex), believed largely responsible for our thoughts, emotions, and behavior. Cortical synaptic action generates electrical signals that change in the 10 to 100-millisecond range. Transcutaneous EEG signals are limited by the relatively insulating nature of the skull surrounding the brain, the conductivity of the cerebrospinal fluid and brain tissue, relatively low amplitude of individual cellular electrical activity, and distances between the cellular current flows and the electrodes. EEG is characterized by: (1) Voltage; (2) Frequency; (3) Spatial location; (4) Inter-hemispheric symmetries; (5) Reactivity (reaction to state change); (6) Character of waveform occurrence (random, serial, continuous); and (7) Morphology of transient events. EEGs can be separated into two main categories. Spontaneous EEG which occur in the absence of specific sensory stimuli and evoked potentials (EPs) which are associated with sensory stimuli like repeated light flashes, auditory tones, finger pressure, or mild electric shocks. The latter is recorded, for example, by time averaging to remove effects of spontaneous EEG. Non-sensory triggered potentials are also known. EP's typically are time synchronized with the trigger, and thus have an organization principle. Event-related potentials (ERPs) provide evidence of a direct link between cognitive events and brain electrical activity in a wide range of cognitive paradigms. It has generally been held that an ERP is the result of a set of discrete stimulus-evoked brain events. Event-related potentials (ERPs) are recorded in the same way as EPs, but occur at longer latencies from the stimuli and are more associated with an endogenous brain state.
Typically, a magnetic sensor with sufficient sensitivity to individual cell depolarization or small groups is a superconducting quantum interference device (SQUID), which requires cryogenic temperature operation, either at liquid nitrogen temperatures (high-temperature superconductors, HTS) or liquid helium temperatures (low-temperature superconductors, LTS). However, current research shows the possible feasibility of room temperature superconductors (20C). Magnetic sensing has an advantage, due to the dipole nature of sources, of having better potential volumetric localization; however, due to this added information, the complexity of signal analysis is increased.
In general, the electromagnetic signals detected represent action potentials, an automatic response of a nerve cell to depolarization beyond a threshold, which briefly opens conduction channels. The cells have ion pumps which seek to maintain a depolarized state. Once triggered, the action potential propagates along the membrane in two-dimensions, causing a brief high level of depolarizing ion flow. There is a quiescent period after depolarization that generally prevents oscillation within a single cell. Since the exon extends from the body of the neuron, the action potential will typically proceed along the length of the axon, which terminates in a synapse with another cell. While direct electrical connections between cells occur, often the axon releases a neurotransmitter compound into the synapse, which causes depolarization or hyperpolarization of the target cell. Indeed, the result may also be the release of a hormone or peptide, which may have a local or more distant effect.
The electrical fields detectable externally tend to not include signals which low-frequency signals, such as static levels of polarization, or cumulative depolarizing or hyperpolarizing effects between action potentials. In myelinated tracts, the current flows at the segments tend to be small, and therefore, the signals from individual cells are small. Therefore, the largest signal components are from the synapses and cell bodies. In the cerebrum and cerebellum, these structures are mainly in the cortex, which is largely near the skull, making electroencephalography useful, since it provides spatial discrimination based on electrode location. However, deep signals are attenuated and poorly localized. Magnetoencephalography detects dipoles, which derive from current flow, rather than voltage changes. In the case of a radially or spherically symmetric current flow within a short distance, the dipoles will tend to cancel, while net current flows long axons will reinforce. Therefore, an electroencephalogram reads a different signal than a magnetoencephalogram.
EEG-based studies of emotional specificity at the single-electrode level demonstrated that asymmetric activity at the frontal site, especially in the alpha (8-12 Hz) band, is associated with emotion. Voluntary facial expressions of smiles of enjoyment produce higher left frontal activation. Decreased left frontal activity is observed during the voluntary facial expressions of fear. In addition to alpha-band activity, theta band power at the frontal midline (Fm) has also been found to relate to emotional states. Pleasant (as opposed to unpleasant) emotions are associated with an increase in frontal midline theta power. Many studies have sought to utilize pattern classification, such as neural networks, statistical classifiers, clustering algorithms, etc., to differentiate between various emotional states reflected in EEG. Ekman and Davidson found that voluntary facial expressions of smiles of enjoyment produced higher left frontal activation (Ekman P, Davidson R J (1993) Voluntary Smiling Changes Regional Brain Activity. Psychol Sci 4: 342-345). Another study by Coan et al. found decreased left frontal activity during the voluntary facial expressions of fear (Coan J A, Allen J J, Harmon-Jones E (2001) Voluntary facial expression and hemispheric asymmetry over the frontal cortex. Psychophysiology 38: 912-925). Sammler and colleagues, for example, showed that pleasant (as opposed to unpleasant) emotion is associated with an increase in frontal midline theta power (Sammler D, Grigutsch M, Fritz T, Koelsch S (2007) Music and emotion: Electrophysiological correlates of the processing of pleasant and unpleasant music. Psychophysiology 44: 293-304). To further demonstrate whether these emotion-specific EEG characteristics are strong enough to differentiate between various emotional states, some studies have utilized a pattern classification analysis approach.
Detecting different emotional states by EEG may be more appropriate using EEG-based functional connectivity. There are various ways to estimate EEG-based functional brain connectivity: correlation, coherence, and phase synchronization indices between each pair of EEG electrodes had been used. The assumption is that a higher correlation map indicates a stronger relationship between two signals. (Brazier M A, Casby J U (1952) Cross-correlation and autocorrelation studies of electroencephalographic potentials. Electroen clin neuro 4: 201-211). Coherence gives information similar to correlation but also includes the covariation between two signals as a function of frequency. (Cantero J L, Atienza M, Salas R M, Gomez C M (1999) Alpha EEG coherence in different brain states: an electrophysiological index of the arousal level in human subjects. Neurosci lett 271: 167-70.) The assumption is that higher correlation indicates a stronger relationship between two signals. (Guevara M A, Corsi-Cabrera M (1996) EEG coherence or EEG correlation? Int J Psychophysiology 23: 145-153; Cantero J L, Atienza M, Salas R M, Gomez C M (1999) Alpha EEG coherence in different brain states: an electrophysiological index of the arousal level in human subjects. Neurosci lett 271: 167-70; Adler G, Brassen S, Jajcevic A (2003) EEG coherence in Alzheimer's dementia. J Neural Transm 110: 1051-1058; Deeny S P, Hillman C H, Janelle C M, Hatfield B D (2003) Cortico-cortical communication and superior performance in skilled marksmen: An EEG coherence analysis. J Sport Exercise Psy 25: 188-204.) Phase synchronization among the neuronal groups estimated based on the phase difference between two signals is another way to estimate the EEG-based functional connectivity among brain areas. It is. (Franaszczuk P J, Bergey G K (1999) An autoregressive method for the measurement of synchronization of interictal and ictal EEG signals. Biol Cybern 81: 3-9.) A number of groups have examined emotional specificity using EEG-based functional brain connectivity. For example, Shin and Park showed that when emotional states become more negative at high room temperatures, correlation coefficients between the channels in temporal and occipital sites increase (Shin J-H, Park D-H. (2011) Analysis for Characteristics of Electroencephalogram (EEG) and Influence of Environmental Factors According to Emotional Changes. In Lee G, Howard D, Slezak D, editors. Convergence and Hybrid Information Technology. Springer Berlin Heidelberg, 488-500.) Hinrichs and Machleidt demonstrated that coherence decreases in the alpha band during sadness, compared to happiness (Hinrichs H, Machleidt W (1992) Basic emotions reflected in EEG-coherences. Int J Psychophysiol 13: 225-232). Miskovic and Schmidt found that EEG coherence between the prefrontal cortex and the posterior cortex increased while viewing highly emotionally arousing (i.e., threatening) images, compared to viewing neutral images (Miskovic V, Schmidt L A (2010) Cross-regional cortical synchronization during affective image viewing. Brain Res 1362: 102-111). Costa and colleagues applied the synchronization index to detect interaction in different brain sites under different emotional states (Costa T, Rognoni E, Galati D (2006) EEG phase synchronization during emotional response to positive and negative film stimuli. Neurosci Lett 406: 159-164). Costa's results showed an overall increase in the synchronization index among frontal channels during emotional stimulation, particularly during negative emotion (i.e., sadness). Furthermore, phase synchronization patterns were found to differ between positive and negative emotions. Costa also found that sadness was more synchronized than happiness at each frequency band and was associated with a wider synchronization both between the right and left frontal sites and within the left hemisphere. In contrast, happiness was associated with a wider synchronization between the frontal and occipital sites.
Different connectivity indices are sensitive to different characteristics of EEG signals. Correlation is sensitive to phase and polarity but is independent of amplitudes. Changes in both amplitude and phase lead to a change in coherence (Guevara M A, Corsi-Cabrera M (1996) EEG coherence or EEG correlation?Int J Psychophysiol 23: 145-153). The phase synchronization index is only sensitive to a change in phase (Lachaux J P, Rodriguez E, Martinerie J, Varela F J (1999) Measuring phase synchrony in brain signals. Hum Brain Mapp 8: 194-208).
A number of studies have tried to classify emotional states by means of recording and statistically analyzing EEG signals from the central nervous systems. See, for example:
You-Yun Lee and Shulan Hsieh studied different emotional states by means of EEG-based functional connectivity patterns. They used emotional film clips to elicit three different emotional states.
The dimensional theory of emotion, which asserts that there are neutral, positive, and negative emotional states, may be used to classify emotional states because numerous studies have suggested that the responses of the central nervous system correlate with emotional valence and arousal. (See, for example, Davidson R J (1993) Cerebral Asymmetry and Emotion—Conceptual and Methodological Conundrums. Cognition Emotion 7: 115-138; Jones N A, Fox N A (1992) Electroencephalogram asymmetry during emotionally evocative films and its relation to positive and negative affectivity. Brain Cogn 20: 280-299; Schmidt L A, Trainor L J (2001) Frontal brain electrical activity (EEG) distinguishes valence and intensity of musical emotions. Cognition Emotion 15: 487-500; Tomarken A J, Davidson R J, Henriques J B (1990) Resting frontal brain asymmetry predicts affective responses to films. J Pers Soc Psychol 59: 791-801.) As suggested by Mauss and Robins (2009), “measures of emotional responding appear to be structured along dimensions (e.g., valence, arousal) rather than discrete emotional states (e.g., sadness, fear, anger)”.
EEG-based functional connectivity change was found to be significantly different among emotional states of neutral, positive, or negative. Lee Y-Y, Hsieh S (2014) Classifying Different Emotional States by Means of EEG-Based Functional Connectivity Patterns. PLoS ONE 9(4): e95415. doi.org/10.1371/journal.pone.0095415. A connectivity pattern may be detected by pattern classification analysis using Quadratic Discriminant Analysis. The results indicated that the classification rate was better than chance. They concluded that estimating EEG-based functional connectivity provides a useful tool for studying the relationship between brain activity and emotional states.
Emotions affects learning. Intelligent Tutoring Systems (ITS) learner model initially composed of a cognitive module was extended to include a psychological module and an emotional module. Alicia Heraz et al. introduced an emomental agent. It interacts with an ITS to communicate the emotional state of the learner based upon his mental state. The mental state was obtained from the learner's brainwaves. The agent learns to predict the learner's emotions by using machine learning techniques. (Alicia Heraz, Ryad Razaki; Claude Frasson, “Using machine learning to predict learner emotional state from brainwaves” Advanced Learning Technologies, 2007. ICALT 2007. Seventh IEEE International Conference on Advanced Learning Technologies (ICALT 2007)) See also:
Using EEG to assess the emotional state has numerous practical applications. One of the first such applications was the development of a travel guide based on emotions by measuring brainwaves by the Singapore tourism group. “By studying the brainwaves of a family on vacation, the researchers drew up the Singapore Emotion Travel Guide, which advises future visitors of the emotions they can expect to experience at different attractions.” (www.lonelyplanet.com/news/2017/04/12/singapore-emotion-travel-guide) Joel Pearson at University of New South Wales and his group developed the protocol of measuring brainwaves of travelers using EEG and decoding specific emotional states.
Another recently released application pertains to virtual reality (VR) technology. On Sep. 18, 2017 Looxid Labs launched a technology that harnesses EEG from a subject waring a VR headset. Looxid Labs intention is to factor in brainwaves into VR applications in order to accurately infer emotions. Other products such as MindMaze and even Samsung have tried creating similar applications through facial muscles recognition. (scottamyx.com/2017/10/13/looxid-labs-vr-brain-waves-human-emotions/). According to its website (looxidlabs.com/device-2/), the Looxid Labs Development Kit provides a VR headset embedded with miniaturized eye and brain sensors. It uses 6 EEG channels: Fp1, Fp2, AF7, AF8, AF3, AF4 in the international 10-20 system.
To assess a user's state of mind, a computer may be used to analyze the EEG signals produced by the brain of the user. However, the emotional states of a brain are complex, and the brainwaves associated with specific emotions seem to change over time. Wei-Long Zheng at Shanghai Jiao Tong University used machine learning to identify the emotional brain states and to repeat it reliably. The machine learning algorithm found a set of patterns that clearly distinguished positive, negative, and neutral emotions that worked for different subjects and for the same subjects over time with an accuracy of about 80 percent. (See Wei-Long Zheng, Jia-Yi Zhu, Bao-Liang Lu, Identifying Stable Patterns over Time for Emotion Recognition from EEG, arxiv.org/abs/1601.02197; see also How One Intelligent Machine Learned to Recognize Human Emotions, MIT Technology Review, Jan. 23, 2016.) MEG: Magnetoencephalography (MEG) is a functional neuroimaging technique for mapping brain activity by recording magnetic fields produced by electrical currents occurring naturally in the brain, using very sensitive magnetometers. Arrays of SQUIDs (superconducting quantum interference devices) are currently the most common magnetometer, while the SERF (spin exchange relaxation-free) magnetometer is being investigated (Hamalainen, Matti; Hari, Riitta; Ilmoniemi, Risto J.; Knuutila, Jukka; Lounasmaa, Olli V. (1993). “Magnetoencephalography-theory, instrumentation, and applications to noninvasive studies of the working human brain”. Reviews of Modern Physics. 65 (2): 413-497. ISSN 0034-6861. doi:10.1103/RevModPhys.65.413.) It is known that “neuronal activity causes local changes in cerebral blood flow, blood volume, and blood oxygenation” (Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. K. K. Kwong, J. W. Belliveau, D. A. Chesler, I. E. Goldberg, R. M. Weisskoff, B. P. Poncelet, D. N. Kennedy, B. E. Hoppel, M. S. Cohen, and R. Turner). Using “a 122-channel D.C. SQUID magnetometer with a helmet-shaped detector array covering the subject's head” it has been shown that the “system allows simultaneous recording of magnetic activity all over the head.” (122-channel squid instrument for investigating the magnetic signals from the human brain.) A. I. Ahonen, M. S. Hämäläinen, M. J. Kajola, J. E. T. Knuutila, P. P. Laine, O. V. Lounasmaa, L. T. Parkkonen, J. T. Simola, and C. D. Tesche Physica Scripta, Volume 1993, T49A).
In some cases, magnetic fields cancel, and thus the detectable electrical activity may fundamentally differ from the detectable electrical activity obtained via EEG. However, the main types of brain rhythms are detectable by both methods.
See: U.S. Pat. Nos. 5,059,814; 5,118,606; 5,136,687; 5,224,203; 5,303,705; 5,325,862; 5,461,699; 5,522,863; 5,640,493; 5,715,821; 5,719,561; 5,722,418; 5,730,146; 5,736,543; 5,737,485; 5,747,492; 5,791,342; 5,816,247; 6,497,658; 6,510,340; 6,654,729; 6,893,407; 6,950,697; 8,135,957; 8,620,206; 8,644,754; 9,118,775; 9,179,875; 9,642,552; 20030018278; 20030171689; 20060293578; 20070156457; 20070259323; 20080015458; 20080154148; 20080229408; 20100010365; 20100076334; 20100090835; 20120046531; 20120052905; 20130041281; 20150081299; 20150262016. See EP1304073A2; EP1304073A3; WO2000025668A1; and WO2001087153A1.
MEG seek to detect the magnetic dipole emission from an electrical discharge in cells, e.g., neural action potentials. Typical sensors for MEGs are superconducting quantum interference devices (SQUIDs). These currently require cooling to liquid nitrogen or liquid helium temperatures. However, the development of room temperature, or near room temperature superconductors, and miniature cryocoolers, may permit field deployments and portable or mobile detectors. Because MEGs are less influenced by medium conductivity and dielectric properties, and because they inherently detect the magnetic field vector, MEG technology permits volumetric mapping of brain activity and distinction of complementary activity that might suppress detectable EEG signals. MEG technology also supports vector mapping of fields, since magnetic emitters are inherently dipoles, and therefore a larger amount of information is inherently available. See, Reference List Table 3.
EEGs and MEGs can monitor the state of consciousness. For example, states of deep sleep are associated with slower EEG oscillations of larger amplitude. Various signal analysis methods allow for robust identifications of distinct sleep stages, depth of anesthesia, epileptic seizures, and connections to detailed cognitive events.
Neurofeedback: Neurofeedback (NFB), also called neurotherapy or neurobiofeedback, is a type of biofeedback that uses real-time displays of brain activity-most commonly electroencephalography (EEG), to teach self-regulation of brain function. Typically, sensors are placed on the scalp to measure activity, with measurements displayed using video displays or sound. The feedback may be in various other forms as well. Typically, the feedback is sought to be presented through primary sensory inputs, but this is not a limitation on the technique.
The applications of neurofeedback to enhance performance extend to the arts in fields such as music, dance, and acting. A study with conservatoire musicians found that alpha-theta training benefitted the three music domains of musicality, communication, and technique. Historically, alpha-theta training, a form of neurofeedback, was created to assist creativity by inducing hypnagogia, a “borderline waking state associated with creative insights”, through the facilitation of neural connectivity. Alpha-theta training has also been shown to improve novice singing in children. Alpha-theta neurofeedback, in conjunction with heart rate variability training, a form of biofeedback, has also produced benefits in dance by enhancing performance in competitive ballroom dancing and increasing cognitive creativity in contemporary dancers. Additionally, neurofeedback has also been shown to instill a superior flow state in actors, possibly due to greater immersion while performing.
Several studies of brain wave activity in experts while performing a task related to their respective area of expertise revealed certain characteristic telltale signs of so-called “flow” associated with top-flight performance. Mihaly Csikszentmihalyi (University of Chicago) found that the most skilled chess players showed less EEG activity in the prefrontal cortex, which is typically associated with higher cognitive processes such as working memory and verbalization, during a game.
Chris Berka et al., Advanced Brain Monitoring, Carlsbad, Calif., The International J. Sport and Society, vol 1, p 87, looked at the brainwaves of Olympic archers and professional golfers. A few seconds before the archers fired off an arrow or the golfers hit the ball, the team spotted a small increase in alpha band patterns. This may correspond to the contingent negative variation observed in evoked potential studies, and the Bereitschaftspotential or BP (from German, “readiness potential”), also called the pre-motor potential or readiness potential (RP), a measure of activity in the motor cortex and supplementary motor area of the brain leading up to voluntary muscle movement. Berka also trained novice marksmen using neurofeedback. Each person was hooked up to electrodes that tease out and display specific brainwaves, along with a monitor that measured their heartbeat. By controlling their breathing and learning to deliberately manipulate the waveforms on the screen in front of them, the novices managed to produce the alpha waves characteristic of the flow state. This, in turn, helped them improve their accuracy at hitting the targets.
Low Energy Neurofeedback System (LENS): The LENS, or Low Energy Neurofeedback System, uses a very low power electromagnetic field, to carry feedback to the person receiving it. The feedback travels down the same wires carrying the brainwaves to the amplifier and computer. Although the feedback signal is weak, it produces a measurable change in the brainwaves without conscious effort from the individual receiving the feedback. The system is software controlled, to receive input from EEG electrodes, to control the stimulation. Through the scalp. Neurofeedback uses a feedback frequency that is different from, but correlates with, the dominant brainwave frequency. When exposed to this feedback frequency, the EEG amplitude distribution changes in power. Most of the time, the brainwaves reduce in power, but at times they also increase in power. In either case, the result is a changed brainwave state and much greater ability for the brain to regulate itself.
Content-Based Brainwave Analysis: Memories are not unique. Janice Chen, Nature Neuroscience, DOI: 10.1038/nn.4450, showed that when people describe the episode from Sherlock Holmes drama, their brain activity patterns were almost exactly the same as each other's, for each scene. Moreover, there is also evidence that, when a person tells someone else about it, they implant that same activity into their brain as well. Moreover, research in which people who have not seen a movie listen to someone else's description of it, Chen et al. have found that the listener's brain activity looks much like that of the person who has seen it. See also “Our brains record and remember things in exactly the same way” by Andy Coghlan, New Scientist, Dec. 5, 2016 (www.newscientist.com/article/2115093-our-brains-record-and-remember-things-in-exactly-the-same-way!) Brian Pasley, Frontiers in Neuroengineering, doi.org/whb, developed a technique for reading thoughts.
The team hypothesized that hearing speech and thinking to oneself might spark some of the same neural signatures in the brain. They supposed that an algorithm trained to identify speech heard out loud might also be able to identify words that are thought. In the experiment, the decoder trained on speech was able to reconstruct which words several of the volunteers were thinking, using neural activity alone. See also “Hearing our inner voice” by Helen Thomson. New Scientist, Oct. 29, 2014 (www.newscientist.com/article/mg22429934-000-brain-decoder-can-eavesdrop-on-your-inner-voicel) Jack Gallant et al. were able to detect which of a set of images someone was looking at from a brain scan, using software that compared the subject's brain activity while looking at an image with that captured while they were looking at “training” photographs. The program then picked the most likely match from a set of previously unseen pictures.
Ann Graybiel and Mark Howe used electrodes to analyze brainwaves in the ventromedial striatum of rats while they were taught to navigate a maze. As rats were learning the task, their brain activity showed bursts of fast gamma waves. Once the rats mastered the task, their brainwaves slowed to almost a quarter of their initial frequency, becoming beta waves. Graybiel's team posited that this transition reflects when learning becomes a habit.
Bernard Balleine, Proceedings of the National Academy of Sciences, DOI: 10.1073/pnas.1113158108. See also “Habits form when brainwaves slow down” by Wendy Zukerman. New Scientist, Sep. 26, 2011 (www.newscientist.com/article/dn20964-habits-form-when-brainwaves-slow-down/) posits that the slower brainwaves may be the brain weeding out excess activity to refine behavior. He suggests it might be possible to boost the rate at which they learn a skill by enhancing such beta-wave activity.
U.S. Pat. No. 9,763,592 provides a system for instructing a user behavior change comprising: collecting and analyzing bioelectrical signal datasets; and providing a behavior change suggestion based upon the analysis. A stimulus may be provided to prompt an action by the user, which may be visual, auditory, or haptic. See also U.S. Pat. Nos. 9,622,660, 20170041699; 20130317384; 20130317382; 20130314243; 20070173733; and 20070066914.
The chess game is a good example of a cognitive task which needs a lot of training and experience. A number of EEG studies have been done on chess players. Pawel Stepien, Wlodzimierz Klonowski and Nikolay Suvorov, Nonlinear analysis of EEG in chess players, EPJ Nonlinear Biomedical Physics 20153:1, showed better applicability of Higuchi Fractal Dimension method for analysis of EEG signals related to chess tasks than that of Sliding Window Empirical Mode Decomposition. The paper shows that the EEG signal during the game is more complex, non-linear, and non-stationary even when there are no significant differences between the game and relaxed state in the contribution of different EEG bands to the total power of the signal. There is the need for gathering more data from more chess experts and of comparing them with data from novice chess players. See also Junior, L. R. S., Cesar, F. H. G., Rocha, F. T., and Thomaz, C. E. EEG and Eye Movement Maps of Chess Players. Proceedings of the Sixth International Conference on Pattern Recognition Applications and Methods. (ICPRAM 2017) pp. 343-441. (fei.edu.br/˜cet/icpram17_LaercioJunior.pdf).
Estimating EEG-based functional connectivity provides a useful tool for studying the relationship between brain activity and emotional states. See You-Yun Lee, Shulan Hsieh. Classifying Different Emotional States by Means of EEG-Based Functional Connectivity Patterns. Apr. 17, 2014, (doi.org/10.1371/journal.pone.0095415), which aimed to classify different emotional states by means of EEG-based functional connectivity patterns, and showed that the EEG-based functional connectivity change was significantly different among emotional states. Furthermore, the connectivity pattern was detected by pattern classification analysis using Quadratic Discriminant Analysis. The results indicated that the classification rate was better than chance. Estimating EEG-based functional connectivity provides a useful tool for studying the relationship between brain activity and emotional states.
Sensory Stimulation: Light, sound or electromagnetic fields may be used to remotely convey a temporal pattern of brainwaves. See Reference List Table 4.
Light Stimulation: The functional relevance of brain oscillations in the alpha frequency range (8-13 Hz) has been repeatedly investigated through the use of rhythmic visual stimulation. There are two hypotheses on the origin of steady-state visual evoked potential (SSVEP) measured in EEG during rhythmic stimulation: entrainment of brain oscillations and superposition of event-related responses (ERPs). The entrainment but not the superposition hypothesis justifies rhythmic visual stimulation as a means to manipulate brain oscillations because superposition assumes a linear summation of single responses, independent from ongoing brain oscillations. Participants stimulated with the rhythmic flickering light of different frequencies and intensities, and entrainment was measured by comparing the phase coupling of brain oscillations stimulated by rhythmic visual flicker with the oscillations induced by arrhythmic jittered stimulation, varying the time, stimulation frequency, and intensity conditions. Phase coupling was found to be more pronounced with increasing stimulation intensity as well as at stimulation frequencies closer to each participant's intrinsic frequency. Even in a single sequence of an SSVEP, non-linear features (intermittency of phase locking) was found that contradict the linear summation of single responses, as assumed by the superposition hypothesis. Thus, evidence suggests that visual rhythmic stimulation entrains brain oscillations, validating the approach of rhythmic stimulation as manipulation of brain oscillations. See, Notbohm A, Kurths J, Herrmann C S, Modification of Brain Oscillations via Rhythmic Light Stimulation Provides Evidence for Entrainment but Not for Superposition of Event-Related Responses, Front Hum Neurosci. 2016 Feb. 3; 10:10. doi: 10.3389/fnhum.2016.00010. eCollection 2016.
It is also known that periodic visual stimulation can trigger epileptic seizures.
It is known to analyze EEG patterns to extract an indication of certain volitional activity (U.S. Pat. No. 6,011,991). This technique describes that an EEG recording can be matched against a stored normalized signal using a computer. This matched signal is then translated into the corresponding reference. The patent application describes a method “a system capable of identifying particular nodes in an individual's brain, the firings of which affect characteristics such as appetite, hunger, thirst, communication skills” and “devices mounted to the person (e.g. underneath the scalp) may be energized in a predetermined manner or sequence to remotely cause particular identified brain node(s) to be fired in order to cause a predetermined feeling or reaction in the individual” without technical description of implementation. This patent also describes, that “brain activity [is monitored] by way of electroencephalograph (EEG) methods, magnetoencephalograph (MEG) methods, and the like.” For example, see U.S. Pat. Nos. 5,816,247 and 5,325,862. See also Reference List Table 5.
Brain Entrainment: Brain entrainment, also referred to as brainwave synchronization and neural entrainment, refers to the capacity of the brain to naturally synchronize its brainwave frequencies with the rhythm of periodic external stimuli, most commonly auditory, visual, or tactile. Brainwave entrainment technologies are used to induce various brain states, such as relaxation or sleep, by creating stimuli that occur at regular, periodic intervals to mimic electrical cycles of the brain during the desired states, thereby “training” the brain to consciously alter states. Recurrent acoustic frequencies, flickering lights, or tactile vibrations are the most common examples of stimuli applied to generate different sensory responses. It is hypothesized that listening to these beats of certain frequencies one can induce a desired state of consciousness that corresponds with specific neural activity. Patterns of neural firing, measured in Hz, correspond with alertness states such as focused attention, deep sleep, etc.
Neural oscillations are rhythmic or repetitive electrochemical activity in the brain and central nervous system. Such oscillations can be characterized by their frequency, amplitude, and phase. Neural tissue can generate oscillatory activity driven by mechanisms within individual neurons, as well as by interactions between them. They may also adjust frequency to synchronize with the periodic vibration of external acoustic or visual stimuli. The functional role of neural oscillations is still not fully understood; however, they have been shown to correlate with emotional responses, motor control, and a number of cognitive functions including information transfer, perception, and memory. Specifically, neural oscillations, in particular theta activity, are extensively linked to memory function, and coupling between theta and gamma activity is considered to be vital for memory functions, including episodic memory. Electroencephalography (EEG) has been most widely used in the study of neural activity generated by large groups of neurons, known as neural ensembles, including investigations of the changes that occur in electroencephalographic profiles during cycles of sleep and wakefulness. EEG signals change dramatically during sleep and show a transition from faster frequencies to increasingly slower frequencies, indicating a relationship between the frequency of neural oscillations and cognitive states, including awareness and consciousness.
The term “entrainment” has been used to describe a shared tendency of many physical and biological systems to synchronize their periodicity and rhythm through interaction. This tendency has been identified as specifically pertinent to the study of sound and music generally, and acoustic rhythms specifically. The most ubiquitous and familiar examples of neuromotor entrainment to acoustic stimuli are observable in spontaneous foot or finger tapping to the rhythmic beat of a song. Exogenous rhythmic entrainment, which occurs outside the body, has been identified and documented for a variety of human activities, which include the way people adjust the rhythm of their speech patterns to those of the subject with whom they communicate, and the rhythmic unison of an audience clapping. Even among groups of strangers, the rate of breathing, locomotive, and subtle expressive motor movements, and rhythmic speech patterns have been observed to synchronize and entrain, in response to an auditory stimulus, such as a piece of music with a consistent rhythm. Furthermore, motor synchronization to repetitive tactile stimuli occurs in animals, including cats and monkeys as well as humans, with accompanying shifts in electroencephalogram (EEG) readings. Examples of endogenous entrainment, which occurs within the body, include the synchronizing of human circadian sleep-wake cycles to the 24-hour cycle of light and dark, and the frequency following response of humans to sounds and music.
Brainwaves, or neural oscillations, share the fundamental constituents with acoustic and optical waves, including frequency, amplitude, and periodicity. The synchronous electrical activity of cortical neural ensembles can synchronize in response to external acoustic or optical stimuli and also entrain or synchronize their frequency and phase to that of a specific stimulus. Brainwave entrainment is a colloquialism for such ‘neural entrainment’, which is a term used to denote the way in which the aggregate frequency of oscillations produced by the synchronous electrical activity in ensembles of cortical neurons can adjust to synchronize with the periodic vibration of an external stimuli, such as a sustained acoustic frequency perceived as pitch, a regularly repeating pattern of intermittent sounds, perceived as rhythm, or of a regularly rhythmically intermittent flashing light.
Changes in neural oscillations, demonstrable through electroencephalogram (EEG) measurements, are precipitated by listening to music, which can modulate autonomic arousal ergotropically and trophotropically, increasing and decreasing arousal respectively. Musical auditory stimulation has also been demonstrated to improve immune function, facilitate relaxation, improve mood, and contribute to the alleviation of stress.
The Frequency following response (FFR), also referred to as Frequency Following Potential (FFP), is a specific response to hearing sound and music, by which neural oscillations adjust their frequency to match the rhythm of auditory stimuli. The use of sound with intent to influence cortical brainwave frequency is called auditory driving, by which frequency of neural oscillation is ‘driven’ to entrain with that of the rhythm of a sound source. See Reference List Table 6.
Baseline correction of event-related time-frequency measure may be made by taking pre-event baseline activity into consideration. In general, a baseline period is defined by the average of the values within a time window preceding the time-locking event. There are at least four common methods for baseline correction in time-frequency analysis. The methods include various baseline value normalizations. See, Reference List Table 7.
The question of whether different emotional states are associated with specific patterns of physiological response has long being a subject of neuroscience research See, for example:
Electroencephalograms (EEG) and functional Magnetic Resonance Imaging, fMRI have been used to study specific brain activity associated with different emotional states. Mauss and Robinson, in their review paper, have indicated that “emotional state is likely to involve circuits rather than any brain region considered in isolation” (Mauss I B, Robinson M D (2009) Measures of emotion: A review. Cogn Emot 23: 209-237.)
The amplitude, latency from the stimulus, and covariance (in the case of multiple electrode sites) of each component can be examined in connection with a cognitive task (ERP) or with no task (EP). Steady-state visually evoked potentials (SSVEPs) use a continuous sinusoidally-modulated flickering light, typically superimposed in front of a TV monitor displaying a cognitive task. The brain response in a narrow frequency band containing the stimulus frequency is measured. Magnitude, phase, and coherence (in the case of multiple electrode sites) may be related to different parts of the cognitive task. Brain entrainment may be detected through EEG or MEG activity.
Brain entrainment may be detected through EEG or MEG activity. See Reference List Table 8.
The entrainment hypothesis (Thut and Miniussi, 2009; Thut et al., 2011a, 2012), suggests the possibility of inducing a particular oscillation frequency in the brain using an external oscillatory force (e.g., rTMS, but also tACS). The physiological basis of oscillatory cortical activity lies in the timing of the interacting neurons; when groups of neurons synchronize their firing activities, brain rhythms emerge, network oscillations are generated, and the basis for interactions between brain areas may develop (Buzsàki, 2006). Because of the variety of experimental protocols for brain stimulation, limits on descriptions of the actual protocols employed, and limited controls, consistency of reported studies is lacking, and extrapolability is limited. Thus, while there is various consensus in various aspects of the effects of extracranial brain stimulation, the results achieved have a degree of uncertainty dependent on details of implementation. On the other hand, within a specific experimental protocol, it is possible to obtain statistically significant and repeatable results. This implies that feedback control might be effective to control implementation of the stimulation for a given purpose; however, studies that employ feedback control are lacking.
Different cognitive states are associated with different oscillatory patterns in the brain (Buzsàki, 2006; Canolty and Knight, 2010; Varela et al., 2001). Thut et al. (2011b) directly tested the entrainment hypothesis by means of a concurrent EEG-TMS experiment. They first determined the individual source of the parietal-occipital alpha modulation and the individual alpha frequency (magnetoencephalography study). They then applied rTMS at the individual alpha power while recording the EEG activity at rest. The results confirmed the three predictions of the entrainment hypothesis: the induction of a specific frequency after TMS, the enhancement of oscillation during TMS stimulation due to synchronization, and phase alignment of the induced frequency and the ongoing activity (Thut et al., 2011b).
If associative stimulation is a general principle for human neural plasticity in which the timing and strength of activation are critical factors, it is possible that synchronization within or between areas using an external force to phase/align oscillations can also favor efficient communication and associative plasticity (or alter communication). In this respect associative, cortico-cortical stimulation has been shown to enhance the coherence of oscillatory activity between the stimulated areas (Plewnia et al., 2008).
In a coherence resonance (Longtin, 1997), the addition of a certain amount of noise in an excitable system results in the most coherent and proficient oscillatory responses. The brain's response to external timing-embedded stimulation can result in a decrease in phase variance and an enhanced alignment (clustering) of the phase components of the ongoing EEG activity (entraining, phase resetting) that can change the signal-to-noise ratio and increase (or decrease) signal efficacy.
If one considers neuron activity within the brain as a set of loosely coupled oscillators, then the various parameters that might be controlled include the size of the region of neurons, frequency of oscillation, resonant frequency or time-constant, oscillator damping, noise, amplitude, coupling to other oscillators, and of course, external influences that may include stimulation and/or power loss. In a human brain, pharmacological intervention may be significant. For example, drugs that alter excitability, such as caffeine neurotransmitter release and reuptake, nerve conductance, etc. can all influence operation of the neural oscillators. Likewise, sub-threshold external stimulation effects, including DC, AC, and electromagnetic effects, can also influence the operation of the neural oscillators.
Phase resetting or shifting can synchronize inputs and favor communication and, eventually, Hebbian plasticity (Hebb, 1949). Thus, rhythmic stimulation may induce a statistically higher degree of coherence in spiking neurons, which facilitates the induction of a specific cognitive process (or hinders that process). Here, the perspective is slightly different (coherence resonance), but the underlining mechanisms are similar to the ones described so far (stochastic resonance), and the additional key factor is the repetition at a specific rhythm of the stimulation.
In the 1970s, the British biophysicist and psychobiologist, C. Maxwell Cade, monitored the brainwave patterns of advanced meditators and 300 of his students. Here he found that the most advanced meditators have a specific brainwave pattern that was different from the rest of his students. He noted that these meditators showed the high activity of alpha brainwaves accompanied by beta, theta, and even delta waves that were about half the amplitude of the alpha waves. See, Cade “The Awakened Mind: Biofeedback and the Development of Higher States of Awareness” (Dell, 1979). Anna Wise extended Cade's studies, and found that extraordinary achievers which included composers, inventors, artists, athletes, dancers, scientists, mathematicians, CEO's and presidents of large corporations have brainwave patterns differ from average performers, with a specific balance between Beta, Alpha, Theta and Delta brainwaves where Alpha had the strongest amplitude. See, Anna Wise, “The High-Performance Mind: Mastering Brainwaves for Insight, Healing, and Creativity”.
Entrainment is plausible because of the characteristics of the demonstrated EEG responses to a single TMS pulse, which have a spectral composition which resembles the spontaneous oscillations of the stimulated cortex. For example, TMS of the “resting” visual (Rosanova et al., 2009) or motor cortices (Veniero et al., 2011) triggers alpha-waves, the natural frequency at the resting state of both types of cortices. With the entrainment hypothesis, the noise generation framework moves to a more complex and extended level in which noise is synchronized with on-going activity. Nevertheless, the model to explain the outcome will not change, stimulation will interact with the system, and the final result will depend on introducing or modifying the noise level. The entrainment hypothesis makes clear predictions with respect to online repetitive TMS paradigms' frequency engagement as well as the possibility of inducing phase alignment, i.e., a reset of ongoing brain oscillations via external spTMS (Thut et al., 2011a, 2012; Veniero et al., 2011). The entrainment hypothesis is superior to the localization approach in gaining knowledge about how the brain works, rather than where or when a single process occurs. TMS pulses may phase-align the natural, ongoing oscillation of the target cortex. When additional TMS pulses are delivered in synchrony with the phase-aligned oscillation (i.e., at the same frequency), further synchronized phase-alignment will occur, which will bring the oscillation of the target area in resonance with the TMS train. Thus, entrainment may be expected when TMS is frequency-tuned to the underlying brain oscillations (Veniero et al., 2011).
Binaural Beats: Binaural beats are auditory brainstem responses which originate in the superior olivary nucleus of each hemisphere. They result from the interaction of two different auditory impulses, originating in opposite ears, below 1000 Hz and which differ in frequency between one and 30 Hz. For example, if a pure tone of 400 Hz is presented to the right ear and a pure tone of 410 Hz is presented simultaneously to the left ear, an amplitude modulated standing wave of 10 Hz, the difference between the two tones, is experienced as the two wave forms mesh in and out of phase within the superior olivary nuclei. This binaural beat is not heard in the ordinary sense of the word (the human range of hearing is from 20-20,000 Hz). It is perceived as an auditory beat and theoretically can be used to entrain specific neural rhythms through the frequency-following response (FFR)—the tendency for cortical potentials to entrain to or resonate at the frequency of an external stimulus. Thus, it is theoretically possible to utilize a specific binaural-beat frequency as a consciousness management technique to entrain a specific cortical rhythm. The binaural-beat appears to be associated with an electroencephalographic (EEG) frequency-following response in the brain.
Uses of audio with embedded binaural beats that are mixed with music or various pink or background sound are diverse. They range from relaxation, meditation, stress reduction, pain management, improved sleep quality, decrease in sleep requirements, super learning, enhanced creativity and intuition, remote viewing, telepathy, and out-of-body experience and lucid dreaming. Audio embedded with binaural beats is often combined with various meditation techniques, as well as positive affirmations and visualization.
When signals of two different frequencies are presented, one to each ear, the brain detects phase differences between these signals. “Under natural circumstances, a detected phase difference would provide directional information. The brain processes this anomalous information differently when these phase differences are heard with stereo headphones or speakers. A perceptual integration of the two signals takes place, producing the sensation of a third “beat” frequency. The difference between the signals waxes and wanes as the two different input frequencies mesh in and out of phase. As a result of these constantly increasing and decreasing differences, an amplitude-modulated standing wave—the binaural beat—is heard. The binaural beat is perceived as a fluctuating rhythm at the frequency of the difference between the two auditory inputs. Evidence suggests that the binaural beats are generated in the brainstem's superior olivary nucleus, the first site of contralateral integration in the auditory system. Studies also suggest that the frequency-following response originates from the inferior colliculus. This activity is conducted to the cortex where it can be recorded by scalp electrodes. Binaural beats can easily be heard at the low frequencies (<30 Hz) that are characteristic of the EEG spectrum.
Synchronized brainwaves have long been associated with meditative and hypnogogic states, and audio with embedded binaural beats has the ability to induce and improve such states of consciousness. The reason for this is physiological. Each ear is “hardwired” (so to speak) to both hemispheres of the brain. Each hemisphere has its own olivary nucleus (sound-processing center) which receives signals from each ear. In keeping with this physiological structure, when a binaural beat is perceived there are actually two standing waves of equal amplitude and frequency present, one in each hemisphere. So, there are two separate standing waves entraining portions of each hemisphere to the same frequency. The binaural beats appear to contribute to the hemispheric synchronization evidenced in meditative and hypnogogic states of consciousness. Brain function is also enhanced through the increase of cross-collosal communication between the left and right hemispheres of the brain. See Reference List Table 9.
Isochronic Tones: Isochronic tones are regular beats of a single tone that are used alongside monaural beats and binaural beats in the process called brainwave entrainment. At its simplest level, an isochronic tone is a tone that is being turned on and off rapidly. They create sharp, distinctive pulses of sound. See Reference List Table 10.
Time-Frequency Analysis: Brian J. Roach and Daniel H. Mathalon, “Event-related EEG time-frequency analysis: an overview of measures and analysis of early gamma band phase locking in schizophrenia. Schizophrenia Bull. USA. 2008; 34:5:907-926., describes a mechanism for EEG time-frequency analysis. Fourier and wavelet transforms (and their inverse) may be performed on EEG signals. See Reference List Table 11.
There are many approaches to time-frequency decomposition of EEG data, including the short-term Fourier transform (STFT), (Gabor D. Theory of Communication. J. Inst. Electr. Engrs. 1946; 93:429-457) continuous (Daubechies I. Ten Lectures on Wavelets. Philadelphia, Pa: Society for Industrial and Applied Mathematics; 1992:357. 21. Combes J M, Grossmann A, Tchamitchian P. Wavelets: Time-Frequency Methods and Phase Space-Proceedings of the International Conference; Dec. 14-18, 1987; Marseille, France) or discrete (Mallat S G. A theory for multiresolution signal decomposition: the wavelet representation. IEEE Trans Pattern Anal Mach Intell. 1989; 11:674-693) wavelet transforms, Hilbert transform (Lyons R G. Understanding Digital Signal Processing. 2nd ed. Upper Saddle River, N.J.: Prentice Hall PTR; 2004:688), and matching pursuits (Mallat S, Zhang Z. Matching pursuits with time-frequency dictionaries. IEEE Trans. Signal Proc. 1993; 41(12):3397-3415). Prototype analysis systems may be implemented using, for example, MatLab with the Wavelet Toolbox, www.mathworks.com/products/wavelet.html. See Reference List Table 12.
Single instruction, multiple data processors, such as graphics processing units including the nVidia CUDA environment or AMD Firepro high-performance computing environment are known, and may be employed for general purpose computing, finding particular application in data matrix transformations. See Reference List Table 13.
Statistical analysis may be presented in a form that permits parallelization, which can be efficiently implemented using various parallel processors, a common form of which is a SIMD (single instruction, multiple data) processor, found in typical graphics processors (GPUs). Artificial neural networks have been employed to analyze EEG signals. See Reference List Table 14.
Principal Component Analysis: Principal component analysis (PCA) is a statistical procedure that uses an orthogonal transformation to convert a set of observations of possibly correlated variables into a set of values of linearly uncorrelated variables called principal components. If there are n observations with p variables, then the number of distinct principal components is min(n−1,p). This transformation is defined in such a way that the first principal component has the largest possible variance (that is, accounts for as much of the variability in the data as possible), and each succeeding component in turn has the highest variance possible under the constraint that it is orthogonal to the preceding components. The resulting vectors are an uncorrelated orthogonal basis set. PCA is sensitive to the relative scaling of the original variables. PCA is the simplest of the true eigenvector-based multivariate analyses. Often, its operation can be thought of as revealing the internal structure of the data in a way that best explains the variance in the data. If a multivariate dataset is visualized as a set of coordinates in high-dimensional data space (1 axis per variable), PCA can supply the user with a lower-dimensional picture, a projection of this object when viewed from its most informative viewpoint. This is done by using only the first few principal components so that the dimensionality of the transformed data is reduced. PCA is closely related to factor analysis. Factor analysis typically incorporates more domain specific assumptions about the underlying structure and solves eigenvectors of a slightly different matrix. PCA is also related to canonical correlation analysis (CCA). CCA defines coordinate systems that optimally describe the cross-covariance between two datasets while PCA defines a new orthogonal coordinate system that optimally describes variance in a single dataset. See, en.wikipedia.org/wiki/Principal_component_analysis.
A general model for confirmatory factor analysis is expressed as x=α+Λξ+ε. The covariance matrix is expressed as E[(x−μ)(x−μ)′]=ΛΦΛ′+Θ. If residual covariance matrix Θ=0 and correlation matrix among latent factors Φ=I, then factor analysis is equivalent to principal component analysis and the resulting covariance matrix is simplified to Σ=ΛΛ′. When there are p number of variables and all p components (or factors) are extracted, this covariance matrix can alternatively be expressed into Σ=DΛD′, or Σ=λDAD′, where D=n×p orthogonal matrix of eigenvectors, and Λ=λA, p×p matrix of eigenvalues, where λ is a scalar, and A is a diagonal matrix whose elements are proportional to the eigenvalues of Σ. The following three components determine the geometric features of the observed data: λ parameterizes the volume of the observation, D indicates the orientation, and A represents the shape of the observation.
When population heterogeneity is explicitly hypothesized as in model-based cluster analysis, the observed covariance matrix is decomposed into the following general form Σk=λkDkAkDkT,
where λk parameterizes the volume of the kth cluster, Dk indicates the orientation of that cluster, and Ak represents the shape of that cluster. The subscript k indicates that each component (or cluster) can have different volume, shape, and orientation.
Assume a random vector X, taking values m, has a mean and covariance matrix of μX and ΣX, respectively. λ1>λ2> . . . >λm>0 are ordered eigenvalues of ΣX, such that the ith eigenvalue of ΣX means the ith largest of them. Similarly, a vector αi is the ith eigenvector of ΣX when it corresponds to the ith eigenvalue of ΣX. To derive the form of principal components (PCs), consider the optimization problem of maximizing var[α1T X]=α1T ΣX α1, subject to α1T α1=1. The Lagrange multiplier method is used to solve this question.
Because −ϕ1 is the eigenvalue of ΣX, with α1 being the corresponding normalized eigenvector, var[α1T X] is maximized by choosing α1 to be the first eigenvector of ΣX. In this case, z1=α1T X is named the first PC of X, α1 is the vector of coefficients for z1, and var(z1)=λ1.
To find the second PC, z2=α2T X, we need to maximize var[α2T X]=α2T ΣX α2 subject to z2 being uncorrelated with z1. Because cov(α1T X,α21 X)=0⇒α1T ΣX α2=0⇒α1T α2=0, this problem is equivalently set as maximizing α2TΣXα2, subject to α1Tα2=0, and α2Tα2=1. We still make use of the Lagrange multiplier method
Because −ϕ2 is the eigenvalue of ΣX, with α2 being the corresponding normalized eigenvector, var[α2T X] is maximized by choosing α2 to be the second eigenvector of ΣX. In this case, z2=α2T X is named the second PC of X, α2 is the vector of coefficients for z2, and var(z2)=λ2. Continuing in this way, it can be shown that the i-th PC zi=αiT X is constructed by selecting αi to be the ith eigenvector of ΣX, and has a variance of λi. The key result in regards to PCA is that the principal components are the only set of linear functions of original data that are uncorrelated and have orthogonal vectors of coefficients.
For any positive integer p≤m, let B=[β1, β2, . . . , βp] be an real m×p matrix with orthonormal columns, i.e., βiT βj=δij, and Y=BT X. Then the trace of covariance matrix of Y is maximized by taking B=[α1, α2, . . . , αp], where αi is the i-th eigenvector of ΣX. Because ΣX is symmetric with all distinct eigenvalues so {α1, α2, . . . , αm} is an orthonormal basis with αi being the i-th eigenvector of ΣX, and we can represent the columns of B as
So we have B=PC, where P=[α1, . . . , αm], C={cij} is an m×p matrix. Then, PTΣX P=Λ, with Λ being a diagonal matrix whose k-th diagonal element is λk, and the covariance matrix of Y is,
ΣY=BTΣXB=CTPTΣXPC=CTΛC=λ1c1c1T+ . . . +λmcmcmT
where ciT is the i-th row of C. So,
Because CT C=BT PPT B=BT B=I, so
and the columns of C are orthonormal. By the Gram-Schmidt method, C can expand to D, such that D has its columns as an orthonormal basis of m and contains C as its first p columns. D is square shape, thus being an orthogonal matrix and having its rows as another orthonormal basis of
m. One row of C is a part of one row of D, so
Considering the constraints
and the objective
We derive that trace(ΣY) is maximized if
for i=1, . . . , p, and
for i=p+1 . . . , m. When B=[α1, α2, . . . , αp], straightforward calculation yields that C is an all zero matrix except cii=1, i=1, . . . , p. This fulfills the maximization condition. Actually, by taking B=[γ1, γ2, . . . , γp], where {γ1, γ2, . . . , γp} is any orthonormal basis of the subspace of span{α1, α2, . . . , αp}, the maximization condition is also satisfied, yielding the same trace of the covariance matrix of Y.
Suppose that we wish to approximate the random vector X by its projection onto a subspace spanned by columns of B, where B=[β1, β2, . . . , βm], is a real m×p matrix with orthonormal columns, i.e., βiT βj=δij. If σi2 is the residual variance for each component of X, then
is minimized if B=[α1, α2, . . . , αp], where {α1, α2, . . . , βp} are the first p eigenvectors of ΣX. In other words, the trace of the covariance matrix of X−BBT X is minimized if B=[α1, α2, . . . , αp]. When E(X)=0, which is a commonly applied preprocessing step in data analysis methods, this property is saying that E∥X−BBT X∥2 is minimized if B=[α1, α2, . . . , αp].
The projection of a random vector X onto a subspace spanned by columns of B is {circumflex over (X)}=BBT X. Then the residual vector is ε=X−BBT X, which has a covariance matrix Σε=(I−BBT)ΣX(I−BBT). Then,
Also, we know:
trace(ΣXBBT)=trace(BBTΣX)=trace(BTΣXB)
trace(BBTΣxBBT)=trace(BTΣXBBTB)=trace(BTΣXB)
The last equation comes from the fact that B has orthonormal columns. So,
To minimize
it suffices to maximize trace(BT ΣX B). This can be done by choosing B=[α1, α2, . . . , αp], where {α1, α2, . . . , αp} are the first p eigenvectors of ΣX, as above.
See, Pietro Amenta, Luigi D'Ambra, “Generalized Constrained Principal Component Analysis with External Information,” (2000). We assume that data on K sets of explanatory variables and S criterion variables of n statistical units are collected in matrices Xk (k=1, . . . , K) and Ys (s=1, . . . , S) of orders (n×p1), . . . , (n×pK) and (n×q1), . . . , (n×qS), respectively. We suppose, without loss of generality, identity matrices for the metrics of the spaces of variables of Xk and Ys with Dn=diag (1/n), weight matrix of statistical units. We assume, moreover, that Xk's and Ys's are centered as to the weights Dn.
Let X=[X1| . . . |XK] and Y=[Y1| . . . |YS], respectively, be K and S matrices column linked to orders (n=Σk pk) and (n×Σs qs). Let be, also, WY=YY′ while we denote vk the coefficients vector (pk,1) of the linear combination for each Xk such that zk=Xkvk. Let Ck be the matrix of dimension pk×m (m≤pk), associated to the external information explanatory variables of set k.
Generalized CPCA (GCPCA) (Amenta, D'Ambra, 1999) with external information consists in seeking for K coefficients vectors vk (or, in same way, K linear combinations zk) subject to the restriction Ck′vk=0 simultaneously, such that:
or, in equivalent way,
where A=Y′X, B=diag(X1′X, . . . , XK′XK), C′=[C1′| . . . |Ck′], v′=(v1′| . . . |vk′) and f=B0.5v, with with
The constrained maximum problem turns out to be an extension of criterion supΣzi, zk
(Sabatier, 1993) with more sets of criterion variables with external information. The solution of this constrained maximum problem leads to solve the eigen-equation
(PX−PXB
where g=Xv, PX−PXBn
n=Im(PX−PXB
with PX
(PX
(which is obtained from the expression (I−PC)X′WYg=λBv) the coefficients vectors vk and the linear combinations zk=Xkvk maximizing (1) can be given by the relations
respectively.
The solution eigenvector g can be written, as the sum of the linear combinations zk:g=ΣkXkvk. Notice that the eigenvalues associated to the eigen-system are, according to the Sturm theorem, lower or equal than those of GCPCA eigen system: Σk=1KPX
Spatial Principal Component Analysis
Let J(t,i;α,s) be the current density in voxel i, as estimated by LORETA, in condition α at t time-frames after stimulus onset for subject s. Let area:Voxel→fBA be a function, which assigns to each voxel i∈Voxel the corresponding fBA b∈fBA. In a first pre-processing step, we calculate for each subject s the value of the current density averaged over each Fba
where Nb is the number of voxels in the fBAb, in condition α for subjects.
In the second analysis stage, the mean current density x(t,b;α,s) from each fBA b, for every subject s and condition α, was subjected to spatial PCA analysis of the correlation matrix and varimax rotation
In the present study, the spatial PCA uses the above-defined fBAs as variables sampled along the time epoch for which EEG has been sampled (0-1000 ms; 512 time-frames), and the inverse solution was estimated. Spatial matrices (each matrix was sized b×t=36×512 elements) for every subject and condition were collected, and subjected to PCA analyses, including the calculation of the covariance matrix; eigenvalue decomposition and varimax rotation, in order to maximize factor loadings. In other words, in the spatial PCA analysis, we approximate the mean current density for each subject in each condition as
where here x(t;α,s)∈R36 is a vector, which denotes the time-dependent activation of the fBAs, x0(α,s) is their mean activation, and xk(α,s) and ck are the principal components and their corresponding coefficients (factor loadings) as computed using the principal PCA.
See, download.lww.com/wolterskluwer.com/WNR_1_1_2010_03_22_ARZY_1_SDC1.doc.
Singular spectrum analysis (SSA): SSA is a nonparametric spectral estimation method. It combines elements of classical time series analysis, multivariate statistics, multivariate geometry, dynamical systems, and signal processing. SSA can be an aid in the decomposition of time series into a sum of components, each having a meaningful interpretation. The name “singular spectrum analysis” relates to the spectrum of eigenvalues in a singular value decomposition of a covariance matrix, and not directly to a frequency domain decomposition. (see en.wikipedia.org/wiki/Singular_spectrum_analysis.) In practice, SSA is a nonparametric spectral estimation method based on embedding a time series {X(t): t=1, . . . , N} in a vector space of dimension M. SSA proceeds by diagonalizing the M×M lag-covariance matrix CX of X(t) to obtain spectral information on the time series, assumed to be stationary in the weak sense. The matrix CX can be estimated directly from the data as a Toeplitz matrix with constant diagonals, i.e., its entries c; depend only on the lag |i−j|:
An alternative way to compute CX, is by using the N′×M “trajectory matrix” D that is formed by M lag-shifted copies of X(t), which are N′=N−M+1 long; then
The M eigenvectors Ek of the lag-covariance matrix CX are called temporal empirical orthogonal functions (EOFs). The eigenvalues λk of CX account for the partial variance in the direction Ek and the sum of the eigenvalues, i.e., the trace of CX, gives the total variance of the original time series X(t). The name of the method derives from the singular values λk1/2 of CX.
Projecting the time series onto each EOF yields the corresponding temporal principal components (PCs) Ak:
An oscillatory mode is characterized by a pair of nearly equal SSA eigenvalues and associated PCs that are in approximate phase quadrature. Such a pair can represent efficiently a nonlinear, nonharmonic oscillation. This is due to the fact that a single pair of data-adaptive SSA eigenmodes often will capture better the basic periodicity of an oscillatory mode than methods with fixed basis functions, such as the sines and cosines used in the Fourier transform.
The window width M determines the longest periodicity captured by SSA. Signal-to-noise separation can be obtained by merely inspecting the slope break in a “scree diagram” of eigenvalues λk or singular values λk1/2 vs. k. The point k*=S at which this break occurs should not be confused with a “dimension” D of the underlying deterministic dynamics.
A Monte-Carlo test can be applied to ascertain the statistical significance of the oscillatory pairs detected by SSA. The entire time series or parts of it that correspond to trends, oscillatory modes or noise can be reconstructed by using linear combinations of the PCs and EOFs, which provide the reconstructed components (RCs) RK:
here K is the set of EOFs on which the reconstruction is based. The values of the normalization factor Mt, as well as of the lower and upper bound of summation Lt and Ut, differ between the central part of the time series and the vicinity of its endpoints.
Multi-channel SSA (or M-SSA) is a natural extension of SSA to an L-channel time series of vectors or maps with N data points {Xl(t): l=1, . . . , L; t=1, . . . , N}. The extended EOF (EEOF) analysis is sometimes assumed to be synonymous with M-SSA. The two methods are both extensions of classical principal component analysis but they differ in emphasis: EEOF analysis typically utilizes a number L of spatial channels much greater than the number M of temporal lags, thus limiting the temporal and spectral information. In M-SSA, on the other hand, one usually chooses L≤M. Often M-SSA is applied to a few leading PCs of the spatial data, with M chosen large enough to extract detailed temporal and spectral information from the multivariate time series.
To avoid a loss of spectral properties, VARIMAX rotation of the spatio-temporal EOFs (ST-EOFs) of the M-SSA and its variations are sometimes used. Alternatively, a closed matrix formulation of the algorithm for the simultaneous rotation of the EOFs by iterative SVD decompositions has been proposed.
Nonlinear Dimensionality Reduction: High-dimensional data, meaning data that requires more than two or three dimensions to represent, can be difficult to interpret. One approach to simplification is to assume that the data of interest lie on an embedded non-linear manifold within the higher-dimensional space. If the manifold is of low enough dimension, the data can be visualized in the low-dimensional space. Non-linear methods can be broadly classified into two groups: those that provide a mapping (either from the high-dimensional space to the low-dimensional embedding or vice versa), and those that just give a visualization. In the context of machine learning, mapping methods may be viewed as a preliminary feature extraction step, after which pattern recognition algorithms are applied. Typically, those that just give a visualization are based on proximity data—that is, distance measurements. Related Linear Decomposition Methods include Independent component analysis (ICA), Principal component analysis (PCA) (also called Karhunen-Loève transform—KLT), Singular value decomposition (SVD), and Factor analysis.
The self-organizing map (SOM, also called Kohonen map) and its probabilistic variant generative topographic mapping (GTM) use a point representation in the embedded space to form a latent variable model based on a non-linear mapping from the embedded space to the high-dimensional space. These techniques are related to work on density networks, which also are based around the same probabilistic model.
Principal curves and manifolds give the natural geometric framework for nonlinear dimensionality reduction and extend the geometric interpretation of PCA by explicitly constructing an embedded manifold, and by encoding using standard geometric projection onto the manifold. How to define the “simplicity” of the manifold is problem-dependent. However, it is commonly measured by the intrinsic dimensionality and/or the smoothness of the manifold. Usually, the principal manifold is defined as a solution to an optimization problem. The objective function includes quality of data approximation and some penalty terms for the bending of the manifold. The popular initial approximations are generated by linear PCA, Kohonen's SOM or autoencoders. The elastic map method provides the expectation-maximization algorithm for principal manifold learning with minimization of quadratic energy functional at the “maximization” step.
An autoencoder is a feed-forward neural network which is trained to approximate the identity function. That is, it is trained to map from a vector of values to the same vector. When used for dimensionality reduction purposes, one of the hidden layers in the network is limited to contain only a small number of network units. Thus, the network must learn to encode the vector into a small number of dimensions and then decode it back into the original space. Thus, the first half of the network is a model which maps from high to low-dimensional space, and the second half maps from low to high-dimensional space. Although the idea of autoencoders is quite old, training of deep autoencoders has only recently become possible through the use of restricted Boltzmann machines and stacked denoising autoencoders. Related to autoencoders is the NeuroScale algorithm, which uses stress functions inspired by multidimensional scaling and Sammon mappings (see below) to learn a non-linear mapping from the high-dimensional to the embedded space. The mappings in NeuroScale are based on radial basis function networks.
Gaussian process latent variable models (GPLVM) are probabilistic dimensionality reduction methods that use Gaussian Processes (GPs) to find a lower dimensional non-linear embedding of high dimensional data. They are an extension of the Probabilistic formulation of PCA. The model is defined probabilistically, and the latent variables are then marginalized, and parameters are obtained by maximizing the likelihood.
Like kernel PCA they use a kernel function to form a nonlinear mapping (in the form of a Gaussian process). However, in the GPLVM the mapping is from the embedded(latent) space to the data space (like density networks and GTM) whereas in kernel PCA it is in the opposite direction. It was originally proposed for visualization of high dimensional data but has been extended to construct a shared manifold model between two observation spaces. GPLVM and its many variants have been proposed specially for human motion modeling, e.g., back constrained GPLVM, GP dynamic model (GPDM), balanced GPDM (B-GPDM) and topologically constrained GPDM. To capture the coupling effect of the pose and gait manifolds in the gait analysis, a multi-layer joint gait-pose manifold was proposed.
Curvilinear component analysis (CCA) looks for the configuration of points in the output space that preserves original distances as much as possible while focusing on small distances in the output space (conversely to Sammon's mapping which focuses on small distances in original space). It should be noticed that CCA, as an iterative learning algorithm, actually starts with a focus on large distances (like the Sammon algorithm), then gradually change focus to small distances. The small distance information will overwrite the large distance information if compromises between the two have to be made. The stress function of CCA is related to a sum of right Bregman divergences. Curvilinear distance analysis (CDA) trains a self-organizing neural network to fit the manifold and seeks to preserve geodesic distances in its embedding. It is based on Curvilinear Component Analysis (which extended Sammon's mapping), but uses geodesic distances instead. Diffeomorphic Dimensionality Reduction or Diffeomap learns a smooth diffeomorphic mapping which transports the data onto a lower-dimensional linear subspace. The method solves for a smooth time indexed vector field such that flows along the field which starts at the data points will end at a lower-dimensional linear subspace, thereby attempting to preserve pairwise differences under both the forward and inverse mapping.
Perhaps the most widely used algorithm for manifold learning is Kernel principal component analysis (kernel PCA). It is a combination of Principal component analysis and the kernel trick. PCA begins by computing the covariance matrix of the M×n Matrix X. It then projects the data onto the first k eigenvectors of that matrix. By comparison, KPCA begins by computing the covariance matrix of the data after being transformed into a higher-dimensional space. It then projects the transformed data onto the first k eigenvectors of that matrix, just like PCA. It uses the kernel trick to factor away much of the computation, such that the entire process can be performed without actually computing ϕ(x). Of course, ϕ must be chosen such that it has a known corresponding kernel.
Laplacian Eigenmaps, (also known as Local Linear Eigenmaps, LLE) are special cases of kernel PCA, performed by constructing a data-dependent kernel matrix. KPCA has an internal model, so it can be used to map points onto its embedding that were not available at training time. Laplacian Eigenmaps uses spectral techniques to perform dimensionality reduction. This technique relies on the basic assumption that the data lies in a low-dimensional manifold in a high-dimensional space. This algorithm cannot embed out of sample points, but techniques based on Reproducing kernel Hilbert space regularization exist for adding this capability. Such techniques can be applied to other nonlinear dimensionality reduction algorithms as well. Traditional techniques like principal component analysis do not consider the intrinsic geometry of the data. Laplacian eigenmaps builds a graph from neighborhood information of the data set. Each data point serves as a node on the graph and connectivity between nodes is governed by the proximity of neighboring points (using e.g. the k-nearest neighbor algorithm). The graph thus generated can be considered as a discrete approximation of the low-dimensional manifold in the high-dimensional space.
Minimization of a cost function based on the graph ensures that points close to each other on the manifold are mapped close to each other in the low-dimensional space, preserving local distances. The eigenfunctions of the Laplace-Beltrami operator on the manifold serve as the embedding dimensions, since under mild conditions this operator has a countable spectrum that is a basis for square integrable functions on the manifold (compare to Fourier series on the unit circle manifold). Attempts to place Laplacian eigenmaps on solid theoretical ground have met with some success, as under certain nonrestrictive assumptions, the graph Laplacian matrix has been shown to converge to the Laplace-Beltrami operator as the number of points goes to infinity. In classification applications, low dimension manifolds can be used to model data classes which can be defined from sets of observed instances. Each observed instance can be described by two independent factors termed ‘content’ and ‘style’, where ‘content’ is the invariant factor related to the essence of the class and ‘style’ expresses variations in that class between instances. Unfortunately, Laplacian Eigenmaps may fail to produce a coherent representation of a class of interest when training data consist of instances varying significantly in terms of style. In the case of classes which are represented by multivariate sequences, Structural Laplacian Eigenmaps has been proposed to overcome this issue by adding additional constraints within the Laplacian Eigenmaps neighborhood information graph to better reflect the intrinsic structure of the class. More specifically, the graph is used to encode both the sequential structure of the multivariate sequences and, to minimize stylistic variations, the proximity between data points of different sequences or even within a sequence, if it contains repetitions. Using dynamic time warping, proximity is detected by finding correspondences between and within sections of the multivariate sequences that exhibit high similarity.
Like LLE, Hessian LLE is also based on sparse matrix techniques. It tends to yield results of a much higher quality than LLE. Unfortunately, it has a very costly computational complexity, so it is not well-suited for heavily sampled manifolds. It has no internal model. Modified LLE (MLLE) is another LLE variant which uses multiple weights in each neighborhood to address the local weight matrix conditioning problem which leads to distortions in LLE maps. MLLE produces robust projections similar to Hessian LLE, but without the significant additional computational cost.
Manifold alignment takes advantage of the assumption that disparate data sets produced by similar generating processes will share a similar underlying manifold representation. By learning projections from each original space to the shared manifold, correspondences are recovered and knowledge from one domain can be transferred to another. Most manifold alignment techniques consider only two data sets, but the concept extends to arbitrarily many initial data sets. Diffusion maps leverage the relationship between heat diffusion and a random walk (Markov Chain); an analogy is drawn between the diffusion operator on a manifold and a Markov transition matrix operating on functions defined on the graph whose nodes were sampled from the manifold. The relational perspective map is a multidimensional scaling algorithm. The algorithm finds a configuration of data points on a manifold by simulating a multi-particle dynamic system on a closed manifold, where data points are mapped to particles and distances (or dissimilarity) between data points represent a repulsive force. As the manifold gradually grows in size, the multi-particle system cools down gradually and converges to a configuration that reflects the distance information of the data points. Local tangent space alignment (LTSA) is based on the intuition that when a manifold is correctly unfolded, all of the tangent hyperplanes to the manifold will become aligned. It begins by computing the k-nearest neighbors of every point. It computes the tangent space at every point by computing the d-first principal components in each local neighborhood. It then optimizes to find an embedding that aligns the tangent spaces. Local Multidimensional Scaling performs multidimensional scaling in local regions and then uses convex optimization to fit all the pieces together.
Maximum Variance Unfolding was formerly known as Semidefinite Embedding. The intuition for this algorithm is that when a manifold is properly unfolded, the variance over the points is maximized. This algorithm also begins by finding the k-nearest neighbors of every point. It then seeks to solve the problem of maximizing the distance between all non-neighboring points, constrained such that the distances between neighboring points are preserved. Nonlinear PCA (NLPCA) uses backpropagation to train a multi-layer perceptron (MLP) to fit to a manifold. Unlike typical MLP training, which only updates the weights, NLPCA updates both the weights and the inputs. That is, both the weights and inputs are treated as latent values. After training, the latent inputs are a low-dimensional representation of the observed vectors, and the MLP maps from that low-dimensional representation to the high-dimensional observation space. Manifold Sculpting uses graduated optimization to find an embedding. Like other algorithms, it computes the k-nearest neighbors and tries to seek an embedding that preserves relationships in local neighborhoods. It slowly scales variance out of higher dimensions, while simultaneously adjusting points in lower dimensions to preserve those relationships.
Ruffini (2015) discusses Multichannel transcranial current stimulation (tCS) systems that offer the possibility of EEG-guided optimized, non-invasive brain stimulation. A tCS electric field realistic brain model is used to create a forward “lead-field” matrix and, from that, an EEG inverter is employed for cortical mapping. Starting from EEG, 2D cortical surface dipole fields are defined that could produce the observed EEG electrode voltages.
Schestatsky et al. (2017) discuss transcranial direct current stimulation (tDCS), which stimulates through the scalp with a constant electric current that induces shifts in neuronal membrane excitability, resulting in secondary changes in cortical activity. Although tDCS has most of its neuromodulatory effects on the underlying cortex, tDCS effects can also be observed in distant neural networks. Concomitant EEG monitoring of the effects of tDCS can provide valuable information on the mechanisms of tDCS. EEG findings can be an important surrogate marker for the effects of tDCS and thus can be used to optimize its parameters. This combined EEG-tDCS system can also be used for preventive treatment of neurological conditions characterized by abnormal peaks of cortical excitability, such as seizures. Such a system would be the basis of a non-invasive closed-loop device. tDCS and EEG can be used concurrently. See Reference List Table 16.
EEG analysis approaches have emerged, in which event-related changes in EEG dynamics in single event-related data records are analyzed. See Allen D. Malony et al., Computational Neuroinformatics for Integrated Electromagnetic Neuroimaging and Analysis, PAR-99-138. Pfurtscheller, reported a method for quantifying the average transient suppression of alpha band (circa 10-Hz) activity following stimulation. Event-related desynchronization (ERD, spectral amplitude decreases), and event-related synchronization (ERS, spectral amplitude increases) are observed in a variety of narrow frequency bands (4-40 Hz) which are systematically dependent on task and cognitive state variables as well as on stimulus parameters. Makeig (1993) was reported event-related changes in the full EEG spectrum, yielding a 2-D time/frequency measure he called the event-related spectral perturbation (ERSP). This method avoided problems associated with the analysis of a priori narrow frequency bands, since bands of interest for the analysis could be based on significant features of the complete time/frequency transform. Rappelsburger et al. introduced event-related coherence (ERCOH). A wide variety of other signal processing measures have been tested for use on EEG and/or MEG data, including dimensionality measures based on chaos theory and the bispectrum. Use of neural networks has also been proposed for EEG pattern recognition applied to clinical and practical problems, though usually these methods have not been employed with the aim of explicitly modeling the neurodynamics involved. Neurodynamics is the mobilization of the nervous system as an approach to physical treatment. The method relies on influencing pain and other neural physiology via the mechanical treatment of neural tissues and the non-neural structures surrounding the nervous system. The body presents the nervous system with a mechanical interface via the musculoskeletal system. With movement, the musculoskeletal system exerts non-uniform stresses and movement in neural tissues, depending on the local anatomical and mechanical characteristics and the pattern of body movement. This activates an array of mechanical and physiological responses in neural tissues. These responses include neural sliding, pressurization, elongation, tension, and changes in intraneural microcirculation, axonal transport, and impulse traffic.
The availability of and interest in larger and larger numbers of EEG (and MEG) channels led immediately to the question of how to combine data from different channels. Donchin advocated the use of linear factor analysis methods based on principal component analysis (PCA) for this purpose. Temporal PCA assumes that the time course of activation of each derived component is the same in all data conditions. Because this is unreasonable for many data sets, spatial PCA (usually followed by a component rotation procedure such as Varimax or Promax) is of potentially greater interest. To this end, several variants of PCA have been proposed for ERP decomposition.
Bell and Sejnowski published an iterative algorithm based on information theory for decomposing linearly mixed signals into temporally independent by minimizing their mutual information. First approaches to blind source separation minimized third and fourth-order correlations among the observed variables and achieved limited success in simulations. A generalized approach uses a simple neural network algorithm that used joint information maximization or ‘infomax’ as a training criterion. By using a compressive nonlinearity to transform the data and then following the entropy gradient of the resulting mixtures, ten recorded voice and music sound sources were unmixed. A similar approach was used for performing blind deconvolution, and the ‘infomax’ method was used for decomposition of visual scenes.
The first applications of blind decomposition to biomedical time series analysis applied the infomax independent component analysis (ICA) algorithm to the decomposition of EEG and event-related potential (ERP) data and reported the use of ICA to monitor alertness. This separated artifacts, and EEG data into constituent components defined by spatial stability and temporal independence. ICA can also be used to remove artifacts from continuous or event-related (single-trial) EEG data prior to averaging. Vigario et al. (1997), using a different ICA algorithm, supported the use of ICA for identifying artifacts in MEG data. Meanwhile, widespread interest in ICA has led to multiple applications to biomedical data as well as to other fields (Jung et al., 2000b). Most relevant to EEG/MEG analysis, ICA is effective in separating functionally independent components of functional magnetic resonance imaging (fMRI) data
Since the publication of the original infomax ICA algorithm, several extensions have been proposed. Incorporation of a ‘natural gradient’ term avoided matrix inversions, greatly speeding the convergence of the algorithm and making it practical for use with personal computers on large data EEG and fMRI data sets. An initial ‘sphering’ step further increased the reliability of convergence of the algorithm. The original algorithm assumed that sources have ‘sparse’ (super-Gaussian) distributions of activation values. This restriction has recently been relaxed in an ‘extended-ICA’ algorithm that allows both super-Gaussian and sub-Gaussian sources to be identified. A number of variant ICA algorithms have appeared in the signal processing literature. In general, these make more specific assumptions about the temporal or spatial structure of the components to be separated and typically are more computationally intensive than the infomax algorithm.
Since individual electrodes (or magnetic sensors) each record a mixture of brain and non-brain sources, spectral measures are difficult to interpret and compare across scalp channels. For example, an increase in coherence between two electrode signals may reflect the activation of a strong brain source projecting to both electrodes or the deactivation of a brain generator projecting mainly to one of the electrodes. If independent components of the EEG (or MEG) data can be considered to measure activity within functionally distinct brain networks, however, event-related coherence between independent components may reveal transient, event-related changes in their coupling and decoupling (at one or more EEG/MEG frequencies). ERCOH analysis has been applied to independent EEG components in a selective attention task.
Electrooculography: Electrooculography (EOG) is a technique for measuring the corneo-retinal standing potential that exists between the front and the back of the human eye. The resulting signal is called the electrooculogram. Primary applications are in the ophthalmological diagnosis and in recording eye movements. Unlike the electroretinogram, the EOG does not measure the response to individual visual stimuli. To measure eye movement, pairs of electrodes are typically placed either above and below the eye or to the left and right of the eye. If the eye moves from a center position toward one of the two electrodes, this electrode “sees” the positive side of the retina and the opposite electrode “sees” the negative side of the retina. Consequently, a potential difference occurs between the electrodes. Assuming that the resting potential is constant, the recorded potential is a measure of the eye's position.
Because sleep patterns have characteristic eye movements, e.g., rapid eye movements (REM), EOG may provide in indication of sleep state.
Electromyography: Electromyography (EMG) is an electrodiagnostic medicine technique for evaluating and recording the electrical activity produced by skeletal muscles. EMG is performed using an instrument called an electromyograph to produce a record called an electromyogram. An electromyograph detects the electric potential generated by muscle cells when these cells are electrically or neurologically activated. EMG reflects muscle tone, which can be indicative of a sleep state. See, Reference List Table 17.
The present invention provides a system and method for inducing brain states in a subject human or animal which represent or are conducive to sleep according to a natural sleep cycle, based on brain activity patterns (e.g., brainwaves) from a representative of the same species, or the same individual, which are processed and converted to a stimulatory signal that is then imposed on the subject. At any time, the stimulation of the subject seeks to induce EEG patterns that are representative of a target sleep state. The sequence of sleep states may be from the species or individual, or designed according to an algorithm designed or optimized to achieve the overall sleep pattern comprising the desired sequence of sleep states. Advantageously, the subject is monitored during stimulation to measure response to the stimulation, and/or interruption of the target sleep cycle. In case of interruption of the sleep cycle, the stimulation is restarted based on the state of the subject and, therefore, progresses again through a natural sequence of sleep states.
In some cases, the goal is to achieve a sleep cycle which differs from a normal or natural sleep cycle and may be modified or controlled in the case of organic pathology or mental illness. The preferred stimulation is non-invasive, and also preferably not electrical. However, transcranial magnetic stimulation, e.g., subthreshold PEMF, may be employed, alone or with auditory, visual, or other stimulation. For example, while visual stimulation may be contraindicated for entry into respectively deeper sleep states, it may be advantageously used for moving the subject to a shallower sleep state, and to awaken the subject. However, such auditory or visual stimulation preferably is modulated to synchronize or control brainwave patterns, in addition to any overt sensory effects that may be provided. The measurement of brain activity, and brain stimulation may be according to the known methods described hereinabove, without limitation, though the preferred implementation is such that the subject need not be encumbered by bulky, uncomfortable, expensive, or exotic equipment, and can be used unmonitored in a home environment. However, the invention is not limited by such constraints, so long as the sleep pattern is effectively controlled.
In some cases, the invention is used for other than sleep induction, and may also be used to control other stages of consciousness or other mental or emotional states, and preferably a desired sequence of states based on subject biology.
Brain-states, which correlate with specific cognitive states, may be monitored with non-invasive techniques such as EEG and MEG that indirectly measure cortical activity. These cortical signatures provide insight into the neuronal activity, which has been used to identify abnormal cortical function in numerous neurological and psychiatric conditions. Further, the induction of entrained cortical rhythms via transcranial stimulation is effective in imbuing brain-states correlated with such cortical rhythms. See, Poltorak, Alexander. 2019. “On the Possibility of Transplanting Mental States.” OSF Preprints. April 16. doi:10.31219/osf.io/sjqfx.
It has been suggested by Crick and Koch [Crick F, Koch C. Towards a neurobiological theory of consciousness. Seminars in the Neurosciences, 1990; (2), 263-75.] (see also [Rees G, Kreiman G, Koch C. Neural correlates of consciousness in humans. Nature Reviews. Neuroscience 2002; 3(4), 261-270. doi.org/10.1038/nrn783]) that every mental state is expressed through unique neural signals, such as frequency oscillations, that are correlated with mood, cognition and motor functions. It is thus possible to induce a desired mental state by replicating its neural correlates.
Functional neuroimaging, such as electroencephalography (EEG) or magnetoencephalography (MEG), can capture the neuronal activity of localized brain regions which correlate with distinct cognitive or behavioral states (mental states). EEG recordings have demonstrated, for example, that the pattern of brain activity changes during meditative acts, and frontal cortex EEG activity has been associated with emotion induction and regulation (Yu et al. [Yu X, Fumoto M, Nakatani Y, Sekiyama T, Kikuchi H, Seki Y, Sato-Suzuki I, Arita H. Activation of the anterior prefrontal cortex and serotonergic system is associated with improvements in mood and EEG changes induced by Zen meditation practice in novices. Int J of Psychophysiology 2011; 80(2), 103-111. doi.org/10.1016/j.ijpsycho.2011.02.004]; Dennis and Solomon [Dennis T A, Solomon B. Frontal EEG and emotion regulation: electrocortical activity in response to emotional film clips is associated with reduced mood induction and attention interference effects. Biological Psychology 2010; 85(3), 456-464. doi.org/10.1016/j.biopsycho.2010.09.008]). EEG recordings reflect ionic fluctuations resultant of neuronal communication in the cortex arising from dendritic depolarizations (Nunez and Srinivasan [Nunez P L, Srinivasan R. Electric fields of the brain: the neurophysics of EEG (2 ed). Oxford: Oxford Univ. Press; 2006.]). Alternatively, MEG measurements reflect intracellular ionic fluctuations, which similarly result from action potentials (Hamalainen et al. [Hamalainen M, Hari R, Ilmoniemi R J, Knuutila J, Lounasmaa O V. Magnetoencephalography-theory, instrumentation, and applications to noninvasive studies of the working human brain. Rev. Mod. Phys. 1993; 65, 413. doi.org/10.1103/revmodphys.65.413]). In both cases, the output measures correlate with localized cortical activity.
These EEG or MEG signatures may be inverted in order to stimulate, rather than record, cortical activity. Specifically, transcranial electric stimulation (TES; Annarumma et al. [Annarumma L, D'Atri A, Alfonsi V, De Gennaro L. The Efficacy of Transcranial Current Stimulation Techniques to Modulate Resting-State EEG, to Affect Vigilance and to Promote Sleepiness. Brain Sci. 2018; 8(7), 137. doi.org/10.3390/brainsci8070137]), including transcranial alternating current stimulation (tACS) and transcranial direct current stimulation (tDCS; Utz et al. [Utz K S, Dimova V, Oppenlander K, Kerkhoff G. Electrified minds: transcranial direct current stimulation (tDCS) and galvanic vestibular stimulation (GVS) as methods of non-invasive brain stimulation in neuropsychology—a review of current data and future implications. Neuropsychologia 2010; 48(10), 2789-2810]) are used to electrically stimulate cortical activity, while transcranial magnetic stimulation (TMS; see [Lawson McLean A. Publication trends in transcranial magnetic stimulation: a 30-year panorama. Brain Stimulation 2019; in press. doi.org/10.1016/j.brs.2019.01.002]) uses a precise magnetic field in order to achieve a similar endpoint of electric current control. Typical brain entrainment methods utilize a constant stimulus (e.g., tDCS) or a synthetic waveform, which may be a step function modulated on a direct current (such as “electrosleep” [Robinovitch L G. Electric analgesia, and electric resuscitation after heart failure under chloroform or electrocution. Journal of the American Medical Association 1911; LVI(7), 478-481. doi.org/10.1001/jama.1911.02560070010003]), a sinusoid modulated on an oscillatory direct current (osc-tDCS; D'Atri et al. [D'Atri A, De Simoni E, Gorgoni M, Ferrara M, Ferlazzo F, Rossini P M, De Gennaro L. Electrical stimulation of the frontal cortex enhances slow-frequency EEG activity and sleepiness. Neuroscience 2016; 324, 119-130. doi.org/10.1016/j.neuroscience.2016.03.007]), or a fixed frequency modulated on alternating current (tACS; [Rosa, M A, Lisanby, S H. Somatic treatments for mood disorders. Neuropsychopharmacology 2012; 37(1), 102-16. 10.1038/npp.2011.225]). Helfrich et al., supra, utilized simultaneous tACS stimulation combined with EEG recordings to show that, when tACS was applied to the parieto-occipital lobe of the brain, alpha wave activity increased and became synchronized with the entrainment frequency.
These techniques may be used in order to record and subsequently induce specific brain states. Thus, EEG/MEG may be used to record mental states, which may then be applied via TES (tDCS, osc-tDCS, tACS) or TMS in order to replicate the cognitive-behavioral state of the “donor.” This technique has been previously investigated in the domain of sleep [Gebodh N, Vacchi L, Adair D, Unal G, Poltorak A, Poltorak V, Bikson M. Proceedings #11: Replay of Endogenous Sleep Rhythms to Produce Sleepiness. Brain Stimulation: Basic, Translational, and Clinical Research in Neuromodulation 2019; 12(2), e71-e72. doi.org/10.1016/j.brs.2018.12.180].
The present technology involves, according to one embodiment, the notion of “transplanting” mental states including sleep, attention, and learning, as well as emotional valence. See
Similarly, emotional arousal and valence are correlated with distinct cortical signatures observable through EEG (Allen et al. [Allen J J B, Keune P M, Schönenberg M, Nusslock R. Frontal EEG alpha asymmetry and emotion: From neural underpinnings and methodological considerations to psychopathology and social cognition. Psychophysiology 2018; 55(1). doi.org/10.1111/psyp.13028]). Previous data indicate that happiness resultant of musical experience, for instance, is associated with increased theta frequency oscillations in the left frontal cortical hemisphere (Rogenmoser et al. [Rogenmoser L, Zollinger N, Elmer S, Jäncke L. Independent component processes underlying emotions during natural music listening. Social Cognitive and Affective Neuroscience 2016; 11(9), 1428-1439. doi.org/10.1093/scan/nsw048]). Cortical oscillations associated with negative affect conversely correlate with decreased theta frequency oscillations in this same region. Notably, aberrant cortical oscillations have been observed in a range of affective disorders including major depression (Van der Vinne et al. [Van der Vinne N, Vollebregt M A, van Putten M J A M, Arns M. Frontal alpha asymmetry as a diagnostic marker in depression: Fact or fiction? A meta-analysis. NeuroImage. Clinical 2017; 16, 79-87. doi.org/10.1016/j.nicl.2017.07.006]). Indeed, the left frontal hemisphere exhibits disrupted cortical rhythms in patients diagnosed with major depression as compared to healthy controls (Nusslock et al. [Nusslock R, Shackman A J, McMenamin B W, Greischar L L, Davidson R J, Kovacs M. Comorbid anxiety moderates the relationship between depression history and prefrontal EEG asymmetry. Psychophysiology 2018; 55(1). doi.org/10.1111/psyp.12953]). Similar data have highlighted cortical asymmetry of frontal lobe oscillations in post-traumatic stress disorder (PTSD; Meyer et al. [Meyer T, Quaedflieg C W E M, Weijland K, Schruers K, Merckelbach H, Smeets T. Frontal EEG asymmetry during symptom provocation predicts subjective responses to intrusions in survivors with and without PTSD. Psychophysiology 2018; 55(1). doi.org/10.1111/psyp.12779]). Simple cortical entrainment via binaural beat stimulation has already proven adequate for inducing specific emotional states (Chaieb et al. [Chaieb L, Wilpert E C, Reber T P, Fell J. Auditory Beat Stimulation and its Effects on Cognition and Mood States. Frontiers in Psychiatry 2015; 6. doi.org/10.3389/fpsyt.2015.00070]). More directly, cranial electrotherapy has been demonstrated as an efficacious treatment for depression, anxiety, and certain forms of insomnia (Kirsch et al. [Kirsch D L, Nichols F. Cranial Electrotherapy Stimulation for Treatment of Anxiety, Depression, and Insomnia. Psychiatric Clinics of North America 2013; 36(1), 169-176. doi.org/10.1016/j.psc.2013.01.006]). Certain forms of depression may respond better to transcranial approaches, such as TMS, as has been demonstrated in early data on patients with treatment-resistant major depression (Rosenberg et al. [Rosenberg O, Shoenfeld N, Zangen A, Kotler M, Dannon P N. Deep TMS in a resistant major depressive disorder: a brief report. Depression and Anxiety 2010; 27(5), 465-469. doi.org/10.1002/da.20689]).
This approach to “transplant” (transfer) mental states by replicating neural correlates of the donor's state in a recipient is founded on two main principles. First, a large body of literature has identified distinct, measurable cortical signatures associated with specific brain-states ranging from those defining the sleep/wake cycle to those underlying emotional experience. Second, TES and TMS have been repeatedly demonstrated as efficacious, safe means by which cortical rhythms may be entrained with a high degree of location-specificity. Together, these findings provide the basis for the hypothesis that mental states can be “transplanted” (transferred) and provide the means by which a cortical signature may be obtained via EEG or EMG associated with a desired mental state of a “donor” that may, in turn, be processed, inverted, and subsequently applied to a recipient in order to induce said cognitive state via cortical rhythm entrainment using tACS, TMS or other stimuli such as light or sound. Theoretical considerations suggest that this hypothesis is plausible and deserves experimental verification. Importantly, using cortical signatures acquired from a “donor,” rather than a fixed-frequency or synthetic waveform applications as is currently typical for TES techniques, offers the distinct advantage of replicating multi-phasic, temporally dynamic signals are more likely to induce naturalistic mind-states holistically. This technique may, therefore, provide a novel approach to the non-invasive treatment of a variety of disorders whose current treatments are limited to pharmacotherapeutic interventions.
Sleep disorders affect a significant portion of the adult population. Between 50 and 70 million adults in the U.S. have a sleep disorder. (Ohayon M M. Epidemiology of insomnia: what we know and what we still need to learn. Sleep medicine reviews. 2002; 6(2):97-111.) Insomnia is the most common specific sleep disorder, with short-term issues reported by about 30% of adults and chronic insomnia by 10%. (Kessler R C, Berglund P A, Coulouvrat C, et al. Insomnia and the performance of US workers: results from the America insomnia survey. Sleep. 2011; 34(9):1161-1171; Sateia M J, Doghramji K, Hauri P J, Morin C M. Evaluation of chronic insomnia. An American Academy of Sleep Medicine review. Sleep. 2000; 23(2):243-308.) Chronic insomnia is associated with deterioration of memory, adverse effects on endocrine functions and immune responses, and an increase in the risk of obesity and diabetes Sateia et al. 2000; Taylor D J, Mallory L J, Lichstein K L, Durrence H H, Riedel B W, Bush A J. Comorbidity of chronic insomnia with medical problems. Sleep. 2007; 30(2):213-218). While at any age, managing insomnia is a challenge, it is especially a critical condition in the elderly due to age-related increases in comorbid medical conditions and medication use, as well as age-related changes in sleep structure, which shorten sleep time and impair sleep quality. (Ancoli-Israel S. Insomnia in the elderly: a review for the primary care practitioner. Sleep. 2000; 23:S23-30; discussion S36-28; Buysse D J. Insomnia, depression, and aging. Assessing sleep and mood interactions in older adults. Geriatrics (Basel, Switzerland). 2004; 59(2):47-51; quiz 52.) As a result, decreased sleep quality is one of the most common health complaints of older adults. Medications are widely prescribed for relief from insomnia. However, sleep-promoting agents, such as hypnotic drugs, can produce adverse effects, particularly in the elderly. (Sateia M J, Buysse D J, Krystal A D, Neubauer D N. Adverse Effects of Hypnotic Medications. J Clin Sleep Med. Jun. 15, 2017; 13(6):839.) Even natural supplements, such as melatonin, can cause some side effects, including headache, depression, daytime sleepiness, dizziness, stomach cramps, and irritability. (Buscemi N, Vandermeer B, Hooton N, et al. The efficacy and safety of exogenous melatonin for primary sleep disorders a meta-analysis. Journal of general internal medicine. 2005; 20(12):1151-1158.)
Aside from the general deterioration of sleep quality with age in adult population, the deterioration in quantity and quality of the slow-wave sleep (SWS), which is non-REM deep sleep, is particularly troubling. (Roth T. Slow wave sleep: does it matter? Journal of clinical sleep medicine: JCSM: official publication of the American Academy of Sleep Medicine. 2009; 5(2 Suppl):S4). SWS plays an important role in cerebral restoration and recovery in humans. Studies have shown that a 15% reduction in the amounts of SWS and increased number and duration of awakenings are associated with normal aging. (Chinoy E D, Frey D J, Kaslovsky D N, Meyer F G, Wright Jr K P. Age-related changes in slow wave activity rise time and NREM sleep EEG with and without zolpidem in healthy young and older adults. Sleep medicine. 2014; 15(9):1037-1045.) Experimental disruption of SWS have been shown to increase shallow sleep, sleep fragmentation, daytime sleep propensity, and impair daytime function. (Dijk D J. Regulation and functional correlates of slow wave sleep. J Clin Sleep Med. Apr. 15, 2009; 5(2 Suppl):S6-15; Restoring Deep, Slow Wave Sleep to Enhance Health and Increase Lifespan, nutritionreview.org/2014/07/restoring-slow-wave-sleep-shown-enhance-health-increase-lifespan/(2014)). Given that SWS contributes to sleep continuity, enhancement of SWS may lead to improvements in sleep quality and daytime function in patients with insomnia and the elderly. Furthermore, accumulating evidence point to the SWS is the time when short-term memory is consolidated into long-term memory. (Born J. Slow-wave sleep and the consolidation of long-term memory. The World Journal of Biological Psychiatry. 2010; 11(sup1):16-21.) Recent research connects the deterioration of the SWS with early onset of Alzheimer's disease and other forms of dementia. (Petit D, Gagnon J-F, Fantini M L, Ferini-Strambi L, Montplaisir J. Sleep and quantitative EEG in neurodegenerative disorders. Journal of psychosomatic research. 2004; 56(5):487-496; McCurry S M, Ancoli-Israel S. Sleep dysfunction in Alzheimer's disease and other dementias. Current treatment options in neurology. 2003; 5(3):261-272). It is also suggested that the loss of SWS stage may play a role in these debilitating age-related diseases. (Mattis J, Sehgal A. Circadian rhythms, sleep, and disorders of aging. Trends in Endocrinology & Metabolism. 2016; 27(4):192-203). Unfortunately, most standard sleeping pills, while alleviating insomnia, do little to improve the SWS. (Walsh J K. Enhancement of slow wave sleep: implications for insomnia. Journal of clinical sleep medicine: JCSM: official publication of the American Academy of Sleep Medicine. 2009; 5(2 Suppl):S27.) Some evidence suggests that some hypnotic drugs change the structure of sleep, adversely affecting the SWS (Sateia et al. (2017); Walsh (2009). Hence, there is an unmet need for non-pharmacological techniques for promoting sleep, particularly, the deep non-REM sleep stage (SWS) lacking in the elderly population.
One of the promising non-pharmacological approaches to promoting sleep is neuromodulation via light, sound, and/or transcranial electric stimulation (TES). Limited human trials conducted by Neuroenhancement Lab in collaboration with the Neuromodulation Laboratory at The City College of New York (CUNY) showed promise in replicating the desired sleep stage o a healthy donor in other subjects (recipients). Electroencephalogram (EEG) of healthy volunteers were recorded as they dozed off entering stage 1 of sleep, as evidenced by the predominance of alpha waves. These EEG recordings were subsequently filtered from noise, inverted, and used for transcranial Endogenous Sleep-Derived stimulation (tESD). Volunteer subjects stimulated with tESD modulated with the indigenous brainwaves recorded in a sleeping donor, quickly dozed off and entered stage 1 of sleep, as evidenced by EEG, heart rate, respiration rate, and post-sleep cognitive test. These results were better as compared to the control arms of the study that included sham stimulation, tDCS, and tACS (10 Hz). These preliminary results suggest that tACS modulated with indigenous brainwaves recorded from a healthy sleeping donor can be used to replicate the desired sleep stage of a healthy donor in another subject.
There is significant research to identify markers of different phases of healthy or pathological sleep; the markers allow to classify observed EEG to one of the phases of sleep/wake categories. The applicants are not aware of any research that aimed at comprehensive identification of all independent components of EEG signals during sleep; and comprehensive analysis of statistically significant inter-dependence of a presence of an independent component with the particular stage of sleep. Comprehensive identification and analysis of independent components associated with sleep would allow to use those components and/or derived signals for a tACS protocol
EEG recordings of brainwaves are obtained and pre-processed from healthy human subjects during various stages of sleep. EEG recordings of three stages of sleep, and while being awake from at least ten healthy subjects (e.g., through public EEG database), which are then smoothed and filtered. The EEG recordings are analyzed to identify statistically significant waveform components correlated with specific sleep stages. A model (e.g., a linear multivariate model) is developed for the coefficients of the components of the EEG, based on sleep stage/wakefulness status; and the statistical significance of the model is measured. Stimulation protocols are developed that can provide safe and effective neurostimulation to induce desired sleep stage.
Great economic burden and the societal cost is incurred due to sleeping disorders, particularly insomnia. Sleep disturbances are common symptoms in adults and are related to various factors, including the use of caffeine, tobacco, and alcohol; sleep habits; and comorbid diseases1. Epidemiologic studies indicate sleep disorders are affecting a significant portion of adult population. Between 50 and 70 million adults in the U.S. have a sleep disorder. Insomnia is the most common specific sleep disorder, with short-term issues reported by about 30% of adults and chronic insomnia by 10%. (Kessler et al. (2011), Sateia et al. (2000), Ancoli-Israel et al. (2000), Ancoli-Israel S, Roth T. Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. I. Sleep. 1999; 22:S347-353.). Chronic insomnia is associated with deterioration of memory, adverse effects on endocrine functions and immune responses, and an increase in the risk of obesity and diabetes. (Sateia et al. (2000)). In addition, there is a significant economic burden and societal cost associated with insomnia due to the impact on health care utilization, impact in the work domain, and quality of life. Recent estimates of direct and indirect costs are upwards of 100 billion dollars annually in the United States. (Fullerton D S. The economic impact of insomnia in managed care: a clearer picture emerges. Am J Manag Care. May 2006; 12(8 Suppl):S246-252.) While at any age, managing insomnia is a challenge, it is especially a critical condition in the elderly due to age-related increases in comorbid medical conditions and medication use, as well as age-related changes in sleep structure, which shorten sleep time and impair sleep quality. (Ancoli-Israel (2000). As a result, decreased subjective sleep quality is one of the most common health complaints of older adults.
There is a deterioration of the slow-wave sleep (SWS) in the elderly. Aside from the general deterioration of sleep quality with age in the adult population, the deterioration in quantity and quality of the slow-wave sleep (SWS), which is the deep non-REM sleep, is particularly troubling. (Roth (2009)). SWS plays an important role in cerebral restoration and recovery in humans. It is the most prominent EEG event during sleep and appears as spontaneous large oscillations of the EEG signal occurring approximately once every second in the deepest stage of non-REM sleep. (Achermann P, Dijk D-J, Brunner D P, Borbely A A. A model of human sleep homeostasis based on EEG slow-wave activity: quantitative comparison of data and simulations. Brain research bulletin. 1993; 31(1-2):97-113.) Studies have shown that a significant decrease (˜15% reduction) in the amounts of SWS and increased number and duration of awakenings are associated with normal aging. (Chinoy et al. (2014)). Given that SWS contributes to sleep continuity and experimental disruption of SWS increases shallow sleep and sleep fragmentation, enhances daytime sleep propensity, and impairs daytime function. (Dijk (2009); NutritionReview.org (2014)), enhancement of SWS may lead to improvements in sleep maintenance and daytime function in patients with insomnia and in the elderly. Furthermore, accumulating evidence point to the SWS as the time when short-term memory is consolidated into long-term memory. (Born (2010)). Recent research connects the deterioration of the SWS with early onset of Alzheimer's disease and other forms of dementia. (Petit et al. (2010); McCurry et al. (2003)). It is also suggested that the loss of SWS stage may be the culprit for these debilitating age-related diseases. (Mattis et al. (2016)).
SWS enhancement is a potential non-pharmacological therapy for the elderly. Given the pivotal role of slow waves during sleep, it is not surprising that several efforts have been made to increase sleep efficacy by potentiating SWS. Recently, a number of drugs have been shown to increase SWS. Although acting on different synaptic sites, overall the slow wave enhancing the effect of these drugs is mediated by enhancing GABAergic transmission. Specifically, clinical investigations showed that both tiagabine and gaboxadol increased the duration of SWS after sleep restriction. (Walsh (2009); Mathias S, Wetter T C, Steiger A, Lancel M. The GABA uptake inhibitor tiagabine promotes slow wave sleep in normal elderly subjects. Neurobiology of aging. 2001; 22(2):247-253; Walsh J K, Snyder E, Hall J, et al. Slow wave sleep enhancement with gaboxadol reduces daytime sleepiness during sleep restriction. Sleep. May 2008; 31(5):659-672; Feld G B, Wilhelm I, Ma Y, et al. Slow wave sleep induced by GABA agonist tiagabine fails to benefit memory consolidation. Sleep. Sep. 1, 2013; 36(9):1317-1326.). Tiagabine also improved performance on cognitive tasks evaluating executive functions and reduced the negative effects of sleep restriction on alertness. (Walsh J K, Randazzo A C, Stone K, et al. Tiagabine is associated with sustained attention during sleep restriction: evidence for the value of slow-wave sleep enhancement? Sleep-New York Then Westchester-. 2006; 29(4):433.). Although these results are positive, pharmacological approaches to sleep enhancement often raise issues related to dependence and tolerance and are commonly associated with residual daytime side effects. Some evidence suggests that some hypnotic drugs, while alleviating insomnia, change the structure of sleep adversely affecting the SWS. (Sateia (2000); Walsh (2009)). Even natural supplements, such as melatonin, can cause some side effects, including headache, short-term feelings of depression, daytime sleepiness, dizziness, stomach cramps, and irritability. (Buscemi et al. (2005)). Hence, there is an unmet need for a non-pharmacological technique for promoting sleep, particularly in the deep non-REM sleep stage lacking in the elderly population.
Brainwaves, e.g., EEG signals, may be acquired in various ways. Traditional signal acquisition by neurologists and encephalography/EEG technicians involves pasted-on electrodes or caps with arrays of electrodes, e.g., 20-256 electrodes positioned on the scalp. However, in some cases, especially where high spatial resolution is not required, and dominant brainwave patterns are sought, simpler and less controlled EEG acquisition systems may be employed, including through commercially available device intended to interface with smartphones. See, kokoon.io, www.thinkmindset.com/; www.choosemuse.com (Muse, Muse2); Neurosky; getvi.com (Vi Sense); Strickland, Eliza, “In-Ear EEG Makes Unobtrusive Brain-Hacking Gadgets a Real Possibility”, IEEE Spectrum Jul. 7, 2016; Strickland, Eliza, “Wireless Earbuds Will Record Your EEG, Send Brainwave Data To Your Phone”, IEEE Spectrum May 17, 2016. The Unicorn “Hybrid Black” wearable EEG headset provides a headset with eight electrode channels and digital data acquisition electronics (24 bit, 250 Hz), intended to provide a brain-computer interface for artistic, control and other tasks. See, www.unicorn-bi.com/. Starkey Laboratories, Inc. US 20190166434 discloses an ear-worn electronic device having a plurality of sensors for EEG signals from a wearer's ear, as a brain-computer interface. A number of designs provide in-ear headphones which integrate EEG electrodes that pick up signals from the ear canal. See Reference List Table 18.
The brain activity of a first subject (a “donor” who is in the desired sleeping state) may be captured by recording neural correlates of the sleep, as expressed by brain activity patterns, such as EEG signals. The representations of the neural correlates of the first subject are used to control stimulation of a second subject (a “recipient”), seeking to induce the same brain activity patterns of the donor in the recipient to assist the recipient in attaining the desired sleep state that had been attained by the donor.
One strategy to enhance deep sleep non-pharmacologically is to stimulate the brain with light, sound, electrical currents, or magnetic fields based on artificial and synthetic stimulation paradigms. Intermittent transcranial direct-current stimulation (tDCS) applied at 0.75 Hz for 5-min intervals separated by 1-min off periods after SWS onset can increase the EEG power in the slow oscillation band (<1 Hz) during the stimulation-free intervals. (Lang N, Siebner H R, Ward N S, et al. How does transcranial DC stimulation of the primary motor cortex alter regional neuronal activity in the human brain? European Journal of Neuroscience. 2005; 22(2):495-504; Marshall L, Helgadottir H, Molle M, Born J. Boosting slow oscillations during sleep potentiates memory. Nature. Nov. 30, 2006; 444(7119):610-613). Similarly, stimulated by tDCS at the beginning of SWS accelerate the SWA homeostatic decay in subjects. (Reato D, Gasca F, Datta A, Bikson M, Marshall L, Parra L C. Transcranial electrical stimulation accelerates human sleep homeostasis. PLoS Comput Biol. 2013; 9(2):e1002898). Furthermore, slow waves can be triggered by directly perturbing the cortex during non-REM sleep using transcranial magnetic stimulation (TMS). (Massimini M, Ferrarelli F, Esser S K, et al. Triggering sleep slow waves by transcranial magnetic stimulation. Proc Natl Acad Sci USA. May 15, 2007; 104(20):8496-8501). Other research has focused on the possibility of inducing slow waves in a more physiological natural manner. In a larger study in healthy adults, bilateral electrical stimulation of the vestibular apparatus shortened sleep onset latency in comparison to sham nights where no stimulation was provided. (Krystal A D, Zammit G K, Wyatt J K, et al. The effect of vestibular stimulation in a four-hour sleep phase advance model of transient insomnia. J Clin Sleep Med. Aug. 15, 2010; 6(4):315-321). The effect of somatosensory and auditory stimulation was also assessed (Krystal et al. 2010; Ngo H V, Martinetz T, Born J, Molle M. Auditory closed-loop stimulation of the sleep slow oscillation enhances memory. Neuron. May 8, 2013; 78(3):545-553). While the change observed with somatosensory stimulation was minor, acoustic stimulation was particularly efficacious in enhancing sleep slow waves. Specifically, using an intermittent stimulation, in which tones were played in blocks of 15 s spaced out by stimulation-free intervals, slow waves appeared remarkably large and numerous during the stimulation blocks. (Tononi G, Riedner B, Hulse B, Ferrarelli F, Sarasso S. Enhancing sleep slow waves with natural stimuli. Medicamundi. 2010; 54(2):73-79; Bellesi M, Riedner B A, Garcia-Molina G N, Cirelli C, Tononi G. Enhancement of sleep slow waves: underlying mechanisms and practical consequences. Frontiers in systems neuroscience. 2014; 8:208). In addition, high-density EEG studies (hdEEG, 256 channels) showed that the morphology, topography, and traveling patterns of induced slow waves were indistinguishable from those of spontaneous slow waves observed during natural sleep. A recent study found that EEG SWA increased following tone presentation during non-REM sleep (Arzi A, Shedlesky L, Ben-Shaul M, et al. Humans can learn new information during sleep. Nature neuroscience. 2012; 15(10):1460), and slow oscillation activity (0.5-1 Hz) was increased in response to continuous acoustic stimulation at 0.8 Hz starting 2 min before lights were turned off and lasting for 90 min. (Ngo H V, Claussen J C, Born J, Molle M. Induction of slow oscillations by rhythmic acoustic stimulation. J Sleep Res. February 2013; 22(1):22-31). Unlike the previous neurostimulation methods with artificial and synthetic stimulation paradigms, the present stimulation protocol uses source-derived waveforms, extracted from the indigenous brain activity EEG recordings of the healthy subjects, processed by statistical methods (e.g., principal component analysis, independent component analysis (Ungureanu M, Bigan C, Strungaru R, Lazarescu V. Independent component analysis applied in biomedical signal processing. Measurement Science Review. 2004; 4(2):18) or spatial principal component analysis, autocorrelation, etc.), which separates components of brain activity. These separated brain EEG activities are then modified or modulated and subsequently inverted and used for transcranial Endogenous Sleep-Derived stimulation (tESD). The application of endogenous brain waveform should not only retain the efficacy in triggering SWS but also alleviate the safety concerns that are associated with long-term brain stimulation using synthetic paradigms.
The present technology provides a method of improving sleep by transplanting sleep states-one desired sleep stage, or the sequences of sleep stages—from the first subject (donor) (or from a plurality of donors) to a second subject (recipient). (In some embodiments, the first and the second subject may be the same subject at different points in time, or based on a protocol or algorithm.)
The process seeks to achieve, in the subject, a brainwave pattern, which is derived from a human. The brainwave pattern is complex, representing a superposition of modulated waveforms. The modulation preferably is determined based on brain wave patterns of another subject or plurality of subjects.
Sleep is a natural periodic suspension of consciousness, basically a process that can hardly be influenced in its individual stages by the person sleeping., It is a subconscious (in a technical sense) mental state, representing a resting state, activity pattern, activity rhythm, readiness, receptivity, or other state, often independent of particular inputs. In essence, a sleep state in a particular sleep stage or a sequence of different sleep stages of the first subject (a “donor” who is in a desired sleep stage or goes through a sequence with its individual stages) is captured by recording neural correlates of the sleep state, e.g., as expressed by brain activity patterns, such as EEG or MEG signals. The neural correlates of the first subject, either as direct or recorded representations, may then be used to control a stimulation of the second subject (a “recipient”), seeking to induce the same brain activity patterns in the second subject (recipient) as were present in the first subject (donor), thereby transplanting the sleep state of the first subject (donor), to assist the second subject (recipient) to attain the desired sleep stage that had been attained by the donor. In an alternative embodiment, the signals from the first subject (donor) being in a first sleep stage are employed to prevent the second subject (recipient) from achieving a second sleep stage, wherein the second sleep stage is an undesirable one. Furthermore, the duration and timing of different sleep stages can be controlled in the second subject. This could enable the change of the individual duration or intensity of each sleep stage and the order in which they appear. In some embodiments, the signals from the first subject can be used to trigger sleep in the second subject or to prevent sleep or sleepiness and associated symptoms such as fatigue, lack of concentration, etc.
In one embodiment, brain activity patterns are recorded during a complete sleep cycle or during several such cycles over the course of a normal night sleeping. In some embodiments, the acquiring of the sleep state information is preceded by or followed by identifying the sleep stage, by direct reporting by the first subject (donor) or an observer, or by automated analysis of the physiological parameters (e.g., brain activity patterns, heartbeat, breathing pattern, oxygen saturation in blood, temperature, eye movement, skin impedance, etc.) or both. In other embodiments, the processing of the brain activity patterns does not seek to classify or characterize it, but rather to filter and transform the information to a form suitable for control of the stimulation of the second subject. In particular, according to this embodiment, the subtleties that are not yet reliably classified in traditional brain activity pattern analysis are respected. For example, it is understood that all brain activity is reflected in synaptic currents and other neural modulation and, therefore, theoretically, conscious and subconscious information is, in theory, accessible through brain activity pattern analysis. Since the available processing technology generally fails to distinguish a large number of different brain activity patterns, that available processing technology, is necessarily deficient, but improving. However, just because a computational algorithm is unavailable to extract the information, does not mean that the information is absent. Therefore, this embodiment employs relatively raw brain activity pattern data, such as filtered or unfiltered EEGs, to control the stimulation of the second subject, without a full comprehension or understanding of exactly what information of significance is present. In one embodiment, brainwaves are recorded and “played back” to another subject, similar to recording and playing back music. Such recording-playback may be digital or analog. Typically, the stimulation may include a low dimensionality stimulus, such as stereo-optic, binaural, isotonic tones, tactile, or other sensory stimulation, operating bilaterally, and with control over frequency and phase and/or waveform and/or transcranial stimulation such as TES, tDCS, HD-tDCS, tACS, or TMS. A plurality of different types of stimulation may be applied concurrently, e.g., visual, auditory, other sensory, magnetic, electrical.
Likewise, a present lack of complete understanding of the essential characteristics of the signal components in the brain activity patterns does not prevent their acquisition, storage, communication, and processing (to some extent). The stimulation may be direct, i.e., a visual, auditory, or tactile stimulus corresponding to the brain activity pattern or a derivative or feedback control based on the second subject's brain activity pattern.
To address the foregoing problems, in whole or in part, and/or other problems that may have been observed by persons skilled in the art, the present disclosure provides methods, processes, systems, apparatus, instruments, and/or devices, as described by way of example in implementations set forth below.
While mental states are typically considered internal to the individual, and subjective such states are common across individuals and have determinable physiological and electrophysiological population characteristics. Further, mental states may be externally changed or induced in a manner that bypasses the normal cognitive processes. In some cases, the triggers for the mental state are subjective, and therefore the particular subject-dependent sensory or excitation scheme required to induce a particular state will differ. For example, olfactory stimulation can have different effects on different people, based on differences in the history of exposure, social and cultural norms, and the like. On the other hand, some mental state response triggers are normative, for example, “tear jerker” media.
Mental states are represented in brainwave patterns, and in normal humans, the brainwave patterns and metabolic (e.g. blood flow, oxygen consumption, etc.) follow prototypical patterns. Therefore, by monitoring brainwave patterns in an individual, a state or series of mental states in that person may be determined or estimated. However, the brainwave patterns may be interrelated with context, other activity, and past history. Further, while prototypical patterns may be observed, there are also individual variations in the patterns. The brainwave patterns may include characteristic spatial and temporal patterns indicative of mental state. The brainwave signals of a person may be processed to extract these patterns, which, for example, may be represented as hemispheric signals within a frequency range of 3-100 Hz. These signals may then be synthesized or modulated into one or more stimulation signals, which are then employed to induce a corresponding mental state into a recipient, in a manner seeking to achieve a similar brainwave pattern from the source. The brainwave pattern to be introduced need not be newly acquired for each case. Rather, signals may be acquired from one or more individuals, to obtain an exemplar for various respective mental state. Once determined, the processed signal representation may be stored in non-volatile memory for later use. However, in cases of complex interaction between a mental state and a context or content or activity, it may be appropriate to derive the signals from a single individual whose context or content-environment or activity is appropriate for the circumstances. Further, in some cases, a single mental state, emotion or mood is not described or fully characterized, and therefore acquiring signals from a source is an efficient exercise.
With a library of target brainwave patterns, a system and method is provided in which a target subject may be immersed in a presentation, which includes not only multimedia content but also a series of defined mental states, emotional states or moods that accompany the multimedia content. In this way, the multimedia presentation becomes fully immersive. The stimulus, in this case, may be provided through a headset, such as a virtual reality or augmented reality headset. This headset is provided with a stereoscopic display, binaural audio, and a set of EEG stimulatory electrodes. These electrodes (if provided) typically deliver a subthreshold signal, which is not painful, which is typically an AC signal which corresponds to the desired frequency, phase, and spatial location of the desired target pattern. The electrodes may also be used to counteract undesired signals, by destructively interfering with them while concurrently imposing the desired patterns. The headset may also generate visual and/or auditory signals which correspond to the desired state. For example, the auditory signals may induce binaural beats, which cause brainwave entrainment. The visual signals may include intensity fluctuations or other modulation patterns, especially those which are subliminal, that are also adapted to cause brainwave entrainment or induction of the desired brainwave pattern.
The headset preferably includes EEG electrodes for receiving feedback from the user. That is, the stimulatory system seeks to achieve a mental state, emotion or mood response from the user. The EEG electrodes permit determination of whether that state is achieved, and if not, what the current state is. It may be that achieving the desired brainwave pattern is state dependent, and therefore that characteristics of the stimulus to achieve the desired state depend on the starting state of the subject. Other ways of determining mental state, emotion, or mood include analysis of facial expression, electromyography (EMG) analysis of facial muscles, explicit user feedback, etc.
An authoring system is provided which permits a content designer to determine what mental states are desired, and then encode those states into media, which is then interpreted by a media reproduction system in order to generate appropriate stimuli. As noted above, the stimuli may be audio, visual, multimedia, other senses, or electrical or magnetic brain stimulation, and therefore a VR headset with transcranial electrical or magnetic stimulation is not required. Further, in some embodiments, the patterns may be directly encoded into the audiovisual content, subliminally encoded. In some cases, the target mental state may be derived from an expert, actor or professional exemplar. The states may be read based on facial expressions, EMG, EEG, or other means, from the actor or exemplar. For example, a prototype exemplar engages in an activity that triggers a response, such as viewing the Grand Canyon or artworks within the Louvre. The responses of the exemplar are then recorded or represented, and preferably brainwave patterns recorded that represent the responses. A representation of the same experience is then presented to the target, with a goal of the target also experiencing the same experience as the exemplar. This is typically a voluntary and disclosed process, so the target will seek to willingly comply with the desired experiences. In some cases, the use of the technology is not disclosed to the target, for example in advertising presentations or billboards. In order for an actor to serve as the exemplar, the emotions achieved by that person must be authentic. However, so-called “method actors” do authentically achieve the emotions they convey. However, in some cases, for example, where facial expressions are used as the indicator of mental state, an actor can present desired facial expressions with inauthentic mental states. The act of making a face corresponding to an emotion often achieves the targeted mental state.
In general, the present technology is directed toward inducing sleep. Note that certain kinds of content are known to assist in induction of sleep, e.g., a lullabye. However, the present technology encompasses both human comprehensible signals and incomprehensible (noise-like) signals.
In order to calibrate the system, the brain pattern of a person may be measured while in the desired state. The brain patterns acquired for calibration or feedback need not be of the same quality, or precision, or data depth, and indeed may represent responses rather than primary indicia. That is, there may be some asymmetry in the system, between the brainwave patterns representative of a mental state, and the stimulus patterns appropriate for inducing the brain state.
The present invention generally relates to achieving a mental state in a subject by conveying to the brain of the subject patterns of brainwaves. These brainwaves may be artificial or synthetic, or derived from the brain of a second subject (e.g., a person experiencing an authentic experience or engaged in an activity). Typically, the wave patterns of the second subject are derived while the second subject is experiencing an authentic experience.
A special case is where the first and second subjects are the same individual. For example, brainwave patterns are recorded while a subject is in a particular mental state. That same pattern may assist in achieving the same mental state at another time. Thus, there may be a time delay between the acquisition of the brainwave information from the second subject, and exposing the first subject to corresponding stimulation. The signals may be recorded and transmitted.
The temporal pattern may be conveyed or induced non-invasively via light (visible or infrared), sound (or infrasound). Alternately, non-sensory stimulation may be employed, e.g., transcranial direct or alternating current stimulation (tDCS or tACS), transcranial magnetic stimulation (TMS), Deep transcranial magnetic stimulation (Deep TMS, or dTMS), Repetitive Transcranial Magnetic Stimulation (rTMS) olfactory stimulation, tactile stimulation, or any other means capable of conveying frequency patterns. In a preferred embodiment, normal human senses are employed to stimulate the subject, such as light, sound, smell, and touch. Combinations of stimuli may be employed. In some cases, the stimulus or combination is innate, and therefore largely pan-subject. In other cases, response to a context is learned, and therefore subject-specific. Therefore, feedback from the subject may be appropriate to determine the triggers and stimuli appropriate to achieve a mental state.
This technology may be advantageously used to enhance mental response to a stimulus or context. Still another aspect provides for a change in the mental state. The technology may be used in humans or animals.
The present technology may employ an event-correlated EEG time and/or frequency analysis performed on neuronal activity patterns. In a time-analysis, the signal is analyzed temporally and spatially, generally looking for changes with respect to time and space. In a frequency analysis, over an epoch of analysis, the data, which is typically a time-sequence of samples, is transformed, using e.g., a Fourier transform (FT, or one implementation, the Fast Fourier Transform, FFT), into a frequency domain representation, and the frequencies present during the epoch are analyzed. The window of analysis may be rolling, and so the frequency analysis may be continuous. In a hybrid time-frequency analysis, for example, a wavelet analysis, the data during the epoch is transformed using a “wavelet transform”, e.g., the Discrete Wavelet Transform (DWT) or continuous wavelet transform (CWT), which has the ability to construct a time-frequency representation of a signal that offers very good time and frequency localization. Changes in transformed data over time and space may be analyzed. In general, the spatial aspect of the brainwave analysis is anatomically modeled. In most cases, anatomy is considered universal, but in some cases, there are significant differences. For example, brain injury, psychiatric disease, age, race, native language, training, sex, handedness, and other factors may lead to distinct spatial arrangement of brain function, and therefore when transferring mood from one individual to another, it is preferred to normalize the brain anatomy of both individuals by experiencing roughly the same experiences, and measuring spatial parameters of the EEG or MEG. Note that spatial organization of the brain is highly persistent, absent injury or disease, and therefore, this need only be performed infrequently. However, since electrode placement may be inexact, a spatial calibration may be performed after electrode placement.
Different aspects of EEG magnitude and phase relationships may be captured, to reveal details of the neuronal activity. The “time-frequency analysis” reveals the brain's parallel processing of information, with oscillations at various frequencies within various regions of the brain reflecting multiple neural processes co-occurring and interacting. See, Lisman J, Buzsaki G. A neural coding scheme formed by the combined function of gamma and theta oscillations. Schizophr Bull. Jun. 16, 2008; doi:10.1093/schbul/sbn060. Such a time-frequency analysis may take the form of a wavelet transform analysis. This may be used to assist in integrative and dynamically adaptive information processing. Of course, the transform may be essentially lossless and may be performed in any convenient information domain representation. These EEG-based data analyses reveal the frequency-specific neuronal oscillations and their synchronization in brain functions ranging from sensory processing to higher-order cognition. Therefore, these patterns may be selectively analyzed, for transfer to or induction in, a subject.
A statistical clustering analysis may be performed in high dimension space to isolate or segment regions which act as signal sources, and to characterize the coupling between various regions. This analysis may also be used to establish signal types within each brain region and decision boundaries characterizing transitions between different signal types. These transitions may be state dependent, and therefore the transitions may be detected based on a temporal analysis, rather than merely a concurrent oscillator state.
The various measures make use of the magnitude and/or phase angle information derived from the complex data extracted from the EEG during spectral decomposition and/or temporal/spatial/spectral analysis. Some measures estimate the magnitude or phase consistency of the EEG within one channel across trials, whereas others estimate the consistency of the magnitude or phase differences between channels across trials. Beyond these two families of calculations, there are also measures that examine the coupling between frequencies, within trials and recording sites. Of course, in the realm of time-frequency analysis, many types of relationships can be examined beyond those already mentioned.
These sensory processing specific neuronal oscillations, e.g., brainwave patterns, e.g., of a subject (a “source”) or to a person trained (for example, an actor trained in “the method”) to create the desired state, and can be stored on a tangible medium and/or can be simultaneously conveyed to a recipient making use of the brain's frequency following response nature. See, Galbraith, Gary C., Darlene M. Olfman, and Todd M. Huffman. “Selective attention affects human brain stem frequency-following response.” Neuroreport 14, no. 5 (2003): 735-738, journals.lww.com/neuroreport/Abstract/2003/04150/Selective_attention_affects_human_brain_stem.15.aspx.
According to one embodiment, the stimulation of the second subject is combined with a feedback process, to verify that the second subject has appropriately responded to the stimulation, e.g., has a predefined similarity to the sleep stage as the first subject, has a sleep stage with a predefined difference from the first subject, or has the desired change from a baseline sleep stage. The feedback may be based on brain activity per se, or neural correlates of sleep stage or, alternatively, or, in addition, physical, psychological, or behavioral effects that may be measured, reported or observed.
The feedback typically is provided to a controller with at least partial model basis, for the stimulator, which alters stimulation parameters to optimize the stimulation.
As discussed above, the model is typically difficult to define. Therefore, the model-based controller is incompletely defined, and the existence of errors and artifacts is to be expected. However, by employing a model-based controller, those parameters that are defined may be used to improve response over the corresponding controller, which lacks the model.
For example, it is believed that brainwaves represent a form of resonance, where ensembles of neurons interact in a coordinated fashion. The frequency of the wave is related to neural responsiveness to neurotransmitters, distances along neural pathways, diffusion limitations, etc. That is, the same sleep stage may be represented by slightly different frequencies in two different individuals, based on differences in the size of their brains, neuromodulators present, other anatomical, morphological and physiological differences, etc. These differences may be measured in microseconds or less, resulting in small changes in frequency. Therefore, the model component of the controller can determine the parameters of neural transmission and ensemble characteristics, vis-à-vis stimulation, and resynthesize the stimulus signal to match the correct frequency and phase of the subject's brainwave, with the optimization of the waveform adaptively determined. This may not be as simple as speeding up or slowing down playback of the signal, as different elements of the various brainwaves representing neural correlates of a sleep stage may have different relative differences between subjects.
Of course, in some cases, one or more components of the stimulation of the target subject (recipient) may be represented as abstract or semantically defined signals, and, more generally, the processing of the signals to define the stimulation will involve high-level modulation or transformation between the source signal received from the first subject (donor) or plurality of donors, to define the target signal for stimulation of the second subject (recipient).
Preferably, each component represents a subset of the neural correlates reflecting brain activity that has a high autocorrelation in space and time, or in a hybrid representation such as wavelet. These may be separated by optimal filtering (e.g., spatial PCA), once the characteristics of the signal are known, and bearing in mind that the signal is accompanied by a modulation pattern and that the two components themselves may have some weak coupling and interaction.
For example, if the first subject (donor) is listening to music, there will be significant components of the neural correlates that are synchronized with the particular music. On the other hand, the music per se may not be part of the desired stimulation of the target subject (recipient). Further, the target subject (recipient) may be in a different acoustic environment, and it may be appropriate to modify the residual signal dependent on the acoustic environment of the recipient, so that the stimulation is appropriate for achieving the desired effect, and does not represent phantoms, distractions, or irrelevant or inappropriate content. In order to perform signal processing, it is convenient to store the signals or a partially processed representation, though a complete real-time signal processing chain may be implemented. According to another embodiment, a particular stage of the sleep state of at least one first subject (donor) is identified, and the neural correlates of brain activity are captured, and the second subject (recipient) is subject to stimulation based on the captured neural correlates and the identified sleep stage. The sleep stage is typically represented as a semantic variable within a limited classification space. The sleep stage identification need not be through analysis of the neural correlates signal and may be a volitional self-identification by the first subject, e.g., based on other body signals or by an observer, or a manual classification by third parties using, for example, observation, fMRI or psychological assessment. The identified sleep stage is useful, for example, because it represents a target toward (or, in some cases, against) which the second subject (recipient) can be steered.
The stimulation may be one or more stimulus applied to the second subject (trainee or recipient), which may be a sensory stimulation (e.g., visual, auditory, or tactile), mechanical stimulation, ultrasonic stimulation, etc., and controlled with respect to waveform, frequency, phase, intensity/amplitude, duration, or controlled via feedback, self-reported effect by the second subject, manual classification by third parties, automated analysis of brain activity, behavior, physiological parameters, etc. of the second subject (recipient).
Typically, the goal of the process is to improve sleep in a recipient by transplanting the desired sleep stages, or a sequence of stages, of at least one first subject (donor) to the second subject (recipient) by inducing in the second subject (recipient) neural correlates of the sleep stage (or a sequence of stages) of at least one first subject (donor) corresponding to the sleep stage of the first subject, through the use of stimulation parameters comprising a waveform over a period of time derived from the neural correlates of the sleep stage of the first subject.
Typically, the first and the second subjects are spatially remote from each other and may be temporally remote as well. In some cases, the first and second subject are the same subject (human or animal), temporally displaced. In other cases, the first and the second subject are spatially proximate to each other. These different embodiments differ principally in the transfer of the signal from at least one first subject (donor) to the second subject (recipient). However, when the first and the second subjects share a common environment, the signal processing of the neural correlates and, especially of real-time feedback of neural correlates from the second subject, may involve interactive algorithms with the neural correlates of the first subject.
According to another embodiment, the first and second subjects are each subject to stimulation. In one particularly interesting embodiment, the first subject and the second subject communicate with each other in real-time, with the first subject receiving stimulation based on the second subject, and the second subject receiving feedback based on the first subject. This can lead to synchronization of neural correlates (e.g., neuronal oscillations, or brainwaves) and, consequently, of sleep stage between the two subjects. The neural correlates may be neuronal oscillations resulting in brainwaves that are detectable as, for example, EEG, qEEG, or MEG signals. Traditionally, these signals are found to have dominant frequencies, which may be determined by various analyses, such as spectral analysis, wavelet analysis, or principal component analysis (PCA), for example. One embodiment provides that the modulation pattern of a brainwave of at least one first subject (donor) is determined independently of the dominant frequency of the brainwave (though, typically, within the same class of brainwaves), and this modulation imposed on a brainwave corresponding to the dominant frequency of the second subject (recipient). That is, once the second subject achieves that same brainwave pattern as the first subject (which may be achieved by means other than electromagnetic, mechanical, or sensory stimulation), the modulation pattern of the first subject is imposed as a way of guiding the sleep stage of the second subject.
According to another embodiment, the second subject (recipient) is stimulated with a stimulation signal, which faithfully represents the frequency composition of a defined component of the neural correlates of at least one first subject (donor). The defined component may be determined based on principal component analysis, independent component analysis (ICI), eigenvector-based multivariable analysis, factor analysis, canonical correlation analysis (CCA), nonlinear dimensionality reduction (NLDR), or related technique.
The stimulation may be performed, for example, by using a light stimulation, a sound stimulation, a tactile stimulation, or olfactory stimulation. An auditory stimulus may be, for example, binaural beats or isochronic tones. Non-sensory stimulation may include a TES device, such as a tDCS device, a high-definition tDCS device, an osc-tDCS device, a pulse-tDCS (“electrosleep”) device, an osc-tDCS, a tACS device, a CES device, a TMS device, rTMS device, a deep TMS device, a light source, or a sound source configured to modulate the dominant frequency on respectively the light signal or the sound signal. The stimulus may be a light signal, a sonic signal (sound), an electric signal, a magnetic field, olfactory or tactile stimulation. The current signal may be a pulse signal or an oscillating signal. The stimulus may be applied via a cranial electric stimulation (CES), a transcranial electric stimulation (TES), a deep electric stimulation, a transcranial magnetic stimulation (TMS), a deep magnetic stimulation,
The technology also provides a processor configured to process the neural correlates of sleep stage from the first subject (donor), and to produce or define a stimulation pattern for the second subject (recipient) selectively dependent on a waveform pattern of the neural correlates from the first subject. Typically, the processor performs signal analysis and calculates at least a dominant frequency of the brainwaves of the first subject, and preferably also spatial and phase patterns within the brain of the first subject. The processor may also perform a PCA, a spatial PCA, an independent component analysis (ICA), eigenvalue decomposition, eigenvector-based multivariate analyses, factor analysis, an autoencoder neural network with a linear hidden layer, linear discriminant analysis, network component analysis, nonlinear dimensionality reduction (NLDR), or another statistical method of data analysis.
A signal is presented to a second apparatus, configured to stimulate the second subject (recipient), which may be an open loop stimulation dependent on a non-feedback-controlled algorithm, or a closed loop feedback dependent algorithm. The second apparatus produces a stimulation intended to induce in the second subject (recipient) the desired sleep stage, e.g., representing the same sleep stage as was present in the first subject (donor).
A typically process performed on the neural correlates is filtering to remove noise. In some embodiments, noise filters may be provided, for example, at 50 Hz, 60 Hz, 100 Hz, 120 Hz, and additional overtones (e.g., tertiary and higher harmonics). The stimulator associated with the second subject (recipient) would typically perform decoding, decompression, decryption, inverse transformation, modulation, etc.
Alternately, an authentic wave or hash thereof may be authenticated via a blockchain, and thus authenticatable by an immutable record. In some cases, it is possible to use the stored encrypted signal in its encrypted form, without decryption. For example, with an asymmetric encryption scheme, which supports distance determination.
Due to different brain sizes, and other anatomical, morphological, and/or physiological differences, dominant frequencies associated with the same sleep stage may be different in different subjects. Consequently, it may not be optimal to forcefully impose on the recipient the frequency of the donor that may or may not precisely correspond to the recipient's frequency associated with the same sleep stage. Accordingly, in some embodiments, the donor's frequency may be used to start the process of inducing the desired sleep stage in a recipient. As some point, when the recipient is closed to achieving the desired sleep state, the stimulation is either stopped or replaced with neurofeedback allowing the brain of the recipient to find its optimal frequency associated with the desired sleep stage.
In one embodiment, the feedback signal from the second subject may be correspondingly encoded as per the source signal, and the error between the two minimized. According to one embodiment, the processor may perform a noise reduction distinct from frequency-band filtering. According to one embodiment, the neural correlates are transformed into a sparse matrix, and in the transform domain, components having a high probability of representing noise are masked, while components having a high probability of representing signal are preserved. That is, in some cases, the components that represent modulation that are important may not be known a priori. However, dependent on their effect in inducing the desired response in the second subject (recipient), the “important” components may be identified, and the remainder filtered or suppressed. The transformed signal may then be inverse-transformed and used as a basis for a stimulation signal.
According to another embodiment, a method of sleep stage modification, e.g., brain entrainment, is provided, comprising: ascertaining a sleep stage in a plurality of first subjects (donors); acquiring brainwaves of the plurality of first subjects (donors), e.g., using one of EEG and MEG, to create a dataset containing brainwaves corresponding to different sleep stages. The database may be encoded with a classification of sleep stages, activities, environment, or stimulus patterns, applied to the plurality of first subjects, and the database may include acquired brainwaves across a large number of sleep stages, activities, environment, or stimulus patterns, for example. In many cases, the database records will reflect a characteristic or dominant frequency of the respective brainwaves.
Sleep stages, activities, environment, or stimulus patterns, for example, and a stimulation pattern for a second subject (recipient) defined based on the database records of one or more subjects (donors).
The record(s) thus retrieved are used to define a stimulation pattern for the second subject (recipient). As a relatively trivial example, a female recipient could be stimulated principally based on records from female donors. Similarly, a child recipient of a certain age could be stimulated principally based on the records from children donors of a similar age. Likewise, various demographic, personality, and/or physiological parameters may be matched to ensure a high degree of correspondence to between the source and target subjects. In the target subject, a guided or genetic algorithm may be employed to select modification parameters from the various components of the signal, which best achieve the desired target state based on feedback from the target subject.
Of course, a more nuanced approach is to process the entirety of the database and stimulate the second subject based on a global brainwave-stimulus model, though this is not required, and also, the underlying basis for the model may prove unreliable or inaccurate. It may be preferred to derive a stimulus waveform from only a single first subject (donor), in order to preserve micro-modulation aspects of the signal, which, as discussed above, have not been fully characterized. However, the selection of the donor(s) need not be static and can change frequently. The selection of donor records may be based on population statistics of other users of the records, i.e., whether or not the record had the expected effect, filtering donors whose response pattern correlates highest with a given recipient, etc. The selection of donor records may also be based on feedback patterns from the recipient.
The process of stimulation typically seeks to target the desired sleep stage in the recipient, which is automatically or semi-automatically determined or manually entered. In one embodiment, the records are used to define a modulation waveform of a synthesized carrier or set of carriers, and the process may include a frequency domain multiplexed multi-subcarrier signal (which is not necessarily orthogonal). A plurality of stimuli may be applied concurrently, through the different subchannels and/or though different stimulator electrodes, electric current stimulators, magnetic field generators, mechanical stimulators, sensory stimulators, etc. The stimulus may be applied to achieve brain entrainment (i.e., synchronization) of the second subject (recipient) with one or more first subjects (donors). If the plurality of donors are mutually entrained, then each will have a corresponding brainwave pattern dependent based on brainwave entrainment. This link between donors may help determine compatibility between a respective donor and the recipient. For example, characteristic patterns in the entrained brainwaves may be determined, even for different target sleep stages, and the characteristic patterns may be correlated to find relatively close matches and to exclude relatively poor matches.
This technology may also provide a basis for a social network, dating site, employment, mission (e.g., space or military), or vocational testing, or other interpersonal environments, wherein people may be matched with each other based on entrainment characteristics. For example, people who efficiently entrain with each other may have better compatibility and, therefore, a better marriage, work, or social relationships than those who do not. The entrainment effect need not be limited to sleep stages and may arise across any context.
As discussed above, the plurality of first subjects (donors) may have their respective brainwave patterns stored in separate database records. However, they may also be combined into a more global model. One such model is a neural network or a deep neural network. Typically, such a network would have recurrent features. Data from a plurality of first subjects (donors) is used to train the neural network, which is then accessed by inputting the target stage and/or feedback information, and which outputs a stimulation pattern or parameters for controlling a stimulator(s). When multiple first subjects (donors) form the basis for the stimulation pattern, it is preferred that the neural network output parameters of the stimulation, derived from and comprising features of the brainwave patterns or other neural correlates of sleep stage from the plurality of first subject (donors), which are then used to control a stimulator which, for example, generates its own carrier wave(s) which are then modulated based on the output of the neural network. A trained neural network need not periodically retrieve records and, therefore, may operate in a more time-continuous manner, rather than the more segmented scheme of record-based control.
In any of the feedback dependent methods, the brainwave patterns or other neural correlates of sleep stages may be processed by a neural network, to produce an output that guides or controls the stimulation. The stimulation, is, for example, at least one of a light signal, a sound signal, an electric signal, a magnetic field, an olfactory signal, a chemical signal, and vibration or mechanical stimulus. The process may employ a relational database of sleep stages and brainwave patterns, e.g., frequencies/neural correlate waveform patterns associated with the respective sleep stages. The relational database may comprise a first table, the first table further comprising a plurality of data records of brainwave patterns, and a second table, the second table comprising a plurality of sleep stages, each of the sleep stages being linked to at least one brainwave pattern. Data related to sleep stages and brainwave patterns associated with the sleep stages are stored in the relational database and maintained. The relational database is accessed by receiving queries for selected (existing or desired) sleep stages, and data records are returned representing the associated brainwave pattern. The brainwave pattern retrieved from the relational database may then be used for modulating a stimulator seeking to produce an effect selectively dependent on the desired sleep stage.
A further aspect of the technology provides a computer apparatus for creating and maintaining a relational database of sleep stages and frequencies associated with the sleep stage. The computer apparatus may comprise a non-volatile memory for storing a relational database of sleep stages and neural correlates of brain activity associated with the sleep stages, the database comprising a first table comprising a plurality of data records of neural correlates of brain activity associated with the sleep stages, and a second table comprising a plurality of sleep stages, each of the sleep stages being linked to one or more records in the first table; a processor coupled with the non-volatile memory, and is configured to process relational database queries, which are then used for searching the database; RAM coupled with the processor and the non-volatile memory for temporary holding database queries and data records retrieved from the relational database; and an 10 interface configured to receive database queries and deliver data records retrieved from the relational database. A structured query language (SQL) or alternate to SQL (e.g., noSQL) database may also be used to store and retrieve records. A relational database described above, maintained and operated by a general-purpose computer, improves the operations of the general-purpose computer by making searches of specific sleep stages and brainwaves associated therewith more efficient thereby, inter alia, reducing the demand on computing power.
A further aspect of the technology provides a method of brain entrainment comprising: ascertaining a sleep stage in at least one first subject (donor), recording brainwaves of said at least one first subject (donor) using at least one channel of EEG and/or MEG; storing the recorded brainwaves in a physical memory device, retrieving the brainwaves from the memory device, applying a stimulus signal comprising a brainwave pattern derived from at least one-channel of the EEG and/or MEG to a second subject (recipient) via sensory stimulation, whereby the sleep stage desired by the second subject (recipient) is achieved. The stimulation may be of the same dimension (number of channels) as the EEG or MEG, or a different number of channels, typically reduced. For example, the EEG or MEG may comprise 64, 128, or 256 channels.
One of the advantages of transforming the data is the ability to select a transform that separates the information of interest represented in the raw data, from noise or other information. Some transforms preserve the spatial and state transition history and may be used for a more global analysis. Another advantage of a transform is that it can present the information of interest in a form where relatively simple linear or statistical functions of a low order may be applied. In some cases, it is desired to perform an inverse transform on the data. For example, if the raw data includes noise, such as 50 or 60 Hz interference, a frequency transform may be performed, followed by a narrow band filtering of the interference and its higher order intermodulation products. An inverse transform may be performed to return the data to its time-domain representation for further processing. (In the case of simple filtering, a finite impulse response (FIR) or infinite impulse response (IIR) filter could be employed). In other cases, the analysis is continued in the transformed domain.
Transforms may be part of an efficient algorithm to compress data for storage or analysis, by making the representation of the information of interest consume fewer bits of information (if in digital form) and/or allow it to be communicated using lower bandwidth. Typically, compression algorithms will not be lossless, and as a result, the compression is irreversible with respect to truncated information.
Typically, the transformation(s) and filtering of the signal are conducted using traditional computer logic, according to defined algorithms. The intermediate stages may be stored and analyzed. However, in some cases, neural networks or deep neural networks may be used, convolutional neural network architectures, or even analog signal processing. According to one set of embodiments, the transforms (if any) and analysis are implemented in a parallel processing environment. Such as using a SIMD processor such as a GPU (or GPGPU). Algorithms implemented in such systems are characterized by an avoidance of data-dependent branch instructions, with many threads concurrently executing the same instructions.
EEG signals are analyzed to determine the location (e.g., voxel or brain region) from which an electrical activity pattern is emitted, and the wave pattern characterized. The spatial processing of the EEG signals will typically precede the content analysis, since noise and artifacts may be useful for spatial resolution. Further, the signal from one brain region will typically be noise or interference in the signal analysis from another brain region; so the spatial analysis may represent part of the comprehension analysis. The spatial analysis is typically in the form of a geometrically and/or anatomically-constrained statistical model, employing all of the raw inputs in parallel. For example, where the input data is transcutaneous electroencephalogram information, from 32 EEG electrodes, the 32 input channels, sampled at e.g., 500 sps, 1 ksps or 2 ksps, are processed in a four or higher dimensional matrix, to permit mapping of locations and communication of impulses over time, space and state.
The matrix processing may be performed in a standard computing environment, e.g., an i9-9900K, i9-9980HK, processor, under the Windows 10 operating system, executing Matlab (Mathworks, Woburn Mass.) software platform. Alternately, the matrix processing may be performed in a computer cluster or grid or cloud computing environment. The processing may also employ parallel processing, in either a distributed and loosely coupled environment, or asynchronous environment. One preferred embodiment employs a single instruction, multiple data processors, such as a graphics processing unit such as the nVidia CUDA environment or AMD Firepro high-performance computing environment.
Artificial intelligence (AI) and machine learning methods, such as artificial neural networks, deep neural networks, etc., may be implemented to extract the signals of interest. Neural networks act as an optimized statistical classifier and may have arbitrary complexity. A so-called deep neural network having multiple hidden layers may be employed. The processing is typically dependent on labeled training data, such as EEG data, or various processed, transformed, or classified representations of the EEG data. The label represents the emotion, mood, context, or state of the subject during acquisition. In order to handle the continuous stream of data represented by the EEG, a recurrent neural network architecture may be implemented. Depending preprocessing before the neural network, formal implementations of recurrence may be avoided. A four or more dimensional data matrix may be derived from the traditional spatial-temporal processing of the EEG and fed to a neural network. Since the time parameter is represented in the input data, a neural network temporal memory is not required, though this architecture may require a larger number of inputs. Principal component analysis (PCA, en.wikipedia.org/wiki/Principal_component_analysis), spatial PCA (arxiv.org/pdf/1501.03221v3.pdf, adegenet.r-forge.r-project.org/files/tutorial-spca.pdf, www.ncbi.nlm.nih.gov/pubmed/1510870); and clustering analysis may also be employed (en.wikipedia.org/wiki/Cluster_analysis, see U.S. Pat. Nos. 9,336,302, 9,607,023 and cited references).
In general, a neural network of this type of implementation will, in operation, be able to receive unlabeled EEG data, and produce the output signals representative of the predicted or estimated task, performance, context, or state of the subject during the acquisition of the unclassified EEG. Of course, statistical classifiers may be used rather than neural networks.
The analyzed EEG, either by conventional processing, neural network processing, or both, serves two purposes. First, it permits one to deduce which areas of the brain are subject to which kinds of electrical activity under which conditions. Second, it permits feedback during the training of a trainee (assuming proper spatial and anatomical correlates between the trainer and trainee), to help the system achieve the desired state, or as may be appropriate, the desired series of states and/or state transitions. According to one aspect of the technology, the applied stimulation is dependent on a measured starting state or status (which may represent a complex context and history-dependent matrix of parameters), and therefore the target represents a desired complex vector change. Therefore, this aspect of the technology seeks to understand a complex time-space-brain activity associated with an activity or task in a trainer, and to seek a corresponding complex time-space-brain activity associated with the same activity or task in a trainee, such that the complex time-space-brain activity state in the trainor is distinct from the corresponding state sought to be achieved in the trainee. This permits the transfer of training paradigms from qualitatively different persons, in different contexts, and, to some extent, to achieve a different result.
The conditions of data acquisition from the trainer will include both task data, and sensory-stimulation data. That is, a preferred application of the system is to acquire EEG data from a trainer or skilled individual, which will then be used to transfer learning, or more likely, learning readiness states, to a naïve trainee. The goal for the trainee is to produce a set of stimulation parameters that will achieve, in the trainee, the corresponding neural activity resulting in the EEG state of the trainer at the time of or preceding the learning of a skill or a task, or performance of the task.
It is noted that EEG is not the only neural or brain activity or state data that may be acquired, and, of course, any and all such data may be included within the scope of the technology, and therefore EEG is a representative example only of the types of data that may be used. Other types include fMRI, magnetoencephalogram, motor neuron activity, PET, etc.
While mapping the stimulus-response patterns distinct from the task is not required in the trainer, it is advantageous to do so, because the trainer may be available for an extended period, the stimulus of the trainee may influence the neural activity patterns, and it is likely that the trainer will have correlated stimulus-response neural activity patterns with the trainee(s). It should be noted that the foregoing has suggested that the trainer is a single individual, while in practice, the trainer may be a population of trainers or skilled individuals. The analysis and processing of brain activity data may, therefore, be adaptive, both for each respective individual and for the population as a whole.
For example, the system may determine that not all human subjects have common stimulus-response brain activity correlates, and therefore that the population needs to be segregated and clustered. If the differences may be normalized, then a normalization matrix or other correction may be employed. On the other hand, if the differences do not permit feasible normalization, the population(s) may be segmented, with different trainers for the different segments. For example, in some tasks, male brains have different activity patterns and capabilities than female brains. This, coupled with anatomical differences between the sexes, implies that the system may provide gender-specific implementations. Similarly, age differences may provide a rational and scientific basis for segmentation of the population. However, depending on the size of the information base and matrices required, and some other factors, each system may be provided with substantially all parameters required for the whole population, with a user-specific implementation based on a user profile or initial setup, calibration, and system training session.
According to one aspect of the present invention, a source subject is instrumented with sensors to determine localized brain activity during experiencing an event. The objective is to identify regions of the brain involved in processing this response.
The sensors will typically seek to determine neuron firing patterns and brain region excitation patterns, which can be detected by implanted electrodes, transcutaneous electroencephalograms, magnetoencephalograms, fMRI, and other technologies. Where appropriate, transcutaneous EEG is preferred, since this is non-invasive and relatively simple.
The source is observed with the sensors in a quiet state, a state in which he or she is experiencing an event, and various control states in which the source is at rest or engaged in different activities resulting in different states. The data may be obtained for a sufficiently long period of time and over repeated trials to determine the effect of duration. The data may also be a population statistical result, and need not be derived from only a single individual at a single time.
The sensor data is then processed using a 4D (or higher) model to determine the characteristic location-dependent pattern of brain activity over time associated with the state of interest. Where the data is derived from a population with various degrees of arousal, the model maintains this arousal state variable dimension.
A recipient is then prepared for receipt of the mental state. The mental state of the recipient may be assessed. This can include responses to a questionnaire, self-assessment, or other psychological assessment methods. Further, the transcutaneous EEG (or other brain activity data) of the recipient may be obtained, to determine the starting state for the recipient, as well as an activity during experiencing the desired mental state.
In addition, a set of stimuli, such as visual patterns, acoustic patterns, vestibular, smell, taste, touch (light touch, deep touch, proprioception, stretch, hot, cold, pain, pleasure, electric stimulation, acupuncture, etc.), vagus nerve (e.g., parasympathetic), are imposed on the subject, optionally over a range of baseline brain states, to acquire data defining the effect of individual and various combinations of sensory stimulation on the brain state of the recipient. Population data may also be used for this aspect.
The data from the source or population of sources (see above) may then be processed in conjunction with the recipient or population of recipient data, to extract information defining the optimal sensory stimulation over time of the recipient to achieve the desired brain state resulting in the desired mental state.
In general, for populations of sources and recipients, the data processing task is immense. However, the statistical analysis will generally be of a form that permits parallelization of mathematical transforms for processing the data, which can be efficiently implemented using various parallel processors, a common form of which is a SIMD (single instruction, multiple data) processor, found in typical graphics processors (GPUs). Because of the cost-efficiency of GPUs, it is referred to implement the analysis using efficient parallelizable algorithms, even if the computational complexity is nominally greater than a CISC-type processor implementation.
During stimulation of the recipient, the EEG pattern may be monitored to determine if the desired state is achieved through the sensory stimulation. A closed loop feedback control system may be implemented to modify the stimulation seeking to achieve the target. An evolving genetic algorithm may be used to develop a user model, which relates the mental state, arousal, and valence, sensory stimulation, and brain activity patterns, both to optimize the current session of stimulation and learning, as well as to facilitate future sessions, where the mental states of the recipient have further enhanced, and to permit use of the system for a range of mental states.
The technology may be embodied in apparatuses for acquiring the brain activity information from the source, processing the brain activity information to reveal a target brain activity state and a set of stimuli, which seek to achieve that state in a recipient, and generating stimuli for the recipient to achieve and maintain the target brain activity state over a period of time and potential state transitions. The generated stimuli may be feedback controlled. A general-purpose computer may be used for the processing of the information, a microprocessor, an FPGA, an ASIC, a system-on-a-chip, or a specialized system, which employs a customized configuration to efficiently achieve the information transformations required. Typically, the source and recipient act asynchronously, with the brain activity of the source recorded and later processed. However, real-time processing and brain activity transfer are also possible. In the case of a general purpose programmable processor implementation or portions of the technology, computer instructions may be stored on a nontransient computer readable medium. Typically, the system will have special-purpose components, such as a sensory stimulator, or a modified audio and/or display system, and therefore the system will not be a general purpose system. Further, even in a general purpose system, the operation per se is enhanced according to the present technology.
Mental states may be induced in a subject non-invasively via light, sound, or other means capable of conveying frequency patterns.
The transmission of the brainwaves can be accomplished through direct electrical contact with the electrodes implanted in the brain or remotely employing light, sound, electromagnetic waves, and other non-invasive techniques. Light, sound, or electromagnetic fields may be used to remotely convey the temporal pattern of prerecorded brainwaves to a subject by modulating the encoded temporal frequency on the light, sound or electromagnetic filed signal to which the subject is exposed.
Every activity, mental or motor, and emotion is associated with unique brainwaves having specific spatial and temporal patterns, i.e., a characteristic frequency or a characteristic distribution of frequencies over time and space. Such waves can be read and recorded by several known techniques, including electroencephalography (EEG), magnetoencephalography (MEG), exact low-resolution brain electromagnetic tomography (eLORETA), sensory evoked potentials (SEP), fMRI, functional near-infrared spectroscopy (fNIRS), etc. The cerebral cortex is composed of neurons that are interconnected in networks. Cortical neurons constantly send and receive nerve impulses-electrical activity-even during sleep. The electrical or magnetic activity measured by an EEG or MEG (or another device) device reflects the intrinsic activity of neurons in the cerebral cortex and the information sent to it by subcortical structures and the sense receptors.
It has been observed that “playing back the brainwaves” to another animal or person by providing decoded temporal pattern through transcranial direct current stimulation (tDCS), transcranial alternating current stimulation (tACS), high definition transcranial alternating current stimulation (HD-tDCS), transcranial magnetic stimulation (TMS), or through electrodes implanted in the brain allows the recipient to achieve the mental state at hand or to increase the speed of achievement. For example, if the brainwaves of a mouse navigated a familiar maze are decoded (by EEG or via implanted electrodes), playing this temporal pattern to another mouse unfamiliar with this maze will allow it to learn to navigate this maze faster.
Similarly, recording brainwaves associated with a specific response of one subject and later “playing back” this response to another subject will induce a similar response in the second subject. More generally, when one animal assumes a mental state, parts of the brain will have characteristic activity patterns. Further, by “artificially” inducing the same pattern in another animal, the other animal will have the same mental state or more easily be induced into that state. The pattern of interest may reside deep in the brain, and thus be overwhelmed in an EEG signal by cortical potentials and patterns. However, techniques other than surface electrode EEG may be used to determine and spatially discriminate deep brain activity, e.g., from the limbic system. For example, various types of magnetic sensors may sense deep brain activity. See, e.g., U.S. Pat. Nos. 9,618,591; 9,261,573; 8,618,799; and 8,593,141.
In some cases, EEGs dominated by cortical excitation patterns may be employed to sense the mental state, since the cortical patterns may correlate with lower-level brain activity. Note that the determination of a state representation of a mental state need not be performed each time the system is used; rather, once the brain spatial and temporal activity patterns and synchronization states associated with a particular mental states are determined, those patterns may be used for multiple targets and over time.
Similarly, while the goal is, for example, to trigger the target to assume the same brain activity patterns are the exemplar, this can be achieved in various ways, and these methods of inducing the desired patterns need not be invasive. Further, user feedback, especially in the case of a human transferee, may be used to tune the process. Finally, using the various senses, especially sight, sound, vestibular, touch, proprioception, taste, smell, vagus afferent, other cranial nerve afferent, etc. can be used to trigger high-level mental activity, that in a particular subject achieves the desired mental state, emotion or mood.
Thus, in an experimental subject, which may include laboratory scale and/or invasive monitoring, a set of brain electrical activity patterns that correspond to particular emotions or mental states is determined. Preferably, these are also correlated with surface EEG findings. For the transferee, a stimulation system is provided that is non-hazardous and non-invasive. For example, audiovisual stimulation may be exclusively used. A set of EEG electrodes is provided to measure brain activity, and an adaptive or genetic algorithm scheme is provided to optimize the audiovisual presentation, seeking to induce in the transferee the target pattern found in the experimental subject. After the stimulation patterns, which may be path dependent, are determined, it is likely that these patterns will be persistent, though over longer time periods, there may be some desensitization to the stimulation pattern(s). In some cases, audiovisual stimulation is insufficient, and TMS, PEMF, or other electromagnetic stimulation (superthreshold, or preferably subthreshold) is employed to assist in achieving the desired state and maintaining it for the desired period.
Employing light, sound or electromagnetic field to remotely convey the temporal pattern of brainwaves (which may be prerecorded) to a subject by modulating the encoded temporal frequency on the light, sound or electromagnetic filed signal to which the subject is exposed.
When a group of neurons fires simultaneously, the activity appears as a brainwave. Different brainwave-frequencies are linked to different mental states in the brain.
The desired mental state may be induced in a target individual (e.g., human, animal), by providing selective stimulation according to a temporal pattern, wherein the temporal pattern is correlated with an EEG pattern of the target when in the desired mental state, or represents a transition which represents an intermediate toward achieving the desired mental state. The temporal pattern may be targeted to a discrete spatial region within the brain, either by a physical arrangement of a stimulator, or natural neural pathways through which the stimulation (or its result) passes.
The EEG pattern may be derived from another individual or individuals, the same individual at a different time, or an in vivo animal model of the desired mental state. The method may, therefore, replicate a mental state of a first subject in a second subject. The mental state typically is not a state of consciousness or an idea, but rather a subconscious (in a technical sense) state, representing an emotion, readiness, receptivity, or another state, often independent of particular thoughts or ideas. In essence, a mental state of the first subject (a “trainer” or “donor” who is in a desired mental state) is captured by recording neural correlates of the mental state, e.g., as expressed by brain activity patterns, such as EEG or MEG signals. The neural correlates of the first subject, either as direct or recorded representations, may then be used to control a stimulation of the second subject (a “trainee” or “recipient”), seeking to induce the same brain activity patterns in the second subject (recipient/trainee) as were present in the first subject (donor/trainer) to assist the second subject (recipient/trainee) to attain the desired mental state that had been attained by the donor/trainer. In an alternative embodiment, the signals from the first subject (donor/trainer) being in the first mental state are employed to prevent the second subject (recipient/trainee) from achieving a second mental state, wherein the second mental state is an undesirable one.
The source brain wave pattern may be acquired through multichannel EEG or MEG, from a human in the desired brain state. A computational model of the brain state is difficult to create. However, such a model is not required according to the present technology. Rather, the signals may be processed by a statistical process (e.g., PCA or a related technology), or a statistically trained process (e.g., a neural network). The processed signals preferably retain information regarding signal source special location, frequency, and phase. In stimulating the recipient's brain, the source may be modified to account for brain size differences, electrode locations, etc. Therefore, the preserved characteristics are normalized spatial characteristics, frequency, phase, and modulation patterns.
The normalization may be based on feedback from the target subject, for example, based on a comparison of a present state of the target subject and a corresponding state of the source subject, or another comparison of known states between the target and source. Typically, the excitation electrodes in the target subject do not correspond to the feedback electrodes or the electrodes on the source subject. Therefore, an additional type of normalization is required, which may also be based on a statistical or statistically trained algorithm.
According to one embodiment, the stimulation of the second subject is associated with a feedback process, to verify that the second subject has appropriately responded to the stimulation, e.g., has a predefined similarity to the mental state as the first subject, has a mental state with a predefined difference from the first subject, or has a desired change from a baseline mental state. Advantageously, the stimulation may be adaptive to the feedback. In some cases, the feedback may be functional, i.e., not based on brain activity per se, or neural correlates of mental state, but rather physical, psychological, or behavioral effects that may be reported or observed.
The feedback typically is provided to a computational model-based controller for the stimulator, which alters stimulation parameters to optimize the stimulation in dependence on a brain and brain state model applicable to the target.
For example, it is believed that brainwaves represent a form of resonance, where ensembles of neurons interact in a coordinated fashion as a set of coupled or interacting oscillators. The frequency of the wave is related to neural responsivity to neurotransmitters, distances along neural pathways, diffusion limitations, etc., and perhaps pacemaker neurons or neural pathways. That is, the same mental state may be represented by different frequencies in two different individuals, based on differences in the size of their brains, neuromodulators present, physiological differences, etc. These differences may be measured in microseconds or less, resulting in fractional changes in frequency. However, if the stimulus is different from the natural or resonant frequency of the target process, the result may be different from that expected. Therefore, the model-based controller can determine the parameters of neural transmission and ensemble characteristics, vis-à-vis stimulation, and resynthesize the stimulus wave to match the correct waveform, with the optimization of the waveform adaptively determined. This may not be as simple as speeding up or slowing down playback of the signal, as different elements of the various waveforms representing neural correlates of mental state may have different relative differences between subjects. Therefore, according to one set of embodiments, the stimulator autocalibrates for the target, based on correspondence (error) of a measured response to the stimulation and the desired mental state sought by the stimulation. In cases where the results are chaotic or unpredictable based on existing data, a genetic algorithm may be employed to explore the range of stimulation parameters, and determine the response of the target.
In some cases, the target has an abnormal or unexpected response to stimulation based on a model maintained within the system. In this case, when the deviance from the expected response is identified, the system may seek to a new model, such as from a model repository that may be online, such as through the Internet. If the models are predictable, a translation may be provided between an applicable model of a source or trainer, and the applicable model of the target, to account for differences. In some cases, the desired mental state is relatively universal, such as sleep and awake. In this case, the brain response model may be a statistical model, rather than a neural network or deep neural network type implementation.
Thus, in one embodiment, a hybrid approach is provided, with the use of donor-derived brainwaves, on the one hand, which may be extracted from the brain activity readings (e.g., EEG or MEG) of the first at least one subject (donor), preferably processed by principal component analysis, or spatial principal component analysis, autocorrelation, or other statistical processing technique (clustering, PCA, etc.) or statistically trained technique (backpropagation of errors, etc.) that separates components of brain activity, which can then be modified or modulated based on high-level parameters, e.g., abstractions. See, ml4a.github.io/ml4a/how_neural_networks_are_trained/. Thus, the stimulator may be programmed to induce a series of brain states defined by name (e.g., sleep stage 1, sleep stage 2, etc.) or as a sequence of “abstract” semantic labels, icons, or other representations, each corresponding to a technical brain state or sequence of sub-states. The sequence may be automatically defined, based on biology and the system training, and thus relieve the programmer of low-level tasks. However, in a general case, the present technology maintains the use of components or subcomponents of the donor's brain activity readings, e.g., EEG or MEG, and does not seek to characterize or abstract them to a semantic level.
According to the present technology, a neural network system or statistical classifier may be employed to characterize the brain wave activity and/or other data from a subject. In addition to the classification or abstraction, a reliability parameter is presented, which predicts the accuracy of the output. Where the accuracy is high, a model-based stimulator may be provided to select and/or parameterize the model and generate a stimulus for a target subject. Where the accuracy is low, a filtered representation of the signal may be used to control the stimulator, bypassing the model(s). The advantage of this hybrid scheme is that when the model-based stimulator is employed, many different parameters may be explicitly controlled independently of the source subject. On the other hand, where the data processing fails to yield a highly useful prediction of the correct model-based stimulator parameters, the model itself may be avoided, in favor of a direct stimulation type system.
Of course, in some cases, one or more components of the stimulation of the target subject may be represented as abstract or semantically defined signals, and more generally the processing of the signals to define the stimulation will involve high-level modulation or transformation between the source signal received from the first subject, to define the target signal for stimulation of the second subject.
Preferably, each component represents a subset of the neural correlates reflecting brain activity that has a high spatial autocorrelation in space and time, or in a hybrid representation such as wavelet. For example, one signal may represent a modulated 10.2 Hz signal, while another signal represents a superposed modulated 15.7 Hz signal, with respectively different spatial origins. These may be separated by optimal filtering, once the spatial and temporal characteristics of the signal are known, and bearing in mind that the signal is accompanied by a modulation pattern, and that the two components themselves may have some weak coupling and interaction.
In some cases, the base frequency, modulation, coupling, noise, phase jitter, or another characteristic of the signal may be substituted. For example, if the first subject is listening to music, there will be significant components of the neural correlates that are synchronized with the particular music. On the other hand, the music per se may not be part of the desired stimulation of the target subject. Therefore, through signal analysis and decomposition, the components of the signal from the first subject, which have a high temporal correlation with the music, may be extracted or suppressed from the resulting signal. Further, the target subject may be in a different acoustic environment, and it may be appropriate to modify the residual signal dependent on the acoustic environment of the target subject, so that the stimulation is appropriate for achieving the desired effect, and does not represent phantoms, distractions, or irrelevant or inappropriate content. In order to perform processing, it is convenient to store the signals or a partially processed representation, though a complete real-time signal processing chain may be implemented. Such a real-time signal processing chain is generally characterized in that the average size of a buffer remains constant, i.e., the lag between output and input is relatively constant, bearing in mind that there may be periodicity to the processing.
The mental state of the first subject may be identified, and the neural correlates of brain activity captured. The second subject is subject to stimulation based on the captured neural correlates and the identified mental state. The mental state may be represented as a semantic variable, within a limited classification space. The mental state identification need not be through analysis of the neural correlates signal and may be a volitional self-identification by the first subject, a manual classification by third parties, or an automated determination. The identified mental state is useful, for example, because it represents a target toward (or against) which the second subject can be steered.
The stimulation may be one or more inputs to the second subject, which may be a sensory stimulation, mechanical stimulation, ultrasonic stimulation, etc., and controlled with respect to waveform, intensity/amplitude, duration, feedback, self-reported effect by the second subject, manual classification by third parties, automated analysis of brain activity, behavior, physiological parameters, etc. of the second subject.
The process may be used to induce in the target subject neural correlates of the desired mental state, which are derived from a different time for the same person, or a different person at the same or a different time. For example, one seeks to induce the neural correlates of the first subject in a desired mental state in a second subject, through the use of stimulation parameters comprising a waveform over a period of time derived from the neural correlates of the mental state of the first subject.
The first and second subjects may be spatially remote from each other and may be temporally remote as well. In some cases, the first and second subject are the same animal (e.g., human), temporally displaced. In other cases, the first and second subject are spatially proximate to each other. In some cases, neural correlates of a desired mental state are derived from a mammal having a simpler brain, which are then extrapolated to a human brain. (Animal brain stimulation is also possible, for example, to enhance training and performance). When the first and second subjects share a common environment, the signal processing of the neural correlates, and especially of real-time feedback of neural correlates from the second subject may involve interactive algorithms with the neural correlates of the first subject.
The first and second subjects may each be subject to stimulators. The first subject and the second subject may communicate with each other in real-time, with the first subject receiving stimulation based on the second subject, and the second subject receiving feedback based on the first subject. This can lead to synchronization of mental state between the two subjects. However, the first subject need not receive stimulation based on real-time signals from the second subject, as the stimulation may derive from a third subject or the first or second subjects at different points in time.
The neural correlates may be, for example, EEG, qEEG, or MEG signals. Traditionally, these signals are found to have dominant frequencies, which may be determined by various analyses. One embodiment provides that the modulation pattern of a brainwave of the first subject is determined independent of the dominant frequency of the brainwave (though typically within the same class of brainwaves), and this modulation imposed on a wave corresponding to the dominant frequency of the second subject. That is, once the second subject achieves that same brainwave pattern as the first subject (which may be achieved by means other than electromagnetic, mechanical, or sensors stimulation), the modulation pattern of the first subject is imposed as a way of guiding the mental state of the second subject.
The second subject may be stimulated with a stimulation signal, which faithfully represents the frequency composition of a defined component of the neural correlates of the first subject.
The stimulation may be performed, for example, by using a source of one of a light signal and a sound signal configured to modulate the dominant frequency on the one of a light signal and a sound signal. The stimulus may be at least one of a light signal, a sound signal, an electric signal, and a magnetic field. The stimulus may be a light stimulation or a sound stimulation. A visual stimulus may be ambient light or direct light. An auditory stimulus may be binaural beats or isochronic tones.
The technology may also provide a processor configured to process the neural correlates of mental state from the first subject, and to produce or define a stimulation pattern for the second subject selectively dependent on a waveform pattern of the neural correlates from the first subject. Typically, the processor performs signal analysis and calculates at least a dominant frequency of the brainwaves of the first subject, and preferably also spatial and phase patterns within the brain of the first subject.
A signal is presented to a second apparatus, configured to stimulate the second subject, which may be an open loop stimulation dependent on a non-feedback controlled algorithm, or a closed loop feedback dependent algorithm. In other cases, analog processing is employed in part or in whole, wherein the algorithm comprises an analog signal processing chain. The second apparatus receives information from the processor (first apparatus), typically comprising a representation of a portion of a waveform represented in the neural correlates. The second apparatus produces a stimulation intended to induce in the second subject the desired mental state, e.g., representing the same mental state as was present in the first subject.
A typical process performed on the neural correlates is filtering to remove noise. For example, notch filters may be provided at 50 Hz, 60 Hz, 100 Hz, 120 Hz, and additional overtones. Other environmental signals may also be filtered in a frequency-selective or waveform-selective (temporal) manner. Higher level filtering may also be employed, as is known in the art. The neural correlates, after noise filtering, may be encoded, compressed (lossy or losslessly), encrypted, or otherwise processed or transformed. The stimulator associated with the second subject would typically perform decoding, decompression, decryption, inverse transformation, etc.
Information security and copy protection technology, similar to that employed for audio signals, may be employed to protect the neural correlate signals from copying or content analysis before use. In some cases, it is possible to use the stored encrypted signal in its encrypted for without decryption. For example, with an asymmetric encryption scheme, which supports distance determination. See U.S. Pat. No. 7,269,277; Sahai and Waters (2005) Annual International Conference on the Theory and Applications of Cryptographic Techniques, pp. 457-473. Springer, Berlin, Heidelberg; Bringer et al. (2009) IEEE International Conference on Communications, pp. 1-6; Juels and Sudan (2006) Designs, Codes and Cryptography 2:237-257; Thaker et al. (2006) IEEE International Conference on Workload Characterization, pp. 142-149; Galil et al. (1987) Conference on the Theory and Application of Cryptographic Techniques, pp. 135-155.
Because the system may act intrusively, it may be desirable to authenticate the stimulator or parameters employed by the stimulator before use. For example, the stimulator and parameters it employs may be authenticated by a distributed ledger, e.g., a blockchain. On the other hand, in a closed system, digital signatures and other hierarchical authentication schemes may be employed. Permissions to perform certain processes may be defined according to smart contracts, which automated permissions (i.e., cryptographic authorization) provided from a blockchain or distributed ledger system. Of course, centralized management may also be employed.
In practice, the feedback signal from the second subject may be correspondingly encoded as per the source signal, and the error between the two minimized. In such an algorithm, the signal sought to be authenticated is typically brought within an error tolerance of the encrypted signal before usable feedback is available. One way to accomplish this is to provide a predetermined range of acceptable authenticatable signals which are then encoded, such that authentication occurs when the putative signal matches any of the predetermined range. In the case of the neural correlates, a large set of digital hash patterns may be provided representing different signals as hash patterns. The net result is relatively weakened encryption, but the cryptographic strength may still be sufficiently high to abate the risks.
The processor may perform a noise reduction distinct from frequency-band filtering. The neural correlates may be transformed into a sparse matrix, and in the transform domain, components representing high probability noise are masked, while components representing high probability signal are preserved. The distinction may be optimized or adaptive. That is, in some cases, the components which represent modulation that are important may not be known a priori. However, dependent on their effect in inducing the desired response in the second subject, the “important” components may be identified, and the remainder filtered or suppressed. The transformed signal may then be inverse-transformed and used as a basis for a stimulation signal.
A mental state modification, e.g., brain entrainment, may be provided, which ascertains a mental state in a plurality of first subjects; acquires brainwaves of the plurality of first subjects, e.g., using one of EEG and MEG, to create a dataset containing representing brainwaves of the plurality of first subjects. The database may be encoded with a classification of mental state, activities, environment, or stimulus patterns, applied to the plurality of first subjects, and the database may include acquired brainwaves across a large number of mental states, activities, environment, or stimulus patterns, for example. In many cases, the database records will reflect a characteristic or dominant frequency of the respective brainwaves. As discussed above, the trainer or first subject is a convenient source of the stimulation parameters but is not the sole available source. The database may be accessed according to its indexing, e.g., mental states, activities, environment, or stimulus patterns, for example, and a stimulation pattern for a second subject defined based on the database records of one or more subjects.
The record(s) thus retrieved are used to define a stimulation pattern for the second subject. The selection of records, and their use, may be dependent on the second subject and/or feedback from the second subject. As a relatively trivial example, a female second subject could be stimulated principally dependent on records from female first subjects. Of course, a more nuanced approach is to process the entirety of the database and stimulate the second subject based on a global brain wave-stimulus model, though this is not required, and also, the underlying basis for the model may prove unreliable or inaccurate. It may be preferred to derive a stimulus waveform from only a single first subject, in order to preserve micro-modulation aspects of the signal, which as discussed above have not been fully characterized. However, the selection of the first subject(s) need not be static and can change frequently. The selection of first subject records may be based on population statistics of other users of the records (i.e., collaborative filtering, i.e., whose response pattern do I correlate highest with? etc.). The selection of first subject records may also be based on feedback patterns from the second user.
The process of stimulation may seek to target a desired mental state in the second subject, which is automatically or semi-automatically determined or manually entered. That target then represents a part of the query against the database to select the desired record(s). The selection of records may be a dynamic process, and reselection of records may be feedback dependent.
The records may be used to define a modulation waveform of a synthesized carrier or set of carriers, and the process may include a frequency domain multiplexed multi-subcarrier signal (which is not necessarily orthogonal). A plurality of stimuli may be applied concurrently, through the suffered subchannels and/or through different stimulator electrodes, magnetic field generators, mechanical stimulators, sensory stimulators, etc. The stimuli for the different subchannels or modalities need not be derived from the same records.
The stimulus may be applied to achieve the desired mental state, e.g., brain entrainment of the second subject with one or more first subjects. Brain entrainment is not the only possible outcome of this process. If the plurality of first subjects is mutually entrained, then each will have a corresponding brain wave pattern dependent based on brainwave entrainment. This link between first subject may help determine compatibility between a respective first subject and the second subject. For example, characteristic patterns in the entrained brainwaves may be determined, even for different target mental states, and the characteristic patterns correlated to find relatively close matches and to exclude relatively poor matches.
This technology may also provide a basis for a social network, dating site, employment or vocational testing, or other interpersonal environments, wherein people may be matched with each other based on entrainment characteristics. For example, people who efficiently entrain with each other may have better social relationships than those who do not. Thus, rather than seeking to match people based on personality profiles, the match could be made based on the ability of each party to efficiently entrain the brainwave pattern of the other party. This enhances non-verbal communication and assists in achieving corresponding states during activities. This can be assessed by monitoring neural responses of each individual to video, and also by providing a test stimulation based on the other party's brainwave correlates of mental state, to see whether coupling is efficiently achieved. On the other hand, the technology could be used to assist in entrainment when the natural coupling is inefficient or to block coupling where the coupling is undesirable. An example of the latter is hostility; when two people are entrained in a hostile environment, emotional escalation ensures. However, if the entrainment is attenuated, undesired escalation may be impeded.
The process may employ a relational database of mental states and brainwave patterns, e.g., frequencies/neural correlate waveform patterns associated with the respective mental states. The relational database may comprise a first table, the first table further comprising a plurality of data records of brainwave patterns, and a second table, the second table comprising a plurality of mental states, each of the mental states being linked to at least one brainwave pattern. Data related to mental states and brainwave patterns associated with the mental states are stored in the relational database and maintained. The relational database is accessed by receiving queries for selected mental states, and data records are returned, representing the associated brainwave pattern. The brainwave pattern retrieved from the relational database may then be used for modulating a stimulator seeking to produce an effect selectively dependent on the mental state at issue.
A computer apparatus may be provided for creating and maintaining a relational database of mental states and frequencies associated with the mental states, the computer apparatus comprising: a non-volatile memory for storing a relational database of mental states and neural correlates of brain activity associated with the mental states, the database comprising a first table, the first table further comprising a plurality of data records of neural correlates of brain activity associated with the mental states, and a second table, the second table comprising a plurality of mental states, each of the mental states being linked to one or more records in the first table; a processor coupled with the non-volatile memory, configured to process relational database queries, which are then used for searching the database; RAM coupled with the processor and the non-volatile memory for temporary holding database queries and data records retrieved from the relational database; and an I/O interface configured to receive database queries and deliver data records retrieved from the relational database. An SQL or noSQL database may also be used to store and retrieve records.
A further aspect of the technology provides a method of brain entrainment comprising: ascertaining a mental state in a first subject; recording brainwaves of the plurality of subjects using at least one channel one of EEG and MEG; storing the recorded brainwaves in a physical memory device; retrieving the brainwaves from the memory device; applying a stimulus signal comprising a brainwave pattern derived from at least one-channel one of the EEG and MEG to a second subject via sensory stimulation, whereby the mental state desired by the second subject is achieved. The stimulation may be of the same order (number of channels) as the EEG or MEG, or a different number of channels, typically reduced. For example, the EEG or MEG may comprise 128 or 256 channels, while the sensory stimulator may have 8 or fewer channels. Transcranial stimulation of various modalities and patterns may accompany the sensory stimulation.
The present technology may be responsive to chronobiology, and in particular to the subjective sense of time. For a subject, this may be determined volitionally subjectively, but also automatically, for example by judging attention span, using, e.g., eye movements, and analyzing the persistence of brainwave patterns or other physiological parameters after a discrete stimulus. Further, time-constants of the brain, reflected by delays and phase may also be analyzed. Further, the contingent negative variation (CNV) preceding a volitional act may be used, both to determine (or measure) conscious action timing, and also the time relationships between thought and action more generally.
Typically, brainwave activity is measured with a large number of EEG electrodes, which each receive signals from a small area on the scalp, or in the case of a MEG, by several sensitive magnetic field detectors, which are responsive to local field differences. Typically, the brainwave capture is performed in a relatively high number of spatial dimensions, e.g., corresponding to the number of sensors. It is often unfeasible to process the brainwave signals to create a source model, given that the brainwaves are created by billions of neurons, connected through axons, which have long distances. Further, the neurons are generally non-linear and interconnected. However, a source model is not required.
Various types of artificial intelligence techniques may be exploited to analyze the neural correlates of a sleep stage represented in the brain activity data of both the first subject (donor) (or a plurality of donors) and the second subject (recipient). The algorithm or implementation need not be the same, though in some cases, it is useful to confirm the approach of the source processing and feedback processing so that the feedback does not achieve or seek a suboptimal target sleep stage. However, given the possible differences in conditions, resources, equipment, and purpose, there is no necessary coordination of these processes. The artificial intelligence may take the form of neural networks or deep neural networks, though rule/expert-based systems, hybrids, and more classical statistical analysis may be used. In a typical case, an artificial intelligence process will have at least one aspect, which is non-linear in its output response to an input signal, and thus at least the principle of linear superposition is violated. Such systems tend to permit discrimination, since a decision and the process of decision-making are, ultimately, non-linear. An artificially intelligent system requires a base of experience or information upon which to train. This can be supervised (external labels applied to data), unsupervised (self-discrimination of classes), or semi-supervised (a portion of the data is externally labeled).
A self-learning or genetic algorithm may be used to tune the system, including both or either the signal processing at the donor system and the recipient system. In a genetic algorithm feedback-dependent self-learning system, the responsivity of a subject, e.g., the target, to various kinds of stimuli may be determined over a stimulus space. This stimulation may be in the context of use, with a specific target sleep stage provided, or unconstrained. The stimulator may operate using a library of stimulus patterns, or seek to generate synthetic patterns or modifications of patterns. Over some time, the system will learn to map the desired sleep stage to optimal context-dependent parameters of the stimulus pattern.
The technology may be used for both the creation of a desired sleep stages in the recipient, elimination of existing sleep stages in the recipient. In the latter case, a decision of what end state is to be achieved is less constrained, and therefore, the optimization is distinct. For example, in the former case, it may be hard to achieve a particular sleep stage that is desired, requiring a set of transitions to cause the brain of the recipient to be enabled/prepared to enter the target state. In the case of a system seeking to eliminate an undesired sleep stage, the issue is principally what path to take to most efficiently leave the current state, bearing in mind the various costs, such as the comfort/discomfort of the stimulation, the time value cost, etc. Therefore, the series of states may differ in the implementation of these distinct goals, even if the endpoints are identical, i.e., the optimal algorithm to achieve state B from state A, may be different from the optimal algorithm to exist state A, and end up at state B.
The technology may be used to address sleep stages or sections of them associated with dreaming. Typically, dreaming is associated with many different brain regions. As such, the biology of dreaming is different. Often, dreams have a biochemical or hormonal component and, perhaps, a physiological component, that may be attenuated or absent from cognitive states. Dreaming had long been thought to occur largely during rapid-eye-movement (REM) sleep, but dreams have also been reported to occur during non-REM sleep. However, dreams are typically remembered, if the dreamer wakes us during the REM phase of the sleep. In addition, it has been shown that dreaming, for example, about faces was linked to increased high-frequency activity in the specific region of the brain involved in face recognition, with dreams involving spatial perception, movement and thinking similarly linked to regions of the brain that handle such tasks when awake. Therefore, while the general brainwave or other neural correlates acquisition from a donor may be similar or identical, the stimulus used on the second subject (recipient) may be distinct in modality, spatial location, intensity/waveform, other stimulation parameters, and the types and application of feedback employed.
It is known that people who have more REM sleep and more intense theta (4 Hz-7 Hz) activity during REM are better able to consolidate emotional memories. It was suggested (Blagrove) that if we attempt to hack our dreams by artificially increasing theta waves, it might lead to the incorporation of more waking experiences into our dreams. (See “Dreams act as overnight therapy” New Scientist magazine on 5 May 2018). Transplanting theta frequency brainwaves from a vivid dreamer may also help achieve the same effect. Moreover, instead of stimulating the subject's brain with a synthetic theta frequency (e.g., isotonic tones or ambient sound beats), stimulating the recipient's brain using donor's brainwaves carrying secondary (and higher) harmonics, in addition to the dominant theta frequency, may induce the same category of dreams, i.e., if the donor dreamed of people, the recipient will be more likely to dream of people, albeit different people, because the donor's brainwaves will stimulate the visual cortex of the recipient. This may be helpful in the treatment of PTSD, stress management, phobias and some psychiatric diseases.
In a medical treatment implementation, in some cases it may be appropriate to administer a drug or pharmacological agent, such as melatonin, hypnotic or soporific drug, a sedative (e.g., barbiturates, benzodiazepines, nonbenzodiazepine hypnotics, orexin antagonists, antihistamines, general anesthetics, Cannabis and other herbal sedatives, methaqualone and analogues, muscle relaxants, opioids) that assists in achieving the target sleep stage, and for emotional states and/or dreams, this may include certain psychotropic drugs, such as epinephrine, norepinephrine reuptake inhibitors, serotonin reuptake inhibitors, peptide endocrine hormones, such as oxytocin, ACTH fragments, insulin, etc. Combining a drug with stimulation may reduce the required dose of the drug and the associated side effects of the drug.
It is an object to provide a method of brain entrainment to facilitate sleep in a subject using a sleep app executing on a user device, the method comprising: executing the sleep app on the user device, configured to select at least one stimulus selected from the group consisting of at least one of a light signal and a sound signal; selecting a waveform from a menu having a plurality of waveforms derived from brainwaves of at least one sleeping donor, wherein said waveform corresponds to at least one specific stage of sleep; and stimulating the subject with said at least one stimulus, wherein said at least one stimulus is modulated with the selected waveform, to thereby entrain the brain of the subject with the selected waveform to facilitate sleep in the subject. The user device may be, e.g., a mobile device, a wearable device, or an implantable device. The stimulus may be a sound signal, comprising at least one of a predetermined soundtrack, a tone, and white noise. The sound signal may comprise a soundtrack representing at least one of a sound of rainfall, a sound of a waterfall, a sound of ocean waves, a lullaby, a melody, and a polyphony.
The effect of the stimulus may be monitored by feedback, e.g., EEG, body temperature, heart rate, respiration rate, facial expression, muscle tone, vasodilation, which may be measured by non-contact sensors or wearable devices, and other electronic sensors embedded in the bed, blanket, mattress, sheets, pillow, etc. Body movement and eye movement may be observed by a video camera or webcam. The sensor signals are advantageously transmitted back to the user device to adjust the regime of stimulation. Of course, the communication path may be indirect to the user device, or the analysis of the signals may be remote from the user device, e.g., in a cloud computing center. An important aspect of the system is synchronizing the cycles with the context and current state of the subject. For example, if the subject got up to go to the bathroom or woke up for other reasons, the modulation cycle would generally need to restart from sleep stage 1. However, depending on the mental state of the subject, the progression through the sleep states may be varied.
The sound may be amplitude modulated on a carrier waveform, which would generally have higher frequencies that the modulation waveform (typically <100 Hz), and/or frequency modulated. When the sound separation between ears is present, the amplitude, frequency, phase, timing, etc. between ears may be modulated. Similarly, optical signals may be modulated by intensity, color, frequency, phase, etc., in addition to morphological objects and dynamic changes in real time.
The at least one waveform may be derived from an EEG recordings of brainwaves of at least one sleeping donor, processed using at least one of a principal component analysis (PCA), a correspondence analysis (CA), a factor analysis, a K-means clustering, a non-negative matrix factorization (NMF), a sparse PCA, a non-linear PCA, a robust PCA, an independent component analysis (ICA), a network component analysis, and a singular spectral analysis.
Gender of the subject may be determined, and the gender of the subject marched with a gender of said at least one sleeping donor.
The at least one specific stage of sleep may be one of stage 1 of sleep, stage 2 of sleep, stage 3 of sleep, and stage 4 of sleep. In some analyses, 4 different non-REM (NREM) stages are classified, with stages 3 and 4 being deep sleep stages. See, www.sleepassociation.org/about-sleep/stages-of-sleep/,
The user device may comprise at least one speaker and wherein the stimulus comprises a sound signal delivered through said at least one speaker, and comprises an isochronic tone. The sound signal may be delivered to the subject through a pair of wireless earbuds, e.g., the modulated selected waveform may comprise binaural beats.
The user device may be configured to control an ambient light, which is selectively controllable to change at least one of brightness and color, and wherein the stimulus comprises a light signal which is presented to the subject through the ambient light. The light signal may be generated by at least one light emitting diode (LED). The LED may be disposed in proximity to the subject's eyes, e.g., in a sleep mask.
The user device may comprise at least one biometric sensor, further comprising the step of monitoring and collecting biometric data of the subject from said at least one biometric sensor.
The method may further comprise monitoring movement of the subject using at least one of a camera in the user device and a webcam coupled with the user device, processed with a neural network configured to classify a subject's sleep as one of a REM sleep, non-REM sleep, and a slow-wave sleep; and adjusting the stimulating of the subject upon determining whether the classification.
The method may further comprise monitoring a facial expression of the subject to determine if the subject is asleep or awake, and controlling a sequence of sleep stages induced by said stimulating in dependence on at least the monitored facial expression. The stimulating may be controlled to progress according to a natural series of sleep stages, further comprising resetting the progress according to the natural series of sleep stages in dependence on an awakening of the subject determined based on the monitored facial expression. The facial expression may be monitored by at least one of a camera in the user device and a webcam communicating with the user device. The facial expression may be monitored according to a signal present in at least one electromyographic electrode.
The method may further comprise obtaining biofeedback from the subject in real time and adjusting the stimulation of the subject in real time according to a biofeedback loop implemented by the user device.
It is also an object to provide a mobile device, comprising a housing; a microprocessor disposed within the housing; and a non-volatile memory disposed within the housing and electrically coupled with the processor, configured to store at least one app for controlling the microprocessor; the at least one app being configured to: (a) select a waveform from a plurality of waveforms derived from brainwaves of at least one sleeping donor, wherein said waveform corresponds to at least one specific stage of sleep; and (b) stimulate a subject with said at least one stimulus, wherein at least one stimulus selected from the group consisting of at least one of an auditory stimulus and a visual stimulus is modulated with the selected waveform, to thereby entrain the brain of the subject with the selected waveform to facilitate sleep in the subject. The mobile device may further comprise a battery electrically coupled with the processor; a display, disposed within the housing, electrically coupled with the microprocessor; a wireless communication transceiver disposed within the housing, electrically coupled with the microprocessor; at least one microphone, electrically coupled with the processor; at least one speaker disposed within the housing, electrically coupled with the processor; and at least one camera electrically coupled with the processor. The mobile device may be wirelessly coupled with a wearable device, wherein said wearable device comprises at least one biometric sensor configured to communicate biometric data from the subject to the mobile device through the wireless communication transceiver. The housing may be wearable by the subject and/or maintained close to the skull of the subject with a headband.
Another object provides a method of brain entrainment to facilitate sleep in a subject using a sleep app, comprising opening the sleep app on a programmable device; choosing at least one stimulus, wherein said at least one stimulus is one of a light signal and a sound signal; choosing a waveform from a menu having a plurality of waveforms derived from brainwaves of at least one sleeping donor, wherein said waveform corresponds to at least one specific stage of sleep; and stimulating the subject's brain with said at least one stimulus, wherein said at least one stimulus is modulated with the chosen waveform to entrain the brain of the subject with frequencies of the brainwaves of the at least one sleeping donor, to facilitate sleep in the subject. The method may further comprise recording a subject's electroencephalogram (EEG) during sleep while stimulated; and adjusting the stimulating based on the subject's electroencephalogram (EEG) in real time using a neurofeedback loop.
A further object provides a method of brain entrainment to facilitate sleep in a subject, comprising: providing a programmable device having a sleep app stored in a non-volatile memory; providing a stimulator, selected from one or more of a light stimulator and a sound stimulator; defining a waveform, by the sleep app, from a plurality of waveforms, each respective waveform being derived from brainwaves of at least one sleeping donor, wherein said waveform corresponds to at least one specific stage of sleep; stimulating the subject with the stimulator, having at least one of a light output or a sound output modulated with the defined waveform, to entrain the brain of the subject with the brainwaves of the at least one sleeping donor, to facilitate sleep in the subject. The method may further comprise recording an electroencephalogram (EEG) from the subject during sleep while being stimulated, and defining at least one new waveform for stimulation, said waveform being selectively dependent on the uploaded recorded electroencephalogram. The at least one new waveform may be used to stimulate the subject one day after the electroencephalogram is recorded. The recorded electroencephalogram may be uploaded to a remote server, and the new waveform for stimulation subsequently downloaded from the remote server.
Another object provides a non-transitory computer readable medium storing instructions for controlling a processor to perform a method comprising: instructions to select a waveform from a plurality of waveforms derived from brainwaves of at least one sleeping donor, wherein said waveform corresponds to at least one specific stage of sleep; and instructions to stimulate a subject with said at least one stimulus, wherein at least one stimulus selected from the group consisting of at least one of an auditory stimulus and a visual stimulus is modulated with the selected waveform, to thereby entrain the brain of the subject with the selected waveform to facilitate sleep in the subject.
A still further object provides a method of generating a waveform for neuromodulation to improve sleep in a subject, the method comprising: collecting EEG recording from at least one sleeping donor; identifying portions of the EEG recordings corresponding to a specific sleep stage; grouping a plurality of portions of the EEG recordings corresponding to the specific sleep stage, each group corresponding to the specific sleep stage; analyzing each group corresponding to the specific sleep stage using a statistical analysis; extracting a cortical signature corresponding to each specific sleep stage; generating a waveform based on the cortical signature for each sleep stage; and modulating a stimulus for the subject according to the waveform. The modulating of the stimulus may be performed under control of a sleep app executing on a mobile or wearable device. The statistical analysis may be at least one of a principal component analysis (PCA), a correspondence analysis (CA), a factor analysis, a K-means clustering, a non-negative matrix factorization (NMF), a sparse PCA, a non-linear PCA, a robust PCA, an independent component analysis (ICA), a network component analysis, and a singular spectral analysis.
It is, therefore, an object to provide a method of inducing sleep in a second subject comprising: recording brain activity patterns of a first subject (donor) who is asleep; and inducing sleep in the second subject (recipient) by replicating the brain activity patterns of the donor in the recipient.
It is also an object to provide a method of preventing sleep in a second subject (recipient) comprising: recording brain activity patterns of a first subject (donor) who is awake; and preventing sleep in the second subject (recipient) by replicating the brain activity patterns of the donor in the recipient.
It is further an object to provide a method of inducing sleep in a second subject (recipient) comprising: identifying the mental state of a first subject (donor); if the donor is asleep, recording brain activity patterns of the donor; and inducing sleep in the recipient by replicating the brain activity patterns of the donor in the recipient. The method may further comprise verifying that the recipient is asleep.
It is still a further object to provide a method of preventing sleep in a second subject (recipient) comprising: identifying a mental state of a first subject (donor); if the donor is awake, recording brain activity patterns of the first subject; and preventing sleep in the second subject by replicating the brain activity patterns of the second subject. The method may further comprise verifying that the second subject is awake.
Another object is a method of transplanting a desired mental state from a first subject (donor) to a second subject (recipient) comprising: identifying a mental state of the donor; capturing a mental state of the donor by recording brain activity patterns; saving the brain activity patterns in a non-volatile memory; retrieving the brain activity patterns from the non-volatile memory; and transplanting the desired mental state of the donor to the recipient by inducing the brain activity patterns in the recipient, wherein the desired mental state is one a sleeping state and a waking state.
Another object is a method of transplanting a desired sleep stage from a first subject (donor) to a second subject (recipient) comprising: identifying a sleep stage of the donor; capturing a sleep stage of the donor by recording brain activity patterns; saving the brain activity patterns in a non-volatile memory; retrieving the brain activity patterns from the non-volatile memory; and transplanting the desired sleep stage of the donor to the recipient by inducing the brain activity patterns in the recipient, wherein the desired sleep stage is one a sleep stage 1, 2, and 3.
Another object is a method of transplanting a desired sleep stage from a first subject (donor) to a second subject (recipient) comprising: identifying a sleep stage of the donor; capturing a sleep stage of the donor by recording brain activity patterns; saving the brain activity patterns in a non-volatile memory; retrieving the brain activity patterns from the non-volatile memory; and transplanting the desired sleep stage of the donor to the recipient by inducing the brain activity patterns in the recipient, wherein the desired sleep stage is one of a REM sleep stage and non-REM sleep stage.
Another object is a method of transplanting a desired sleep stage from a first subject (donor) to a second subject (recipient) comprising: identifying a sleep stage of the donor; capturing a sleep stage of the donor by recording brain activity patterns; saving the brain activity patterns in a non-volatile memory; retrieving the brain activity patterns from the non-volatile memory; and transplanting the desired sleep stage of the donor to the recipient by inducing the brain activity patterns in the recipient, wherein the desired sleep stage is a slow-wave deep non-REM sleep.
A further object is a method of improving sleep in a recipient by transplanting a mental state of a donor to the recipient comprising: recording brainwaves of the donor; and transplanting the mental state of the donor to the recipient by inducing the recorded brainwaves of the donor in the recipient, wherein the mental state is one of a waking state and a sleeping state.
A still further object is a method of transplanting a desired mental state of a first subject (donor) to a second subject comprising: identifying a mental state of the donor; recording brainwaves of the donor in a desired mental state; and transplanting the desired mental state of the donor to the recipient by inducing the brainwaves of the first subject in the second subject, wherein the desired mental state is one of a sleeping state and a waking state.
Another object is a method of improving sleep in a recipient by transplanting the desired state of a healthy sleep to the recipient comprising: identifying a mental state of the plurality of healthy donors; recording brainwaves of the plurality of healthy donor in a state of sleep; saving the brainwaves in a non-volatile memory; retrieving the brainwaves from the non-volatile memory; and transplanting the state of healthy sleep from the plurality of healthy donors to the recipient by inducing the brainwaves of the donor in the recipient. The method may comprise identifying a mental state of the recipient to verify that the recipient has the desired mental state. The brainwaves may be recorded using EEG, qEEG, or MEG. The method may further comprise filtering the recorded brainwaves from noise and/or performing PCA to determine dominant frequencies and secondary (and, possibly, higher) harmonics.
A further object is a system for transplanting a desired mental state from a first subject (donor) to a second subject (recipient) comprising: a first apparatus for recording brainwaves of the donor in a desired mental state; a non-volatile memory coupled with the first apparatus for storing the recording of the brainwaves; and a second apparatus for inducing the brainwaves in the recipient to transplant to the recipient the desired mental state of the donor, the second apparatus configured to receive the recording of the brainwaves of the donor from the non-volatile memory, wherein the desired mental state is one of a sleeping state and a waking state. The first apparatus may be one of an electroencephalograph and a magnetoencephalograph. The second apparatus may be one of a source of light signal or sound signal configured to modulate donor's brainwave frequencies on the light signal or the sound signal.
Another object is a method of transplanting a desired mental state of a first subject (donor) to a second subject (recipient) comprising: identifying a mental state of the donor; recording at least one of EEG and MEG of the donor, said donor being in a desired mental state; processing the EEG or MEG signal; saving the processed signal in a nonvolatile memory; retrieving the processed signal from the nonvolatile memory; modulating the processed signal on at least one stimulus; and transplanting the desired mental state of the first subject to the second subject by stimulating the second subject with said at least one stimulus, wherein the desired mental state is a sleeping state or a waking state. The processing may comprise removing noise from the EEG or MEG signal; and/or compressing the EEG or MEG signal. The EEG or MEG signal retrieved from the nonvolatile memory may be decompressed. The stimulus may be a light signal, a sound signal, or a combination thereof. The light stimulation may be an ambient light or a direct light. The sound stimulation may be binaural beats or isochronic tones.
A still another object is a system for transplanting a desired mental state of a first subject (donor) to a second subject (recipient) comprising: an electroencephalograph or a magnetoencephalograph for recoding brainwaves of the donor, the donor being in a desired mental state; a processor coupled with an electroencephalograph or a magnetoencephalograph, the processor configured to perform signal analysis and calculate at least one dominant frequency of the brainwaves of the donor; a nonvolatile memory coupled with the first processor for storing the at least one frequency of the brainwaves of the donor; a second apparatus for inducing the brainwaves in the recipient to transplant to the recipient the desired mental state of the donor, the second apparatus configured to receive said at least one dominant frequency of the brainwaves of the donor from the non-volatile memory, wherein the desired mental state is one of a sleeping state and a waking state.
The second apparatus may be a light source capable of modulating said at least one dominant frequency on the light, a sound source capable of modulating said at least one dominant frequency on the sound, or a combination thereof. The sound source may be binaural beats source or isochronic tones source.
A further object is a method of transplanting a circadian rhythm of a first subject (donor) to a second subject (recipient) comprising: recording EEG or MEG of the donor, the donor having a desirable phase of the circadian rhythm; processing the recorded EEG or MEG to remove noise; saving the processed EEG or MEG in a nonvolatile memory; retrieving the processed EEG or MEG from the nonvolatile memory; and transplanting the desired phase of the circadian rhythm of the donor to the recipient by “playing back” the processed EEG or MEG of the donor to the recipient via sensory stimulation or other one or more stimulus on which the donor's EEG or MEG is modulated. The method may further comprise compressing the recorded EEG or MEG, before saving it in the non-volatile memory; and decompressing the recorded EEG or MEG after retrieving compressed EEG or MEG from the non-volatile memory.
Yet another object is a system for transplanting a circadian rhythm of a first subject (donor) to a second subject (recipient) comprising: an electroencephalograph or a magnetoencephalograph for recording EEG or MEG respectively; a first processor coupled to the electroencephalograph or the magnetoencephalograph and configured for digital signal processing for removing noise from the recorded EEG or MEG; a non-volatile memory coupled with the processor for storing the processed EEG or MEG; and a stimulation device coupled to the non-volatile memory for playing back the processed EEG or MEG to the recipient to induce the circadian rhythm of the donor to the recipient. The stimulation device may be a sensory stimulation device, a source of light or a source of the sound, each capable of modulating recorded EEG or MEG on a light signal or a sound signal respectively. The first processor may be further configured to compress the processed EEG or MEG. A second processor configured to decompress compressed EEG or MEG may be coupled to the non-volatile memory and to the stimulation device.
The technology may be used to modify or alter a mental state (e.g., from sleep to waking and vice versa) in a subject. Typically, the starting mental state, brain state, or brainwave pattern is assessed, such as by EEG, MEG, observation, stimulus-response amplitude and/or delay, or the like. Of particular interest in uncontrolled environments are automated mental state assessments, which do not rely on human observation or EEG signals, and rather may be acquired through MEG (e.g., SQID, optically-pumped magnetometer), EMG, MMG (magnetomyogram), mechanical (e.g., accelerometer, gyroscope, etc.), data from physiological sensors (e.g., EKG, heartrate, respiration rate, temperature, galvanic skim potential, etc.), or automated camera sensors.
For example, cortical stimulus-response pathways and reflexes may be exercised automatically, to determine their characteristics on a generally continuous basis. These characteristics may include, for example, a delay between stimulus and the observed central (e.g., EEG) or peripheral response (e.g., EMG, limb accelerometer, video). Typically, the same modality will be used to assess the pre-stimulation state, stimulus response, and post-stimulation state, though this is not a limitation.
In order to change the mental state, a stimulus is applied in a way designed to alter the mental state in the desired manner. A state transition table, or algorithm, may be employed to optimize the transition from a starting mental state to a desired mental state. The stimulus may be provided in an open loop (predetermined stimulus protocol) or closed loop (feedback adapted stimulus protocol), based on observed changes in a monitored variable.
Advantageously, a characteristic delay between application of stimulus and determination of response varies with the brain or mental state. For example, some mental states may lead to an increased delay or greater variability in delay, while others may lead to decreased or lower variability. Further, some states may lead to attenuation of response, while others may lead to an exaggerated response. In addition, different mental states can be associated with qualitatively different responses. Typically, the mere assessment of the brain or mental state should not itself alter the state, though in some cases the assessment and transition influence may be combined. For example, in seeking to assist in achieving a deep sleep state, the excitation that disturbs sleep is contraindicated.
In cases where a brainwave pattern is itself determined by EEG (which may be limited to relatively controlled environments), brainwaves representing that pattern represent coherent firing of an ensemble of neurons, defining a phase. One way to change the state is to advance or retard the triggering of the neuronal excitation, which can be a direct or indirect excitation or inhibition, caused, for example, by electrical, magnetic, mechanical, or sensory stimulation. This stimulation may be time-synchronized with the detected (e.g., by EEG) brainwaves, for example with a phase lead or lag with respect to the detected pattern. Further, the excitation can steer the brainwave signal by continually advancing to the desired state, which through the continual phase rotation represents a different frequency. After the desired new state is achieved, the stimulus may cease, or be maintained in a phase-locked manner to hold the desired state.
A predictive model may be used to determine the current mental state, optimal transition to a desired mental state, when the subject has achieved the desired mental state, and how to maintain the desired mental state. The desired mental state itself may represent a dynamic sequence (e.g., stage 1→stage 2→stage 3, etc.), such that the subject's mental state is held for the desired period in a defined condition. Accordingly, the stimulus may be time-synchronized with respect to the measured brainwave pattern.
Direct measurement or determination of brainwaves or their phase relationships is not necessarily required. Rather, the system may determine tremor or reflex patterns. Typically, the reflex patterns of interest involve central pathways, and more preferably brain reflex pathways, and not spinal cord mediated reflexes, which are less dependent on instantaneous brain state. The central reflex patterns can reflect a time delay between stimulation and motor response, an amplitude of motor response, distribution of response through various afferent pathways, the variability of response, tremor or other modulation of motor activity, etc. Combinations of these characteristics may be employed, and different subsets may be employed at different times or to reflect different states. Similar to evoked potentials, the stimulus may be any sense, especially sight, sound, touch/proprioception/pain/etc., though the other senses, such as taste, smell, balance, etc., may also be exercised. A direct electrical or magnetic excitation is also possible. As discussed, the response may be determined through EEG, MEG, or peripheral afferent pathways.
A further object provides a system and method for enhancing deep non-REM sleep, comprising statistically separating slow-wave sleep components from acquired brainwave patterns; defining a stimulation pattern based on the statistically separating slow-wave sleep components, and stimulating a subject with the defined stimulation pattern. The neurological stimulator comprises a memory configured to store acquired brainwave patterns; at least one processor configured to: statistically separate slow-wave non-REM sleep components from the acquired brainwave patterns; and define a brain stimulation pattern based on the statistically separating slow-wave non-REM deep sleep components; and an output signal generator configured to defined brain stimulation pattern.
A still further object provides a system and method for enhancing deep sleep, comprising: extracting brainwave patterns representing a deep sleep state comprising slow wave sleep, from indigenous brain activity EEG recordings of at least one subject; processing the extracted brainwave patterns using a statistical processing algorithm to separate slow wave sleep components from the indigenous brain activity EEG recordings of the at least one subject; inverting the processed extracted brainwave patterns; and stimulating a subject with the inverted processed extracted brainwave patterns. The corresponding system for enhancing deep sleep comprises a memory configured to store brainwave patterns representing a deep sleep state comprising slow wave sleep, from indigenous brain activity EEG recordings of at least one subject; at least one processor configured to process the extracted brainwave patterns using a statistical processing algorithm to separate slow wave sleep components from the indigenous brain activity EEG recordings of the at least one subject; and a stimulator, configured to generate a stimulation signal based on the processed extracted brainwave patterns. The stimulator may comprise a sensory stimulator (e.g., sight, sound, vestibular, touch, taste, smell, etc.). In order to format the signal for stimulating the brain, it may be inverted. Normalization of brain activity information may be spatial and/or temporal.
See also US 2016/0066838 (DeCharms); US 2009/0099623 (Bentwich); US 201210289869 A1 (Tyler); US 2004/0131998 (Marmon et al.); U.S. Pat. No. 5,356,368 (Monroe); US 2002/0198577 (Jaillet); and US 2015/0294074 (Advanced Telecommunications Research Institute International). DeCharms discloses a computer-assisted method for treating pain in a subject comprising measuring activity of one or more internal voxels of a brain of said subject associated with pain; communicating instructions to said subject which modulate the activity of said voxel, and training said subject to control said internal voxel. DeCharms provides methods, software, and systems that may be used to provide and enhance the activation and control of one or more regions of interest, particularly through training and exercising those regions of interest. Data analysis/behavioral control software performs computations of brain scan image data to produce activity metrics that are measures of physiological activity in brain regions of interest. The results and other information and ongoing collected data may be stored to data files of progress and a record of the stimuli used. The selected instruction, measured information, or stimulus, is then presented via a display to a subject. This encourages the subject to engage in imagined or performed behaviors or exercises or to perceive stimuli. If the subject undertakes overt behaviors, such as responding to questions, the responses and other behavioral measurements are fed to the data analysis/behavioral control software. According to DeCharms, a subject can be trained to control the activation of a region of interest of that subject's brain, and then exercise the use of that region to further increase the strength and control of its activation. This training and exercise can have beneficial effects on the subject. In the case of regions that release endogenous neuromodulatory agents, this control can serve a role similar to that of externally applied drugs.
It is also an object to provide a method of generating a waveform for neuromodulation to improve sleep in a subject, the method comprising: collecting EEG recordings from at least one sleeping donor for a plurality of sleep stages; grouping a plurality of portions of the EEG recordings corresponding to the plurality of sleep stages, into a plurality of groups corresponding to the plurality of sleep stages; analyzing each group using a statistical analysis; extracting a cortical signature corresponding characteristic of each analyzed group; generating a waveform based on the characteristic cortical signature for each of the plurality of sleep stages; and modulating a stimulus for the subject according to the generated waveforms for the plurality of sleep stages.
It is a further object to provide a mobile device contained within a housing, comprising: a microprocessor; an electrical power source, electrically coupled with the microprocessor; a wireless communication transceiver, electrically coupled with the microprocessor; at least one microphone port, electrically coupled with the microprocessor, configured to receive an electrical signal corresponding to a sound; at least one camera port electrically coupled with the microprocessor, configured to receive an electrical signal corresponding to an image; a display, electrically coupled with the microprocessor; at least one speaker port, electrically coupled with the microprocessor, configured to generate an electrical signal corresponding to a sound; a non-volatile memory and electrically coupled with the microprocessor, configured to store at least one app downloadable through the wireless communication transceiver for controlling the microprocessor, said at least one downloadable app being configured to: (a) select a waveform from a plurality of waveforms derived from brainwaves of at least one sleeping donor, wherein said waveform corresponds to at least one a specific stage of sleep, a gender, and an age group; and (b) define a stimulus for stimulation of a subject, selected from the group consisting of at least one of an auditory stimulus generated through the at least one speaker, and a visual stimulus generated through the display, modulated with the selected waveform, and adapted to entrain the brain of the subject with the selected waveform to facilitate sleep in the subject; wherein at least one of the selection of the waveform and the definition of the stimulus is responsive to the at least one microphone or the at least one camera.
It is another object to provide a method of facilitating sleep, comprising: providing data defining a plurality of waveforms in a memory; retrieving a selected waveform from the memory, selectively dependent on at least one of a determined sleep phase of a human subject and a predetermined sequence; and stimulating the human subject with a stimulus modulated according to the selected waveform; to thereby entrain the brain of the human subject with the selected waveform to facilitate sleep in the subject.
The plurality of waveforms in the memory may be derived from brain activity measurements acquired during at least one sleep cycle of at least one human, or from brain activity measurements acquired during at least one sleep cycle of the human subject.
The method may further comprise acquiring brain activity measurements during at least one sleep cycle of at least one human; and processing the acquired brain activity measurements to define the plurality of waveforms in the memory.
The stimulus may be modulated in a human subject device, according to a sleep app stored within the human subject device, the sleep app being downloadable and upgradable from a remote server.
The predetermined sequence may be defined by a human user interface menu of a human subject device for selecting at least one respective waveform.
The sleep phase of the human subject may be determined based on at least electroencephalographic activity of the human subject or based on at least bioelectric signals received from the human subject.
The stimulus modulated according to the selected waveform may entrain the brain of the human subject with the selected waveform to facilitate sleep in the human subject.
The stimulus modulated according to the selected waveform may be one of a light stimulus and a sound stimulus.
The selected waveform may correspond to at least one specific stage of sleep.
Each of the plurality of waveforms may be derived from recordings of brainwaves of at least one sleeping donor, processed using a statistical decision analysis.
The method may further comprise adaptively defining a sequence of sleep stages dependent on biometric information received from a sleeping human subject; and selecting waveforms from the memory in dependence on a correspondence to a respective sleep stage of the adaptively defined sequence of sleep stages; wherein said stimulating the human subject comprises altering a sleep stage of the human subject dependent on both the determined sleep phase of a human subject and the adaptively defined sequence of sleep stages.
The human subject may be stimulated with at least one audio transducer and wherein the stimulus comprises at least one of an isochronic tone and binaural beats or with an ambient light stimulus, selectively moldulated according to the selected waveform to change at least one of brightness and color.
The ambient light stimulus may be emitted by at least one light emitting diode disposed in a sleep mask proximate the human subject's eyes.
The method may further comprise providing at least one sensor to determine at least one of an eye movement and a facial expression of the human subject, to at least one of determine a current determined sleep phase of a human subject or select the predetermined sequence.
The predetermined sequence may be a natural series of sleep stages, the method further comprising resetting the progress according to the natural series of sleep stages in dependence on an awakening of the human subject.
The detailed description is described with reference to the accompanying figures. In the figures, the left-most digit(s) of a reference number identifies the figure in which the reference number first appears. The use of the same reference number in different figures indicates similar or identical items.
Hereinafter, embodiments of the present disclosure will be described in detail with reference to the accompanying drawings so that the present disclosure may be readily implemented by those skilled in the art. However, it is to be noted that the present disclosure is not limited to the embodiments but can be embodied in various other ways. In drawings, parts irrelevant to the description are omitted for the simplicity of explanation, and like reference numerals denote like parts through the whole document.
The stored data from the first subject (donor) is then used to induce sleep in a second subject (a recipient—also typically a human, but may be an animal) by replicating the brain activity patterns (or sequences of brain activity patterns) of the first subject (donor) in the second subject (recipient) 150. The replication of brain activity patterns, dependent on the stored patterns, typically seeks to stimulate or induce the brain of the second subject (recipient) by modulating a stimulus (or several stimuli) in a manner synchronized with the frequency, phase and/or waveform pattern represented in the brain activity patterns of the first subject (donor) in the sleep state. Typically, when the second subject (recipient) achieves the sleep state 160 (assuming that the first subject and second subject are physiologically compatible—a donor and a recipient should both be either human or animals), the brain activity patterns of the first and second subject will be corresponding.
According to the present technology, the modulation of stimulation, which is, for example, a sensory stimulation, whose waveform is modulated to correspond to the raw or processed brainwave pattern of the first subject (donor) for the brain region associated with the stimulation electrode.
For example, the brain activity pattern of the first subject (donor) is measured by EEG electrodes. In a sleep state, it may assume various wave patterns, over the range <1 Hz to about 25 Hz, which vary in amplitude, frequency, spatial location, and relative phase. For example, the first stage of sleep is initially dominated by alpha brainwaves with a frequency of 8 Hz to 13 Hz. Typically, brain activity pattern measurement from the first subject (donor) has a higher spatial resolution, e.g., 64 or 128 electrode EEGs, than the stimulator for the second subject (recipient), and the stimulus electrodes tend to be larger than the EEG electrode. The stimulus for the second subject (recipient) is therefore processed using a dimensionality (or spatial) reduction algorithm to account for these differences, which will tend to filter the stimulus signal. By applying this stimulus modulated with the brain activity of the first subject (donor), the second subject (recipient) is made susceptible to synchronization with the brain activity pattern of the first subject (donor). For example, by temporally modulating the polarization level of the cells near the electrode, the cells will better couple to excitation stimuli in the brain of the second subject (recipient) having the characteristics of the brain activity pattern of the first subject (donor).
The donor's indigenous brainwaves may be modulated on light, sound, vibrations or any number of other stimuli amenable to frequency modulation. For example, donor's brainwaves may be modulated on ambient light, on binaural beats, or isochronic tones.
The verification that the recipient has achieved the desired sleep state may optionally be done by visual observation, by EEG, EKG, measuring heart and/or respiration rate, body temperature or any number of other physiological parameters that will be well understood by a person skilled in the art. These measurements should be, preferably, done automatically via biosensors.
The stored data from the first subject (donor) is then retrieved from the non-volatile memory 140 and used to “transplant” the state of alertness to prevent sleep, or maintain alertness, in a second subject (a recipient—also typically, but not necessarily, a human) by replicating the awake brain activity patterns of the first subject (donor), or sequences of brain activity patterns, in the second subject (recipient) 170. The replication of brain activity patterns, dependent on the stored patterns, typically seeks to stimulate or induce the brain of the second subject (recipient) by modulating indigenous brainwaves of the donor on a stimulus in a manner synchronized with the frequency, and preferably phase and/or waveform pattern represented in the brain activity patterns of the first subject (donor) in the awake or wakening state. Typically, when the second subject is awake or wakes up, 180, the brain activity patterns of the first and second subject will be corresponding.
The brainwaves are analyzed using statistical data mining techniques such as principal component analysis (PCA) to determine a set of linearly-uncorrelated variables-principal components. At least one dominant frequency in the recorded brainwaves is identified 220. Optionally, secondary and higher harmonics may be identified as well. It will be well-understood by a person skilled in the art that any number of similar statistical data analysis technics may be used, such as signal processing, independent component analysis, network component analysis, correspondence analysis, multiple correspondence analysis, factor analysis, canonical correlation, functional principal component analysis, independent component analysis, singular spectrum analysis, weighted PCA, sparse PCA, principal geodesic analysis, eigenvector-based multivariate analyses, etc.
The stored data from the first subject is then retrieved, at least the dominant frequency is modulated on at least one stimulus and used to “transplant” the desired mental state of the donor in a second subject (recipient) by seeking to replicate the brain activity patterns of the first subject (donor), or sequences of brain activity patterns, in the second subject (recipient) 240. The second subject (recipient) is then monitored for induction of the desired mental state 250.
After the various data is acquired from the subject 400, along with information about the pre-sleep experience and or context 410, and sensory stimulation during sleep, a memory, database, statistical model, the rule-based model is generated, and/or neural network is trained, reflecting the subject (donor).
Data may be aggregated from a plurality of subjects (donors), but typically, these are processed for the particular subject before aggregation. Based on single or multiple subject data, a normalization process may occur 420. The normalization may be spatial and/or temporal. For example, the EEG electrodes between sessions or for the different subject may be in different locations, leading to a distortion of the multichannel spatial arrangement. Further, the head size and shape of different individuals are different, and this needs to be normalized and/or encoded as well. The size and shape of the head/skull and/or brain may also lead to temporal differences in the signals, such as characteristic time delays, resonant or characteristic frequencies, etc.
One way to account for these effects is through the use of a time-space transform, such as a wavelet-type transform. It is noted that, in a corresponding way that statistical processes are subject to frequency decomposition analysis through Fourier transforms, they are also subject to time-frequency decomposition through wavelet transforms. Typically, the wavelet transform is a discrete wavelet transform (DWT), though more complex and less regular transforms may be employed. As discussed above, principal component analysis (PCA) and spatial PCA may be used to analyze signals, presuming linearity (linear superposition) and statistical independence of components. However, these presumptions technically do not apply to brainwave data, and practically, one would normally expect interaction between brain wave components (non-independence) and lack of linearity (since “neural networks” by their nature are non-linear), defeating the use of PCA or spatial PCA unmodified. However, a field of nonlinear dimensionality reduction provides various techniques to permit corresponding analyses under the presumptions of non-linearity and non-independence. See, en.wikipedia.org/wiki/Nonlinear_dimensionality_reduction, www.image.ucar.edu/pub/toylV/monahan_5_16.pdf (An Introduction to Nonlinear Principal Component Analysis, Adam Monahan), Nonlinear PCA toolbox for MATLAB (www.nlpca.org), Nonlinear PCA (www.comp.nus.edu.sg/-cs5240/lecture/nonlinear-pca.pdf), Nonlinear Principal Components Analysis: Introduction and Application (openaccess.leidenuniv.nl/bitstream/handle/1887/12386/Chapter2.pdf?sequence=10, 2007), Nonlinear Principal Component Analysis: Neural Network Models and Applications (pdfs.semanticscholar.org/9d31/23542031a227d2f4c4602066cf8ebceaeb7a.pdf), Karl Friston, “Nonlinear PCA: characterizing interactions between modes of brain activity” (www.fil.ion.ucl.ac.uk/-karl/Nonlinear PCA.pdf, 2000), Howard et al., “Distinct Variation Pattern Discovery Using Alternating Nonlinear Principal Component Analysis”, IEEE Trans Neural Network Learn Syst. 2018 January; 29(1):156-166. doi: 10.1109/TNNLS.2016.2616145. Epub 2016 Oct. 26 (www.ncbi.nlm.nih.gov/pubmed/27810837); Jolliffe, I. T., “Principal Component Analysis, Second Edition”, Springer 2002, cda.psych.uiuc.edu/statistical_learning_course/Jolliffe I. Principal Component Analysis (2ed., Springer, 2002)(518s)_MVsa_.pdf, Stone, James V. “Blind source separation using temporal predictability.” Neural computation 13, no. 7 (2001): 1559-1574.; Barros, Allan Kardec, and Andrzej Cichocki. “Extraction of specific signals with temporal structure.” Neural computation 13, no. 9 (2001): 1995-2003.; Lee, Soo-Young. “Blind source separation and independent component analysis: A review.” Neural Information Processing-Letters and Reviews 6, no. 1 (2005): 1-57.; Hyvsrinen, Aapo, and Patrik Hoyer. “Emergence of phase- and shift-invariant features by decomposition of natural images into independent feature subspaces.” Neural computation 12, no. 7 (2000): 1705-1720.; Wahlund, Björn, Wlodzimierz Klonowski, Pawel Stepien, Robert Stepien, Tatjana von Rosen, and Dietrich von Rosen. “EEG data, fractal dimension and multivariate statistics.” Journal of Computer Science and Engineering 3, no. 1 (2010): 10-14.; Yu, Xianchuan, Dan Hu, and Jindong Xu. Blind source separation: theory and applications. John Wiley & Sons, 2013.; Parida, Shantipriya, Satchidananda Dehuri, and Sung-Bae Cho. “Machine Learning Approaches for Cognitive State Classification and Brain Activity Prediction: A Survey.” Current Bioinformatics 10, no. 4 (2015): 344-359.; Friston, Karl J., Andrew P. Holmes, Keith J. Worsley, J-P. Poline, Chris D. Frith, and Richard S J Frackowiak. “Statistical parametric maps in functional imaging: a general linear approach.” Human brain mapping 2, no. 4 (1994): 189-210.; Wang, Yan, Matthew T. Sutherland, Lori L. Sanfratello, and Akaysha C. Tang. “Single-trial classification of ERPS using second-order blind identification (SOBI).” In Machine Learning and Cybernetics, 2004. Proceedings of 2004 International Conference on, vol. 7, pp. 4246-4251. IEEE, 2004.; Jutten, Christian, and Massoud Babaie-Zadeh. “Source separation: Principles, current advances and applications.” IAR Annu Meet Nancy Fr 110 (2006).; Saproo, Sameer, Victor Shih, David C. Jangraw, and Paul Sajda. “Neural mechanisms underlying catastrophic failure in human-machine interaction during aerial navigation.” Journal of neural engineering 13, no. 6 (2016): 066005.; Valente, Giancarlo. “Separazione cieca di sorgenti in ambienti reali: nuovi algoritmi, applicazioni e implementazioni.” (2006).; SAPIENZA, L A. “Blind Source Separation in real-world environments: new algorithms, applications and implementations Separazione cieca di sorgenti in ambienti reali: nuovi algoritmi, applicazioni e.”; Ewald, Arne. “Novel multivariate data analysis techniques to determine functionally connected networks within the brain from EEG or MEG data.” (2014).; Friston, Karl J. “Basic concepts and overview.” SPMcourse, Short course; Crainiceanu, Ciprian M., Ana-Maria Staicu, Shubankar Ray, and Naresh Punjabi. “Statistical inference on the difference in the means of two correlated functional processes: an application to sleep EEG power spectra.” Johns Hopkins University, Dept. of Biostatistics Working Papers (2011): 225.; Konar, Amit, and Aruna Chakraborty. Emotion recognition: A pattern analysis approach. John Wiley & Sons, 2014.; Kohl, Florian. “Blind separation of dependent source signals for MEG sensory stimulation experiments.” (2013).; Onken, Arno, Jian K. Liu, P P Chamanthi R. Karunasekara, Ioannis Delis, Tim Gollisch, and Stefano Panzeri. “Using matrix and tensor factorizations for the single-trial analysis of population spike trains.” PLoS computational biology 12, no. 11 (2016): e1005189.; Tressoldi, Patrizio, Luciano Pederzoli, Marco Bilucaglia, Patrizio Caini, Pasquale Fedele, Alessandro Ferrini, Simone Melloni, Diana Richeldi, Florentina Richeldi, and Agostino Accardo. “Brain-to-Brain (Mind-to-Mind) Interaction at Distance: A Confirmatory Study.” (2014). f1000researchdata. s3.amazonaws.com/manuscripts/5914/5adbf847-787a-4fc1-ac04-2e1cd61ca972_4336_-_patrizio_tressoldi_v3.pdf?doi=10.12688/f1000research.4336.3; Tsiaparas, Nikolaos N. “Wavelet analysis in coherence estimation of electroencephalographic signals in children for the detection of dyslexia-related abnormalities.” PhD diss., 2006.
As shown in
Therefore, statistical approaches are available for separating EEG signals from other signals, and for analyzing components of EEG signals themselves. According to the present invention, various components that might be considered noise in other contexts, e.g., according to prior technologies, such as a modulation pattern of a brainwave, are preserved. Likewise, interactions and characteristic delays between significant brainwave events are preserved. This information may be stored either integrated with the brainwave pattern in which it occurs or as a separated modulation pattern that can then be recombined with an unmodulated brainwave pattern to approximate the original subject.
According to the present technology, lossy “perceptual” encoding (i.e., functionally optimized with respect to a subjective response) of the brainwaves may be employed to process, store, and communicate the brainwave information. In a testing scenario, the “perceptual” features may be tested, so that important information is preserved over information that does not strongly correspond to the effective signal. Thus, while one might not know a priori which components represent useful information, a genetic algorithm may empirically determine which features or data reduction algorithms or parameter sets optimize retention of useful information vs. information efficiency. It is noted that subjects may differ in their response to signal components, and therefore the “perceptual” encoding may be subjective with respect to the recipient. On the other hand, different donors may have different information patterns, and therefore, each donor may also require individual processing. As a result, pairs of donor and recipient may require optimization, to ensure accurate and efficient communication of the relevant information. According to the present invention, sleep/wake mental states and their corresponding patterns are sought to be transferred. In the recipient, these patterns have characteristic brainwave patterns. Thus, the donor may be used, under a variety of alternate processing schemes, to stimulate the recipient, and the sleep/wake response of the recipient determined based on objective criteria, such as resulting brainwave patterns or expert observer reports, or subjective criteria, such as recipient self-reporting, survey or feedback. Thus, after a training period, optimized processing of the donor, which may include filtering, dominant frequency resynthesis, feature extraction, etc., may be employed, which is optimized for both donor and recipient. In other cases, the donor characteristics may be sufficiently normalized, that only recipient characteristics need be compensated. In a trivial case, there is only one exemplar donor, and the signal is oversampled and losslessly recorded, leaving only recipient variation as a significant factor.
Because dominant frequencies tend to have low information content (as compared to the modulation of these frequencies and interrelation of various sources within the brain), one efficient way to encode the main frequencies is by location, frequency, phase, and amplitude. The modulation of a wave may also be represented as a set of parameters. By decomposing the brainwaves according to functional attributes, it becomes possible, during stimulation, to modify the sequence of “events” from the donor, so that the recipient need not experience the same events, in the same order, and in the same duration, as the donor. Rather, a high-level control may select states, dwell times, and transitions between states, based on classified patterns of the donor brainwaves. The extraction and analysis of the brainwaves of the donors, and response of the recipient, may be performed using statistical processes, such as principal components analysis (PCA), independent component analysis (ICA), and related techniques; clustering, classification, dimensionality reduction and related techniques; neural networks and other known technologies. These algorithms may be implemented on general purpose CPUs, array processors such as GPUs, and other technologies.
In practice, a brainwave pattern of the first subject may be analyzed by a PCA technique that respects the non-linearity and non-independence of the brainwave signals, to extract the major cyclic components, their respective modulation patterns, and their respective interrelation. The major cyclic components may be resynthesized by a waveform synthesizer, and thus may be efficiently coded. Further, a waveform synthesizer may modify frequencies or relationships of components from the donor based on normalization and recipient characteristic parameters. For example, the brain of the second subject (recipient) may have characteristic classified brainwave frequencies 3% lower than the donor (or each type of wave may be separately parameterized), and therefore the resynthesis may take this difference into account. The modulation patterns and interrelations may then be reimposed onto the resynthesized patterns. The normalization of the modulation patterns and interrelations may be distinct from the underlying major cyclic components, and this correction may also be made, and the normalized modulation patterns and interrelations included in the resynthesis. If the temporal modifications are not equal, the modulation patterns and interrelations may be decimated or interpolated to provide a correct continuous time sequence of the stimulator. The stimulator may include one or more stimulation channels, which may be implemented as electrical, magnetic, auditory, visual, tactile, or another stimulus, and/or combinations.
The stimulator is preferably feedback controlled. The feedback may relate to the brainwave pattern of the recipient, and/or context or ancillary biometric basis. For example, if the second subject (recipient) begins to awaken from sleep, which differs from the first subject (donor) sleep pattern, then the stimulator may resynchronize based on this finding. That is, the stimulator control will enter a mode corresponding to the actual state of the recipient, and seek to guide the recipient to the desired state from a current state, using the available range and set of stimulation parameters. The feedback may also be used to tune the stimulator, to minimize error from a predicted or desired state of the recipient subject based on the prior and current stimulation.
The control for the stimulator is preferably adaptive and may employ a genetic algorithm to improve performance over time. For example, if there are multiple first subjects (donors), the second subject (recipient) may be matched with those donors from whose brainwave signals (or algorithmically modified versions thereof) the predicted response in the recipient is best, and distinguished from those donors from whose brainwave signals the predicted response in the recipient subject poorly corresponds. Similarly, if the donors have brainwave patterns determined over a range of time and context and stored in a database, the selection of alternates from the database may be optimized to ensure best correspondence of the recipient subject to the desired response.
It is noted that a resynthesizer-based stimulator is not required, if a signal pattern from a donor is available that properly corresponds to the recipient and permits a sufficiently low error between the desired response and the actual response. For example, if a donor and a recipient are the same subject at different times, a large database may be unnecessary, and the stimulation signal may be a minimally processed recording of the same subject at an earlier time. Likewise, in some cases, a deviation is tolerable, and an exemplar signal may be emitted, with relatively slow periodic correction. For example, a sleep signal may be derived from a single subject and replayed with a periodicity of 90 minutes or 180 minutes, such as a light or sound signal, which may be useful in a dormitory setting, where individual feedback is unavailable or unhelpful.
In some cases, it is useful to provide a stimulator and feedback-based controller on the donor. This will better match the conditions of the donor and recipient, and further allow determination of not only the brainwave pattern of the donor but also responsivity of the donor to the feedback. One difference between the donors and the recipients is that in the donor, the natural sleep pattern is sought to be maintained and not interrupted. Thus, the adaptive multi-subject database may include data records from all subject, whether selected ab initio as a useful exemplar or not. Therefore, the issue is whether a predictable and useful response can be induced in the recipient from the database record and, if so, that record may be employed. If the record would produce an unpredictable result or a non-useful result, the use of that record should be avoided. The predictability and usefulness of the responses may be determined by a genetic algorithm or other parameter-space searching technology.
Extending the sleep signal illumination example, an illuminator (e.g., red LED lightbulb) may have an intensity modulated based on a donors' brainwave pattern. The illuminator may have a flash memory module with tens or hundreds of different brainwave patterns available. The illuminator may further include a sensor, such as a camera or non-imaging optical or infrared sensor, and speech control, similar to Amazon Alexa. The illuminator may also include an associated speaker, to play synchronized sounds or music. When a sleep cycle is commenced, the illuminator begins displaying (and playing and associated audio) the brainwave pattern as a program, seeking to induce a predetermined sleep pattern. The sensors may be used to determine whether the recipient is in the predicted sleep state based on the program. If the recipient has a sleep state that deviates from the program, then the program may be reset to a portion that corresponds to the actual state of the recipient or reset to a guiding state that seeks to guide the sleep state of the recipient back to the desired program. If the target subject cannot be efficiently synchronized or guided, then the illuminator may adopt a different source subject brainwave pattern. In this case, no electrical stimulation or electrical feedback is employed, and the entire operation may be non-contact.
IR controller 14, when provided, can be generally configured as a dedicated controller for processing infrared codes transmitted/received by an IR transceiver module 16 and for capturing the same as computer data. Wireless unit 17 can be generally configured as a dedicated controller and transceiver module for processing all wireless data transmitted from and to a wireless communications network. It can be appreciated that other variations for wireless transceiver module 17 can also be provided, such as standardized Bluetooth, NFC, Zigbee, etc., and proprietary RF protocols that may be developed for specialized applications.
Port 12 can be connected to CPU 10 and can be temporarily attached, for example, to a docking station to transmit information to and from the mobile device 11 to other devices, such as personal computers. In light of the present invention, port 12 can also be connected to external probes and external sensors for monitoring or providing data. Port 12 can also be configured, for example to link with a battery charger, data communication device, and can permit network devices, a personal computer, or other computing devices to communicate with mobile device 11.
User controls 32 can permit a user to enter data to mobile device 11 and/or initiate particular processing operations via CPU 10. A user interface 33 can be linked to user controls 32 to permit a user to access and manipulate electronic wireless hand held multimedia device 11 for a particular purpose, such as, for example, viewing video images on display 18. User interface 33 can be implemented as a touch screen manipulated user interface, as indicated by the dashed lines linking display 18 with user interface 33. User interface 33 can be configured to accept user input into the mobile device 11. In addition, CPU 10 can cause a sound generator 28 to generate sounds of predetermined frequencies from a speaker 30. Speaker 30 can be utilized to produce music and other audio information associated with video data transmitted to mobile device 11 from an outside source.
A GPS (Global Positioning System) module 13 can be included in the mobile device and can be connected to bus 26. GPS module 13 can be configured to provide location information for the mobile device 11 and can operate with mapping software and resources to provide navigable directions on the display screen 18 to the user, which can be referred to as GPS mapping. The CPU 10 can execute “apps”, which are downloadable programs that provide a user interface, and access to various application programming interface (API) calls made available through the operating system, but are generally limited to executing in a low privilege mode and without direct hardware or driver level access. The aps may be downloaded from the Internet, or an on-line service (e.g., iTunes store, Google Play) or through a wireless transceiver.
See Reference List Table 19
Through the whole document, the term “connected to” or “coupled to” that is used to designate a connection or coupling of one element to another element includes both a case that an element is “directly connected or coupled to” another element and a case that an element is “electronically connected or coupled to” another element via still another element. Further, it is to be understood that the term “comprises or includes” and/or “comprising or including” used in the document means that one or more other components, steps, operation and/or existence or addition of elements are not excluded in addition to the described components, steps, operation and/or elements unless context dictates otherwise.
Through the whole document, the term “unit” or “module” includes a unit implemented by hardware or software and a unit implemented by both of them. One unit may be implemented by two or more pieces of hardware, and two or more units may be implemented by one piece of hardware.
Other devices, apparatus, systems, methods, features, and advantages of the invention will be or will become apparent to one with skill in the art upon examination of the following figures and detailed description. It is intended that all such additional systems, methods, features, and advantages be included within this description, be within the scope of the invention, and be protected by the accompanying claims.
In this description, several preferred embodiments were discussed. Persons skilled in the art will, undoubtedly, have other ideas as to how the systems and methods described herein may be used. It is understood that this broad invention is not limited to the embodiments discussed herein. Rather, the invention is limited only by the following claims.
The aspects of the invention are intended to be separable and may be implemented in combination, sub-combination, and with various permutations of embodiments. Therefore, the various disclosure herein, including that which is represented by acknowledged prior art, may be combined, sub-combined and permuted in accordance with the teachings hereof, without departing from the spirit and scope of the invention. All references and information sources cited herein are expressly incorporated herein by reference in their entirety.
What is claimed is:
Each reference is expressly incorporated herein by reference in its entirety.
The present application is a non-provisional of, and claims benefit of priority under 35 U.S.C. § 119(e) from U.S. Provisional Patent Application No. 62/862,656, filed Jun. 17, 2019, and from U.S. Provisional Patent Application No. 62/852,877, filed May 24, 2019, each of which is expressly incorporated herein by reference in its entirety.
| Number | Name | Date | Kind |
|---|---|---|---|
| 3565059 | Hauser | Feb 1971 | A |
| 3735753 | Pisarski | May 1973 | A |
| 3951134 | Malech | Apr 1976 | A |
| 3957036 | Normann | May 1976 | A |
| 4375219 | Schmid | Mar 1983 | A |
| 4407299 | Culver | Oct 1983 | A |
| 4408616 | Duffy et al. | Oct 1983 | A |
| 4421122 | Duffy | Dec 1983 | A |
| 4437064 | Overton, Jr. et al. | Mar 1984 | A |
| 4493327 | Bergelson et al. | Jan 1985 | A |
| 4550736 | Broughton et al. | Nov 1985 | A |
| 4557270 | John | Dec 1985 | A |
| 4561448 | Buchas | Dec 1985 | A |
| 4579125 | Strobl et al. | Apr 1986 | A |
| 4583190 | Salb | Apr 1986 | A |
| 4585011 | Broughton et al. | Apr 1986 | A |
| 4591787 | Hoenig | May 1986 | A |
| 4595017 | Semenov et al. | Jun 1986 | A |
| 4610259 | Cohen et al. | Sep 1986 | A |
| 4613817 | Hoenig | Sep 1986 | A |
| 4618230 | Ens et al. | Oct 1986 | A |
| 4626090 | Charlier et al. | Dec 1986 | A |
| 4638807 | Ryder | Jan 1987 | A |
| 4649482 | Raviv et al. | Mar 1987 | A |
| 4678640 | Hamano et al. | Jul 1987 | A |
| 4689559 | Hastings et al. | Aug 1987 | A |
| 4693000 | Hoenig | Sep 1987 | A |
| 4700135 | Hoenig | Oct 1987 | A |
| 4705049 | John | Nov 1987 | A |
| 4733180 | Hoenig et al. | Mar 1988 | A |
| 4736307 | Salb | Apr 1988 | A |
| 4736751 | Gevins et al. | Apr 1988 | A |
| 4744029 | Raviv et al. | May 1988 | A |
| 4749946 | Hoenig | Jun 1988 | A |
| 4753246 | Freeman | Jun 1988 | A |
| 4761611 | Hoenig | Aug 1988 | A |
| 4776345 | Cohen et al. | Oct 1988 | A |
| 4792145 | Eisenberg et al. | Dec 1988 | A |
| 4794533 | Cohen | Dec 1988 | A |
| 4801882 | Daalmans | Jan 1989 | A |
| 4815839 | Waldorf | Mar 1989 | A |
| 4818095 | Takeuchi | Apr 1989 | A |
| 4836219 | Hobson et al. | Jun 1989 | A |
| 4838681 | Pavlidis | Jun 1989 | A |
| 4846190 | John | Jul 1989 | A |
| 4862359 | Trivedi et al. | Aug 1989 | A |
| 4863259 | Schneider et al. | Sep 1989 | A |
| 4883067 | Knispel | Nov 1989 | A |
| 4889422 | Pavlidis | Dec 1989 | A |
| 4907597 | Chamoun | Mar 1990 | A |
| 4913152 | Ko et al. | Apr 1990 | A |
| 4924875 | Chamoun | May 1990 | A |
| 4934378 | Perry, Jr. | Jun 1990 | A |
| 4937525 | Daalmans | Jun 1990 | A |
| 4940058 | Taff et al. | Jul 1990 | A |
| 4947480 | Lewis | Aug 1990 | A |
| 4949725 | Raviv et al. | Aug 1990 | A |
| 4951674 | Zanakis et al. | Aug 1990 | A |
| 4967038 | Gevins et al. | Oct 1990 | A |
| 4972492 | Tanaka et al. | Nov 1990 | A |
| 4974602 | Abraham-Fuchs et al. | Dec 1990 | A |
| 4982157 | Seifert | Jan 1991 | A |
| 4983912 | Roehrlein et al. | Jan 1991 | A |
| 4988183 | Kasahara et al. | Jan 1991 | A |
| 4993825 | Abe et al. | Feb 1991 | A |
| 4996479 | Hoenig | Feb 1991 | A |
| 5002385 | Kasahara et al. | Mar 1991 | A |
| 5008622 | Overton, Jr. et al. | Apr 1991 | A |
| 5010891 | Chamoun | Apr 1991 | A |
| 5012190 | Dossel | Apr 1991 | A |
| 5020538 | Morgan et al. | Jun 1991 | A |
| 5020540 | Chamoun | Jun 1991 | A |
| 5027817 | John | Jul 1991 | A |
| 5029082 | Shen et al. | Jul 1991 | A |
| 5059814 | Mead et al. | Oct 1991 | A |
| 5061680 | Paulson et al. | Oct 1991 | A |
| 5070399 | Martel | Dec 1991 | A |
| 5070883 | Kasahara | Dec 1991 | A |
| 5083571 | Prichep | Jan 1992 | A |
| 5092341 | Kelen | Mar 1992 | A |
| 5092835 | Schurig et al. | Mar 1992 | A |
| 5094521 | Jolson et al. | Mar 1992 | A |
| 5095270 | Ludeke | Mar 1992 | A |
| 5105354 | Nishimura | Apr 1992 | A |
| 5109862 | Kelen et al. | May 1992 | A |
| 5118606 | Lynch et al. | Jun 1992 | A |
| 5126315 | Nishino et al. | Jun 1992 | A |
| RE34015 | Duffy | Aug 1992 | E |
| 5136687 | Edelman et al. | Aug 1992 | A |
| 5137345 | Waldorf et al. | Aug 1992 | A |
| 5158932 | Hinshaw et al. | Oct 1992 | A |
| 5159703 | Lowery | Oct 1992 | A |
| 5159928 | Keppel | Nov 1992 | A |
| 5166614 | Yokosawa et al. | Nov 1992 | A |
| 5187327 | Ohta et al. | Feb 1993 | A |
| 5198977 | Salb | Mar 1993 | A |
| 5204703 | Hutchinson et al. | Apr 1993 | A |
| 5213338 | Brotz | May 1993 | A |
| 5213562 | Monroe | May 1993 | A |
| 5218530 | Jastrzebski et al. | Jun 1993 | A |
| 5224203 | Skeirik | Jun 1993 | A |
| 5230344 | Ozdamar et al. | Jul 1993 | A |
| 5230346 | Leuchter et al. | Jul 1993 | A |
| 5233517 | Jindra | Aug 1993 | A |
| 5241967 | Yasushi et al. | Sep 1993 | A |
| 5243281 | Ahonen et al. | Sep 1993 | A |
| 5243517 | Schmidt et al. | Sep 1993 | A |
| 5263488 | Van Veen et al. | Nov 1993 | A |
| 5265611 | Hoenig et al. | Nov 1993 | A |
| 5269315 | Leuchter et al. | Dec 1993 | A |
| 5269325 | Robinson et al. | Dec 1993 | A |
| 5273037 | Itil et al. | Dec 1993 | A |
| 5273038 | Beavin | Dec 1993 | A |
| 5280791 | Lavie | Jan 1994 | A |
| 5282474 | Valdes Sosa et al. | Feb 1994 | A |
| 5283523 | Uhl et al. | Feb 1994 | A |
| 5287859 | John | Feb 1994 | A |
| 5291888 | Tucker | Mar 1994 | A |
| 5293187 | Knapp et al. | Mar 1994 | A |
| 5303705 | Nenov | Apr 1994 | A |
| 5306228 | Rubins | Apr 1994 | A |
| 5307807 | Valdes Sosa et al. | May 1994 | A |
| 5309095 | Ahonen et al. | May 1994 | A |
| 5309917 | Wang et al. | May 1994 | A |
| 5309923 | Leuchter et al. | May 1994 | A |
| 5311129 | Ludwig et al. | May 1994 | A |
| 5313952 | Hoch | May 1994 | A |
| 5320109 | Chamoun et al. | Jun 1994 | A |
| 5323777 | Ahonen et al. | Jun 1994 | A |
| 5325862 | Lewis et al. | Jul 1994 | A |
| 5326745 | Nishino et al. | Jul 1994 | A |
| 5331970 | Gevins et al. | Jul 1994 | A |
| 5339811 | Ohta et al. | Aug 1994 | A |
| 5339826 | Schmidt et al. | Aug 1994 | A |
| 5356368 | Monroe | Oct 1994 | A |
| 5360971 | Kaufman et al. | Nov 1994 | A |
| 5377100 | Pope et al. | Dec 1994 | A |
| 5406956 | Farwell | Apr 1995 | A |
| 5406957 | Tansey | Apr 1995 | A |
| 5409445 | Rubins | Apr 1995 | A |
| 5417211 | Abraham-Fuchs et al. | May 1995 | A |
| 5418512 | Ohta et al. | May 1995 | A |
| 5422689 | Knapp et al. | Jun 1995 | A |
| 5442289 | DiIorio et al. | Aug 1995 | A |
| 5443073 | Wang et al. | Aug 1995 | A |
| 5447154 | Cinquin et al. | Sep 1995 | A |
| 5447166 | Gevins | Sep 1995 | A |
| 5458117 | Chamoun et al. | Oct 1995 | A |
| 5458142 | Farmer et al. | Oct 1995 | A |
| 5461699 | Arbabi et al. | Oct 1995 | A |
| 5469057 | Robinson | Nov 1995 | A |
| 5474082 | Junker | Dec 1995 | A |
| 5476438 | Edrich et al. | Dec 1995 | A |
| 5479934 | Imran | Jan 1996 | A |
| 5491492 | Knapp et al. | Feb 1996 | A |
| 5496798 | Sakai et al. | Mar 1996 | A |
| 5503149 | Beavin | Apr 1996 | A |
| 5513649 | Gevins et al. | May 1996 | A |
| 5515301 | Corby, Jr. et al. | May 1996 | A |
| 5517021 | Kaufman et al. | May 1996 | A |
| 5522863 | Spano et al. | Jun 1996 | A |
| 5546943 | Gould | Aug 1996 | A |
| 5552375 | Nishino et al. | Sep 1996 | A |
| 5555889 | Karagueuzian et al. | Sep 1996 | A |
| 5568816 | Gevins et al. | Oct 1996 | A |
| 5570698 | Liang et al. | Nov 1996 | A |
| 5574473 | Sekiguchi | Nov 1996 | A |
| 5579241 | Corby, Jr. et al. | Nov 1996 | A |
| 5594849 | Kuc et al. | Jan 1997 | A |
| 5600243 | Colclough | Feb 1997 | A |
| 5601081 | Tomita et al. | Feb 1997 | A |
| 5611350 | John | Mar 1997 | A |
| 5617856 | Tamura et al. | Apr 1997 | A |
| 5619995 | Lobodzinski | Apr 1997 | A |
| 5621424 | Shimada et al. | Apr 1997 | A |
| 5622168 | Keusch et al. | Apr 1997 | A |
| 5626145 | Clapp et al. | May 1997 | A |
| 5632272 | Diab et al. | May 1997 | A |
| 5640493 | Skeirik | Jun 1997 | A |
| 5643325 | Karagueuzian et al. | Jul 1997 | A |
| 5649061 | Smyth | Jul 1997 | A |
| 5656937 | Cantor | Aug 1997 | A |
| 5662109 | Hutson | Sep 1997 | A |
| 5671740 | Tomita et al. | Sep 1997 | A |
| 5678561 | Karagueuzian et al. | Oct 1997 | A |
| 5682889 | Tomita et al. | Nov 1997 | A |
| 5685313 | Mayevsky | Nov 1997 | A |
| 5692517 | Junker | Dec 1997 | A |
| 5694939 | Cowings | Dec 1997 | A |
| 5699808 | John | Dec 1997 | A |
| 5701909 | Amir et al. | Dec 1997 | A |
| 5706402 | Bell | Jan 1998 | A |
| 5706811 | Takeda et al. | Jan 1998 | A |
| 5707652 | Lewy et al. | Jan 1998 | A |
| 5715821 | Faupel | Feb 1998 | A |
| 5719561 | Gonzales | Feb 1998 | A |
| 5720619 | Fisslinger | Feb 1998 | A |
| 5722418 | Bro | Mar 1998 | A |
| 5724987 | Gevins et al. | Mar 1998 | A |
| 5726916 | Smyth | Mar 1998 | A |
| 5729046 | Nishino et al. | Mar 1998 | A |
| 5730146 | Itil et al. | Mar 1998 | A |
| 5736543 | Rogers et al. | Apr 1998 | A |
| 5737485 | Flanagan et al. | Apr 1998 | A |
| 5740812 | Cowan | Apr 1998 | A |
| 5743854 | Dobson et al. | Apr 1998 | A |
| 5743860 | Hively et al. | Apr 1998 | A |
| 5747492 | Lynch et al. | May 1998 | A |
| 5752514 | Okamura et al. | May 1998 | A |
| 5752521 | Dardik | May 1998 | A |
| 5752911 | Canedo et al. | May 1998 | A |
| 5755227 | Tomita et al. | May 1998 | A |
| 5755739 | Sun et al. | May 1998 | A |
| 5761332 | Wischmann et al. | Jun 1998 | A |
| 5762611 | Lewis et al. | Jun 1998 | A |
| 5767043 | Cantor et al. | Jun 1998 | A |
| 5771261 | Anbar | Jun 1998 | A |
| 5771893 | Kassai et al. | Jun 1998 | A |
| 5771894 | Richards et al. | Jun 1998 | A |
| 5771897 | Zufrin | Jun 1998 | A |
| 5791342 | Woodard | Aug 1998 | A |
| 5794623 | Forbes | Aug 1998 | A |
| 5795304 | Sun et al. | Aug 1998 | A |
| 5797840 | Akselrod et al. | Aug 1998 | A |
| 5797853 | Musha et al. | Aug 1998 | A |
| 5810737 | Dardik | Sep 1998 | A |
| 5813993 | Kaplan et al. | Sep 1998 | A |
| 5815413 | Hively et al. | Sep 1998 | A |
| 5816247 | Maynard | Oct 1998 | A |
| 5823190 | Voipio | Oct 1998 | A |
| 5827195 | Lander | Oct 1998 | A |
| 5840040 | Altschuler et al. | Nov 1998 | A |
| 5842986 | Avrin et al. | Dec 1998 | A |
| 5845639 | Hochman et al. | Dec 1998 | A |
| 5846189 | Pincus | Dec 1998 | A |
| 5846208 | Pichlmayr et al. | Dec 1998 | A |
| 5851193 | Arikka et al. | Dec 1998 | A |
| 5853005 | Scanlon | Dec 1998 | A |
| 5857978 | Hively et al. | Jan 1999 | A |
| 5871517 | Abrams et al. | Feb 1999 | A |
| 5884626 | Kuroda et al. | Mar 1999 | A |
| 5885976 | Sandyk | Mar 1999 | A |
| 5899867 | Collura | May 1999 | A |
| 5916171 | Mayevsky | Jun 1999 | A |
| 5920375 | Fahle et al. | Jul 1999 | A |
| 5921245 | O'Donnell, Jr. | Jul 1999 | A |
| 5933210 | Ron | Aug 1999 | A |
| 5938598 | Takeda et al. | Aug 1999 | A |
| 5938688 | Schiff | Aug 1999 | A |
| 5942954 | Galiana et al. | Aug 1999 | A |
| 5970499 | Smith et al. | Oct 1999 | A |
| 5983129 | Cowan et al. | Nov 1999 | A |
| 5995868 | Dorfmeister et al. | Nov 1999 | A |
| 6002254 | Kassai et al. | Dec 1999 | A |
| 6002952 | Diab et al. | Dec 1999 | A |
| 6011990 | Schultz et al. | Jan 2000 | A |
| 6011991 | Mardirossian | Jan 2000 | A |
| 6016444 | John | Jan 2000 | A |
| 6021345 | Karagueuzian et al. | Feb 2000 | A |
| 6023161 | Dantsker et al. | Feb 2000 | A |
| 6032072 | Greenwald et al. | Feb 2000 | A |
| 6033073 | Potapova et al. | Mar 2000 | A |
| 6042548 | Giuffre | Mar 2000 | A |
| 6044292 | Heyrend et al. | Mar 2000 | A |
| 6050940 | Braun et al. | Apr 2000 | A |
| 6050962 | Kramer et al. | Apr 2000 | A |
| 6052619 | John | Apr 2000 | A |
| 6066084 | Edrich et al. | May 2000 | A |
| 6067462 | Diab et al. | May 2000 | A |
| 6067467 | John | May 2000 | A |
| 6069369 | Nishino et al. | May 2000 | A |
| 6070098 | Moore-Ede et al. | May 2000 | A |
| 6071246 | Sturzebecher et al. | Jun 2000 | A |
| 6076003 | Rogel | Jun 2000 | A |
| 6080164 | Oshio et al. | Jun 2000 | A |
| 6081735 | Diab et al. | Jun 2000 | A |
| 6088611 | Lauterbur et al. | Jul 2000 | A |
| 6091334 | Galiana et al. | Jul 2000 | A |
| 6092058 | Smyth | Jul 2000 | A |
| 6097980 | Monastra et al. | Aug 2000 | A |
| 6097981 | Freer | Aug 2000 | A |
| 6099319 | Zaltman et al. | Aug 2000 | A |
| 6115631 | Heyrend et al. | Sep 2000 | A |
| 6117075 | Barnea | Sep 2000 | A |
| 6117092 | Weinstein et al. | Sep 2000 | A |
| 6129681 | Kuroda et al. | Oct 2000 | A |
| 6144872 | Graetz | Nov 2000 | A |
| 6149586 | Elkind | Nov 2000 | A |
| 6154026 | Dantsker et al. | Nov 2000 | A |
| 6154699 | Williams | Nov 2000 | A |
| 6155966 | Parker | Dec 2000 | A |
| 6155993 | Scott | Dec 2000 | A |
| 6157850 | Diab et al. | Dec 2000 | A |
| 6157857 | Dimpfel | Dec 2000 | A |
| 6161031 | Hochman et al. | Dec 2000 | A |
| 6164278 | Nissani | Dec 2000 | A |
| 6167298 | Levin | Dec 2000 | A |
| 6167311 | Rezai | Dec 2000 | A |
| 6171239 | Humphrey | Jan 2001 | B1 |
| 6171258 | Karakasoglu et al. | Jan 2001 | B1 |
| 6195576 | John | Feb 2001 | B1 |
| 6196972 | Moehring | Mar 2001 | B1 |
| 6224549 | Drongelen | May 2001 | B1 |
| 6230037 | Tsukada et al. | May 2001 | B1 |
| 6231187 | Munoz et al. | May 2001 | B1 |
| 6236872 | Diab et al. | May 2001 | B1 |
| 6239145 | Utsumi et al. | May 2001 | B1 |
| 6240308 | Hardy et al. | May 2001 | B1 |
| 6241686 | Balkin et al. | Jun 2001 | B1 |
| 6263189 | Reagor | Jul 2001 | B1 |
| 6270466 | Weinstein et al. | Aug 2001 | B1 |
| 6272370 | Gillies et al. | Aug 2001 | B1 |
| 6280393 | Granger et al. | Aug 2001 | B1 |
| 6287328 | Snyder et al. | Sep 2001 | B1 |
| 6290638 | Canedo et al. | Sep 2001 | B1 |
| 6292688 | Patton | Sep 2001 | B1 |
| 6293904 | Blazey et al. | Sep 2001 | B1 |
| 6298259 | Kucharczyk et al. | Oct 2001 | B1 |
| 6305943 | Pougatchev et al. | Oct 2001 | B1 |
| 6306077 | Prabhu et al. | Oct 2001 | B1 |
| 6309342 | Blazey et al. | Oct 2001 | B1 |
| 6309361 | Thornton | Oct 2001 | B1 |
| 6315736 | Tsutsumi et al. | Nov 2001 | B1 |
| 6317627 | Ennen et al. | Nov 2001 | B1 |
| 6319205 | Goor et al. | Nov 2001 | B1 |
| 6322515 | Goor et al. | Nov 2001 | B1 |
| 6325475 | Hayes et al. | Dec 2001 | B1 |
| 6325761 | Jay | Dec 2001 | B1 |
| 6331164 | Shaw et al. | Dec 2001 | B1 |
| 6338713 | Chamoun et al. | Jan 2002 | B1 |
| 6343229 | Siebler et al. | Jan 2002 | B1 |
| 6346887 | Van Orden et al. | Feb 2002 | B1 |
| 6349231 | Musha | Feb 2002 | B1 |
| 6354087 | Nakahara et al. | Mar 2002 | B1 |
| 6356079 | Mizoguchi et al. | Mar 2002 | B1 |
| 6356781 | Lee et al. | Mar 2002 | B1 |
| 6358201 | Childre et al. | Mar 2002 | B1 |
| 6366813 | DiLorenzo | Apr 2002 | B1 |
| 6370414 | Robinson | Apr 2002 | B1 |
| 6370423 | Guerrero et al. | Apr 2002 | B1 |
| 6374131 | Tomita et al. | Apr 2002 | B1 |
| 6375614 | Braun et al. | Apr 2002 | B1 |
| 6377833 | Albert | Apr 2002 | B1 |
| 6385479 | Sibbitt et al. | May 2002 | B1 |
| 6385486 | John et al. | May 2002 | B1 |
| 6390979 | Njemanze | May 2002 | B1 |
| 6394963 | Blazey et al. | May 2002 | B1 |
| 6402520 | Freer | Jun 2002 | B1 |
| 6402689 | Scarantino et al. | Jun 2002 | B1 |
| 6418344 | Rezai et al. | Jul 2002 | B1 |
| 6419629 | Balkin et al. | Jul 2002 | B1 |
| 6428490 | Kramer et al. | Aug 2002 | B1 |
| 6442421 | Le Van Quyen et al. | Aug 2002 | B1 |
| 6442948 | Takeda | Sep 2002 | B1 |
| 6466816 | Granger et al. | Oct 2002 | B2 |
| 6470220 | Kraus, Jr. et al. | Oct 2002 | B1 |
| 6475163 | Smits et al. | Nov 2002 | B1 |
| 6482165 | Patton et al. | Nov 2002 | B1 |
| 6488617 | Katz | Dec 2002 | B1 |
| 6490472 | Li et al. | Dec 2002 | B1 |
| 6493577 | Williams | Dec 2002 | B1 |
| 6496724 | Levendowski et al. | Dec 2002 | B1 |
| 6497658 | Roizen et al. | Dec 2002 | B2 |
| 6503085 | Elkind | Jan 2003 | B1 |
| 6507754 | Le Van Quyen et al. | Jan 2003 | B2 |
| 6510340 | Jordan | Jan 2003 | B1 |
| 6511424 | Moore-Ede et al. | Jan 2003 | B1 |
| 6516246 | Derakhshan | Feb 2003 | B2 |
| 6520905 | Surve et al. | Feb 2003 | B1 |
| 6520921 | Patton et al. | Feb 2003 | B1 |
| 6522906 | Salisbury, Jr. et al. | Feb 2003 | B1 |
| 6524249 | Moehring et al. | Feb 2003 | B2 |
| 6526297 | Merilainen | Feb 2003 | B1 |
| 6526415 | Smith et al. | Feb 2003 | B2 |
| 6527715 | Balkin et al. | Mar 2003 | B2 |
| 6527730 | Blazey et al. | Mar 2003 | B2 |
| 6529759 | Tucker et al. | Mar 2003 | B1 |
| 6529773 | Dewan | Mar 2003 | B1 |
| 6530884 | Balkin et al. | Mar 2003 | B2 |
| 6538436 | Simola et al. | Mar 2003 | B1 |
| 6539245 | Tsukada et al. | Mar 2003 | B2 |
| 6539263 | Schiff et al. | Mar 2003 | B1 |
| 6544170 | Kajihara et al. | Apr 2003 | B1 |
| 6545650 | Yamada et al. | Apr 2003 | B1 |
| 6546378 | Cook | Apr 2003 | B1 |
| 6547736 | Moehring et al. | Apr 2003 | B1 |
| 6547746 | Marino | Apr 2003 | B1 |
| 6549804 | Osorio et al. | Apr 2003 | B1 |
| 6551243 | Bocionek et al. | Apr 2003 | B2 |
| 6553252 | Balkin et al. | Apr 2003 | B2 |
| 6556695 | Packer et al. | Apr 2003 | B1 |
| 6556861 | Prichep | Apr 2003 | B1 |
| 6557558 | Tajima et al. | May 2003 | B1 |
| 6565518 | Blazey et al. | May 2003 | B2 |
| 6574513 | Collura et al. | Jun 2003 | B1 |
| 6574573 | Asano | Jun 2003 | B1 |
| 6587729 | O'Loughlin et al. | Jul 2003 | B2 |
| 6591132 | Gotman et al. | Jul 2003 | B2 |
| 6594524 | Esteller et al. | Jul 2003 | B2 |
| 6602202 | John et al. | Aug 2003 | B2 |
| 6609030 | Rezai et al. | Aug 2003 | B1 |
| 6611698 | Yamashita et al. | Aug 2003 | B1 |
| 6616611 | Moehring | Sep 2003 | B1 |
| 6622036 | Suffin | Sep 2003 | B1 |
| 6625485 | Levendowski et al. | Sep 2003 | B2 |
| 6626676 | Freer | Sep 2003 | B2 |
| 6640122 | Manoli et al. | Oct 2003 | B2 |
| 6644976 | Kullok et al. | Nov 2003 | B2 |
| 6648822 | Hamamoto et al. | Nov 2003 | B2 |
| 6648880 | Chauvet et al. | Nov 2003 | B2 |
| 6650917 | Diab et al. | Nov 2003 | B2 |
| 6652458 | Blazey et al. | Nov 2003 | B2 |
| 6652470 | Patton et al. | Nov 2003 | B2 |
| 6654632 | Lange et al. | Nov 2003 | B2 |
| 6654729 | Hickman et al. | Nov 2003 | B1 |
| 6656137 | Tyldsley et al. | Dec 2003 | B1 |
| 6658287 | Litt et al. | Dec 2003 | B1 |
| 6663571 | Njemanze | Dec 2003 | B1 |
| 6665552 | Yokosawa et al. | Dec 2003 | B2 |
| 6665553 | Kandori et al. | Dec 2003 | B2 |
| 6665560 | Becker et al. | Dec 2003 | B2 |
| 6665562 | Gluckman et al. | Dec 2003 | B2 |
| 6669627 | Campbell et al. | Dec 2003 | B1 |
| 6678548 | Echauz et al. | Jan 2004 | B1 |
| 6681774 | Dewan | Jan 2004 | B2 |
| 6684098 | Oshio et al. | Jan 2004 | B2 |
| 6687525 | Llinas et al. | Feb 2004 | B2 |
| 6695761 | Oschman et al. | Feb 2004 | B2 |
| 6697660 | Robinson | Feb 2004 | B1 |
| RE38476 | Diab et al. | Mar 2004 | E |
| 6699194 | Diab et al. | Mar 2004 | B1 |
| 6701173 | Nowinski et al. | Mar 2004 | B2 |
| 6708051 | Durousseau | Mar 2004 | B1 |
| 6708064 | Rezai | Mar 2004 | B2 |
| 6708184 | Smith et al. | Mar 2004 | B2 |
| 6709399 | Shen et al. | Mar 2004 | B1 |
| 6710051 | Trier | Mar 2004 | B1 |
| 6725080 | Melkent et al. | Apr 2004 | B2 |
| 6726624 | Keirsbilck et al. | Apr 2004 | B2 |
| 6728564 | Lahteenmaki | Apr 2004 | B2 |
| 6731975 | Viertio-Oja et al. | May 2004 | B1 |
| 6735460 | Tsukada et al. | May 2004 | B2 |
| 6735467 | Wilson | May 2004 | B2 |
| 6740032 | Balkin et al. | May 2004 | B2 |
| 6743167 | Balkin et al. | Jun 2004 | B2 |
| 6743182 | Miller et al. | Jun 2004 | B2 |
| 6745060 | Diab et al. | Jun 2004 | B2 |
| 6745156 | Cook | Jun 2004 | B2 |
| 6746409 | Keirsbilck et al. | Jun 2004 | B2 |
| 6751499 | Lange et al. | Jun 2004 | B2 |
| 6758813 | Meadows | Jul 2004 | B2 |
| 6768920 | Lange et al. | Jul 2004 | B2 |
| 6773400 | Njemanze | Aug 2004 | B2 |
| 6774929 | Kopp | Aug 2004 | B1 |
| 6785409 | Suri | Aug 2004 | B1 |
| 6795724 | Hogan | Sep 2004 | B2 |
| 6798898 | Fedorovskaya et al. | Sep 2004 | B1 |
| 6801648 | Cheng | Oct 2004 | B2 |
| 6801803 | Viertio-Oja | Oct 2004 | B2 |
| 6804661 | Cook | Oct 2004 | B2 |
| 6815949 | Kandori et al. | Nov 2004 | B2 |
| 6816744 | Garfield et al. | Nov 2004 | B2 |
| 6819956 | DiLorenzo | Nov 2004 | B2 |
| 6826426 | Lange et al. | Nov 2004 | B2 |
| 6842670 | Lin et al. | Jan 2005 | B2 |
| 6843774 | Foust et al. | Jan 2005 | B2 |
| 6853186 | Li | Feb 2005 | B2 |
| 6856830 | He | Feb 2005 | B2 |
| 6865494 | Duensing et al. | Mar 2005 | B2 |
| 6873872 | Gluckman et al. | Mar 2005 | B2 |
| 6875174 | Braun et al. | Apr 2005 | B2 |
| 6876196 | Taulu et al. | Apr 2005 | B1 |
| 6882881 | Lesser et al. | Apr 2005 | B1 |
| 6885192 | Clarke et al. | Apr 2005 | B2 |
| 6886964 | Gardiner et al. | May 2005 | B2 |
| 6893407 | Brooks et al. | May 2005 | B1 |
| 6896655 | Patton et al. | May 2005 | B2 |
| RE38749 | Dardik | Jun 2005 | E |
| 6907280 | Becerra et al. | Jun 2005 | B2 |
| 6915241 | Kohlmorgen et al. | Jul 2005 | B2 |
| 6926921 | Stasiak et al. | Aug 2005 | B2 |
| 6928354 | Ryu et al. | Aug 2005 | B2 |
| 6931274 | Williams | Aug 2005 | B2 |
| 6931275 | Collura | Aug 2005 | B2 |
| 6936012 | Wells | Aug 2005 | B2 |
| 6947790 | Gevins et al. | Sep 2005 | B2 |
| 6950697 | Jordan | Sep 2005 | B2 |
| 6950698 | Sarkela et al. | Sep 2005 | B2 |
| 6963770 | Scarantino et al. | Nov 2005 | B2 |
| 6963771 | Scarantino et al. | Nov 2005 | B2 |
| 6978179 | Flagg et al. | Dec 2005 | B1 |
| 6980863 | van Venrooij et al. | Dec 2005 | B2 |
| 6981947 | Melker | Jan 2006 | B2 |
| 6983184 | Price | Jan 2006 | B2 |
| 6983264 | Shimizu | Jan 2006 | B2 |
| 6985769 | Jordan | Jan 2006 | B2 |
| 6988056 | Cook | Jan 2006 | B2 |
| 6993380 | Modarres | Jan 2006 | B1 |
| 6996261 | deCharms | Feb 2006 | B2 |
| 7010340 | Scarantino et al. | Mar 2006 | B2 |
| 7011410 | Bolger et al. | Mar 2006 | B2 |
| 7011814 | Suddarth et al. | Mar 2006 | B2 |
| 7014613 | John et al. | Mar 2006 | B2 |
| 7016722 | Prichep | Mar 2006 | B2 |
| 7022083 | Tanaka et al. | Apr 2006 | B2 |
| 7023206 | Viehland et al. | Apr 2006 | B2 |
| 7024247 | Gliner et al. | Apr 2006 | B2 |
| 7035685 | Ryu et al. | Apr 2006 | B2 |
| 7035686 | Hogan | Apr 2006 | B2 |
| 7037260 | Keirsbilck et al. | May 2006 | B2 |
| 7038450 | Romalis et al. | May 2006 | B2 |
| 7039266 | Doty | May 2006 | B1 |
| 7039547 | Wilson | May 2006 | B2 |
| 7043293 | Baura | May 2006 | B1 |
| 7053610 | Clarke et al. | May 2006 | B2 |
| 7054454 | Causevic et al. | May 2006 | B2 |
| 7062391 | Wilson | Jun 2006 | B2 |
| 7070571 | Kramer et al. | Jul 2006 | B2 |
| 7079977 | Osorio et al. | Jul 2006 | B2 |
| 7089927 | John et al. | Aug 2006 | B2 |
| 7092748 | Valdes Sosa et al. | Aug 2006 | B2 |
| 7099714 | Houben | Aug 2006 | B2 |
| 7103398 | Sieburg | Sep 2006 | B2 |
| 7104947 | Riehl | Sep 2006 | B2 |
| 7104963 | Melker et al. | Sep 2006 | B2 |
| 7105824 | Stoddart et al. | Sep 2006 | B2 |
| 7107090 | Salisbury, Jr. et al. | Sep 2006 | B2 |
| 7116102 | Clarke et al. | Oct 2006 | B2 |
| 7120486 | Leuthardt et al. | Oct 2006 | B2 |
| 7123955 | Gao et al. | Oct 2006 | B1 |
| 7128713 | Moehring et al. | Oct 2006 | B2 |
| 7130673 | Tolvanen-Laakso et al. | Oct 2006 | B2 |
| 7130675 | Ewing et al. | Oct 2006 | B2 |
| 7130691 | Falci | Oct 2006 | B2 |
| 7145333 | Romalis et al. | Dec 2006 | B2 |
| 7146211 | Frei et al. | Dec 2006 | B2 |
| 7146218 | Esteller et al. | Dec 2006 | B2 |
| 7149572 | Frei et al. | Dec 2006 | B2 |
| 7150710 | Haber et al. | Dec 2006 | B2 |
| 7150715 | Collura et al. | Dec 2006 | B2 |
| 7150718 | Okada et al. | Dec 2006 | B2 |
| 7162295 | Ryu et al. | Jan 2007 | B2 |
| 7163512 | Childre et al. | Jan 2007 | B1 |
| 7164941 | Misczynski et al. | Jan 2007 | B2 |
| 7171252 | Scarantino et al. | Jan 2007 | B1 |
| 7171339 | Repucci et al. | Jan 2007 | B2 |
| 7176680 | Veryaskin | Feb 2007 | B1 |
| 7177675 | Suffin et al. | Feb 2007 | B2 |
| 7183381 | Varadhachary et al. | Feb 2007 | B2 |
| 7186209 | Jacobson et al. | Mar 2007 | B2 |
| 7187169 | Clarke et al. | Mar 2007 | B2 |
| 7190826 | Russell et al. | Mar 2007 | B2 |
| 7190995 | Chervin et al. | Mar 2007 | B2 |
| 7193413 | Kandori et al. | Mar 2007 | B2 |
| 7196514 | Li | Mar 2007 | B2 |
| 7197352 | Gott et al. | Mar 2007 | B2 |
| 7199708 | Terauchi et al. | Apr 2007 | B2 |
| 7207948 | Coyle | Apr 2007 | B2 |
| 7209787 | DiLorenzo | Apr 2007 | B2 |
| 7209788 | Nicolelis et al. | Apr 2007 | B2 |
| 7212851 | Donoghue et al. | May 2007 | B2 |
| 7215986 | Diab et al. | May 2007 | B2 |
| 7215994 | Huiku | May 2007 | B2 |
| 7218104 | Clarke et al. | May 2007 | B2 |
| 7222964 | Gotze et al. | May 2007 | B2 |
| 7224282 | Terauchi et al. | May 2007 | B2 |
| 7225013 | Geva et al. | May 2007 | B2 |
| 7228169 | Viertio-Oja et al. | Jun 2007 | B2 |
| 7228171 | Lesser et al. | Jun 2007 | B2 |
| 7228178 | Carroll et al. | Jun 2007 | B2 |
| 7231245 | Greenwald et al. | Jun 2007 | B2 |
| 7231254 | DiLorenzo | Jun 2007 | B2 |
| 7242984 | DiLorenzo | Jul 2007 | B2 |
| 7248928 | Yagi | Jul 2007 | B2 |
| 7254433 | Diab et al. | Aug 2007 | B2 |
| 7254439 | Misczynski et al. | Aug 2007 | B2 |
| 7254500 | Makeig et al. | Aug 2007 | B2 |
| 7258659 | Anninou et al. | Aug 2007 | B2 |
| 7260430 | Wu et al. | Aug 2007 | B2 |
| 7267652 | Coyle et al. | Sep 2007 | B2 |
| 7269455 | Pineda | Sep 2007 | B2 |
| 7269456 | Collura | Sep 2007 | B2 |
| 7269516 | Brunner et al. | Sep 2007 | B2 |
| 7277758 | DiLorenzo | Oct 2007 | B2 |
| 7280861 | Thomas et al. | Oct 2007 | B2 |
| 7280867 | Frei et al. | Oct 2007 | B2 |
| 7280870 | Nurmikko et al. | Oct 2007 | B2 |
| 7282030 | Frei et al. | Oct 2007 | B2 |
| 7283861 | Bystritsky | Oct 2007 | B2 |
| 7286871 | Cohen | Oct 2007 | B2 |
| 7288066 | Drew | Oct 2007 | B2 |
| 7297110 | Goyal et al. | Nov 2007 | B2 |
| 7299088 | Thakor et al. | Nov 2007 | B1 |
| 7313442 | Velasco et al. | Dec 2007 | B2 |
| 7321837 | Osorio et al. | Jan 2008 | B2 |
| 7324845 | Mietus et al. | Jan 2008 | B2 |
| 7324851 | DiLorenzo | Jan 2008 | B1 |
| 7328053 | Diab et al. | Feb 2008 | B1 |
| 7330032 | Donnangelo | Feb 2008 | B2 |
| 7333619 | Causevic et al. | Feb 2008 | B2 |
| 7333851 | Echauz et al. | Feb 2008 | B2 |
| 7334892 | Goodall et al. | Feb 2008 | B2 |
| 7338171 | Hsieh et al. | Mar 2008 | B2 |
| 7338455 | White et al. | Mar 2008 | B2 |
| 7340125 | Doty | Mar 2008 | B1 |
| 7340289 | Kandori et al. | Mar 2008 | B2 |
| 7343198 | Behbehani et al. | Mar 2008 | B2 |
| 7346382 | McIntyre et al. | Mar 2008 | B2 |
| 7346395 | Lozano et al. | Mar 2008 | B2 |
| 7353064 | Gliner et al. | Apr 2008 | B2 |
| 7353065 | Morrell | Apr 2008 | B2 |
| 7367949 | Korhonen et al. | May 2008 | B2 |
| 7369896 | Gesotti | May 2008 | B2 |
| 7371365 | Poduslo et al. | May 2008 | B2 |
| 7373198 | Bibian et al. | May 2008 | B2 |
| 7376453 | Diab et al. | May 2008 | B1 |
| 7376459 | Rosenfeld | May 2008 | B2 |
| 7378056 | Black | May 2008 | B2 |
| 7381185 | Zhirnov et al. | Jun 2008 | B2 |
| 7383070 | Diab et al. | Jun 2008 | B2 |
| 7392079 | Donoghue et al. | Jun 2008 | B2 |
| 7394246 | Chieh et al. | Jul 2008 | B2 |
| 7395292 | Johnson | Jul 2008 | B2 |
| 7396333 | Stahmann et al. | Jul 2008 | B2 |
| 7399282 | John et al. | Jul 2008 | B2 |
| 7400984 | Kandori et al. | Jul 2008 | B2 |
| 7403124 | Arakawa et al. | Jul 2008 | B2 |
| 7403809 | Tsukada et al. | Jul 2008 | B2 |
| 7403814 | Cox et al. | Jul 2008 | B2 |
| 7403815 | Katz et al. | Jul 2008 | B2 |
| 7403820 | DiLorenzo | Jul 2008 | B2 |
| 7407485 | Huiku | Aug 2008 | B2 |
| 7409321 | Repucci et al. | Aug 2008 | B2 |
| 7418290 | Devlin et al. | Aug 2008 | B2 |
| 7420033 | Varadhachary et al. | Sep 2008 | B2 |
| 7429247 | Okada et al. | Sep 2008 | B2 |
| 7437196 | Wyler et al. | Oct 2008 | B2 |
| 7440789 | Hannula et al. | Oct 2008 | B2 |
| 7448751 | Kiderman et al. | Nov 2008 | B2 |
| 7450986 | Nguyen et al. | Nov 2008 | B2 |
| 7453263 | Kim et al. | Nov 2008 | B2 |
| 7454240 | Diab et al. | Nov 2008 | B2 |
| 7454387 | Abercrombie et al. | Nov 2008 | B2 |
| 7457653 | Fujimaki | Nov 2008 | B2 |
| 7460903 | Pineda et al. | Dec 2008 | B2 |
| 7461045 | Chaovalitwongse et al. | Dec 2008 | B1 |
| 7462151 | Childre et al. | Dec 2008 | B2 |
| 7462155 | England | Dec 2008 | B2 |
| 7463024 | Simola et al. | Dec 2008 | B2 |
| 7463142 | Lindsay | Dec 2008 | B2 |
| 7466132 | Clarke et al. | Dec 2008 | B2 |
| 7468040 | Hartley et al. | Dec 2008 | B2 |
| 7468350 | Gong et al. | Dec 2008 | B2 |
| 7469697 | Lee et al. | Dec 2008 | B2 |
| 7471971 | Diab et al. | Dec 2008 | B2 |
| 7471978 | John et al. | Dec 2008 | B2 |
| 7478108 | Townsend et al. | Jan 2009 | B2 |
| 7482298 | Nepela | Jan 2009 | B2 |
| 7488294 | Torch | Feb 2009 | B2 |
| 7489958 | Diab et al. | Feb 2009 | B2 |
| 7489964 | Suffin et al. | Feb 2009 | B2 |
| 7490085 | Walker et al. | Feb 2009 | B2 |
| 7491173 | Heim | Feb 2009 | B2 |
| 7496393 | Diab et al. | Feb 2009 | B2 |
| 7497828 | Wilk et al. | Mar 2009 | B1 |
| 7499741 | Diab et al. | Mar 2009 | B2 |
| 7499745 | Littrup et al. | Mar 2009 | B2 |
| 7502720 | Taulu | Mar 2009 | B2 |
| 7509154 | Diab et al. | Mar 2009 | B2 |
| 7509161 | Viertio-Oja | Mar 2009 | B2 |
| 7509163 | Luo et al. | Mar 2009 | B1 |
| 7510531 | Lee et al. | Mar 2009 | B2 |
| 7510699 | Black et al. | Mar 2009 | B2 |
| 7515054 | Torch | Apr 2009 | B2 |
| 7520614 | Joos et al. | Apr 2009 | B2 |
| 7530955 | Diab et al. | May 2009 | B2 |
| 7537568 | Moehring | May 2009 | B2 |
| 7539528 | Xiong et al. | May 2009 | B2 |
| 7539532 | Tran | May 2009 | B2 |
| 7539533 | Tran | May 2009 | B2 |
| 7539543 | Schiff et al. | May 2009 | B2 |
| 7546158 | Allison et al. | Jun 2009 | B2 |
| 7547284 | Brainard, II | Jun 2009 | B2 |
| 7553810 | Gong et al. | Jun 2009 | B2 |
| 7554549 | Sagar et al. | Jun 2009 | B2 |
| 7555344 | Maschino et al. | Jun 2009 | B2 |
| 7558622 | Tran | Jul 2009 | B2 |
| 7559903 | Moussavi et al. | Jul 2009 | B2 |
| 7565193 | Laken | Jul 2009 | B2 |
| 7565200 | Wyler et al. | Jul 2009 | B2 |
| 7565809 | Takeda | Jul 2009 | B2 |
| 7567693 | deCharms | Jul 2009 | B2 |
| 7570054 | Lin | Aug 2009 | B1 |
| 7570991 | Milgramm et al. | Aug 2009 | B2 |
| 7572225 | Stahmann et al. | Aug 2009 | B2 |
| 7573264 | Xu et al. | Aug 2009 | B2 |
| 7573268 | Volegov et al. | Aug 2009 | B2 |
| 7574007 | Shaw et al. | Aug 2009 | B2 |
| 7574254 | Milgramm et al. | Aug 2009 | B2 |
| 7577472 | Li et al. | Aug 2009 | B2 |
| 7580742 | Tan et al. | Aug 2009 | B2 |
| 7580798 | Brunner et al. | Aug 2009 | B2 |
| 7593767 | Modarres | Sep 2009 | B1 |
| 7594122 | Milgramm et al. | Sep 2009 | B2 |
| 7596535 | de Voir et al. | Sep 2009 | B2 |
| 7597665 | Wilk et al. | Oct 2009 | B2 |
| 7599735 | Viertio-Oja et al. | Oct 2009 | B2 |
| 7603168 | Bibian et al. | Oct 2009 | B2 |
| 7603174 | De Ridder | Oct 2009 | B2 |
| 7604603 | Sackner et al. | Oct 2009 | B2 |
| 7608579 | Gong et al. | Oct 2009 | B2 |
| 7610094 | Stahmann et al. | Oct 2009 | B2 |
| 7613502 | Yamamoto et al. | Nov 2009 | B2 |
| 7613519 | De Ridder | Nov 2009 | B2 |
| 7613520 | De Ridder | Nov 2009 | B2 |
| 7620456 | Gliner et al. | Nov 2009 | B2 |
| 7623912 | Akselrod et al. | Nov 2009 | B2 |
| 7623927 | Rezai | Nov 2009 | B2 |
| 7623928 | DiLorenzo | Nov 2009 | B2 |
| 7624293 | Osorio et al. | Nov 2009 | B2 |
| 7625340 | Sarkela | Dec 2009 | B2 |
| 7627370 | Marks | Dec 2009 | B2 |
| 7630757 | Dorfmeister et al. | Dec 2009 | B2 |
| 7639146 | Baura | Dec 2009 | B2 |
| 7640055 | Geva et al. | Dec 2009 | B2 |
| 7643655 | Liang et al. | Jan 2010 | B2 |
| 7647097 | Flaherty et al. | Jan 2010 | B2 |
| 7647098 | Prichep | Jan 2010 | B2 |
| 7649351 | Kajola et al. | Jan 2010 | B2 |
| 7653433 | Lozano et al. | Jan 2010 | B2 |
| 7654948 | Kaplan et al. | Feb 2010 | B2 |
| 7665845 | Kiderman et al. | Feb 2010 | B2 |
| 7668579 | Lynn | Feb 2010 | B2 |
| 7668591 | Lee et al. | Feb 2010 | B2 |
| 7672707 | Takeda | Mar 2010 | B2 |
| 7672717 | Zikov et al. | Mar 2010 | B1 |
| 7676263 | Harris et al. | Mar 2010 | B2 |
| 7678041 | Prenzel et al. | Mar 2010 | B2 |
| 7678061 | Lee et al. | Mar 2010 | B2 |
| 7678767 | Gong et al. | Mar 2010 | B2 |
| 7680526 | McIntyre et al. | Mar 2010 | B2 |
| 7682024 | Plant et al. | Mar 2010 | B2 |
| 7684856 | Virtanen et al. | Mar 2010 | B2 |
| D613267 | Suwalski et al. | Apr 2010 | S |
| 7697979 | Martinerie et al. | Apr 2010 | B2 |
| 7702502 | Ricci et al. | Apr 2010 | B2 |
| 7706871 | Devlin et al. | Apr 2010 | B2 |
| 7706992 | Ricci et al. | Apr 2010 | B2 |
| 7711417 | John et al. | May 2010 | B2 |
| 7715894 | Dunseath et al. | May 2010 | B2 |
| 7715910 | Hargrove et al. | May 2010 | B2 |
| 7715919 | Osorio et al. | May 2010 | B2 |
| 7720519 | Ruohonen | May 2010 | B2 |
| 7720530 | Causevic | May 2010 | B2 |
| 7725174 | Kern et al. | May 2010 | B2 |
| 7727161 | Coyle et al. | Jun 2010 | B2 |
| 7729740 | Kraus, Jr. et al. | Jun 2010 | B2 |
| 7729753 | Kremliovsky et al. | Jun 2010 | B2 |
| 7729755 | Laken | Jun 2010 | B2 |
| 7729773 | Sloan | Jun 2010 | B2 |
| 7731360 | MacDougall et al. | Jun 2010 | B2 |
| 7733224 | Tran | Jun 2010 | B2 |
| 7733973 | Moriya et al. | Jun 2010 | B2 |
| 7734334 | Mietus et al. | Jun 2010 | B2 |
| 7734340 | De Ridder | Jun 2010 | B2 |
| 7737687 | Na et al. | Jun 2010 | B2 |
| 7740592 | Graham et al. | Jun 2010 | B2 |
| 7742820 | Wyler et al. | Jun 2010 | B2 |
| 7746979 | Dilmanian et al. | Jun 2010 | B2 |
| 7747325 | Dilorenzo | Jun 2010 | B2 |
| 7747326 | Velasco et al. | Jun 2010 | B2 |
| 7747551 | Snyder | Jun 2010 | B2 |
| 7749155 | Anderson et al. | Jul 2010 | B1 |
| 7751877 | Flaherty et al. | Jul 2010 | B2 |
| 7751878 | Merkle et al. | Jul 2010 | B1 |
| 7753523 | Kiderman et al. | Jul 2010 | B2 |
| 7754190 | Suffin | Jul 2010 | B2 |
| 7756564 | Matsui et al. | Jul 2010 | B2 |
| 7756568 | Scarantino et al. | Jul 2010 | B2 |
| 7757690 | Stahmann et al. | Jul 2010 | B2 |
| 7758503 | Lynn et al. | Jul 2010 | B2 |
| 7763588 | van Praag et al. | Jul 2010 | B2 |
| 7764283 | Scott et al. | Jul 2010 | B2 |
| 7764987 | Dorr et al. | Jul 2010 | B2 |
| 7766827 | Balkin et al. | Aug 2010 | B2 |
| 7769424 | Sato | Aug 2010 | B2 |
| 7769431 | Scarantino et al. | Aug 2010 | B2 |
| 7771341 | Rogers | Aug 2010 | B2 |
| 7771364 | Arbel et al. | Aug 2010 | B2 |
| 7773767 | Wahl et al. | Aug 2010 | B2 |
| 7774052 | Burton et al. | Aug 2010 | B2 |
| 7774064 | Meyer et al. | Aug 2010 | B2 |
| 7778692 | Scarantino et al. | Aug 2010 | B2 |
| 7778693 | Barbour et al. | Aug 2010 | B2 |
| 7783332 | Laufer et al. | Aug 2010 | B2 |
| 7787937 | Scarantino et al. | Aug 2010 | B2 |
| 7787946 | Stahmann et al. | Aug 2010 | B2 |
| 7792575 | Fujimaki et al. | Sep 2010 | B2 |
| 7794403 | Schaafsma | Sep 2010 | B2 |
| 7794406 | Reisfeld et al. | Sep 2010 | B2 |
| 7797040 | Pesaran et al. | Sep 2010 | B2 |
| 7800493 | Terauchi et al. | Sep 2010 | B2 |
| 7801591 | Shusterman | Sep 2010 | B1 |
| 7801592 | Shan et al. | Sep 2010 | B2 |
| 7801593 | Behbehani et al. | Sep 2010 | B2 |
| 7801686 | Hyde et al. | Sep 2010 | B2 |
| 7803118 | Reisfeld et al. | Sep 2010 | B2 |
| 7803119 | Reisfeld | Sep 2010 | B2 |
| 7809433 | Keenan | Oct 2010 | B2 |
| 7809434 | Kofol et al. | Oct 2010 | B2 |
| 7811279 | John | Oct 2010 | B2 |
| 7819794 | Becker | Oct 2010 | B2 |
| 7819812 | John et al. | Oct 2010 | B2 |
| D626949 | Wahl et al. | Nov 2010 | S |
| D627476 | Gaw et al. | Nov 2010 | S |
| 7831302 | Thomas | Nov 2010 | B2 |
| 7831305 | Gliner | Nov 2010 | B2 |
| 7833966 | Peyman | Nov 2010 | B2 |
| 7834627 | Sakai et al. | Nov 2010 | B2 |
| 7835498 | Bonfiglio et al. | Nov 2010 | B2 |
| 7835787 | Sajda et al. | Nov 2010 | B2 |
| 7840039 | Fuchs | Nov 2010 | B2 |
| 7840248 | Fuchs et al. | Nov 2010 | B2 |
| 7840250 | Tucker | Nov 2010 | B2 |
| 7840257 | Chance | Nov 2010 | B2 |
| 7853329 | DiLorenzo | Dec 2010 | B2 |
| 7856264 | Firlik et al. | Dec 2010 | B2 |
| 7860548 | McIntyre et al. | Dec 2010 | B2 |
| 7860552 | Borsook et al. | Dec 2010 | B2 |
| 7860561 | Modarres | Dec 2010 | B1 |
| 7865234 | Modarres | Jan 2011 | B1 |
| 7865235 | Le et al. | Jan 2011 | B2 |
| 7865244 | Giftakis et al. | Jan 2011 | B2 |
| 7866818 | Schroeder et al. | Jan 2011 | B2 |
| 7872235 | Rousso et al. | Jan 2011 | B2 |
| 7872635 | Mitchell | Jan 2011 | B2 |
| 7873411 | Eda et al. | Jan 2011 | B2 |
| 7878965 | Haber et al. | Feb 2011 | B2 |
| 7879043 | Meneghini et al. | Feb 2011 | B2 |
| 7881760 | Matsui et al. | Feb 2011 | B2 |
| 7881770 | Melkent et al. | Feb 2011 | B2 |
| 7881780 | Flaherty | Feb 2011 | B2 |
| 7882135 | Brunner et al. | Feb 2011 | B2 |
| 7885419 | Wahl et al. | Feb 2011 | B2 |
| 7887493 | Stahmann et al. | Feb 2011 | B2 |
| 7890176 | Jaax et al. | Feb 2011 | B2 |
| 7891814 | Harada et al. | Feb 2011 | B2 |
| 7892764 | Xiong et al. | Feb 2011 | B2 |
| 7894890 | Sun et al. | Feb 2011 | B2 |
| 7894903 | John | Feb 2011 | B2 |
| 7895033 | Joublin et al. | Feb 2011 | B2 |
| 7896807 | Clancy et al. | Mar 2011 | B2 |
| 7899524 | Kozel | Mar 2011 | B2 |
| 7899525 | John et al. | Mar 2011 | B2 |
| 7904134 | McIntyre et al. | Mar 2011 | B2 |
| 7904139 | Chance | Mar 2011 | B2 |
| 7904144 | Causevic et al. | Mar 2011 | B2 |
| 7904507 | Jung et al. | Mar 2011 | B2 |
| 7907994 | Stolarski et al. | Mar 2011 | B2 |
| 7907998 | Arad | Mar 2011 | B2 |
| 7908009 | Wyler et al. | Mar 2011 | B2 |
| 7909771 | Meyer et al. | Mar 2011 | B2 |
| 7912530 | Seki et al. | Mar 2011 | B2 |
| 7917206 | Frei et al. | Mar 2011 | B2 |
| 7917221 | Tass | Mar 2011 | B2 |
| 7917225 | Wyler et al. | Mar 2011 | B2 |
| 7918779 | Haber et al. | Apr 2011 | B2 |
| 7918807 | Lau et al. | Apr 2011 | B2 |
| 7920914 | Shieh et al. | Apr 2011 | B2 |
| 7929693 | Terauchi et al. | Apr 2011 | B2 |
| 7930035 | DiLorenzo | Apr 2011 | B2 |
| 7932225 | Gong et al. | Apr 2011 | B2 |
| 7933645 | Strychacz et al. | Apr 2011 | B2 |
| 7933646 | Frei et al. | Apr 2011 | B2 |
| 7933727 | Taulu et al. | Apr 2011 | B2 |
| 7937138 | Liley | May 2011 | B2 |
| 7937152 | Lozano | May 2011 | B1 |
| 7938782 | Stahmann et al. | May 2011 | B2 |
| 7938785 | Aguilar et al. | May 2011 | B2 |
| 7941209 | Hughes et al. | May 2011 | B2 |
| 7942824 | Kayyali et al. | May 2011 | B1 |
| 7944551 | Addison et al. | May 2011 | B2 |
| 7945304 | Feinberg | May 2011 | B2 |
| 7945316 | Giftakis et al. | May 2011 | B2 |
| 7962204 | Suffin et al. | Jun 2011 | B2 |
| 7967439 | Shelhamer et al. | Jun 2011 | B2 |
| 7970734 | Townsend et al. | Jun 2011 | B2 |
| 7972278 | Graham et al. | Jul 2011 | B2 |
| 7974696 | DiLorenzo | Jul 2011 | B1 |
| 7974787 | Hyde et al. | Jul 2011 | B2 |
| 7976465 | Frei et al. | Jul 2011 | B2 |
| 7983740 | Culver et al. | Jul 2011 | B2 |
| 7983741 | Chance | Jul 2011 | B2 |
| 7983757 | Miyazawa et al. | Jul 2011 | B2 |
| 7986991 | Prichep | Jul 2011 | B2 |
| 7988613 | Becker | Aug 2011 | B2 |
| 7988969 | Poduslo et al. | Aug 2011 | B2 |
| 7991461 | Flaherty et al. | Aug 2011 | B2 |
| 7993279 | Hartley et al. | Aug 2011 | B2 |
| 7996075 | Korzinov et al. | Aug 2011 | B2 |
| 7996076 | Burns et al. | Aug 2011 | B2 |
| 8000767 | Eden et al. | Aug 2011 | B2 |
| 8000773 | Rousso et al. | Aug 2011 | B2 |
| 8000793 | Libbus | Aug 2011 | B2 |
| 8000794 | Lozano | Aug 2011 | B2 |
| 8001179 | Jung et al. | Aug 2011 | B2 |
| 8002553 | Hatlestad et al. | Aug 2011 | B2 |
| 8005534 | Greenwald et al. | Aug 2011 | B2 |
| 8005624 | Starr | Aug 2011 | B1 |
| 8005766 | Tian et al. | Aug 2011 | B2 |
| 8005894 | Jung et al. | Aug 2011 | B2 |
| 8010178 | Seki et al. | Aug 2011 | B2 |
| 8010347 | Ricci et al. | Aug 2011 | B2 |
| 8012107 | Einav et al. | Sep 2011 | B2 |
| 8014847 | Shastri et al. | Sep 2011 | B2 |
| 8014870 | Seidman | Sep 2011 | B2 |
| 8019400 | Diab et al. | Sep 2011 | B2 |
| 8019410 | Bharmi et al. | Sep 2011 | B1 |
| 8021299 | Miesel et al. | Sep 2011 | B2 |
| 8024032 | Osorio et al. | Sep 2011 | B1 |
| 8025404 | Bolger et al. | Sep 2011 | B2 |
| 8027730 | John | Sep 2011 | B2 |
| 8029553 | Nemenov | Oct 2011 | B2 |
| 8032209 | He et al. | Oct 2011 | B2 |
| 8032486 | Townsend et al. | Oct 2011 | B2 |
| 8032842 | Kwon et al. | Oct 2011 | B2 |
| 8033996 | Behar | Oct 2011 | B2 |
| 8036434 | Hewett et al. | Oct 2011 | B2 |
| 8036728 | Diab et al. | Oct 2011 | B2 |
| 8036736 | Snyder et al. | Oct 2011 | B2 |
| 8041136 | Causevic | Oct 2011 | B2 |
| 8041418 | Giftakis et al. | Oct 2011 | B2 |
| 8041419 | Giftakis et al. | Oct 2011 | B2 |
| 8046041 | Diab et al. | Oct 2011 | B2 |
| 8046042 | Diab et al. | Oct 2011 | B2 |
| 8055591 | Jung et al. | Nov 2011 | B2 |
| 8055722 | Hille | Nov 2011 | B2 |
| 8059879 | Tsukimoto | Nov 2011 | B2 |
| 8060194 | Flaherty | Nov 2011 | B2 |
| 8065011 | Echauz et al. | Nov 2011 | B2 |
| 8065360 | Jung et al. | Nov 2011 | B2 |
| 8066637 | Childre et al. | Nov 2011 | B2 |
| 8066647 | Armitstead | Nov 2011 | B2 |
| 8068904 | Sun et al. | Nov 2011 | B2 |
| 8068911 | Giftakis et al. | Nov 2011 | B2 |
| 8069125 | Jung et al. | Nov 2011 | B2 |
| 8073534 | Low | Dec 2011 | B2 |
| 8073631 | Wilber et al. | Dec 2011 | B2 |
| 8075499 | Nathan et al. | Dec 2011 | B2 |
| 8079953 | Braun et al. | Dec 2011 | B2 |
| 8082031 | Ochs | Dec 2011 | B2 |
| 8082215 | Jung et al. | Dec 2011 | B2 |
| 8083786 | Gafni et al. | Dec 2011 | B2 |
| 8085902 | Bonfiglio et al. | Dec 2011 | B2 |
| 8086294 | Echauz et al. | Dec 2011 | B2 |
| 8086296 | Bystritsky | Dec 2011 | B2 |
| 8086563 | Jung et al. | Dec 2011 | B2 |
| 8088057 | Honeycutt et al. | Jan 2012 | B2 |
| 8089283 | Kaplan et al. | Jan 2012 | B2 |
| 8095209 | Flaherty | Jan 2012 | B2 |
| 8095210 | Burdick et al. | Jan 2012 | B2 |
| 8103333 | Tran | Jan 2012 | B2 |
| 8108036 | Tran | Jan 2012 | B2 |
| 8108038 | Giftakis et al. | Jan 2012 | B2 |
| 8108039 | Saliga et al. | Jan 2012 | B2 |
| 8108046 | Giftakis et al. | Jan 2012 | B2 |
| 8112148 | Giftakis et al. | Feb 2012 | B2 |
| 8112153 | Giftakis et al. | Feb 2012 | B2 |
| 8114021 | Robertson et al. | Feb 2012 | B2 |
| 8116874 | Tass | Feb 2012 | B2 |
| 8116877 | Lozano | Feb 2012 | B2 |
| 8121673 | Tran | Feb 2012 | B2 |
| 8121694 | Molnar et al. | Feb 2012 | B2 |
| 8121695 | Gliner et al. | Feb 2012 | B2 |
| 8126528 | Diab et al. | Feb 2012 | B2 |
| 8128422 | Mellott et al. | Mar 2012 | B2 |
| 8128572 | Diab et al. | Mar 2012 | B2 |
| 8131354 | Arad | Mar 2012 | B2 |
| 8133172 | Shachar et al. | Mar 2012 | B2 |
| 8135957 | Dinges et al. | Mar 2012 | B2 |
| 8137269 | Sheikhzadeh-Nadjar et al. | Mar 2012 | B2 |
| 8137270 | Keenan et al. | Mar 2012 | B2 |
| 8145310 | Dong et al. | Mar 2012 | B2 |
| 8150523 | Schiff et al. | Apr 2012 | B2 |
| 8150796 | Jung et al. | Apr 2012 | B2 |
| 8152732 | Lynn et al. | Apr 2012 | B2 |
| 8155726 | Seki et al. | Apr 2012 | B2 |
| 8155736 | Sullivan et al. | Apr 2012 | B2 |
| 8160273 | Visser et al. | Apr 2012 | B2 |
| 8160287 | Slippy et al. | Apr 2012 | B2 |
| 8160689 | Jadidi | Apr 2012 | B2 |
| 8162479 | Humphries et al. | Apr 2012 | B2 |
| 8167784 | Honeycutt et al. | May 2012 | B1 |
| 8170637 | Lee et al. | May 2012 | B2 |
| 8172766 | Kayyali et al. | May 2012 | B1 |
| 8175696 | Liley et al. | May 2012 | B2 |
| 8177724 | Derchak et al. | May 2012 | B2 |
| 8177726 | John | May 2012 | B2 |
| 8177727 | Kwak | May 2012 | B2 |
| 8177732 | Einav et al. | May 2012 | B2 |
| 8180420 | Diab et al. | May 2012 | B2 |
| 8180601 | Butson et al. | May 2012 | B2 |
| 8185207 | Molnar et al. | May 2012 | B2 |
| 8185382 | Joublin et al. | May 2012 | B2 |
| 8187181 | Osorio et al. | May 2012 | B2 |
| 8187201 | Lynn | May 2012 | B2 |
| 8190227 | Diab et al. | May 2012 | B2 |
| 8190248 | Besio et al. | May 2012 | B2 |
| 8190249 | Gharieb et al. | May 2012 | B1 |
| 8190251 | Molnar et al. | May 2012 | B2 |
| 8190264 | Lozano et al. | May 2012 | B2 |
| 8192376 | Lovett et al. | Jun 2012 | B2 |
| 8195593 | Jung et al. | Jun 2012 | B2 |
| 8197395 | Jassemidis et al. | Jun 2012 | B2 |
| 8197437 | Kalafut et al. | Jun 2012 | B2 |
| 8200319 | Pu et al. | Jun 2012 | B2 |
| 8202840 | Peyman | Jun 2012 | B2 |
| 8203530 | Chiang | Jun 2012 | B2 |
| 8204583 | Sackellares et al. | Jun 2012 | B2 |
| 8204597 | Gerber et al. | Jun 2012 | B2 |
| 8209009 | Giftakis et al. | Jun 2012 | B2 |
| 8209019 | Giftakis et al. | Jun 2012 | B2 |
| 8209224 | Pradeep et al. | Jun 2012 | B2 |
| 8211035 | Melker et al. | Jul 2012 | B2 |
| 8212556 | Schwindt et al. | Jul 2012 | B1 |
| 8213670 | Lai | Jul 2012 | B2 |
| 8214007 | Baker et al. | Jul 2012 | B2 |
| 8214035 | Giftakis et al. | Jul 2012 | B2 |
| 8222378 | Masure | Jul 2012 | B2 |
| 8224433 | Suffin et al. | Jul 2012 | B2 |
| 8229540 | Sami et al. | Jul 2012 | B2 |
| 8233682 | Fessler et al. | Jul 2012 | B2 |
| 8233965 | Bjornerud et al. | Jul 2012 | B2 |
| 8235907 | Wilk et al. | Aug 2012 | B2 |
| 8236005 | Meneghini et al. | Aug 2012 | B2 |
| 8236038 | Nofzinger | Aug 2012 | B2 |
| 8239014 | Ochs | Aug 2012 | B2 |
| 8239029 | De Ridder | Aug 2012 | B2 |
| 8239030 | Hagedorn et al. | Aug 2012 | B1 |
| 8241213 | Lynn et al. | Aug 2012 | B2 |
| 8244340 | Wu et al. | Aug 2012 | B2 |
| 8244341 | Hinrikus et al. | Aug 2012 | B2 |
| 8244475 | Aguilar et al. | Aug 2012 | B2 |
| 8244552 | Firminger et al. | Aug 2012 | B2 |
| 8244553 | Firminger et al. | Aug 2012 | B2 |
| 8248069 | Buracas | Aug 2012 | B2 |
| 8249316 | Hu et al. | Aug 2012 | B2 |
| 8249698 | Mugler et al. | Aug 2012 | B2 |
| 8259169 | Sugio et al. | Sep 2012 | B2 |
| 8262714 | Hulvershorn et al. | Sep 2012 | B2 |
| 8265743 | Aguilar et al. | Sep 2012 | B2 |
| 8267851 | Kroll | Sep 2012 | B1 |
| 8270814 | Pradeep et al. | Sep 2012 | B2 |
| 8271075 | Chuang et al. | Sep 2012 | B2 |
| 8271077 | Rotenberg | Sep 2012 | B1 |
| 8271411 | Kaplan | Sep 2012 | B2 |
| 8280502 | Hargrove et al. | Oct 2012 | B2 |
| 8280503 | Linderman | Oct 2012 | B2 |
| 8280514 | Lozano et al. | Oct 2012 | B2 |
| 8280515 | Greenspan | Oct 2012 | B2 |
| 8284233 | Bennett et al. | Oct 2012 | B2 |
| 8285351 | Johnson et al. | Oct 2012 | B2 |
| 8285368 | Chen et al. | Oct 2012 | B2 |
| 8290208 | Kurtz et al. | Oct 2012 | B2 |
| 8290563 | Jin et al. | Oct 2012 | B2 |
| 8290575 | Tarassenko et al. | Oct 2012 | B2 |
| 8290596 | Wei et al. | Oct 2012 | B2 |
| 8295914 | Kalafut et al. | Oct 2012 | B2 |
| 8295934 | Leyde | Oct 2012 | B2 |
| 8296108 | Tanaka | Oct 2012 | B2 |
| 8298078 | Sutton et al. | Oct 2012 | B2 |
| 8298140 | Beck-Nielsen et al. | Oct 2012 | B2 |
| 8301218 | Nguyen et al. | Oct 2012 | B2 |
| 8301222 | Rongen et al. | Oct 2012 | B2 |
| 8301232 | Albert et al. | Oct 2012 | B2 |
| 8301233 | Zhang et al. | Oct 2012 | B2 |
| 8301257 | Hsu et al. | Oct 2012 | B2 |
| D671523 | Daniel | Nov 2012 | S |
| 8303636 | Schiffer | Nov 2012 | B2 |
| 8304246 | Cook et al. | Nov 2012 | B2 |
| 8305078 | Savukov et al. | Nov 2012 | B2 |
| 8306607 | Levi et al. | Nov 2012 | B1 |
| 8306610 | Mirow | Nov 2012 | B2 |
| 8308646 | Belohlavek et al. | Nov 2012 | B2 |
| 8309530 | Szentirmai et al. | Nov 2012 | B2 |
| 8311622 | Snyder et al. | Nov 2012 | B2 |
| 8313441 | Dalton | Nov 2012 | B2 |
| 8314707 | Kobetski et al. | Nov 2012 | B2 |
| 8315703 | Lozano | Nov 2012 | B2 |
| 8315970 | Zalay et al. | Nov 2012 | B2 |
| 8318485 | Gavrilova et al. | Nov 2012 | B2 |
| 8320649 | Shahaf et al. | Nov 2012 | B2 |
| 8323188 | Tran | Dec 2012 | B2 |
| 8323189 | Tran et al. | Dec 2012 | B2 |
| 8323204 | Stahmann et al. | Dec 2012 | B2 |
| 8326433 | Blum et al. | Dec 2012 | B2 |
| 8328718 | Tran | Dec 2012 | B2 |
| 8332017 | Tarassenko et al. | Dec 2012 | B2 |
| 8332024 | Rapoport et al. | Dec 2012 | B2 |
| 8334690 | Kitching et al. | Dec 2012 | B2 |
| 8335561 | Modarres | Dec 2012 | B1 |
| 8335664 | Eberle | Dec 2012 | B2 |
| 8335715 | Pradeep et al. | Dec 2012 | B2 |
| 8335716 | Pradeep et al. | Dec 2012 | B2 |
| 8337404 | Osorio | Dec 2012 | B2 |
| 8340752 | Cox et al. | Dec 2012 | B2 |
| 8340753 | Hardt | Dec 2012 | B2 |
| 8343026 | Gardiner et al. | Jan 2013 | B2 |
| 8343066 | Eagleman et al. | Jan 2013 | B1 |
| 8345191 | Yan et al. | Jan 2013 | B2 |
| 8346331 | Bunce et al. | Jan 2013 | B2 |
| 8346342 | Kalafut | Jan 2013 | B2 |
| 8346349 | Guttag et al. | Jan 2013 | B2 |
| 8350804 | Moll | Jan 2013 | B1 |
| 8352023 | John et al. | Jan 2013 | B2 |
| 8353837 | John et al. | Jan 2013 | B2 |
| 8354438 | Chez | Jan 2013 | B2 |
| 8354881 | Denison | Jan 2013 | B2 |
| 8355768 | Masmanidis et al. | Jan 2013 | B2 |
| 8356004 | Jung et al. | Jan 2013 | B2 |
| 8356594 | Ujhazy et al. | Jan 2013 | B2 |
| 8357101 | Sugio et al. | Jan 2013 | B2 |
| 8358818 | Miga et al. | Jan 2013 | B2 |
| 8359080 | Diab et al. | Jan 2013 | B2 |
| 8364226 | Diab et al. | Jan 2013 | B2 |
| 8364254 | Jacquin et al. | Jan 2013 | B2 |
| 8364255 | Isenhart et al. | Jan 2013 | B2 |
| 8364271 | De Ridder | Jan 2013 | B2 |
| 8369940 | Sun et al. | Feb 2013 | B2 |
| 8374412 | Kimura | Feb 2013 | B2 |
| 8374690 | Ma | Feb 2013 | B2 |
| 8374696 | Sanchez et al. | Feb 2013 | B2 |
| 8374703 | Imran | Feb 2013 | B2 |
| 8376965 | Schuette et al. | Feb 2013 | B2 |
| 8379952 | McIntyre et al. | Feb 2013 | B2 |
| 8380289 | Zellers et al. | Feb 2013 | B2 |
| 8380290 | Scarantino et al. | Feb 2013 | B2 |
| 8380296 | Lee et al. | Feb 2013 | B2 |
| 8380314 | Panken et al. | Feb 2013 | B2 |
| 8380316 | Hagedorn et al. | Feb 2013 | B2 |
| 8380658 | Jung et al. | Feb 2013 | B2 |
| 8382667 | Osorio | Feb 2013 | B2 |
| 8386244 | Ricci et al. | Feb 2013 | B2 |
| 8386261 | Mellott et al. | Feb 2013 | B2 |
| 8386312 | Pradeep et al. | Feb 2013 | B2 |
| 8386313 | Pradeep et al. | Feb 2013 | B2 |
| RE44097 | Wilber et al. | Mar 2013 | E |
| 8388530 | Shusterman | Mar 2013 | B2 |
| 8391942 | Benni | Mar 2013 | B2 |
| 8391956 | Zellers et al. | Mar 2013 | B2 |
| 8391966 | Luo et al. | Mar 2013 | B2 |
| 8392250 | Pradeep et al. | Mar 2013 | B2 |
| 8392251 | Pradeep et al. | Mar 2013 | B2 |
| 8392253 | Pradeep et al. | Mar 2013 | B2 |
| 8392254 | Pradeep et al. | Mar 2013 | B2 |
| 8392255 | Pradeep et al. | Mar 2013 | B2 |
| 8396529 | Lee et al. | Mar 2013 | B2 |
| 8396542 | Johnson et al. | Mar 2013 | B2 |
| 8396545 | Berridge et al. | Mar 2013 | B2 |
| 8396546 | Hirata et al. | Mar 2013 | B2 |
| 8396557 | DiLorenzo | Mar 2013 | B2 |
| 8396744 | Pradeep et al. | Mar 2013 | B2 |
| 8398538 | Dothie et al. | Mar 2013 | B2 |
| 8400313 | Noguchi et al. | Mar 2013 | B2 |
| 8401624 | Govari | Mar 2013 | B2 |
| 8401626 | Mietus et al. | Mar 2013 | B2 |
| 8401655 | De Ridder | Mar 2013 | B2 |
| 8403848 | Mietus et al. | Mar 2013 | B2 |
| 8405610 | Cole | Mar 2013 | B1 |
| 8406838 | Kato | Mar 2013 | B2 |
| 8406841 | Lin et al. | Mar 2013 | B2 |
| 8406848 | Wu et al. | Mar 2013 | B2 |
| 8406862 | Hopenfeld | Mar 2013 | B2 |
| 8406890 | Goetz | Mar 2013 | B2 |
| 8412337 | Lozano | Apr 2013 | B2 |
| 8412655 | Colman et al. | Apr 2013 | B2 |
| 8417185 | Braho et al. | Apr 2013 | B2 |
| 8419654 | Sugio et al. | Apr 2013 | B2 |
| 8423125 | Rousso et al. | Apr 2013 | B2 |
| 8423144 | Tass et al. | Apr 2013 | B2 |
| 8423297 | Wilber | Apr 2013 | B2 |
| 8425415 | Tran | Apr 2013 | B2 |
| 8425583 | Nofzinger | Apr 2013 | B2 |
| 8428696 | Foo | Apr 2013 | B2 |
| 8428703 | Hopenfeld | Apr 2013 | B2 |
| 8428704 | Johnson et al. | Apr 2013 | B2 |
| 8429225 | Jung et al. | Apr 2013 | B2 |
| 8430510 | Sugio et al. | Apr 2013 | B2 |
| 8431537 | Gong et al. | Apr 2013 | B2 |
| 8433388 | Blunt et al. | Apr 2013 | B2 |
| 8433414 | Gliner et al. | Apr 2013 | B2 |
| 8433418 | DeRidder | Apr 2013 | B2 |
| 8434868 | Sato et al. | May 2013 | B2 |
| 8437843 | Kayyali et al. | May 2013 | B1 |
| 8437844 | Syed Momen et al. | May 2013 | B2 |
| 8438659 | Shen | May 2013 | B2 |
| 8439845 | Folkerts et al. | May 2013 | B2 |
| 8441356 | Tedesco et al. | May 2013 | B1 |
| 8442626 | Zavoronkovs et al. | May 2013 | B2 |
| 8444571 | Folkerts et al. | May 2013 | B2 |
| 8445021 | Akhtari et al. | May 2013 | B2 |
| 8445851 | Rousso et al. | May 2013 | B2 |
| 8447407 | Talathi et al. | May 2013 | B2 |
| 8449116 | Sato et al. | May 2013 | B2 |
| 8449471 | Tran | May 2013 | B2 |
| 8452544 | Hymel | May 2013 | B2 |
| 8454555 | Struijk et al. | Jun 2013 | B2 |
| 8456164 | Subbarao | Jun 2013 | B2 |
| 8457730 | Makinen | Jun 2013 | B2 |
| 8457746 | Libbus | Jun 2013 | B2 |
| 8461988 | Tran | Jun 2013 | B2 |
| 8463007 | Steinberg et al. | Jun 2013 | B2 |
| 8463349 | Diab et al. | Jun 2013 | B2 |
| 8463370 | Korhonen et al. | Jun 2013 | B2 |
| 8463371 | Guan et al. | Jun 2013 | B2 |
| 8463374 | Hudson et al. | Jun 2013 | B2 |
| 8463378 | Tass | Jun 2013 | B2 |
| 8463386 | Tass | Jun 2013 | B2 |
| 8463387 | De Ridder | Jun 2013 | B2 |
| 8464288 | Pradeep et al. | Jun 2013 | B2 |
| 8465408 | Phillips et al. | Jun 2013 | B2 |
| 8466875 | Nakada et al. | Jun 2013 | B2 |
| 8467877 | Imran | Jun 2013 | B2 |
| 8467878 | Lozano et al. | Jun 2013 | B2 |
| 8473024 | Causevic et al. | Jun 2013 | B2 |
| 8473044 | Lee et al. | Jun 2013 | B2 |
| 8473306 | Seely | Jun 2013 | B2 |
| 8473345 | Pradeep et al. | Jun 2013 | B2 |
| 8475354 | Phillips et al. | Jul 2013 | B2 |
| 8475368 | Tran et al. | Jul 2013 | B2 |
| 8475371 | Derchak et al. | Jul 2013 | B2 |
| 8475387 | Derchak et al. | Jul 2013 | B2 |
| 8477425 | Border et al. | Jul 2013 | B2 |
| 8478389 | Brockway et al. | Jul 2013 | B1 |
| 8478394 | Prichep et al. | Jul 2013 | B2 |
| 8478402 | Wahlstrand et al. | Jul 2013 | B2 |
| 8480554 | Phillips et al. | Jul 2013 | B2 |
| 8482859 | Border et al. | Jul 2013 | B2 |
| 8483795 | Okada | Jul 2013 | B2 |
| 8483815 | Liley | Jul 2013 | B2 |
| 8483816 | Payton et al. | Jul 2013 | B1 |
| 8484081 | Pradeep et al. | Jul 2013 | B2 |
| 8484270 | Kurtz et al. | Jul 2013 | B2 |
| 8485979 | Giftakis et al. | Jul 2013 | B2 |
| 8487760 | Kangas et al. | Jul 2013 | B2 |
| 8488246 | Border et al. | Jul 2013 | B2 |
| 8492336 | Masure | Jul 2013 | B2 |
| 8494507 | Tedesco et al. | Jul 2013 | B1 |
| 8494610 | Pradeep et al. | Jul 2013 | B2 |
| 8494829 | Teixeira | Jul 2013 | B2 |
| 8494857 | Pakhomov | Jul 2013 | B2 |
| 8494905 | Pradeep et al. | Jul 2013 | B2 |
| 8498697 | Yong et al. | Jul 2013 | B2 |
| 8498699 | Wells et al. | Jul 2013 | B2 |
| 8498708 | Bentwich | Jul 2013 | B2 |
| RE44408 | Lindsay | Aug 2013 | E |
| 8500282 | Bolger et al. | Aug 2013 | B2 |
| 8500636 | Tran | Aug 2013 | B2 |
| 8509879 | Durkin et al. | Aug 2013 | B2 |
| 8509881 | Thiagarajan et al. | Aug 2013 | B2 |
| 8509885 | Snyder et al. | Aug 2013 | B2 |
| 8509904 | Rickert et al. | Aug 2013 | B2 |
| 8512221 | Kaplan et al. | Aug 2013 | B2 |
| 8512240 | Zuckerman-Stark et al. | Aug 2013 | B1 |
| 8515535 | Hopper et al. | Aug 2013 | B2 |
| 8517909 | Honeycutt et al. | Aug 2013 | B2 |
| 8517912 | Clare | Aug 2013 | B2 |
| 8519705 | Savukov et al. | Aug 2013 | B2 |
| 8519853 | Eskandarian et al. | Aug 2013 | B2 |
| 8521284 | Kim et al. | Aug 2013 | B2 |
| 8525673 | Tran | Sep 2013 | B2 |
| 8525687 | Tran | Sep 2013 | B2 |
| 8525788 | Chiang | Sep 2013 | B2 |
| 8527029 | Okada | Sep 2013 | B2 |
| 8527035 | Diamond | Sep 2013 | B2 |
| 8527435 | Han et al. | Sep 2013 | B1 |
| 8529463 | Della Santina et al. | Sep 2013 | B2 |
| 8531291 | Tran | Sep 2013 | B2 |
| 8532756 | Schalk et al. | Sep 2013 | B2 |
| 8532757 | Molnar et al. | Sep 2013 | B2 |
| 8533042 | Pradeep et al. | Sep 2013 | B2 |
| 8538512 | Bibian et al. | Sep 2013 | B1 |
| 8538513 | Molnar et al. | Sep 2013 | B2 |
| 8538514 | Sun et al. | Sep 2013 | B2 |
| 8538536 | Rezai et al. | Sep 2013 | B2 |
| 8538705 | Greenwald | Sep 2013 | B2 |
| 8542900 | Tolkowsky et al. | Sep 2013 | B2 |
| 8542916 | Tognoli et al. | Sep 2013 | B2 |
| 8543189 | Paitel et al. | Sep 2013 | B2 |
| 8543199 | Snyder et al. | Sep 2013 | B2 |
| 8543219 | Tass | Sep 2013 | B2 |
| 8545416 | Kayyali et al. | Oct 2013 | B1 |
| 8545420 | Einav et al. | Oct 2013 | B2 |
| 8545436 | Robertson et al. | Oct 2013 | B2 |
| 8548555 | Jin et al. | Oct 2013 | B2 |
| 8548558 | Dunagan et al. | Oct 2013 | B2 |
| 8548786 | Plenz | Oct 2013 | B2 |
| 8548852 | Pradeep et al. | Oct 2013 | B2 |
| 8552860 | Baughman et al. | Oct 2013 | B2 |
| 8553956 | Wu et al. | Oct 2013 | B2 |
| 8554311 | Warner et al. | Oct 2013 | B2 |
| 8554325 | Molnar et al. | Oct 2013 | B2 |
| 8559645 | Corona-Strauss et al. | Oct 2013 | B2 |
| 8560034 | Diab et al. | Oct 2013 | B1 |
| 8560041 | Flaherty et al. | Oct 2013 | B2 |
| 8560073 | Osorio | Oct 2013 | B2 |
| 8562525 | Nakashima et al. | Oct 2013 | B2 |
| 8562526 | Heneghan et al. | Oct 2013 | B2 |
| 8562527 | Braun et al. | Oct 2013 | B2 |
| 8562540 | Goodall et al. | Oct 2013 | B2 |
| 8562548 | Shimada et al. | Oct 2013 | B2 |
| 8562951 | Suffin et al. | Oct 2013 | B2 |
| 8565606 | Kim et al. | Oct 2013 | B2 |
| 8568231 | Solanki et al. | Oct 2013 | B2 |
| 8568329 | Lee et al. | Oct 2013 | B2 |
| 8570176 | Farbos | Oct 2013 | B2 |
| 8571629 | Faro et al. | Oct 2013 | B2 |
| 8571642 | Gill et al. | Oct 2013 | B2 |
| 8574279 | Schiffer | Nov 2013 | B2 |
| 8579786 | Osorio et al. | Nov 2013 | B2 |
| 8579793 | Honeycutt | Nov 2013 | B1 |
| 8579795 | Martel | Nov 2013 | B2 |
| 8585568 | Phillips et al. | Nov 2013 | B2 |
| 8586019 | Satchi-Fainaro et al. | Nov 2013 | B2 |
| 8586932 | Rousso et al. | Nov 2013 | B2 |
| 8587304 | Budker et al. | Nov 2013 | B2 |
| 8588933 | Floyd et al. | Nov 2013 | B2 |
| 8591419 | Tyler | Nov 2013 | B2 |
| 8591498 | John | Nov 2013 | B2 |
| 8593141 | Radparvar et al. | Nov 2013 | B1 |
| 8597171 | Altman et al. | Dec 2013 | B2 |
| 8597193 | Grunwald et al. | Dec 2013 | B2 |
| 8600493 | Tanner et al. | Dec 2013 | B2 |
| 8600502 | Lovett et al. | Dec 2013 | B2 |
| 8600696 | Zafiris | Dec 2013 | B2 |
| 8602555 | Backus et al. | Dec 2013 | B2 |
| 8603790 | Deisseroth et al. | Dec 2013 | B2 |
| 8606349 | Rousso et al. | Dec 2013 | B2 |
| 8606351 | Wheeler | Dec 2013 | B2 |
| 8606356 | Lee et al. | Dec 2013 | B2 |
| 8606360 | Butson et al. | Dec 2013 | B2 |
| 8606592 | Hyde et al. | Dec 2013 | B2 |
| 8606923 | Tekwani | Dec 2013 | B2 |
| 8612005 | Rezai et al. | Dec 2013 | B2 |
| 8613695 | Von Ohlsen et al. | Dec 2013 | B2 |
| 8613905 | El-Agnaf | Dec 2013 | B2 |
| 8614254 | Llinas et al. | Dec 2013 | B2 |
| 8614873 | Beran | Dec 2013 | B1 |
| 8615293 | Jacobson et al. | Dec 2013 | B2 |
| 8615479 | Jung et al. | Dec 2013 | B2 |
| 8615664 | Jung et al. | Dec 2013 | B2 |
| 8618799 | Radparvar et al. | Dec 2013 | B1 |
| 8620021 | Knudson et al. | Dec 2013 | B2 |
| 8620206 | Brown et al. | Dec 2013 | B2 |
| 8620419 | Rotenberg et al. | Dec 2013 | B2 |
| 8626264 | Beran | Jan 2014 | B1 |
| 8626301 | Libbus | Jan 2014 | B2 |
| 8628328 | Palacios | Jan 2014 | B2 |
| 8628462 | Berka et al. | Jan 2014 | B2 |
| 8628480 | Derchak | Jan 2014 | B2 |
| 8630633 | Tedesco et al. | Jan 2014 | B1 |
| 8630699 | Baker et al. | Jan 2014 | B2 |
| 8632465 | Brockway | Jan 2014 | B1 |
| 8632750 | Suffin et al. | Jan 2014 | B2 |
| 8634892 | Lee et al. | Jan 2014 | B2 |
| 8635105 | Pradeep et al. | Jan 2014 | B2 |
| 8636640 | Chang | Jan 2014 | B2 |
| 8638950 | Anderson et al. | Jan 2014 | B2 |
| 8641632 | Quintin et al. | Feb 2014 | B2 |
| 8644754 | Brown | Feb 2014 | B2 |
| 8644910 | Rousso et al. | Feb 2014 | B2 |
| 8644914 | Hunt | Feb 2014 | B2 |
| 8644921 | Wilson | Feb 2014 | B2 |
| 8647278 | Ji et al. | Feb 2014 | B2 |
| 8648017 | Umansky et al. | Feb 2014 | B2 |
| 8649866 | Brooke | Feb 2014 | B2 |
| 8652038 | Tran et al. | Feb 2014 | B2 |
| 8652189 | Gafni et al. | Feb 2014 | B2 |
| 8655428 | Pradeep et al. | Feb 2014 | B2 |
| 8655437 | Pradeep et al. | Feb 2014 | B2 |
| 8655817 | Hasey et al. | Feb 2014 | B2 |
| 8657756 | Stahmann et al. | Feb 2014 | B2 |
| 8658149 | Satchi-Fainaro et al. | Feb 2014 | B2 |
| 8659397 | Vargo et al. | Feb 2014 | B2 |
| 8660649 | Ruffini et al. | Feb 2014 | B2 |
| 8660799 | Watson et al. | Feb 2014 | B2 |
| 8666099 | Nielsen et al. | Mar 2014 | B2 |
| 8666467 | Lynn et al. | Mar 2014 | B2 |
| 8666478 | LaViolette et al. | Mar 2014 | B2 |
| 8668496 | Nolen | Mar 2014 | B2 |
| 8669864 | Tedesco et al. | Mar 2014 | B1 |
| 8670603 | Tolkowsky et al. | Mar 2014 | B2 |
| 8670833 | Makous et al. | Mar 2014 | B2 |
| 8672852 | Gavish | Mar 2014 | B2 |
| 8676230 | Alexander et al. | Mar 2014 | B2 |
| 8679009 | Osorio | Mar 2014 | B2 |
| 8679013 | Ziarno et al. | Mar 2014 | B2 |
| 8680991 | Tran | Mar 2014 | B2 |
| 8682422 | Hopenfeld | Mar 2014 | B2 |
| 8682441 | De Ridder | Mar 2014 | B2 |
| 8682687 | Hyde et al. | Mar 2014 | B2 |
| 8684742 | Siefert | Apr 2014 | B2 |
| 8684900 | Tran | Apr 2014 | B2 |
| 8684922 | Tran | Apr 2014 | B2 |
| 8684926 | Arndt | Apr 2014 | B2 |
| 8688208 | Kapoor et al. | Apr 2014 | B2 |
| 8688209 | Verbitskiy | Apr 2014 | B2 |
| 8690748 | Fu | Apr 2014 | B1 |
| 8693756 | Tolkowsky et al. | Apr 2014 | B2 |
| 8693765 | Mercier et al. | Apr 2014 | B2 |
| 8694087 | Schiff | Apr 2014 | B2 |
| 8694089 | Arad | Apr 2014 | B2 |
| 8694107 | Falci | Apr 2014 | B2 |
| 8694157 | Wenderow et al. | Apr 2014 | B2 |
| 8696113 | Lewis | Apr 2014 | B2 |
| 8696722 | Deisseroth et al. | Apr 2014 | B2 |
| 8699747 | Rodriguez | Apr 2014 | B2 |
| 8700137 | Albert | Apr 2014 | B2 |
| 8700141 | Causevic | Apr 2014 | B2 |
| 8700142 | John et al. | Apr 2014 | B2 |
| 8700167 | Sabel | Apr 2014 | B2 |
| 8703114 | Satchi-Fainaro et al. | Apr 2014 | B2 |
| 8706183 | Cui et al. | Apr 2014 | B2 |
| 8706205 | Shahaf et al. | Apr 2014 | B2 |
| 8706206 | Kanai et al. | Apr 2014 | B2 |
| 8706207 | Flint | Apr 2014 | B2 |
| 8706241 | Firlik et al. | Apr 2014 | B2 |
| 8706518 | Hyde et al. | Apr 2014 | B2 |
| 8708903 | Tran | Apr 2014 | B2 |
| 8712507 | Cazares et al. | Apr 2014 | B2 |
| 8712512 | Doidge et al. | Apr 2014 | B2 |
| 8712513 | Modarres | Apr 2014 | B1 |
| 8716447 | Deisseroth et al. | May 2014 | B2 |
| 8717292 | Niikawa | May 2014 | B2 |
| 8717430 | Simon et al. | May 2014 | B2 |
| 8718747 | Bjornerud et al. | May 2014 | B2 |
| 8721341 | Mitchell | May 2014 | B2 |
| 8721695 | Tass et al. | May 2014 | B2 |
| 8725238 | Liu et al. | May 2014 | B2 |
| 8725243 | Dilorenzo et al. | May 2014 | B2 |
| 8725264 | Soler Fernandez et al. | May 2014 | B2 |
| 8725311 | Breed | May 2014 | B1 |
| 8725668 | Georgopoulos | May 2014 | B2 |
| 8725669 | Fu | May 2014 | B1 |
| 8725796 | Serena | May 2014 | B2 |
| 8726294 | Benedek et al. | May 2014 | B2 |
| 8727978 | Tran et al. | May 2014 | B2 |
| 8728001 | Lynn | May 2014 | B2 |
| 8731650 | Sajda et al. | May 2014 | B2 |
| 8733290 | Gerashchenko | May 2014 | B2 |
| 8733927 | Lewis | May 2014 | B1 |
| 8733928 | Lewis | May 2014 | B1 |
| 8738121 | Virag et al. | May 2014 | B2 |
| 8738136 | Frei et al. | May 2014 | B2 |
| 8738395 | Hyde et al. | May 2014 | B2 |
| 8744562 | Giftakis et al. | Jun 2014 | B2 |
| 8744563 | Yoshida | Jun 2014 | B2 |
| 8747313 | Tran et al. | Jun 2014 | B2 |
| 8747336 | Tran | Jun 2014 | B2 |
| 8747382 | D'Souza et al. | Jun 2014 | B2 |
| 8750971 | Tran | Jun 2014 | B2 |
| 8750974 | Baker et al. | Jun 2014 | B2 |
| 8750992 | Hopper et al. | Jun 2014 | B2 |
| 8751670 | Xu | Jun 2014 | B2 |
| 8753296 | Einav et al. | Jun 2014 | B2 |
| 8755854 | Addison et al. | Jun 2014 | B2 |
| 8755856 | Diab et al. | Jun 2014 | B2 |
| 8755868 | Yazicioglu | Jun 2014 | B2 |
| 8755869 | Zhang et al. | Jun 2014 | B2 |
| 8755871 | Weng et al. | Jun 2014 | B2 |
| 8755877 | Zoica | Jun 2014 | B2 |
| 8755879 | Hang et al. | Jun 2014 | B2 |
| 8761866 | Chance | Jun 2014 | B2 |
| 8761868 | Giftakis et al. | Jun 2014 | B2 |
| 8761869 | Leuthardt et al. | Jun 2014 | B2 |
| 8761889 | Wingeier et al. | Jun 2014 | B2 |
| 8762065 | DiLorenzo | Jun 2014 | B2 |
| 8762202 | Pradeep et al. | Jun 2014 | B2 |
| 8762852 | Davis et al. | Jun 2014 | B2 |
| 8764193 | Kiderman et al. | Jul 2014 | B2 |
| 8764651 | Tran | Jul 2014 | B2 |
| 8764652 | Lee et al. | Jul 2014 | B2 |
| 8764653 | Kaminska et al. | Jul 2014 | B2 |
| 8764673 | McCraty et al. | Jul 2014 | B2 |
| 8766819 | Dorfmann et al. | Jul 2014 | B2 |
| 8768022 | Miga et al. | Jul 2014 | B2 |
| 8768427 | Sjaaheim et al. | Jul 2014 | B2 |
| 8768447 | Ermes et al. | Jul 2014 | B2 |
| 8768449 | Pesaran et al. | Jul 2014 | B2 |
| 8771194 | John et al. | Jul 2014 | B2 |
| 8774784 | Kader | Jul 2014 | B2 |
| 8775340 | Waxman et al. | Jul 2014 | B2 |
| 8780512 | Sullivan | Jul 2014 | B2 |
| 8781193 | Steinberg et al. | Jul 2014 | B2 |
| 8781197 | Wang et al. | Jul 2014 | B2 |
| 8781557 | Dean et al. | Jul 2014 | B2 |
| 8781563 | Foo | Jul 2014 | B2 |
| 8781570 | Chuang et al. | Jul 2014 | B2 |
| 8781595 | Grevious et al. | Jul 2014 | B2 |
| 8781597 | DiLorenzo | Jul 2014 | B2 |
| 8781796 | Mott et al. | Jul 2014 | B2 |
| 8784322 | Kim et al. | Jul 2014 | B2 |
| 8786624 | Echauz et al. | Jul 2014 | B2 |
| 8788030 | Payton et al. | Jul 2014 | B1 |
| 8790255 | Behar | Jul 2014 | B2 |
| 8790272 | Sackner et al. | Jul 2014 | B2 |
| 8790297 | Bromander et al. | Jul 2014 | B2 |
| 8792974 | Rothman | Jul 2014 | B2 |
| 8798598 | Rossmann | Aug 2014 | B2 |
| 8798717 | Roscher | Aug 2014 | B2 |
| 8798735 | Bibian et al. | Aug 2014 | B1 |
| 8798736 | Sullivan et al. | Aug 2014 | B2 |
| 8801620 | Melker et al. | Aug 2014 | B2 |
| 8805489 | Ofek | Aug 2014 | B1 |
| 8805516 | Bentwich | Aug 2014 | B2 |
| 8812075 | Nguyen et al. | Aug 2014 | B2 |
| 8812098 | Giftakis et al. | Aug 2014 | B2 |
| 8814923 | Nissila et al. | Aug 2014 | B2 |
| 8815582 | Deisseroth et al. | Aug 2014 | B2 |
| 8816861 | Shepherd et al. | Aug 2014 | B2 |
| 8821376 | Tolkowsky | Sep 2014 | B2 |
| 8821397 | Al-Ali et al. | Sep 2014 | B2 |
| 8821408 | Hu et al. | Sep 2014 | B2 |
| 8825149 | Kraus et al. | Sep 2014 | B2 |
| 8825167 | Tass et al. | Sep 2014 | B2 |
| 8825428 | Addison et al. | Sep 2014 | B2 |
| 8827912 | Bukhman | Sep 2014 | B2 |
| 8827917 | Watson et al. | Sep 2014 | B2 |
| 8830164 | Sakata et al. | Sep 2014 | B2 |
| 8831705 | Dobak | Sep 2014 | B2 |
| 8831731 | Blum et al. | Sep 2014 | B2 |
| 8834546 | Deisseroth et al. | Sep 2014 | B2 |
| 8838225 | Ahonen et al. | Sep 2014 | B2 |
| 8838226 | Bibian et al. | Sep 2014 | B2 |
| 8838227 | Causevic et al. | Sep 2014 | B2 |
| 8838247 | Hagedorn et al. | Sep 2014 | B2 |
| 8843199 | Kim et al. | Sep 2014 | B2 |
| 8843202 | Greenspan | Sep 2014 | B2 |
| 8843210 | Simon et al. | Sep 2014 | B2 |
| 8845545 | Folkerts et al. | Sep 2014 | B2 |
| 8849368 | Madsen et al. | Sep 2014 | B2 |
| 8849390 | Echauz et al. | Sep 2014 | B2 |
| 8849392 | Lozano | Sep 2014 | B2 |
| 8849632 | Sparks et al. | Sep 2014 | B2 |
| 8849681 | Hargrove et al. | Sep 2014 | B2 |
| 8849727 | Lu et al. | Sep 2014 | B2 |
| 8852073 | Genereux et al. | Oct 2014 | B2 |
| 8852100 | Osorio | Oct 2014 | B2 |
| 8852103 | Rothberg et al. | Oct 2014 | B2 |
| 8855758 | Rodriquez-Villegas et al. | Oct 2014 | B2 |
| 8855773 | Kokones et al. | Oct 2014 | B2 |
| 8855775 | Leyde | Oct 2014 | B2 |
| 8858440 | Tyler | Oct 2014 | B2 |
| 8858449 | Inan et al. | Oct 2014 | B2 |
| 8862196 | Lynn | Oct 2014 | B2 |
| 8862210 | Yazicioglu et al. | Oct 2014 | B2 |
| 8862217 | McKinley et al. | Oct 2014 | B2 |
| 8862219 | Garcia Molina et al. | Oct 2014 | B2 |
| 8862581 | Zhang et al. | Oct 2014 | B2 |
| 8864310 | Gross et al. | Oct 2014 | B2 |
| 8868039 | Rodriguez | Oct 2014 | B2 |
| 8868148 | Engelbrecht et al. | Oct 2014 | B2 |
| 8868163 | Guttag et al. | Oct 2014 | B2 |
| 8868172 | Leyde et al. | Oct 2014 | B2 |
| 8868173 | Nelson et al. | Oct 2014 | B2 |
| 8868174 | Sato et al. | Oct 2014 | B2 |
| 8868175 | Arad | Oct 2014 | B2 |
| 8868216 | Dunagan | Oct 2014 | B2 |
| 8870737 | Phillips et al. | Oct 2014 | B2 |
| 8872640 | Horseman | Oct 2014 | B2 |
| 8874439 | Kim et al. | Oct 2014 | B2 |
| D717956 | Alexander et al. | Nov 2014 | S |
| 8878782 | Cole | Nov 2014 | B1 |
| 8880207 | Abeyratne et al. | Nov 2014 | B2 |
| 8880576 | Ochs et al. | Nov 2014 | B2 |
| 8886299 | Yazicioglu et al. | Nov 2014 | B2 |
| 8888672 | Phillips et al. | Nov 2014 | B2 |
| 8888673 | Phillips et al. | Nov 2014 | B2 |
| 8888702 | Osorio | Nov 2014 | B2 |
| 8888708 | Diab et al. | Nov 2014 | B2 |
| 8888723 | Einav | Nov 2014 | B2 |
| 8893120 | Pinsky et al. | Nov 2014 | B2 |
| 8897859 | Shimuta et al. | Nov 2014 | B2 |
| 8898037 | Watson et al. | Nov 2014 | B2 |
| 8898344 | Frank et al. | Nov 2014 | B2 |
| 8898443 | Reeves et al. | Nov 2014 | B2 |
| 8902070 | Kobetski et al. | Dec 2014 | B2 |
| 8903479 | Zoicas | Dec 2014 | B2 |
| 8903483 | Sun et al. | Dec 2014 | B2 |
| 8903494 | Goldwasser et al. | Dec 2014 | B2 |
| 8907668 | Okada | Dec 2014 | B2 |
| 8914100 | Adachi et al. | Dec 2014 | B2 |
| 8914119 | Wu et al. | Dec 2014 | B2 |
| 8915741 | Hatlestad et al. | Dec 2014 | B2 |
| 8915871 | Einav | Dec 2014 | B2 |
| 8918162 | Prokoski | Dec 2014 | B2 |
| 8918176 | Nelson et al. | Dec 2014 | B2 |
| 8918178 | Simon et al. | Dec 2014 | B2 |
| 8922376 | Kangas et al. | Dec 2014 | B2 |
| 8922788 | Addison et al. | Dec 2014 | B2 |
| 8923958 | Gupta et al. | Dec 2014 | B2 |
| 8924235 | Seely | Dec 2014 | B2 |
| 8932199 | Berka et al. | Jan 2015 | B2 |
| 8932218 | Thompson | Jan 2015 | B1 |
| 8932227 | Lynn | Jan 2015 | B2 |
| 8933696 | Nishikawa | Jan 2015 | B2 |
| 8934965 | Rogers et al. | Jan 2015 | B2 |
| 8934986 | Goetz | Jan 2015 | B2 |
| 8936630 | Denison et al. | Jan 2015 | B2 |
| 8938289 | Einav et al. | Jan 2015 | B2 |
| 8938290 | Wingeier et al. | Jan 2015 | B2 |
| 8938301 | Hagedorn | Jan 2015 | B2 |
| 8939579 | Agurok | Jan 2015 | B2 |
| 8942777 | Diab et al. | Jan 2015 | B2 |
| 8942813 | Hagedorn et al. | Jan 2015 | B1 |
| 8948834 | Diab et al. | Feb 2015 | B2 |
| 8948849 | Diamond et al. | Feb 2015 | B2 |
| 8948860 | Causevic | Feb 2015 | B2 |
| 8951189 | Osorio | Feb 2015 | B2 |
| 8951190 | Chmiel et al. | Feb 2015 | B2 |
| 8951192 | Osorio | Feb 2015 | B2 |
| 8954139 | Hopenfeld et al. | Feb 2015 | B2 |
| 8954146 | Hopper et al. | Feb 2015 | B2 |
| 8954293 | Klinkenbusch | Feb 2015 | B2 |
| 8955010 | Pradeep et al. | Feb 2015 | B2 |
| 8955974 | Gross et al. | Feb 2015 | B2 |
| 8956277 | Mishelevich | Feb 2015 | B2 |
| 8958868 | Ghovanloo et al. | Feb 2015 | B2 |
| 8958882 | Hagedorn | Feb 2015 | B1 |
| 8961187 | Boers et al. | Feb 2015 | B2 |
| 8961386 | Phillips et al. | Feb 2015 | B2 |
| 8964298 | Haddick et al. | Feb 2015 | B2 |
| 8965492 | Baker et al. | Feb 2015 | B2 |
| 8965513 | Wingeier et al. | Feb 2015 | B2 |
| 8968176 | Altman et al. | Mar 2015 | B2 |
| 8968195 | Tran | Mar 2015 | B2 |
| 8971936 | Derchak | Mar 2015 | B2 |
| 8972295 | Johnson et al. | Mar 2015 | B2 |
| 8974365 | Best | Mar 2015 | B2 |
| 8977024 | Rex et al. | Mar 2015 | B1 |
| 8977110 | Pradeep et al. | Mar 2015 | B2 |
| 8977362 | Saab | Mar 2015 | B2 |
| 8983155 | McIntyre et al. | Mar 2015 | B2 |
| 8983591 | Leininger et al. | Mar 2015 | B2 |
| 8983628 | Simon et al. | Mar 2015 | B2 |
| 8983629 | Simon et al. | Mar 2015 | B2 |
| 8986207 | Li et al. | Mar 2015 | B2 |
| 8988350 | Karmarkar et al. | Mar 2015 | B2 |
| 8989835 | Badower et al. | Mar 2015 | B2 |
| 8989836 | Machon et al. | Mar 2015 | B2 |
| 8992230 | Tuchschmid et al. | Mar 2015 | B2 |
| 8993623 | Goodenowe | Mar 2015 | B2 |
| 8996112 | Brooke | Mar 2015 | B2 |
| 8998828 | Reichow et al. | Apr 2015 | B2 |
| 9002458 | Pal et al. | Apr 2015 | B2 |
| 9004687 | Stack | Apr 2015 | B2 |
| 9005126 | Beach et al. | Apr 2015 | B2 |
| 9008367 | Tolkowsky et al. | Apr 2015 | B2 |
| 9008754 | Steinberg et al. | Apr 2015 | B2 |
| 9008771 | Dong et al. | Apr 2015 | B2 |
| 9013264 | Parshionikar et al. | Apr 2015 | B2 |
| 9014216 | Lazar et al. | Apr 2015 | B2 |
| 9014453 | Steinberg et al. | Apr 2015 | B2 |
| 9014661 | deCharms | Apr 2015 | B2 |
| 9014811 | Pal et al. | Apr 2015 | B2 |
| 9014819 | Lee et al. | Apr 2015 | B2 |
| 9015057 | Phillips et al. | Apr 2015 | B2 |
| 9015087 | Li et al. | Apr 2015 | B2 |
| 9020576 | Nagatani | Apr 2015 | B2 |
| 9020585 | John et al. | Apr 2015 | B2 |
| 9020586 | Yamada et al. | Apr 2015 | B2 |
| 9020789 | Butson et al. | Apr 2015 | B2 |
| 9022936 | Rothberg et al. | May 2015 | B2 |
| 9025800 | Kidmose et al. | May 2015 | B2 |
| 9026194 | Okada | May 2015 | B2 |
| 9026202 | Albert | May 2015 | B2 |
| 9026217 | Kokones et al. | May 2015 | B2 |
| 9026218 | Lozano et al. | May 2015 | B2 |
| 9026372 | O'Donnell, Jr. et al. | May 2015 | B2 |
| 9026709 | Reeves et al. | May 2015 | B2 |
| 9028405 | Tran | May 2015 | B2 |
| 9028412 | Rothberg et al. | May 2015 | B2 |
| 9031631 | Tong et al. | May 2015 | B2 |
| 9031644 | Johnson et al. | May 2015 | B2 |
| 9031653 | Mashiach | May 2015 | B2 |
| 9031658 | Chiao et al. | May 2015 | B2 |
| 9032110 | Frank et al. | May 2015 | B2 |
| 9033884 | Rothberg et al. | May 2015 | B2 |
| 9034055 | Vinjamuri et al. | May 2015 | B2 |
| 9034923 | Goodenowe | May 2015 | B2 |
| 9037224 | Fu | May 2015 | B1 |
| 9037225 | Saliga et al. | May 2015 | B1 |
| 9037530 | Tan et al. | May 2015 | B2 |
| 9042074 | Beran | May 2015 | B1 |
| 9042201 | Tyler et al. | May 2015 | B2 |
| 9042952 | Lynn et al. | May 2015 | B2 |
| 9042958 | Karmarkar et al. | May 2015 | B2 |
| 9042988 | DiLorenzo | May 2015 | B2 |
| 9044188 | DiLorenzo et al. | Jun 2015 | B2 |
| 9050470 | Carlton et al. | Jun 2015 | B2 |
| 9053516 | Stempora | Jun 2015 | B2 |
| 9055871 | Inan et al. | Jun 2015 | B2 |
| 9055974 | Goetz | Jun 2015 | B2 |
| 9058200 | Frank et al. | Jun 2015 | B2 |
| 9058473 | Navratil et al. | Jun 2015 | B2 |
| 9060671 | Badower et al. | Jun 2015 | B2 |
| 9060683 | Tran | Jun 2015 | B2 |
| 9060695 | Peters | Jun 2015 | B2 |
| 9060722 | Teixeira | Jun 2015 | B2 |
| 9060746 | Weng et al. | Jun 2015 | B2 |
| 9063183 | Toda et al. | Jun 2015 | B2 |
| 9063798 | Benedek et al. | Jun 2015 | B2 |
| 9064036 | Hyde et al. | Jun 2015 | B2 |
| 9067052 | Moses et al. | Jun 2015 | B2 |
| 9069031 | Guedes et al. | Jun 2015 | B2 |
| 9070492 | Yarmush et al. | Jun 2015 | B2 |
| 9071649 | Tekwani | Jun 2015 | B2 |
| 9072482 | Sarkela et al. | Jul 2015 | B2 |
| 9072832 | Frei et al. | Jul 2015 | B2 |
| 9072870 | Wu et al. | Jul 2015 | B2 |
| 9072905 | Kokones et al. | Jul 2015 | B2 |
| 9074976 | Adolphi et al. | Jul 2015 | B2 |
| 9078577 | He et al. | Jul 2015 | B2 |
| 9078584 | Jorge et al. | Jul 2015 | B2 |
| 9079940 | Deisseroth et al. | Jul 2015 | B2 |
| 9081890 | An et al. | Jul 2015 | B2 |
| 9084549 | Desain et al. | Jul 2015 | B2 |
| 9084584 | Weiland et al. | Jul 2015 | B2 |
| 9084896 | Kokones et al. | Jul 2015 | B2 |
| 9086884 | Frank et al. | Jul 2015 | B1 |
| 9089310 | Isenhart et al. | Jul 2015 | B2 |
| 9089400 | Nofzinger | Jul 2015 | B2 |
| 9089683 | Mishelevich | Jul 2015 | B2 |
| 9092556 | Amble et al. | Jul 2015 | B2 |
| 9095266 | Fu | Aug 2015 | B1 |
| 9095268 | Kurtz et al. | Aug 2015 | B2 |
| 9095295 | Eagleman et al. | Aug 2015 | B2 |
| 9095303 | Osorio | Aug 2015 | B2 |
| 9095618 | Satchi-Fainaro et al. | Aug 2015 | B2 |
| 9095713 | Foster et al. | Aug 2015 | B2 |
| 9098437 | Benedek et al. | Aug 2015 | B2 |
| 9100758 | Adachi et al. | Aug 2015 | B2 |
| 9101263 | Jung et al. | Aug 2015 | B2 |
| 9101276 | Georgopoulos | Aug 2015 | B2 |
| 9101279 | Ritchey et al. | Aug 2015 | B2 |
| 9101296 | Schroeder et al. | Aug 2015 | B2 |
| 9102717 | Huang et al. | Aug 2015 | B2 |
| 9104467 | Frank et al. | Aug 2015 | B2 |
| 9104969 | Frank et al. | Aug 2015 | B1 |
| 9107586 | Tran | Aug 2015 | B2 |
| 9107595 | Smyth | Aug 2015 | B1 |
| 9107616 | Kiderman et al. | Aug 2015 | B2 |
| 9107622 | Nistico et al. | Aug 2015 | B2 |
| 9113777 | Mittal | Aug 2015 | B2 |
| 9113801 | DiLorenzo | Aug 2015 | B2 |
| 9113803 | Zhang | Aug 2015 | B2 |
| 9113830 | Galen et al. | Aug 2015 | B2 |
| 9116201 | Shah et al. | Aug 2015 | B2 |
| 9116835 | Smyth | Aug 2015 | B1 |
| 9118775 | Lim et al. | Aug 2015 | B2 |
| 9119551 | Qi et al. | Sep 2015 | B2 |
| 9119583 | Tass | Sep 2015 | B2 |
| 9119597 | Dripps et al. | Sep 2015 | B2 |
| 9119598 | Engelbrecht et al. | Sep 2015 | B2 |
| 9125574 | Zia et al. | Sep 2015 | B2 |
| 9125581 | Wu et al. | Sep 2015 | B2 |
| 9125788 | Tee et al. | Sep 2015 | B2 |
| 9128281 | Osterhout et al. | Sep 2015 | B2 |
| 9129478 | Smith et al. | Sep 2015 | B2 |
| 9131864 | Korenberg | Sep 2015 | B2 |
| 9133024 | Phan et al. | Sep 2015 | B2 |
| 9134534 | Border et al. | Sep 2015 | B2 |
| 9135221 | Shahaf et al. | Sep 2015 | B2 |
| 9135400 | McIntyre et al. | Sep 2015 | B2 |
| 9138156 | Wu et al. | Sep 2015 | B2 |
| 9138183 | McKenna et al. | Sep 2015 | B2 |
| 9142145 | Tuchschmid et al. | Sep 2015 | B2 |
| 9142185 | Fateh | Sep 2015 | B2 |
| 9144392 | Santosh et al. | Sep 2015 | B2 |
| 9146618 | Tait et al. | Sep 2015 | B2 |
| RE45766 | Lindsay | Oct 2015 | E |
| 9149214 | Adachi et al. | Oct 2015 | B2 |
| 9149226 | Jadidi | Oct 2015 | B2 |
| 9149255 | Rothberg et al. | Oct 2015 | B2 |
| 9149577 | Robertson et al. | Oct 2015 | B2 |
| 9149719 | Guan et al. | Oct 2015 | B2 |
| 9152582 | Reeves et al. | Oct 2015 | B2 |
| 9155373 | Allen et al. | Oct 2015 | B2 |
| 9155484 | Baker et al. | Oct 2015 | B2 |
| 9155487 | Linderman et al. | Oct 2015 | B2 |
| 9155521 | Rothberg et al. | Oct 2015 | B2 |
| 9160796 | Reeves et al. | Oct 2015 | B2 |
| 9161715 | Jung et al. | Oct 2015 | B2 |
| 9165472 | Hagedorn et al. | Oct 2015 | B2 |
| 9167356 | Higgins et al. | Oct 2015 | B2 |
| 9167970 | Gratton et al. | Oct 2015 | B2 |
| 9167976 | Wingeier et al. | Oct 2015 | B2 |
| 9167977 | Wingeier et al. | Oct 2015 | B2 |
| 9167978 | Wingeier et al. | Oct 2015 | B2 |
| 9167979 | Skidmore et al. | Oct 2015 | B2 |
| 9171131 | Meyer et al. | Oct 2015 | B2 |
| 9171366 | Declerck et al. | Oct 2015 | B2 |
| D743039 | Hagedorn | Nov 2015 | S |
| 9173582 | Popovic et al. | Nov 2015 | B2 |
| 9173609 | Nelson | Nov 2015 | B2 |
| 9173610 | Navakatikyan | Nov 2015 | B2 |
| 9179850 | Wingeier et al. | Nov 2015 | B2 |
| 9179854 | Doidge et al. | Nov 2015 | B2 |
| 9179855 | Burdea et al. | Nov 2015 | B2 |
| 9179858 | Hasson et al. | Nov 2015 | B2 |
| 9179875 | Hua | Nov 2015 | B2 |
| 9179876 | Ochs et al. | Nov 2015 | B2 |
| 9183351 | Shusterman | Nov 2015 | B2 |
| 9183580 | Rhoads et al. | Nov 2015 | B2 |
| 9186105 | Leininger et al. | Nov 2015 | B2 |
| 9191764 | Baughman et al. | Nov 2015 | B2 |
| 9192300 | Jung et al. | Nov 2015 | B2 |
| 9192309 | Hopenfeld et al. | Nov 2015 | B1 |
| 9198571 | Kiderman et al. | Dec 2015 | B2 |
| 9198621 | Fernstrom et al. | Dec 2015 | B2 |
| 9198637 | Rothberg et al. | Dec 2015 | B2 |
| 9198707 | McKay et al. | Dec 2015 | B2 |
| 9202360 | Tedesco et al. | Dec 2015 | B1 |
| 9204835 | Parsey et al. | Dec 2015 | B2 |
| 9208558 | Dean et al. | Dec 2015 | B2 |
| 9210517 | Pontoppidan et al. | Dec 2015 | B2 |
| 9211076 | Kim | Dec 2015 | B2 |
| 9211077 | Jung et al. | Dec 2015 | B2 |
| 9211078 | Meggiolaro et al. | Dec 2015 | B2 |
| 9211212 | Nofzinger et al. | Dec 2015 | B2 |
| 9211411 | Wu et al. | Dec 2015 | B2 |
| 9211417 | Heldman et al. | Dec 2015 | B2 |
| 9213074 | van der Kouwe et al. | Dec 2015 | B2 |
| 9213076 | Liu | Dec 2015 | B2 |
| 9213185 | Starner et al. | Dec 2015 | B1 |
| 9213403 | Raffle et al. | Dec 2015 | B1 |
| 9213406 | Ou-Yang et al. | Dec 2015 | B2 |
| 9215978 | Knight et al. | Dec 2015 | B2 |
| 9218530 | Davis et al. | Dec 2015 | B2 |
| 9223893 | Rodriguez | Dec 2015 | B2 |
| 9224309 | Mutlu et al. | Dec 2015 | B2 |
| D747495 | Attal et al. | Jan 2016 | S |
| 9229080 | Lin | Jan 2016 | B2 |
| 9230539 | Pakhomov | Jan 2016 | B2 |
| 9232910 | Alshaer et al. | Jan 2016 | B2 |
| 9232984 | Guthart et al. | Jan 2016 | B2 |
| 9233244 | Pal et al. | Jan 2016 | B2 |
| 9235685 | McIntyre et al. | Jan 2016 | B2 |
| 9238142 | Heldman et al. | Jan 2016 | B2 |
| 9238150 | Deisseroth et al. | Jan 2016 | B2 |
| 9239615 | Frank et al. | Jan 2016 | B2 |
| 9240021 | Rodriguez | Jan 2016 | B2 |
| 9241665 | deCharms | Jan 2016 | B2 |
| 9242067 | Shore et al. | Jan 2016 | B2 |
| 9247870 | Kiderman et al. | Feb 2016 | B2 |
| 9247890 | Turnbull et al. | Feb 2016 | B2 |
| 9247911 | Galloway et al. | Feb 2016 | B2 |
| 9247924 | Rothberg et al. | Feb 2016 | B2 |
| 9248003 | Wright et al. | Feb 2016 | B2 |
| 9248286 | Simon et al. | Feb 2016 | B2 |
| 9248288 | Panken et al. | Feb 2016 | B2 |
| 9249200 | Deisseroth et al. | Feb 2016 | B2 |
| 9249234 | Deisseroth et al. | Feb 2016 | B2 |
| 9251566 | Bajic | Feb 2016 | B1 |
| 9254097 | Espy et al. | Feb 2016 | B2 |
| 9254099 | Connor | Feb 2016 | B2 |
| 9254383 | Simon et al. | Feb 2016 | B2 |
| 9258301 | Dabbiere | Feb 2016 | B2 |
| 9259180 | McCaffrey | Feb 2016 | B2 |
| 9259482 | Satchi-Fainaro et al. | Feb 2016 | B2 |
| 9259591 | Brown et al. | Feb 2016 | B2 |
| 9261573 | Radparvar et al. | Feb 2016 | B1 |
| 9265943 | Yun et al. | Feb 2016 | B2 |
| 9265965 | Fox et al. | Feb 2016 | B2 |
| 9268014 | Rothberg et al. | Feb 2016 | B2 |
| 9268015 | Rothberg et al. | Feb 2016 | B2 |
| 9268905 | Garripoli | Feb 2016 | B2 |
| 9271651 | Avinash et al. | Mar 2016 | B2 |
| 9271660 | Luo et al. | Mar 2016 | B2 |
| 9271674 | Deisseroth et al. | Mar 2016 | B2 |
| 9271679 | Cho et al. | Mar 2016 | B2 |
| 9275191 | Dean et al. | Mar 2016 | B2 |
| 9277871 | Keenan et al. | Mar 2016 | B2 |
| 9277873 | Sarma et al. | Mar 2016 | B2 |
| 9280784 | Barnett et al. | Mar 2016 | B2 |
| 9282927 | Hyde et al. | Mar 2016 | B2 |
| 9282930 | Machon et al. | Mar 2016 | B2 |
| 9282934 | Liley et al. | Mar 2016 | B2 |
| 9283279 | Satchi-Fainaro et al. | Mar 2016 | B2 |
| 9284353 | Deisseroth et al. | Mar 2016 | B2 |
| 9285249 | Schober et al. | Mar 2016 | B2 |
| 9286515 | Nakamura et al. | Mar 2016 | B2 |
| 9289143 | Wingeier et al. | Mar 2016 | B2 |
| 9289595 | Floyd et al. | Mar 2016 | B2 |
| 9289603 | Giuffrida et al. | Mar 2016 | B1 |
| 9292858 | Marci et al. | Mar 2016 | B2 |
| 9292895 | Rodriguez et al. | Mar 2016 | B2 |
| 9292920 | Dean et al. | Mar 2016 | B2 |
| 9301675 | Kiderman et al. | Apr 2016 | B2 |
| 9302069 | Tass et al. | Apr 2016 | B2 |
| 9302110 | Kokones et al. | Apr 2016 | B2 |
| 9307925 | Russell et al. | Apr 2016 | B2 |
| 9307944 | Colman et al. | Apr 2016 | B2 |
| 9308372 | Sparks et al. | Apr 2016 | B2 |
| 9309296 | Deisseroth et al. | Apr 2016 | B2 |
| 9311640 | Filler | Apr 2016 | B2 |
| 9317457 | Reeves et al. | Apr 2016 | B2 |
| 9320449 | Gu | Apr 2016 | B2 |
| 9320450 | Badower | Apr 2016 | B2 |
| 9320900 | DiLorenzo | Apr 2016 | B2 |
| 9322895 | Santosh et al. | Apr 2016 | B2 |
| 9324234 | Ricci et al. | Apr 2016 | B2 |
| 9326705 | Derchak | May 2016 | B2 |
| 9326720 | McLaughlin | May 2016 | B2 |
| 9326742 | Hirschman et al. | May 2016 | B2 |
| 9327069 | Foster et al. | May 2016 | B2 |
| 9329758 | Guzak et al. | May 2016 | B2 |
| 9330206 | Dean et al. | May 2016 | B2 |
| 9330497 | Byrd et al. | May 2016 | B2 |
| 9330523 | Sutton et al. | May 2016 | B2 |
| 9331841 | Kim et al. | May 2016 | B2 |
| 9332939 | Osorio | May 2016 | B2 |
| 9333334 | Jeffery et al. | May 2016 | B2 |
| 9336302 | Swamy | May 2016 | B1 |
| 9336535 | Pradeep et al. | May 2016 | B2 |
| 9336611 | Bilgic et al. | May 2016 | B2 |
| 9339227 | D'arcy et al. | May 2016 | B2 |
| 9339495 | During | May 2016 | B2 |
| 9345609 | Hyde et al. | May 2016 | B2 |
| 9351651 | Nagasaka | May 2016 | B2 |
| 9352145 | Whitehurst et al. | May 2016 | B2 |
| 9354445 | Weaver et al. | May 2016 | B1 |
| 9354778 | Cornaby et al. | May 2016 | B2 |
| 9357240 | Pradeep et al. | May 2016 | B2 |
| 9357298 | Hiroe | May 2016 | B2 |
| 9357329 | Jeffery et al. | May 2016 | B2 |
| 9357938 | Ang et al. | Jun 2016 | B2 |
| 9357941 | Simon | Jun 2016 | B2 |
| 9357970 | Clark et al. | Jun 2016 | B2 |
| 9358393 | Lozano | Jun 2016 | B1 |
| 9359449 | Deisseroth et al. | Jun 2016 | B2 |
| 9364462 | Simpson, Jr. | Jun 2016 | B2 |
| 9365628 | Deisseroth et al. | Jun 2016 | B2 |
| 9367131 | Klappert et al. | Jun 2016 | B2 |
| 9367288 | Wilber | Jun 2016 | B2 |
| 9367738 | Harumatsu et al. | Jun 2016 | B2 |
| 9368018 | Kangas et al. | Jun 2016 | B2 |
| 9368265 | Park et al. | Jun 2016 | B2 |
| 9370302 | Krueger | Jun 2016 | B2 |
| 9370309 | Ko et al. | Jun 2016 | B2 |
| 9370667 | Schmidt | Jun 2016 | B2 |
| 9375145 | Chin et al. | Jun 2016 | B2 |
| 9375151 | Hopenfeld et al. | Jun 2016 | B1 |
| 9375171 | Teixeira | Jun 2016 | B2 |
| 9375564 | Wingeier et al. | Jun 2016 | B2 |
| 9375571 | Errico et al. | Jun 2016 | B2 |
| 9375573 | Dilorenzo | Jun 2016 | B2 |
| 9377348 | Kataoka | Jun 2016 | B2 |
| 9377515 | Kim et al. | Jun 2016 | B2 |
| 9377869 | Tait et al. | Jun 2016 | B2 |
| 9381352 | Yun et al. | Jul 2016 | B2 |
| 9383208 | Mohanty | Jul 2016 | B2 |
| 9387320 | Wingeier et al. | Jul 2016 | B2 |
| 9389685 | Pathirage et al. | Jul 2016 | B1 |
| 9391988 | Cronin | Jul 2016 | B2 |
| 9392955 | Folkerts et al. | Jul 2016 | B2 |
| 9392956 | Luo et al. | Jul 2016 | B2 |
| 9394347 | Deisseroth et al. | Jul 2016 | B2 |
| 9395425 | Diamond et al. | Jul 2016 | B2 |
| 9396669 | Karkanias et al. | Jul 2016 | B2 |
| 9398873 | Van Dooren et al. | Jul 2016 | B2 |
| 9399126 | Pal et al. | Jul 2016 | B2 |
| 9400805 | Knudson | Jul 2016 | B2 |
| 9401033 | Bajic | Jul 2016 | B2 |
| 9401977 | Gaw | Jul 2016 | B1 |
| 9402099 | Rodriguez | Jul 2016 | B2 |
| 9402558 | John et al. | Aug 2016 | B2 |
| 9403038 | Tyler | Aug 2016 | B2 |
| 9405366 | Segal | Aug 2016 | B2 |
| 9408575 | Bordoley et al. | Aug 2016 | B2 |
| 9408997 | Kelley | Aug 2016 | B2 |
| 9410885 | Schober et al. | Aug 2016 | B2 |
| 9411033 | He et al. | Aug 2016 | B2 |
| 9412233 | Bagherzadeh et al. | Aug 2016 | B1 |
| 9414029 | Miyazaki et al. | Aug 2016 | B2 |
| 9414776 | Sillay et al. | Aug 2016 | B2 |
| 9414780 | Rhoads | Aug 2016 | B2 |
| 9414907 | Wortz et al. | Aug 2016 | B2 |
| 9415219 | Simon et al. | Aug 2016 | B2 |
| 9415222 | DiLorenzo | Aug 2016 | B2 |
| 9418368 | Jung et al. | Aug 2016 | B2 |
| 9420970 | Dagum | Aug 2016 | B2 |
| 9421373 | DiLorenzo | Aug 2016 | B2 |
| 9424761 | Tuchschmid et al. | Aug 2016 | B2 |
| 9426582 | Pontoppidan | Aug 2016 | B2 |
| 9427474 | Satchi-Fainaro et al. | Aug 2016 | B2 |
| 9427581 | Simon et al. | Aug 2016 | B2 |
| 9430615 | Michaelis et al. | Aug 2016 | B2 |
| 9432501 | Vishwanath | Aug 2016 | B2 |
| 9432777 | Lunner et al. | Aug 2016 | B2 |
| 9436279 | Beaty | Sep 2016 | B2 |
| 9436989 | Uber, III | Sep 2016 | B2 |
| 9438650 | Serena | Sep 2016 | B2 |
| 9439593 | Shepherd et al. | Sep 2016 | B2 |
| 9439595 | Leininger et al. | Sep 2016 | B2 |
| 9439596 | Leininger et al. | Sep 2016 | B2 |
| 9439736 | Olson | Sep 2016 | B2 |
| 9440064 | Wingeier et al. | Sep 2016 | B2 |
| 9440070 | Goldwasser et al. | Sep 2016 | B2 |
| 9442525 | Choi et al. | Sep 2016 | B2 |
| 9443141 | Mirowski et al. | Sep 2016 | B2 |
| 9444998 | Kim et al. | Sep 2016 | B2 |
| 9445730 | Snyder et al. | Sep 2016 | B2 |
| 9445739 | Payton et al. | Sep 2016 | B1 |
| 9445763 | Davis et al. | Sep 2016 | B2 |
| 9445768 | Alexander et al. | Sep 2016 | B2 |
| 9446028 | During | Sep 2016 | B2 |
| 9446238 | Lozano | Sep 2016 | B2 |
| 9448289 | Wang et al. | Sep 2016 | B2 |
| 9451303 | Kothuri et al. | Sep 2016 | B2 |
| 9451406 | Cornaby et al. | Sep 2016 | B2 |
| 9451734 | Onuma et al. | Sep 2016 | B2 |
| 9451883 | Gallant et al. | Sep 2016 | B2 |
| 9451886 | Teixeira | Sep 2016 | B2 |
| 9451899 | Ritchey et al. | Sep 2016 | B2 |
| 9454646 | Siefert | Sep 2016 | B2 |
| 9454777 | Kruglick | Sep 2016 | B2 |
| 9456740 | Leinonen et al. | Oct 2016 | B2 |
| 9458208 | Deisseroth et al. | Oct 2016 | B2 |
| 9459597 | Kahn et al. | Oct 2016 | B2 |
| 9460400 | De Bruin et al. | Oct 2016 | B2 |
| 9462433 | Rodriguez | Oct 2016 | B2 |
| 9462733 | Hokari | Oct 2016 | B2 |
| 9462956 | Pandia et al. | Oct 2016 | B2 |
| 9462975 | Sackner et al. | Oct 2016 | B2 |
| 9462977 | Horseman | Oct 2016 | B2 |
| 9463327 | Lempka et al. | Oct 2016 | B2 |
| 9468541 | Contreras-Vidal et al. | Oct 2016 | B2 |
| 9470728 | George et al. | Oct 2016 | B2 |
| 9471978 | Chen et al. | Oct 2016 | B2 |
| 9474481 | Dagum | Oct 2016 | B2 |
| 9474852 | Lozano et al. | Oct 2016 | B2 |
| 9477290 | Frank et al. | Oct 2016 | B2 |
| 9477317 | Clements | Oct 2016 | B1 |
| 9477701 | Kundu et al. | Oct 2016 | B1 |
| RE46189 | Prichep et al. | Nov 2016 | E |
| RE46209 | Gong et al. | Nov 2016 | E |
| 9480402 | Leuthardt et al. | Nov 2016 | B2 |
| 9480425 | Culver et al. | Nov 2016 | B2 |
| 9480429 | Nakada et al. | Nov 2016 | B2 |
| 9480812 | Thompson | Nov 2016 | B1 |
| 9480845 | Harris et al. | Nov 2016 | B2 |
| 9480854 | Von Ohlsen et al. | Nov 2016 | B2 |
| 9482606 | Kim et al. | Nov 2016 | B2 |
| 9483117 | Karkkainen et al. | Nov 2016 | B2 |
| 9486168 | Bonmassar et al. | Nov 2016 | B2 |
| 9486332 | Harshbarger et al. | Nov 2016 | B2 |
| 9486381 | Juto et al. | Nov 2016 | B2 |
| 9486389 | Tass | Nov 2016 | B2 |
| 9486618 | Wingeier et al. | Nov 2016 | B2 |
| 9486632 | Saab | Nov 2016 | B2 |
| 9489854 | Haruta et al. | Nov 2016 | B2 |
| 9492084 | Behar et al. | Nov 2016 | B2 |
| 9492114 | Reiman | Nov 2016 | B2 |
| 9492120 | Horseman | Nov 2016 | B2 |
| 9492313 | Nofzinger | Nov 2016 | B2 |
| 9492432 | Vavvas et al. | Nov 2016 | B2 |
| 9492630 | Cho et al. | Nov 2016 | B2 |
| 9495684 | Jung et al. | Nov 2016 | B2 |
| 9497017 | Kim et al. | Nov 2016 | B1 |
| 9497530 | Campbell et al. | Nov 2016 | B1 |
| 9498134 | Trobaugh et al. | Nov 2016 | B1 |
| 9498634 | De Ridder | Nov 2016 | B2 |
| 9500722 | Takahashi | Nov 2016 | B2 |
| 9503772 | Azam | Nov 2016 | B2 |
| 9504410 | Gal | Nov 2016 | B2 |
| 9504420 | Davis et al. | Nov 2016 | B2 |
| 9504788 | Hyde et al. | Nov 2016 | B2 |
| 9505817 | Deisseroth et al. | Nov 2016 | B2 |
| 9507974 | Todeschini | Nov 2016 | B1 |
| 9510752 | Klin et al. | Dec 2016 | B2 |
| 9510790 | Kang et al. | Dec 2016 | B2 |
| 9511877 | Masson | Dec 2016 | B2 |
| 9516430 | Jensen et al. | Dec 2016 | B2 |
| 9517031 | Jung | Dec 2016 | B2 |
| 9517222 | Goodenowe | Dec 2016 | B2 |
| 9519981 | Sudarsky et al. | Dec 2016 | B2 |
| 9521958 | Nagasaka et al. | Dec 2016 | B2 |
| 9521976 | Greco | Dec 2016 | B2 |
| 9522278 | Heldman et al. | Dec 2016 | B1 |
| 9526419 | Derchak et al. | Dec 2016 | B2 |
| 9526906 | Mashiach | Dec 2016 | B2 |
| 9531708 | Cornell et al. | Dec 2016 | B2 |
| 9532748 | Denison et al. | Jan 2017 | B2 |
| 9533113 | Lain et al. | Jan 2017 | B2 |
| 9534044 | El-Agnaf | Jan 2017 | B2 |
| 9538062 | Cronin | Jan 2017 | B2 |
| 9538635 | Beran | Jan 2017 | B1 |
| 9538934 | Ang et al. | Jan 2017 | B2 |
| 9538948 | Dagum | Jan 2017 | B2 |
| 9539118 | Leuthardt et al. | Jan 2017 | B2 |
| 9541383 | Abovitz et al. | Jan 2017 | B2 |
| 9545221 | Adhikari et al. | Jan 2017 | B2 |
| 9545222 | Derchak et al. | Jan 2017 | B2 |
| 9545225 | Cavuoto et al. | Jan 2017 | B2 |
| 9545285 | Ghaffari et al. | Jan 2017 | B2 |
| 9548050 | Gruber et al. | Jan 2017 | B2 |
| 9554484 | Rogers et al. | Jan 2017 | B2 |
| 9556487 | Umansky et al. | Jan 2017 | B2 |
| 9557957 | Guan et al. | Jan 2017 | B2 |
| 9558558 | Stehle et al. | Jan 2017 | B2 |
| 9560458 | Lunner et al. | Jan 2017 | B2 |
| 9560967 | Hyde et al. | Feb 2017 | B2 |
| 9560984 | Pradeep et al. | Feb 2017 | B2 |
| 9560986 | Varcoe | Feb 2017 | B2 |
| 9563273 | Mann | Feb 2017 | B2 |
| 9563740 | Abdelghani et al. | Feb 2017 | B2 |
| 9563927 | Sinclair | Feb 2017 | B2 |
| 9563950 | Raj | Feb 2017 | B2 |
| 9563998 | Hoyos et al. | Feb 2017 | B2 |
| 9568564 | Ma et al. | Feb 2017 | B2 |
| 9569986 | Levine et al. | Feb 2017 | B2 |
| 9572996 | Tass et al. | Feb 2017 | B2 |
| 9577992 | Zizi et al. | Feb 2017 | B2 |
| 9579035 | Sarkela | Feb 2017 | B2 |
| 9579048 | Rayner et al. | Feb 2017 | B2 |
| 9579060 | Lisy et al. | Feb 2017 | B1 |
| 9582072 | Connor | Feb 2017 | B2 |
| 9582925 | Durand et al. | Feb 2017 | B2 |
| 9584928 | Laudanski et al. | Feb 2017 | B2 |
| 9585581 | Mullins et al. | Mar 2017 | B1 |
| 9588203 | Zhu et al. | Mar 2017 | B2 |
| 9588490 | Tsang | Mar 2017 | B2 |
| 9590986 | Zizi et al. | Mar 2017 | B2 |
| 9592383 | Schiff et al. | Mar 2017 | B2 |
| 9592384 | Tass | Mar 2017 | B2 |
| 9592389 | Moffitt | Mar 2017 | B2 |
| 9592409 | Yoo et al. | Mar 2017 | B2 |
| 9594500 | Clements | Mar 2017 | B2 |
| 9595059 | Knudson et al. | Mar 2017 | B2 |
| 9596224 | Woods et al. | Mar 2017 | B2 |
| 9596584 | Hyde et al. | Mar 2017 | B2 |
| 9596986 | Kiderman et al. | Mar 2017 | B2 |
| 9597493 | Wingeier et al. | Mar 2017 | B2 |
| 9597494 | Wingeier et al. | Mar 2017 | B2 |
| 9599492 | Hwang | Mar 2017 | B2 |
| 9600138 | Thomas et al. | Mar 2017 | B2 |
| 9604073 | Deisseroth et al. | Mar 2017 | B2 |
| 9607023 | Swamy | Mar 2017 | B1 |
| 9609453 | Jabri | Mar 2017 | B2 |
| 9612295 | Toda et al. | Apr 2017 | B2 |
| 9615746 | Horseman | Apr 2017 | B2 |
| 9615749 | Clifton et al. | Apr 2017 | B2 |
| 9615789 | Deisseroth et al. | Apr 2017 | B2 |
| 9616166 | Kalafut et al. | Apr 2017 | B2 |
| 9618591 | Radparvar et al. | Apr 2017 | B1 |
| 9618759 | Morifuji et al. | Apr 2017 | B2 |
| 9619613 | Meyer et al. | Apr 2017 | B2 |
| 9622660 | Le et al. | Apr 2017 | B2 |
| 9622672 | Yoshida et al. | Apr 2017 | B2 |
| 9622675 | Leyde et al. | Apr 2017 | B2 |
| 9622676 | Masmanidis et al. | Apr 2017 | B2 |
| 9622702 | Badower et al. | Apr 2017 | B2 |
| 9622703 | Badower et al. | Apr 2017 | B2 |
| 9623240 | Simon et al. | Apr 2017 | B2 |
| 9626561 | Cho et al. | Apr 2017 | B2 |
| 9626756 | Dean et al. | Apr 2017 | B2 |
| 9629568 | Hagedorn et al. | Apr 2017 | B2 |
| 9630008 | McLaughlin et al. | Apr 2017 | B2 |
| 9632585 | Niikawa | Apr 2017 | B2 |
| 9635605 | Hyde et al. | Apr 2017 | B2 |
| 9636019 | Hendler et al. | May 2017 | B2 |
| 9636063 | Arbas | May 2017 | B2 |
| 9640167 | DeFranks et al. | May 2017 | B2 |
| 9641665 | Lee et al. | May 2017 | B2 |
| 9642552 | Hua | May 2017 | B2 |
| 9642553 | Hokari | May 2017 | B2 |
| 9642554 | Simola et al. | May 2017 | B2 |
| 9642699 | Wortz et al. | May 2017 | B2 |
| 9643019 | Higgins et al. | May 2017 | B2 |
| 9646248 | Benvenuto et al. | May 2017 | B1 |
| 9649030 | Gross et al. | May 2017 | B2 |
| 9649036 | Teixeira | May 2017 | B2 |
| 9649501 | Best | May 2017 | B2 |
| 9651368 | Abovitz et al. | May 2017 | B2 |
| 9652626 | Son et al. | May 2017 | B2 |
| 9655573 | Majewski et al. | May 2017 | B2 |
| 9655669 | Palti et al. | May 2017 | B2 |
| 9658473 | Lewis | May 2017 | B2 |
| 9659186 | Pinsky et al. | May 2017 | B2 |
| 9659229 | Clifton et al. | May 2017 | B2 |
| 9662045 | Skelton et al. | May 2017 | B2 |
| 9662049 | Scarantino et al. | May 2017 | B2 |
| 9662492 | Tucker et al. | May 2017 | B1 |
| 9664856 | Nagasaka | May 2017 | B2 |
| 9665824 | Chang et al. | May 2017 | B2 |
| 9665987 | Fateh | May 2017 | B2 |
| 9668694 | Badower | Jun 2017 | B2 |
| 9669185 | Nofzinger | Jun 2017 | B2 |
| 9672302 | Dean et al. | Jun 2017 | B2 |
| 9672617 | Dean et al. | Jun 2017 | B2 |
| 9672760 | Breuer et al. | Jun 2017 | B1 |
| 9675292 | Fadem | Jun 2017 | B2 |
| 9678810 | Reeves et al. | Jun 2017 | B2 |
| 9681814 | Galloway et al. | Jun 2017 | B2 |
| 9681820 | Wagner | Jun 2017 | B2 |
| 9682232 | Shore et al. | Jun 2017 | B2 |
| 9684051 | Nieminen et al. | Jun 2017 | B2 |
| 9684335 | Kim et al. | Jun 2017 | B2 |
| 9685600 | Washington, II et al. | Jun 2017 | B2 |
| 9687187 | Dagum | Jun 2017 | B2 |
| 9687562 | Satchi-Fainaro et al. | Jun 2017 | B2 |
| 9692756 | Poisner et al. | Jun 2017 | B2 |
| 9693684 | Lopez et al. | Jul 2017 | B2 |
| 9693724 | Dagum | Jul 2017 | B2 |
| 9693734 | Horseman | Jul 2017 | B2 |
| 9694155 | Panova et al. | Jul 2017 | B2 |
| 9694178 | Ruffini et al. | Jul 2017 | B2 |
| 9694197 | Segal | Jul 2017 | B2 |
| 9700261 | Lunner | Jul 2017 | B2 |
| 9704205 | Akutagawa et al. | Jul 2017 | B2 |
| 9706060 | Hyde et al. | Jul 2017 | B2 |
| 9706237 | Chen et al. | Jul 2017 | B2 |
| 9706382 | Hyde et al. | Jul 2017 | B2 |
| 9706910 | Blaha et al. | Jul 2017 | B1 |
| 9706957 | Wu et al. | Jul 2017 | B2 |
| 9706963 | Gupta et al. | Jul 2017 | B2 |
| 9707372 | Smith | Jul 2017 | B2 |
| 9707396 | Su et al. | Jul 2017 | B2 |
| 9710788 | Horseman | Jul 2017 | B2 |
| 9712736 | Kearns et al. | Jul 2017 | B2 |
| 9713013 | Hyde et al. | Jul 2017 | B2 |
| 9713428 | Chon et al. | Jul 2017 | B2 |
| 9713433 | Gadot et al. | Jul 2017 | B2 |
| 9713444 | Severson | Jul 2017 | B2 |
| 9713712 | Wingeier et al. | Jul 2017 | B2 |
| 9717440 | Abdelghani et al. | Aug 2017 | B2 |
| 9722472 | Horseman et al. | Aug 2017 | B2 |
| 9723422 | Jensen et al. | Aug 2017 | B2 |
| 9723981 | Kiderman et al. | Aug 2017 | B2 |
| 9724357 | Vavvas et al. | Aug 2017 | B2 |
| 9729252 | Tyler et al. | Aug 2017 | B2 |
| 9730583 | Kiderman et al. | Aug 2017 | B2 |
| 9736603 | Osborne et al. | Aug 2017 | B2 |
| 9737231 | Tveit | Aug 2017 | B2 |
| 9740285 | Beaty | Aug 2017 | B2 |
| 9756096 | Lilienthal et al. | Sep 2017 | B1 |
| 9760236 | Sivakumar et al. | Sep 2017 | B2 |
| 9763613 | Shepherd et al. | Sep 2017 | B2 |
| 9764109 | Brewer et al. | Sep 2017 | B2 |
| 9775545 | Al-Ali et al. | Oct 2017 | B2 |
| 9775554 | Jung et al. | Oct 2017 | B2 |
| 9779575 | Bagherzadeh et al. | Oct 2017 | B1 |
| 9781521 | Kofod-Hansen et al. | Oct 2017 | B2 |
| 9781554 | Hyde et al. | Oct 2017 | B2 |
| 9782122 | Pulliam et al. | Oct 2017 | B1 |
| 9783162 | Hoyos et al. | Oct 2017 | B2 |
| 9785242 | Parshionikar | Oct 2017 | B2 |
| 9788714 | Krueger | Oct 2017 | B2 |
| 9794672 | Campbell et al. | Oct 2017 | B2 |
| 9795324 | Sales et al. | Oct 2017 | B2 |
| 9800717 | Ma et al. | Oct 2017 | B2 |
| 9805339 | Horseman | Oct 2017 | B2 |
| 9805381 | Frank et al. | Oct 2017 | B2 |
| 9807582 | Hyde et al. | Oct 2017 | B2 |
| 9808156 | Horseman | Nov 2017 | B2 |
| 9811154 | Raffle et al. | Nov 2017 | B2 |
| 9813887 | Hyde et al. | Nov 2017 | B2 |
| 9814426 | Connor | Nov 2017 | B2 |
| 9818150 | Rhoads et al. | Nov 2017 | B2 |
| 9820120 | deCharms | Nov 2017 | B2 |
| 9821162 | Wu et al. | Nov 2017 | B2 |
| 9824607 | Bhattacharyya et al. | Nov 2017 | B1 |
| 9829971 | San Agustin Lopez et al. | Nov 2017 | B2 |
| 9830576 | Horseman | Nov 2017 | B2 |
| 9830577 | Horseman | Nov 2017 | B2 |
| 9832353 | Weaver et al. | Nov 2017 | B2 |
| 9833142 | Horseman | Dec 2017 | B2 |
| 9833185 | Leininger et al. | Dec 2017 | B2 |
| 9835864 | Morifuji et al. | Dec 2017 | B2 |
| 9836896 | Zizi et al. | Dec 2017 | B2 |
| 9836931 | Rivaud et al. | Dec 2017 | B1 |
| 9841812 | Kitazawa et al. | Dec 2017 | B2 |
| 9842299 | Stolarz et al. | Dec 2017 | B2 |
| 9843917 | Hyde et al. | Dec 2017 | B2 |
| 9844344 | Horseman | Dec 2017 | B2 |
| 9853976 | Zizi et al. | Dec 2017 | B2 |
| 9854987 | Chang et al. | Jan 2018 | B2 |
| 9857590 | Hall, Jr. | Jan 2018 | B2 |
| 9858540 | Firminger et al. | Jan 2018 | B2 |
| 9858745 | Bagherzadeh et al. | Jan 2018 | B1 |
| 9860273 | Myron | Jan 2018 | B2 |
| 9861307 | Klin et al. | Jan 2018 | B2 |
| 9864431 | Keskin et al. | Jan 2018 | B2 |
| 9865093 | Mullins | Jan 2018 | B1 |
| 9866706 | Hyde et al. | Jan 2018 | B2 |
| 9867546 | Tzvieli et al. | Jan 2018 | B2 |
| 9872968 | de Zambotti et al. | Jan 2018 | B2 |
| 9883396 | Rodriguez | Jan 2018 | B2 |
| D809474 | Attal et al. | Feb 2018 | S |
| 9886493 | Coleman et al. | Feb 2018 | B2 |
| 9886729 | Firminger et al. | Feb 2018 | B2 |
| 9886981 | Pradeep et al. | Feb 2018 | B2 |
| 9888090 | Poisner et al. | Feb 2018 | B2 |
| 9889271 | Adamczyk et al. | Feb 2018 | B2 |
| 9892435 | Firminger et al. | Feb 2018 | B2 |
| 9895077 | Shahaf et al. | Feb 2018 | B2 |
| 9898082 | Greenwald | Feb 2018 | B1 |
| 9898793 | Rodriguez | Feb 2018 | B2 |
| 9900669 | Touma et al. | Feb 2018 | B2 |
| 9904891 | Stolarz et al. | Feb 2018 | B2 |
| 9904892 | Stolarz et al. | Feb 2018 | B2 |
| 9905239 | Chang et al. | Feb 2018 | B2 |
| 9910298 | Sales et al. | Mar 2018 | B1 |
| 9911165 | Firminger et al. | Mar 2018 | B2 |
| 9916010 | Harris et al. | Mar 2018 | B2 |
| 9921663 | Niikawa | Mar 2018 | B2 |
| 9922053 | Caughey | Mar 2018 | B1 |
| 9923764 | Garg et al. | Mar 2018 | B2 |
| 9927872 | Yang et al. | Mar 2018 | B2 |
| 9930155 | Gaw | Mar 2018 | B2 |
| 9936250 | Marci et al. | Apr 2018 | B2 |
| 9936916 | Sahin | Apr 2018 | B2 |
| 9943698 | Chase et al. | Apr 2018 | B2 |
| 9946344 | Ayaz et al. | Apr 2018 | B2 |
| 9949640 | Horseman | Apr 2018 | B2 |
| 9953650 | Falevsky | Apr 2018 | B1 |
| 9955895 | Jin et al. | May 2018 | B2 |
| 9955902 | Frank et al. | May 2018 | B2 |
| 9955905 | Intrator | May 2018 | B2 |
| 9962082 | Kim et al. | May 2018 | B2 |
| 9962083 | Horseman | May 2018 | B2 |
| 9965860 | Nguyen et al. | May 2018 | B2 |
| 9968297 | Connor | May 2018 | B2 |
| 9968780 | Pal et al. | May 2018 | B2 |
| 9978095 | Davis et al. | May 2018 | B2 |
| 9980114 | Hyde et al. | May 2018 | B2 |
| 9983670 | Coleman et al. | May 2018 | B2 |
| 9990727 | Yoon et al. | Jun 2018 | B2 |
| 9993190 | Preminger | Jun 2018 | B2 |
| 9993386 | Racette | Jun 2018 | B2 |
| 9993517 | Vavvas et al. | Jun 2018 | B2 |
| 9994228 | Krueger | Jun 2018 | B2 |
| 9996151 | Iwasaki et al. | Jun 2018 | B2 |
| 9996154 | Kim et al. | Jun 2018 | B2 |
| 9996983 | Mullins | Jun 2018 | B2 |
| 20010009975 | Tsukada et al. | Jul 2001 | A1 |
| 20010020127 | Oshio et al. | Sep 2001 | A1 |
| 20010021800 | Balkin et al. | Sep 2001 | A1 |
| 20010031930 | Roizen et al. | Oct 2001 | A1 |
| 20010049480 | John et al. | Dec 2001 | A1 |
| 20010051774 | Littrup et al. | Dec 2001 | A1 |
| 20020005784 | Balkin et al. | Jan 2002 | A1 |
| 20020016552 | Granger et al. | Feb 2002 | A1 |
| 20020017994 | Balkin et al. | Feb 2002 | A1 |
| 20020024450 | Townsend et al. | Feb 2002 | A1 |
| 20020033454 | Cheng et al. | Mar 2002 | A1 |
| 20020035317 | Cheng et al. | Mar 2002 | A1 |
| 20020035338 | Dear et al. | Mar 2002 | A1 |
| 20020037095 | Cheng | Mar 2002 | A1 |
| 20020042563 | Becerra et al. | Apr 2002 | A1 |
| 20020055675 | Llinas et al. | May 2002 | A1 |
| 20020058867 | Breiter et al. | May 2002 | A1 |
| 20020059159 | Cook | May 2002 | A1 |
| 20020077534 | DuRousseau | Jun 2002 | A1 |
| 20020077536 | Diab et al. | Jun 2002 | A1 |
| 20020082513 | Ennen et al. | Jun 2002 | A1 |
| 20020085174 | Bolger et al. | Jul 2002 | A1 |
| 20020091319 | Moehring et al. | Jul 2002 | A1 |
| 20020091335 | John et al. | Jul 2002 | A1 |
| 20020095099 | Quyen et al. | Jul 2002 | A1 |
| 20020099273 | Bocionek et al. | Jul 2002 | A1 |
| 20020099295 | Gil et al. | Jul 2002 | A1 |
| 20020099306 | Shaw et al. | Jul 2002 | A1 |
| 20020103428 | deCharms | Aug 2002 | A1 |
| 20020103429 | deCharms | Aug 2002 | A1 |
| 20020103512 | Echauz et al. | Aug 2002 | A1 |
| 20020107454 | Collura et al. | Aug 2002 | A1 |
| 20020112732 | Blazey et al. | Aug 2002 | A1 |
| 20020117176 | Mantzaridis et al. | Aug 2002 | A1 |
| 20020128540 | Kim et al. | Sep 2002 | A1 |
| 20020128544 | Diab et al. | Sep 2002 | A1 |
| 20020128638 | Chauvet et al. | Sep 2002 | A1 |
| 20020138013 | Guerrero et al. | Sep 2002 | A1 |
| 20020151771 | Braun et al. | Oct 2002 | A1 |
| 20020158631 | Kandori et al. | Oct 2002 | A1 |
| 20020173714 | Tsukada et al. | Nov 2002 | A1 |
| 20020177882 | DiLorenzo | Nov 2002 | A1 |
| 20020182574 | Freer | Dec 2002 | A1 |
| 20020183644 | Levendowski et al. | Dec 2002 | A1 |
| 20020193670 | Garfield et al. | Dec 2002 | A1 |
| 20030001098 | Stoddart et al. | Jan 2003 | A1 |
| 20030004429 | Price | Jan 2003 | A1 |
| 20030009078 | Fedorovskaya et al. | Jan 2003 | A1 |
| 20030009096 | Lahteenmaki | Jan 2003 | A1 |
| 20030013981 | Gevins et al. | Jan 2003 | A1 |
| 20030018277 | He | Jan 2003 | A1 |
| 20030018278 | Jordan | Jan 2003 | A1 |
| 20030023183 | Williams | Jan 2003 | A1 |
| 20030028081 | Blazey et al. | Feb 2003 | A1 |
| 20030028121 | Blazey et al. | Feb 2003 | A1 |
| 20030032870 | Farwell | Feb 2003 | A1 |
| 20030032888 | Dewan | Feb 2003 | A1 |
| 20030032889 | Wells | Feb 2003 | A1 |
| 20030035301 | Gardiner et al. | Feb 2003 | A1 |
| 20030036689 | Diab et al. | Feb 2003 | A1 |
| 20030040660 | Jackowski et al. | Feb 2003 | A1 |
| 20030046018 | Kohlmorgen et al. | Mar 2003 | A1 |
| 20030055355 | Viertio-Oja | Mar 2003 | A1 |
| 20030068605 | Kullok et al. | Apr 2003 | A1 |
| 20030069516 | Becker et al. | Apr 2003 | A1 |
| 20030070685 | Patton et al. | Apr 2003 | A1 |
| 20030074032 | Gliner | Apr 2003 | A1 |
| 20030081818 | Fujimaki | May 2003 | A1 |
| 20030083596 | Kramer et al. | May 2003 | A1 |
| 20030093004 | Sosa et al. | May 2003 | A1 |
| 20030093005 | Tucker | May 2003 | A1 |
| 20030093129 | Nicolelis et al. | May 2003 | A1 |
| 20030097159 | Schiff et al. | May 2003 | A1 |
| 20030100844 | Miller et al. | May 2003 | A1 |
| 20030105408 | Gotman et al. | Jun 2003 | A1 |
| 20030120140 | Bango | Jun 2003 | A1 |
| 20030120172 | Foust et al. | Jun 2003 | A1 |
| 20030128801 | Eisenberg et al. | Jul 2003 | A1 |
| 20030130709 | D.C. et al. | Jul 2003 | A1 |
| 20030135128 | Suffin et al. | Jul 2003 | A1 |
| 20030139681 | Melker et al. | Jul 2003 | A1 |
| 20030139683 | Ryu et al. | Jul 2003 | A1 |
| 20030144601 | Prichep | Jul 2003 | A1 |
| 20030149351 | Nowinski et al. | Aug 2003 | A1 |
| 20030149678 | Cook | Aug 2003 | A1 |
| 20030150465 | Dewan | Aug 2003 | A1 |
| 20030153818 | Bocionek et al. | Aug 2003 | A1 |
| 20030158466 | Lynn et al. | Aug 2003 | A1 |
| 20030158495 | Hogan | Aug 2003 | A1 |
| 20030158496 | Keirsbilck et al. | Aug 2003 | A1 |
| 20030158497 | Graham et al. | Aug 2003 | A1 |
| 20030158587 | Esteller et al. | Aug 2003 | A1 |
| 20030160622 | Duensing et al. | Aug 2003 | A1 |
| 20030163027 | Balkin et al. | Aug 2003 | A1 |
| 20030163028 | Balkin et al. | Aug 2003 | A1 |
| 20030167019 | Viertio-Oja et al. | Sep 2003 | A1 |
| 20030171658 | Keirsbilck et al. | Sep 2003 | A1 |
| 20030171685 | Lesser et al. | Sep 2003 | A1 |
| 20030171689 | Millan et al. | Sep 2003 | A1 |
| 20030176804 | Melker | Sep 2003 | A1 |
| 20030181821 | Greenwald et al. | Sep 2003 | A1 |
| 20030185408 | Causevic et al. | Oct 2003 | A1 |
| 20030187359 | Njemanze | Oct 2003 | A1 |
| 20030195429 | Wilson | Oct 2003 | A1 |
| 20030199749 | Lowery, Jr. et al. | Oct 2003 | A1 |
| 20030204135 | Bystritsky | Oct 2003 | A1 |
| 20030216654 | Xu et al. | Nov 2003 | A1 |
| 20030225335 | Njemanze | Dec 2003 | A1 |
| 20030225340 | Collura | Dec 2003 | A1 |
| 20030229291 | Collura | Dec 2003 | A1 |
| 20030236458 | Hochman | Dec 2003 | A1 |
| 20040002635 | Hargrove et al. | Jan 2004 | A1 |
| 20040006265 | Alhussiny | Jan 2004 | A1 |
| 20040006376 | Falci | Jan 2004 | A1 |
| 20040010203 | Bibian et al. | Jan 2004 | A1 |
| 20040013609 | Trier | Jan 2004 | A1 |
| 20040019257 | Meadows | Jan 2004 | A1 |
| 20040019370 | Gliner et al. | Jan 2004 | A1 |
| 20040024287 | Patton et al. | Feb 2004 | A1 |
| 20040030585 | Sariel | Feb 2004 | A1 |
| 20040034299 | Kandori et al. | Feb 2004 | A1 |
| 20040039268 | Barbour et al. | Feb 2004 | A1 |
| 20040049484 | Kamba | Mar 2004 | A1 |
| 20040059203 | Guerrero et al. | Mar 2004 | A1 |
| 20040059241 | Suffin | Mar 2004 | A1 |
| 20040064020 | Diab et al. | Apr 2004 | A1 |
| 20040064066 | John et al. | Apr 2004 | A1 |
| 20040068164 | Diab et al. | Apr 2004 | A1 |
| 20040068172 | Nowinski et al. | Apr 2004 | A1 |
| 20040068199 | Echauz et al. | Apr 2004 | A1 |
| 20040070729 | Wiebe et al. | Apr 2004 | A1 |
| 20040072133 | Kullok et al. | Apr 2004 | A1 |
| 20040073098 | Geva et al. | Apr 2004 | A1 |
| 20040073129 | Caldwell et al. | Apr 2004 | A1 |
| 20040077960 | Tanaka et al. | Apr 2004 | A1 |
| 20040077967 | Jordan | Apr 2004 | A1 |
| 20040079372 | John et al. | Apr 2004 | A1 |
| 20040082862 | Chance | Apr 2004 | A1 |
| 20040082876 | Viertio-Oja et al. | Apr 2004 | A1 |
| 20040092809 | DeCharms | May 2004 | A1 |
| 20040096395 | Xiong et al. | May 2004 | A1 |
| 20040097802 | Cohen | May 2004 | A1 |
| 20040101146 | Laitinen et al. | May 2004 | A1 |
| 20040102843 | Yagi | May 2004 | A1 |
| 20040116784 | Gavish | Jun 2004 | A1 |
| 20040116791 | Miyauchi | Jun 2004 | A1 |
| 20040116798 | Cancro et al. | Jun 2004 | A1 |
| 20040116825 | Sturzebecher | Jun 2004 | A1 |
| 20040117098 | Ryu et al. | Jun 2004 | A1 |
| 20040122787 | Avinash et al. | Jun 2004 | A1 |
| 20040122790 | Walker et al. | Jun 2004 | A1 |
| 20040127803 | Berkes et al. | Jul 2004 | A1 |
| 20040133119 | Osorio et al. | Jul 2004 | A1 |
| 20040133120 | Frei et al. | Jul 2004 | A1 |
| 20040133390 | Osorio et al. | Jul 2004 | A1 |
| 20040138536 | Frei et al. | Jul 2004 | A1 |
| 20040138580 | Frei et al. | Jul 2004 | A1 |
| 20040138711 | Osorio et al. | Jul 2004 | A1 |
| 20040143170 | DuRousseau | Jul 2004 | A1 |
| 20040144925 | Stoddart et al. | Jul 2004 | A1 |
| 20040152958 | Frei et al. | Aug 2004 | A1 |
| 20040152995 | Cox et al. | Aug 2004 | A1 |
| 20040158119 | Osorio et al. | Aug 2004 | A1 |
| 20040158300 | Gardiner | Aug 2004 | A1 |
| 20040163648 | Burton | Aug 2004 | A1 |
| 20040166536 | Kerkman et al. | Aug 2004 | A1 |
| 20040167418 | Nguyen et al. | Aug 2004 | A1 |
| 20040181162 | Wilson | Sep 2004 | A1 |
| 20040181168 | Plant et al. | Sep 2004 | A1 |
| 20040186542 | van Venrooij et al. | Sep 2004 | A1 |
| 20040193037 | Tsukada et al. | Sep 2004 | A1 |
| 20040193068 | Burton et al. | Sep 2004 | A1 |
| 20040199482 | Wilson | Oct 2004 | A1 |
| 20040204636 | Diab et al. | Oct 2004 | A1 |
| 20040204637 | Diab et al. | Oct 2004 | A1 |
| 20040204656 | Tolvanen-Laakso et al. | Oct 2004 | A1 |
| 20040204659 | John et al. | Oct 2004 | A1 |
| 20040210127 | Kandori et al. | Oct 2004 | A1 |
| 20040210146 | Diab et al. | Oct 2004 | A1 |
| 20040210156 | Hogan | Oct 2004 | A1 |
| 20040215082 | Chance | Oct 2004 | A1 |
| 20040220494 | Sturzebecher | Nov 2004 | A1 |
| 20040220704 | Lin et al. | Nov 2004 | A1 |
| 20040220782 | Cook | Nov 2004 | A1 |
| 20040225179 | Kaplan et al. | Nov 2004 | A1 |
| 20040227699 | Mitchell | Nov 2004 | A1 |
| 20040230105 | Geva et al. | Nov 2004 | A1 |
| 20040243017 | Causevic | Dec 2004 | A1 |
| 20040249237 | Campbell et al. | Dec 2004 | A1 |
| 20040254493 | Chervin et al. | Dec 2004 | A1 |
| 20040260169 | Sternnickel | Dec 2004 | A1 |
| 20040263162 | Kandori et al. | Dec 2004 | A1 |
| 20040267152 | Pineda | Dec 2004 | A1 |
| 20050004489 | Sarkela et al. | Jan 2005 | A1 |
| 20050007091 | Makeig et al. | Jan 2005 | A1 |
| 20050010091 | Woods et al. | Jan 2005 | A1 |
| 20050010116 | Korhonen et al. | Jan 2005 | A1 |
| 20050015205 | Repucci et al. | Jan 2005 | A1 |
| 20050017870 | Allison et al. | Jan 2005 | A1 |
| 20050018858 | John | Jan 2005 | A1 |
| 20050019734 | Peled | Jan 2005 | A1 |
| 20050020918 | Wilk et al. | Jan 2005 | A1 |
| 20050025704 | Keirsbilck et al. | Feb 2005 | A1 |
| 20050027284 | Lozano et al. | Feb 2005 | A1 |
| 20050033122 | Balkin et al. | Feb 2005 | A1 |
| 20050033154 | deCharms | Feb 2005 | A1 |
| 20050033174 | Moehring et al. | Feb 2005 | A1 |
| 20050033379 | Lozano et al. | Feb 2005 | A1 |
| 20050038354 | Miller et al. | Feb 2005 | A1 |
| 20050043652 | Lovett et al. | Feb 2005 | A1 |
| 20050043774 | Devlin et al. | Feb 2005 | A1 |
| 20050059874 | Fuchs et al. | Mar 2005 | A1 |
| 20050075568 | Moehring | Apr 2005 | A1 |
| 20050079474 | Lowe | Apr 2005 | A1 |
| 20050079636 | White et al. | Apr 2005 | A1 |
| 20050080349 | Okada et al. | Apr 2005 | A1 |
| 20050080828 | Johnson | Apr 2005 | A1 |
| 20050085744 | Beverina et al. | Apr 2005 | A1 |
| 20050096517 | Diab et al. | May 2005 | A1 |
| 20050099601 | MacDougall et al. | May 2005 | A1 |
| 20050106713 | Phan et al. | May 2005 | A1 |
| 20050107654 | Riehl | May 2005 | A1 |
| 20050110950 | Thorpe et al. | May 2005 | A1 |
| 20050113713 | Foust et al. | May 2005 | A1 |
| 20050119547 | Shastri et al. | Jun 2005 | A1 |
| 20050119586 | Coyle et al. | Jun 2005 | A1 |
| 20050124848 | Holzner | Jun 2005 | A1 |
| 20050124851 | Patton et al. | Jun 2005 | A1 |
| 20050124863 | Cook | Jun 2005 | A1 |
| 20050131311 | Leuthardt et al. | Jun 2005 | A1 |
| 20050135102 | Gardiner et al. | Jun 2005 | A1 |
| 20050136002 | Fossheim et al. | Jun 2005 | A1 |
| 20050137493 | Ryu et al. | Jun 2005 | A1 |
| 20050137494 | Viertio-Oja | Jun 2005 | A1 |
| 20050148828 | Lindsay | Jul 2005 | A1 |
| 20050148893 | Misczynski et al. | Jul 2005 | A1 |
| 20050148894 | Misczynski et al. | Jul 2005 | A1 |
| 20050148895 | Misczynski et al. | Jul 2005 | A1 |
| 20050149123 | Lesser et al. | Jul 2005 | A1 |
| 20050153268 | Junkin et al. | Jul 2005 | A1 |
| 20050154290 | Langleben | Jul 2005 | A1 |
| 20050154426 | Boveja et al. | Jul 2005 | A1 |
| 20050159670 | Sneddon | Jul 2005 | A1 |
| 20050159671 | Sneddon | Jul 2005 | A1 |
| 20050167588 | Donnangelo | Aug 2005 | A1 |
| 20050182287 | Becker | Aug 2005 | A1 |
| 20050182456 | Ziobro et al. | Aug 2005 | A1 |
| 20050192514 | Kearby et al. | Sep 2005 | A1 |
| 20050195165 | Mitchell | Sep 2005 | A1 |
| 20050197590 | Osorio et al. | Sep 2005 | A1 |
| 20050209517 | Diab et al. | Sep 2005 | A1 |
| 20050215916 | Fadem et al. | Sep 2005 | A1 |
| 20050216071 | Devlin et al. | Sep 2005 | A1 |
| 20050222639 | Seifritz et al. | Oct 2005 | A1 |
| 20050228451 | Jaax et al. | Oct 2005 | A1 |
| 20050228785 | Wolcott et al. | Oct 2005 | A1 |
| 20050240087 | Keenan et al. | Oct 2005 | A1 |
| 20050240253 | Tyler et al. | Oct 2005 | A1 |
| 20050245796 | Woods et al. | Nov 2005 | A1 |
| 20050251055 | Zhirnov et al. | Nov 2005 | A1 |
| 20050256378 | Takai et al. | Nov 2005 | A1 |
| 20050256385 | Diab et al. | Nov 2005 | A1 |
| 20050256418 | Mietus et al. | Nov 2005 | A1 |
| 20050267343 | Woods et al. | Dec 2005 | A1 |
| 20050267344 | Woods et al. | Dec 2005 | A1 |
| 20050267362 | Mietus et al. | Dec 2005 | A1 |
| 20050273017 | Gordon | Dec 2005 | A1 |
| 20050277813 | Katz et al. | Dec 2005 | A1 |
| 20050277912 | John | Dec 2005 | A1 |
| 20050283053 | deCharms | Dec 2005 | A1 |
| 20050283090 | Wells | Dec 2005 | A1 |
| 20060004298 | Kennedy et al. | Jan 2006 | A1 |
| 20060004422 | De Ridder | Jan 2006 | A1 |
| 20060009704 | Okada et al. | Jan 2006 | A1 |
| 20060015034 | Martinerie et al. | Jan 2006 | A1 |
| 20060018525 | Barbour | Jan 2006 | A1 |
| 20060020184 | Woods et al. | Jan 2006 | A1 |
| 20060036152 | Kozel | Feb 2006 | A1 |
| 20060036153 | Laken | Feb 2006 | A1 |
| 20060041201 | Behbehani et al. | Feb 2006 | A1 |
| 20060047187 | Goyal et al. | Mar 2006 | A1 |
| 20060047216 | Dorr et al. | Mar 2006 | A1 |
| 20060047324 | Tass | Mar 2006 | A1 |
| 20060051814 | Jackowski et al. | Mar 2006 | A1 |
| 20060052706 | Hynynen et al. | Mar 2006 | A1 |
| 20060058590 | Shaw et al. | Mar 2006 | A1 |
| 20060058683 | Chance | Mar 2006 | A1 |
| 20060061544 | Min et al. | Mar 2006 | A1 |
| 20060064140 | Whitehurst et al. | Mar 2006 | A1 |
| 20060071934 | Sagar et al. | Apr 2006 | A1 |
| 20060074290 | Chen et al. | Apr 2006 | A1 |
| 20060074298 | Borsook et al. | Apr 2006 | A1 |
| 20060074334 | Coyle | Apr 2006 | A1 |
| 20060074822 | Eda et al. | Apr 2006 | A1 |
| 20060077064 | Baura | Apr 2006 | A1 |
| 20060078183 | deCharms | Apr 2006 | A1 |
| 20060082727 | Bolger et al. | Apr 2006 | A1 |
| 20060084858 | Marks | Apr 2006 | A1 |
| 20060084877 | Ujhazy et al. | Apr 2006 | A1 |
| 20060087746 | Lipow | Apr 2006 | A1 |
| 20060089541 | Braun et al. | Apr 2006 | A1 |
| 20060089549 | Diab et al. | Apr 2006 | A1 |
| 20060094968 | Drew | May 2006 | A1 |
| 20060094974 | Cain | May 2006 | A1 |
| 20060100526 | Yamamoto et al. | May 2006 | A1 |
| 20060100530 | Kliot et al. | May 2006 | A1 |
| 20060102171 | Gavish | May 2006 | A1 |
| 20060106434 | Padgitt et al. | May 2006 | A1 |
| 20060111644 | Guttag et al. | May 2006 | A1 |
| 20060116556 | Duhamel | Jun 2006 | A1 |
| 20060122481 | Sievenpiper et al. | Jun 2006 | A1 |
| 20060129277 | Wu et al. | Jun 2006 | A1 |
| 20060129324 | Rabinoff et al. | Jun 2006 | A1 |
| 20060135877 | Giftakis et al. | Jun 2006 | A1 |
| 20060135879 | Liley | Jun 2006 | A1 |
| 20060135880 | Sarkela | Jun 2006 | A1 |
| 20060135881 | Giftakis et al. | Jun 2006 | A1 |
| 20060136006 | Giftakis et al. | Jun 2006 | A1 |
| 20060145457 | Prenzel et al. | Jul 2006 | A1 |
| 20060149144 | Lynn et al. | Jul 2006 | A1 |
| 20060149160 | Kofol et al. | Jul 2006 | A1 |
| 20060153396 | John | Jul 2006 | A1 |
| 20060155206 | Lynn | Jul 2006 | A1 |
| 20060155207 | Lynn et al. | Jul 2006 | A1 |
| 20060155495 | Osorio et al. | Jul 2006 | A1 |
| 20060161071 | Lynn et al. | Jul 2006 | A1 |
| 20060161075 | Kurtz | Jul 2006 | A1 |
| 20060161218 | Danilov | Jul 2006 | A1 |
| 20060161384 | Osorio et al. | Jul 2006 | A1 |
| 20060167370 | Greenwald et al. | Jul 2006 | A1 |
| 20060167722 | Struys et al. | Jul 2006 | A1 |
| 20060173364 | Clancy et al. | Aug 2006 | A1 |
| 20060173510 | Besio et al. | Aug 2006 | A1 |
| 20060178709 | Foster et al. | Aug 2006 | A1 |
| 20060184059 | Jadidi | Aug 2006 | A1 |
| 20060189866 | Thomas et al. | Aug 2006 | A1 |
| 20060189880 | Lynn et al. | Aug 2006 | A1 |
| 20060189882 | Thomas | Aug 2006 | A1 |
| 20060195144 | Giftakis et al. | Aug 2006 | A1 |
| 20060200013 | Smith et al. | Sep 2006 | A1 |
| 20060200016 | Diab et al. | Sep 2006 | A1 |
| 20060200034 | Ricci et al. | Sep 2006 | A1 |
| 20060200035 | Ricci et al. | Sep 2006 | A1 |
| 20060204532 | John | Sep 2006 | A1 |
| 20060206033 | Guerrero et al. | Sep 2006 | A1 |
| 20060206165 | Jaax et al. | Sep 2006 | A1 |
| 20060206174 | Honeycutt et al. | Sep 2006 | A1 |
| 20060217609 | Diab et al. | Sep 2006 | A1 |
| 20060217781 | John | Sep 2006 | A1 |
| 20060217816 | Pesaran et al. | Sep 2006 | A1 |
| 20060224067 | Giftakis et al. | Oct 2006 | A1 |
| 20060225437 | Kazami | Oct 2006 | A1 |
| 20060233390 | Causevic et al. | Oct 2006 | A1 |
| 20060235315 | Akselrod et al. | Oct 2006 | A1 |
| 20060235324 | Lynn | Oct 2006 | A1 |
| 20060241373 | Strychacz et al. | Oct 2006 | A1 |
| 20060241382 | Li et al. | Oct 2006 | A1 |
| 20060241562 | John et al. | Oct 2006 | A1 |
| 20060241718 | Tyler et al. | Oct 2006 | A1 |
| 20060247728 | Foster et al. | Nov 2006 | A1 |
| 20060251303 | He et al. | Nov 2006 | A1 |
| 20060252978 | Vesely et al. | Nov 2006 | A1 |
| 20060252979 | Vesely et al. | Nov 2006 | A1 |
| 20060253003 | Laufer et al. | Nov 2006 | A1 |
| 20060255956 | Arakawa et al. | Nov 2006 | A1 |
| 20060258896 | Haber et al. | Nov 2006 | A1 |
| 20060258950 | Hargrove et al. | Nov 2006 | A1 |
| 20060265022 | John et al. | Nov 2006 | A1 |
| 20060276695 | Lynn et al. | Dec 2006 | A9 |
| 20060281543 | Sutton et al. | Dec 2006 | A1 |
| 20060281980 | Randlov et al. | Dec 2006 | A1 |
| 20060293578 | Rennaker | Dec 2006 | A1 |
| 20070005115 | Lozano et al. | Jan 2007 | A1 |
| 20070005391 | Repucci et al. | Jan 2007 | A1 |
| 20070007454 | Stoddart et al. | Jan 2007 | A1 |
| 20070008172 | Hewett et al. | Jan 2007 | A1 |
| 20070010748 | Rauch et al. | Jan 2007 | A1 |
| 20070015976 | Miesel et al. | Jan 2007 | A1 |
| 20070015985 | Tolvanen-Laakso et al. | Jan 2007 | A1 |
| 20070016095 | Low et al. | Jan 2007 | A1 |
| 20070016264 | Falci | Jan 2007 | A1 |
| 20070017534 | Thorpe | Jan 2007 | A1 |
| 20070021673 | Arbel et al. | Jan 2007 | A1 |
| 20070021675 | Childre et al. | Jan 2007 | A1 |
| 20070032733 | Burton | Feb 2007 | A1 |
| 20070032737 | Causevic et al. | Feb 2007 | A1 |
| 20070036355 | Terauchi et al. | Feb 2007 | A1 |
| 20070038067 | Kandori et al. | Feb 2007 | A1 |
| 20070038264 | Jaax et al. | Feb 2007 | A1 |
| 20070038382 | Keenan | Feb 2007 | A1 |
| 20070040691 | Lau et al. | Feb 2007 | A1 |
| 20070043392 | Gliner et al. | Feb 2007 | A1 |
| 20070043401 | John | Feb 2007 | A1 |
| 20070049844 | Rosenfeld | Mar 2007 | A1 |
| 20070050715 | Behar | Mar 2007 | A1 |
| 20070055145 | Zelnik et al. | Mar 2007 | A1 |
| 20070060830 | Le et al. | Mar 2007 | A1 |
| 20070060831 | Le et al. | Mar 2007 | A1 |
| 20070066403 | Conkwright | Mar 2007 | A1 |
| 20070066914 | Le et al. | Mar 2007 | A1 |
| 20070066915 | Frei et al. | Mar 2007 | A1 |
| 20070078077 | Peyman | Apr 2007 | A1 |
| 20070083128 | Cote et al. | Apr 2007 | A1 |
| 20070093721 | Lynn et al. | Apr 2007 | A1 |
| 20070100246 | Hyde | May 2007 | A1 |
| 20070100251 | Prichep | May 2007 | A1 |
| 20070100278 | Frei et al. | May 2007 | A1 |
| 20070100666 | Stivoric et al. | May 2007 | A1 |
| 20070121068 | MacDougall et al. | May 2007 | A1 |
| 20070129647 | Lynn | Jun 2007 | A1 |
| 20070132841 | MacDougall et al. | Jun 2007 | A1 |
| 20070135724 | Ujhazy et al. | Jun 2007 | A1 |
| 20070135728 | Snyder et al. | Jun 2007 | A1 |
| 20070138886 | Krebs et al. | Jun 2007 | A1 |
| 20070142862 | Dilorenzo | Jun 2007 | A1 |
| 20070142873 | Esteller et al. | Jun 2007 | A1 |
| 20070146368 | Scott et al. | Jun 2007 | A1 |
| 20070149860 | Lynn et al. | Jun 2007 | A1 |
| 20070156457 | Brown | Jul 2007 | A1 |
| 20070161919 | DiLorenzo | Jul 2007 | A1 |
| 20070162086 | DiLorenzo | Jul 2007 | A1 |
| 20070165915 | Fuchs | Jul 2007 | A1 |
| 20070167694 | Causevic et al. | Jul 2007 | A1 |
| 20070167723 | Park et al. | Jul 2007 | A1 |
| 20070167853 | Melker et al. | Jul 2007 | A1 |
| 20070167858 | Virtanen et al. | Jul 2007 | A1 |
| 20070167991 | DiLorenzo | Jul 2007 | A1 |
| 20070173733 | Le et al. | Jul 2007 | A1 |
| 20070179395 | Sotos et al. | Aug 2007 | A1 |
| 20070179396 | Le et al. | Aug 2007 | A1 |
| 20070179534 | Firlik et al. | Aug 2007 | A1 |
| 20070179558 | Gliner et al. | Aug 2007 | A1 |
| 20070179734 | Chmiel et al. | Aug 2007 | A1 |
| 20070184507 | Jackowski et al. | Aug 2007 | A1 |
| 20070185697 | Tan et al. | Aug 2007 | A1 |
| 20070191688 | Lynn | Aug 2007 | A1 |
| 20070191691 | Polanco | Aug 2007 | A1 |
| 20070191697 | Lynn et al. | Aug 2007 | A1 |
| 20070191704 | DeCharms | Aug 2007 | A1 |
| 20070191727 | Fadem | Aug 2007 | A1 |
| 20070197930 | Sarkela | Aug 2007 | A1 |
| 20070203401 | Gordon et al. | Aug 2007 | A1 |
| 20070203448 | Melker et al. | Aug 2007 | A1 |
| 20070208212 | DiLorenzo | Sep 2007 | A1 |
| 20070208269 | Mumford et al. | Sep 2007 | A1 |
| 20070209669 | Derchak | Sep 2007 | A1 |
| 20070213786 | Sackellares et al. | Sep 2007 | A1 |
| 20070225581 | Diab et al. | Sep 2007 | A1 |
| 20070225674 | Molnar et al. | Sep 2007 | A1 |
| 20070225932 | Halford | Sep 2007 | A1 |
| 20070238934 | Viswanathan | Oct 2007 | A1 |
| 20070238939 | Giftakis et al. | Oct 2007 | A1 |
| 20070239054 | Giftakis et al. | Oct 2007 | A1 |
| 20070239059 | McIver | Oct 2007 | A1 |
| 20070239060 | Giftakis et al. | Oct 2007 | A1 |
| 20070239230 | Giftakis et al. | Oct 2007 | A1 |
| 20070249918 | Diab et al. | Oct 2007 | A1 |
| 20070249952 | Rubin et al. | Oct 2007 | A1 |
| 20070250119 | Tyler et al. | Oct 2007 | A1 |
| 20070250138 | Nofzinger | Oct 2007 | A1 |
| 20070255122 | Vol et al. | Nov 2007 | A1 |
| 20070255135 | Kalafut et al. | Nov 2007 | A1 |
| 20070255164 | Viertio-Oja et al. | Nov 2007 | A1 |
| 20070259323 | Brown et al. | Nov 2007 | A1 |
| 20070260147 | Giftakis et al. | Nov 2007 | A1 |
| 20070260151 | Clifford | Nov 2007 | A1 |
| 20070260286 | Giftakis et al. | Nov 2007 | A1 |
| 20070260289 | Giftakis et al. | Nov 2007 | A1 |
| 20070265508 | Sheikhzadeh-Nadjar et al. | Nov 2007 | A1 |
| 20070265533 | Tran | Nov 2007 | A1 |
| 20070265536 | Giftakis et al. | Nov 2007 | A1 |
| 20070265677 | Giftakis et al. | Nov 2007 | A1 |
| 20070273504 | Tran | Nov 2007 | A1 |
| 20070273611 | Torch | Nov 2007 | A1 |
| 20070276270 | Tran | Nov 2007 | A1 |
| 20070276278 | Coyle et al. | Nov 2007 | A1 |
| 20070276279 | Echauz et al. | Nov 2007 | A1 |
| 20070276609 | Greenwald | Nov 2007 | A1 |
| 20070282228 | Einav et al. | Dec 2007 | A1 |
| 20070287896 | Derchak et al. | Dec 2007 | A1 |
| 20070291832 | Diab et al. | Dec 2007 | A1 |
| 20070293760 | Schaafsma | Dec 2007 | A1 |
| 20070299370 | Bystritsky | Dec 2007 | A1 |
| 20070299371 | Einav et al. | Dec 2007 | A1 |
| 20080001600 | deCharms | Jan 2008 | A1 |
| 20080001735 | Tran | Jan 2008 | A1 |
| 20080004514 | Diab et al. | Jan 2008 | A1 |
| 20080004550 | Einav et al. | Jan 2008 | A1 |
| 20080004904 | Tran | Jan 2008 | A1 |
| 20080009685 | Kim et al. | Jan 2008 | A1 |
| 20080009772 | Tyler et al. | Jan 2008 | A1 |
| 20080013747 | Tran | Jan 2008 | A1 |
| 20080015458 | Buarque de Macedo et al. | Jan 2008 | A1 |
| 20080021332 | Brainard | Jan 2008 | A1 |
| 20080021336 | Dobak | Jan 2008 | A1 |
| 20080021340 | Sarkela | Jan 2008 | A1 |
| 20080021341 | Harris et al. | Jan 2008 | A1 |
| 20080021342 | Echauz et al. | Jan 2008 | A1 |
| 20080021345 | Kern et al. | Jan 2008 | A1 |
| 20080027346 | Litt et al. | Jan 2008 | A1 |
| 20080027347 | Harris et al. | Jan 2008 | A1 |
| 20080027348 | Harris et al. | Jan 2008 | A1 |
| 20080027515 | Harris et al. | Jan 2008 | A1 |
| 20080033266 | Diab et al. | Feb 2008 | A1 |
| 20080033291 | Rousso et al. | Feb 2008 | A1 |
| 20080033297 | Sliwa | Feb 2008 | A1 |
| 20080033490 | Giftakis et al. | Feb 2008 | A1 |
| 20080033502 | Harris et al. | Feb 2008 | A1 |
| 20080033508 | Frei et al. | Feb 2008 | A1 |
| 20080036752 | Diab et al. | Feb 2008 | A1 |
| 20080039677 | Adams | Feb 2008 | A1 |
| 20080039698 | Burton | Feb 2008 | A1 |
| 20080039737 | Breiter et al. | Feb 2008 | A1 |
| 20080039904 | Bulkes et al. | Feb 2008 | A1 |
| 20080042067 | Rousso et al. | Feb 2008 | A1 |
| 20080045823 | Diab et al. | Feb 2008 | A1 |
| 20080045844 | Arbel et al. | Feb 2008 | A1 |
| 20080049186 | MacDougall et al. | Feb 2008 | A1 |
| 20080049187 | Joos et al. | Feb 2008 | A1 |
| 20080051669 | Meyer et al. | Feb 2008 | A1 |
| 20080051858 | Haber et al. | Feb 2008 | A1 |
| 20080058664 | Mirro | Mar 2008 | A1 |
| 20080058668 | Seyed Momen et al. | Mar 2008 | A1 |
| 20080064934 | Frei et al. | Mar 2008 | A1 |
| 20080074307 | Boric-Lubecke et al. | Mar 2008 | A1 |
| 20080074618 | Qi | Mar 2008 | A1 |
| 20080077010 | Cohen-Solal et al. | Mar 2008 | A1 |
| 20080077015 | Boric-Lubecke et al. | Mar 2008 | A1 |
| 20080081963 | Naghavi et al. | Apr 2008 | A1 |
| 20080082018 | Sackner et al. | Apr 2008 | A1 |
| 20080091118 | Georgopoulos | Apr 2008 | A1 |
| 20080097197 | Kalafut et al. | Apr 2008 | A1 |
| 20080097235 | Ofek et al. | Apr 2008 | A1 |
| 20080097785 | Ali | Apr 2008 | A1 |
| 20080119716 | Boric-Lubecke et al. | May 2008 | A1 |
| 20080119747 | Mietus et al. | May 2008 | A1 |
| 20080119763 | Wiener | May 2008 | A1 |
| 20080119900 | DiLorenzo | May 2008 | A1 |
| 20080123927 | Miga et al. | May 2008 | A1 |
| 20080125669 | Suffin et al. | May 2008 | A1 |
| 20080128626 | Rousso et al. | Jun 2008 | A1 |
| 20080132383 | Einav et al. | Jun 2008 | A1 |
| 20080139953 | Baker et al. | Jun 2008 | A1 |
| 20080140403 | Hughes et al. | Jun 2008 | A1 |
| 20080154111 | Wu et al. | Jun 2008 | A1 |
| 20080154126 | Culver et al. | Jun 2008 | A1 |
| 20080154148 | Chung et al. | Jun 2008 | A1 |
| 20080167535 | Stivoric et al. | Jul 2008 | A1 |
| 20080167540 | Korhonen et al. | Jul 2008 | A1 |
| 20080167569 | Ermes et al. | Jul 2008 | A1 |
| 20080167571 | Gevins | Jul 2008 | A1 |
| 20080177195 | Armitstead | Jul 2008 | A1 |
| 20080177196 | Burdick et al. | Jul 2008 | A1 |
| 20080177197 | Lee et al. | Jul 2008 | A1 |
| 20080181452 | Kwon et al. | Jul 2008 | A1 |
| 20080183314 | Klouzal et al. | Jul 2008 | A1 |
| 20080188765 | Stolarski et al. | Aug 2008 | A1 |
| 20080188777 | Bedziouk et al. | Aug 2008 | A1 |
| 20080195166 | Sun et al. | Aug 2008 | A1 |
| 20080200831 | Sturzebecher | Aug 2008 | A1 |
| 20080208072 | Fadem et al. | Aug 2008 | A1 |
| 20080208073 | Causevic | Aug 2008 | A1 |
| 20080214902 | Lee et al. | Sep 2008 | A1 |
| 20080221400 | Lee et al. | Sep 2008 | A1 |
| 20080221401 | Derchak et al. | Sep 2008 | A1 |
| 20080221441 | Bjornerud et al. | Sep 2008 | A1 |
| 20080221472 | Lee et al. | Sep 2008 | A1 |
| 20080221969 | Lee et al. | Sep 2008 | A1 |
| 20080228077 | Wilk et al. | Sep 2008 | A1 |
| 20080228100 | Navakatikyan | Sep 2008 | A1 |
| 20080228239 | Tyler et al. | Sep 2008 | A1 |
| 20080229408 | Dinges et al. | Sep 2008 | A1 |
| 20080230702 | Rousso et al. | Sep 2008 | A1 |
| 20080230705 | Rousso et al. | Sep 2008 | A1 |
| 20080234113 | Einav | Sep 2008 | A1 |
| 20080234598 | Snyder et al. | Sep 2008 | A1 |
| 20080234601 | Wexelman | Sep 2008 | A1 |
| 20080235164 | Tian et al. | Sep 2008 | A1 |
| 20080242521 | Einav | Oct 2008 | A1 |
| 20080243014 | Moussavi et al. | Oct 2008 | A1 |
| 20080243017 | Moussavi et al. | Oct 2008 | A1 |
| 20080243021 | Causevic et al. | Oct 2008 | A1 |
| 20080249430 | John et al. | Oct 2008 | A1 |
| 20080252850 | Plagwitz et al. | Oct 2008 | A1 |
| 20080253519 | Bonfiglio et al. | Oct 2008 | A1 |
| 20080255469 | Shieh et al. | Oct 2008 | A1 |
| 20080255949 | Genco et al. | Oct 2008 | A1 |
| 20080257349 | Hedner et al. | Oct 2008 | A1 |
| 20080260212 | Moskal et al. | Oct 2008 | A1 |
| 20080262327 | Kato | Oct 2008 | A1 |
| 20080262367 | Mugler et al. | Oct 2008 | A1 |
| 20080262371 | Causevic | Oct 2008 | A1 |
| 20080262373 | Burns et al. | Oct 2008 | A1 |
| 20080273084 | MacDougall et al. | Nov 2008 | A1 |
| 20080275327 | Faarbaek et al. | Nov 2008 | A1 |
| 20080275340 | Beach et al. | Nov 2008 | A1 |
| 20080278685 | MacDougall et al. | Nov 2008 | A1 |
| 20080294019 | Tran | Nov 2008 | A1 |
| 20080294063 | Bibian et al. | Nov 2008 | A1 |
| 20080300449 | Gerber et al. | Dec 2008 | A1 |
| 20080304691 | Lai | Dec 2008 | A1 |
| 20080304731 | Kimura | Dec 2008 | A1 |
| 20080306365 | Bunce et al. | Dec 2008 | A1 |
| 20080309855 | Yan et al. | Dec 2008 | A1 |
| 20080311549 | Belitsiotis | Dec 2008 | A1 |
| 20080319326 | Behbehani et al. | Dec 2008 | A1 |
| 20080319430 | Zenzie et al. | Dec 2008 | A1 |
| 20080319505 | Boyden et al. | Dec 2008 | A1 |
| 20090005667 | Cui et al. | Jan 2009 | A1 |
| 20090005675 | Grunwald et al. | Jan 2009 | A1 |
| 20090009284 | Sako | Jan 2009 | A1 |
| 20090012387 | Hanson et al. | Jan 2009 | A1 |
| 20090018407 | Jung et al. | Jan 2009 | A1 |
| 20090018419 | Torch | Jan 2009 | A1 |
| 20090018429 | Saliga et al. | Jan 2009 | A1 |
| 20090018431 | Feiweier et al. | Jan 2009 | A1 |
| 20090018432 | He et al. | Jan 2009 | A1 |
| 20090018462 | Bell | Jan 2009 | A1 |
| 20090022825 | Kerkman et al. | Jan 2009 | A1 |
| 20090024007 | Lee et al. | Jan 2009 | A1 |
| 20090024050 | Jung et al. | Jan 2009 | A1 |
| 20090024449 | Pradeep et al. | Jan 2009 | A1 |
| 20090025023 | Pradeep et al. | Jan 2009 | A1 |
| 20090030476 | Hargrove | Jan 2009 | A1 |
| 20090033333 | Gribova et al. | Feb 2009 | A1 |
| 20090036755 | Pradeep et al. | Feb 2009 | A1 |
| 20090036756 | Pradeep et al. | Feb 2009 | A1 |
| 20090036791 | Plenz | Feb 2009 | A1 |
| 20090043221 | Kaplan et al. | Feb 2009 | A1 |
| 20090048507 | Feiweier et al. | Feb 2009 | A1 |
| 20090048530 | Sarkela et al. | Feb 2009 | A1 |
| 20090054788 | Hauger et al. | Feb 2009 | A1 |
| 20090054800 | Martinerie et al. | Feb 2009 | A1 |
| 20090054801 | Hinrikus et al. | Feb 2009 | A1 |
| 20090054958 | Nofzinger | Feb 2009 | A1 |
| 20090058660 | Torch | Mar 2009 | A1 |
| 20090062629 | Pradeep et al. | Mar 2009 | A1 |
| 20090062660 | Chance | Mar 2009 | A1 |
| 20090062670 | Sterling et al. | Mar 2009 | A1 |
| 20090062676 | Kruglikov et al. | Mar 2009 | A1 |
| 20090062679 | Tan et al. | Mar 2009 | A1 |
| 20090062680 | Sandford | Mar 2009 | A1 |
| 20090062681 | Pradeep et al. | Mar 2009 | A1 |
| 20090062696 | Nathan et al. | Mar 2009 | A1 |
| 20090062698 | Einav et al. | Mar 2009 | A1 |
| 20090063255 | Pradeep et al. | Mar 2009 | A1 |
| 20090063256 | Pradeep et al. | Mar 2009 | A1 |
| 20090076339 | Quintin et al. | Mar 2009 | A1 |
| 20090076399 | Arbel et al. | Mar 2009 | A1 |
| 20090076400 | Diab et al. | Mar 2009 | A1 |
| 20090076406 | Graham et al. | Mar 2009 | A1 |
| 20090076407 | John et al. | Mar 2009 | A1 |
| 20090078875 | Rousso et al. | Mar 2009 | A1 |
| 20090082688 | Wagner | Mar 2009 | A1 |
| 20090082689 | Guttag et al. | Mar 2009 | A1 |
| 20090082690 | Phillips et al. | Mar 2009 | A1 |
| 20090082829 | Panken et al. | Mar 2009 | A1 |
| 20090083071 | Phillips et al. | Mar 2009 | A1 |
| 20090088658 | Luo et al. | Apr 2009 | A1 |
| 20090094305 | Johnson | Apr 2009 | A1 |
| 20090099474 | Pineda et al. | Apr 2009 | A1 |
| 20090099627 | Molnar et al. | Apr 2009 | A1 |
| 20090099783 | Reisberg | Apr 2009 | A1 |
| 20090105785 | Wei et al. | Apr 2009 | A1 |
| 20090112077 | Nguyen et al. | Apr 2009 | A1 |
| 20090112117 | Rewari | Apr 2009 | A1 |
| 20090112273 | Wingeier et al. | Apr 2009 | A1 |
| 20090112277 | Wingeier et al. | Apr 2009 | A1 |
| 20090112278 | Wingeier et al. | Apr 2009 | A1 |
| 20090112279 | Wingeier et al. | Apr 2009 | A1 |
| 20090112280 | Wingeier et al. | Apr 2009 | A1 |
| 20090112281 | Miyazawa et al. | Apr 2009 | A1 |
| 20090112523 | Townsend et al. | Apr 2009 | A1 |
| 20090118610 | Karmarkar et al. | May 2009 | A1 |
| 20090118622 | Durkin et al. | May 2009 | A1 |
| 20090118636 | Collura | May 2009 | A1 |
| 20090124869 | Hu et al. | May 2009 | A1 |
| 20090124921 | Milgramm et al. | May 2009 | A1 |
| 20090124922 | Milgramm et al. | May 2009 | A1 |
| 20090124923 | Sackellares et al. | May 2009 | A1 |
| 20090131995 | Sloan et al. | May 2009 | A1 |
| 20090137915 | Childre et al. | May 2009 | A1 |
| 20090137923 | Suffin et al. | May 2009 | A1 |
| 20090149148 | Kurtz et al. | Jun 2009 | A1 |
| 20090149736 | Skidmore et al. | Jun 2009 | A1 |
| 20090156907 | Jung et al. | Jun 2009 | A1 |
| 20090156925 | Jin et al. | Jun 2009 | A1 |
| 20090156954 | Cox et al. | Jun 2009 | A1 |
| 20090156955 | Jung et al. | Jun 2009 | A1 |
| 20090156956 | Milgramm et al. | Jun 2009 | A1 |
| 20090157323 | Jung et al. | Jun 2009 | A1 |
| 20090157481 | Jung et al. | Jun 2009 | A1 |
| 20090157482 | Jung et al. | Jun 2009 | A1 |
| 20090157625 | Jung et al. | Jun 2009 | A1 |
| 20090157662 | Suffin et al. | Jun 2009 | A1 |
| 20090157751 | Jung et al. | Jun 2009 | A1 |
| 20090157813 | Jung et al. | Jun 2009 | A1 |
| 20090163777 | Jung et al. | Jun 2009 | A1 |
| 20090164131 | Jung et al. | Jun 2009 | A1 |
| 20090164132 | Jung et al. | Jun 2009 | A1 |
| 20090171164 | Jung et al. | Jul 2009 | A1 |
| 20090171232 | Hu et al. | Jul 2009 | A1 |
| 20090171240 | Aguilar et al. | Jul 2009 | A1 |
| 20090172540 | Jung et al. | Jul 2009 | A1 |
| 20090177050 | Griffiths et al. | Jul 2009 | A1 |
| 20090177090 | Grunwald et al. | Jul 2009 | A1 |
| 20090177108 | Shieh et al. | Jul 2009 | A1 |
| 20090177144 | Masmanidis et al. | Jul 2009 | A1 |
| 20090179642 | deCharms | Jul 2009 | A1 |
| 20090182211 | Diab et al. | Jul 2009 | A1 |
| 20090191131 | Fossheim et al. | Jul 2009 | A1 |
| 20090192394 | Guttag et al. | Jul 2009 | A1 |
| 20090192556 | Wu et al. | Jul 2009 | A1 |
| 20090198144 | Phillips et al. | Aug 2009 | A1 |
| 20090198145 | Chow | Aug 2009 | A1 |
| 20090204015 | Phillips et al. | Aug 2009 | A1 |
| 20090209831 | Kucharczyk et al. | Aug 2009 | A1 |
| 20090209835 | Diab et al. | Aug 2009 | A1 |
| 20090209845 | Christen et al. | Aug 2009 | A1 |
| 20090214060 | Chuang et al. | Aug 2009 | A1 |
| 20090214485 | Gavrilova et al. | Aug 2009 | A1 |
| 20090216091 | Arndt | Aug 2009 | A1 |
| 20090216146 | Teicher et al. | Aug 2009 | A1 |
| 20090216288 | Schiff et al. | Aug 2009 | A1 |
| 20090220425 | Moxon et al. | Sep 2009 | A1 |
| 20090220429 | Johnsen et al. | Sep 2009 | A1 |
| 20090221928 | Einav et al. | Sep 2009 | A1 |
| 20090221930 | Laken | Sep 2009 | A1 |
| 20090227876 | Tran | Sep 2009 | A1 |
| 20090227877 | Tran | Sep 2009 | A1 |
| 20090227882 | Foo | Sep 2009 | A1 |
| 20090227889 | John et al. | Sep 2009 | A2 |
| 20090240119 | Schwaibold et al. | Sep 2009 | A1 |
| 20090246138 | Santosh et al. | Oct 2009 | A1 |
| 20090247893 | Lapinlampi et al. | Oct 2009 | A1 |
| 20090247894 | Causevic | Oct 2009 | A1 |
| 20090264785 | Causevic et al. | Oct 2009 | A1 |
| 20090264789 | Molnar et al. | Oct 2009 | A1 |
| 20090264952 | Jassemidis et al. | Oct 2009 | A1 |
| 20090265298 | Kaplan | Oct 2009 | A1 |
| 20090267758 | Hyde et al. | Oct 2009 | A1 |
| 20090270687 | Hyde et al. | Oct 2009 | A1 |
| 20090270688 | Hyde et al. | Oct 2009 | A1 |
| 20090270692 | Hyde et al. | Oct 2009 | A1 |
| 20090270693 | Hyde et al. | Oct 2009 | A1 |
| 20090270694 | Hyde et al. | Oct 2009 | A1 |
| 20090270758 | Eagleman et al. | Oct 2009 | A1 |
| 20090270786 | Hyde et al. | Oct 2009 | A1 |
| 20090270944 | Whitehurst et al. | Oct 2009 | A1 |
| 20090275853 | Sarkela | Nov 2009 | A1 |
| 20090281400 | McCraty et al. | Nov 2009 | A1 |
| 20090281408 | Lee et al. | Nov 2009 | A1 |
| 20090281448 | Wright et al. | Nov 2009 | A1 |
| 20090287107 | Beck-Nielsen et al. | Nov 2009 | A1 |
| 20090287108 | Levy | Nov 2009 | A1 |
| 20090287271 | Blum et al. | Nov 2009 | A1 |
| 20090287272 | Kokones et al. | Nov 2009 | A1 |
| 20090287273 | Carlton et al. | Nov 2009 | A1 |
| 20090287274 | De Ridder | Nov 2009 | A1 |
| 20090287467 | Sparks et al. | Nov 2009 | A1 |
| 20090289895 | Nakada et al. | Nov 2009 | A1 |
| 20090292180 | Mirow | Nov 2009 | A1 |
| 20090292223 | Sugio et al. | Nov 2009 | A1 |
| 20090292713 | Jung et al. | Nov 2009 | A1 |
| 20090292724 | Jung et al. | Nov 2009 | A1 |
| 20090295738 | Chiang | Dec 2009 | A1 |
| 20090297000 | Shahaf et al. | Dec 2009 | A1 |
| 20090299169 | deCharms | Dec 2009 | A1 |
| 20090299209 | Farbos | Dec 2009 | A1 |
| 20090304582 | Rousso et al. | Dec 2009 | A1 |
| 20090306531 | Leuthardt et al. | Dec 2009 | A1 |
| 20090306532 | Tucker | Dec 2009 | A1 |
| 20090306534 | Pizzagalli | Dec 2009 | A1 |
| 20090306741 | Hogle et al. | Dec 2009 | A1 |
| 20090311655 | Karkanias et al. | Dec 2009 | A1 |
| 20090312624 | Berridge et al. | Dec 2009 | A1 |
| 20090312646 | Binder et al. | Dec 2009 | A1 |
| 20090312663 | John et al. | Dec 2009 | A1 |
| 20090312664 | Rodriguez Villegas et al. | Dec 2009 | A1 |
| 20090312665 | Daimoto et al. | Dec 2009 | A1 |
| 20090312808 | Tyler et al. | Dec 2009 | A1 |
| 20090312817 | Hogle et al. | Dec 2009 | A1 |
| 20090316925 | Eisenfeld et al. | Dec 2009 | A1 |
| 20090318773 | Jung et al. | Dec 2009 | A1 |
| 20090318779 | Tran | Dec 2009 | A1 |
| 20090318794 | DeCharms | Dec 2009 | A1 |
| 20090319001 | Schiff | Dec 2009 | A1 |
| 20090319004 | Sabel | Dec 2009 | A1 |
| 20090322331 | Buracas | Dec 2009 | A1 |
| 20090323049 | Addison et al. | Dec 2009 | A1 |
| 20090326353 | Watson et al. | Dec 2009 | A1 |
| 20090326404 | Sajda et al. | Dec 2009 | A1 |
| 20090326604 | Tyler et al. | Dec 2009 | A1 |
| 20090327068 | Pradeep et al. | Dec 2009 | A1 |
| 20090328089 | Pradeep et al. | Dec 2009 | A1 |
| 20100004500 | Gliner et al. | Jan 2010 | A1 |
| 20100004977 | Marci et al. | Jan 2010 | A1 |
| 20100010289 | Clare | Jan 2010 | A1 |
| 20100010364 | Verbitskiy | Jan 2010 | A1 |
| 20100010365 | Terao et al. | Jan 2010 | A1 |
| 20100010366 | Silberstein | Jan 2010 | A1 |
| 20100010385 | Skelton et al. | Jan 2010 | A1 |
| 20100010844 | Isaksen | Jan 2010 | A1 |
| 20100021378 | Rousso et al. | Jan 2010 | A1 |
| 20100023089 | DiLorenzo | Jan 2010 | A1 |
| 20100028841 | Eatough et al. | Feb 2010 | A1 |
| 20100030073 | Kalafut | Feb 2010 | A1 |
| 20100030097 | Silberstein | Feb 2010 | A1 |
| 20100030287 | Jaax et al. | Feb 2010 | A1 |
| 20100036211 | La Rue et al. | Feb 2010 | A1 |
| 20100036233 | Zhu et al. | Feb 2010 | A1 |
| 20100036276 | Ochs | Feb 2010 | A1 |
| 20100036290 | Noguchi et al. | Feb 2010 | A1 |
| 20100036453 | Hulvershorn et al. | Feb 2010 | A1 |
| 20100041949 | Tolkowsky | Feb 2010 | A1 |
| 20100041962 | Causevic et al. | Feb 2010 | A1 |
| 20100042011 | Doidge et al. | Feb 2010 | A1 |
| 20100043795 | Ujhazy et al. | Feb 2010 | A1 |
| 20100045932 | Shelhamer et al. | Feb 2010 | A1 |
| 20100049069 | Tarassenko et al. | Feb 2010 | A1 |
| 20100049075 | Bolger et al. | Feb 2010 | A1 |
| 20100049276 | Blum et al. | Feb 2010 | A1 |
| 20100049482 | He et al. | Feb 2010 | A1 |
| 20100056276 | Silberstein | Mar 2010 | A1 |
| 20100056854 | Chang | Mar 2010 | A1 |
| 20100056939 | Tarassenko et al. | Mar 2010 | A1 |
| 20100068146 | Luther-Forsstrom et al. | Mar 2010 | A1 |
| 20100068751 | Eberle | Mar 2010 | A1 |
| 20100069739 | deCharms | Mar 2010 | A1 |
| 20100069762 | Mietus et al. | Mar 2010 | A1 |
| 20100069775 | Milgramm et al. | Mar 2010 | A1 |
| 20100069777 | Marks | Mar 2010 | A1 |
| 20100069780 | Schuette et al. | Mar 2010 | A1 |
| 20100069993 | Greenspan | Mar 2010 | A1 |
| 20100076253 | Altman et al. | Mar 2010 | A1 |
| 20100076274 | Severson | Mar 2010 | A1 |
| 20100076333 | Burton et al. | Mar 2010 | A9 |
| 20100076334 | Rothblatt | Mar 2010 | A1 |
| 20100076338 | Kwak | Mar 2010 | A1 |
| 20100079292 | Lynn et al. | Apr 2010 | A1 |
| 20100081707 | Ali et al. | Apr 2010 | A1 |
| 20100082506 | Avinash et al. | Apr 2010 | A1 |
| 20100087701 | Berka et al. | Apr 2010 | A1 |
| 20100087719 | Benni | Apr 2010 | A1 |
| 20100087900 | Flint | Apr 2010 | A1 |
| 20100090835 | Liu et al. | Apr 2010 | A1 |
| 20100092934 | Silberstein | Apr 2010 | A1 |
| 20100094097 | Liu et al. | Apr 2010 | A1 |
| 20100094103 | Kaplan et al. | Apr 2010 | A1 |
| 20100094152 | Semmlow | Apr 2010 | A1 |
| 20100094154 | Schalk et al. | Apr 2010 | A1 |
| 20100094155 | Prichep | Apr 2010 | A1 |
| 20100098289 | Tognoli et al. | Apr 2010 | A1 |
| 20100099954 | Dickinson et al. | Apr 2010 | A1 |
| 20100099975 | Faro et al. | Apr 2010 | A1 |
| 20100100001 | Aguilar et al. | Apr 2010 | A1 |
| 20100106041 | Ghovanloo et al. | Apr 2010 | A1 |
| 20100106043 | Robinson et al. | Apr 2010 | A1 |
| 20100106044 | Linderman | Apr 2010 | A1 |
| 20100113959 | Pascual-Leone et al. | May 2010 | A1 |
| 20100114193 | Lozano et al. | May 2010 | A1 |
| 20100114237 | Giftakis et al. | May 2010 | A1 |
| 20100114813 | Zalay et al. | May 2010 | A1 |
| 20100125219 | Harris et al. | May 2010 | A1 |
| 20100130812 | Martel | May 2010 | A1 |
| 20100130869 | Hauger et al. | May 2010 | A1 |
| 20100131034 | Gliner et al. | May 2010 | A1 |
| 20100137728 | Govari | Jun 2010 | A1 |
| 20100137937 | John et al. | Jun 2010 | A1 |
| 20100143256 | Suffin et al. | Jun 2010 | A1 |
| 20100152621 | Janna et al. | Jun 2010 | A1 |
| 20100160737 | Shachar et al. | Jun 2010 | A1 |
| 20100163027 | Hyde et al. | Jul 2010 | A1 |
| 20100163028 | Hyde et al. | Jul 2010 | A1 |
| 20100163035 | Hyde et al. | Jul 2010 | A1 |
| 20100165093 | Sugio et al. | Jul 2010 | A1 |
| 20100165593 | Townsend et al. | Jul 2010 | A1 |
| 20100168525 | Hyde et al. | Jul 2010 | A1 |
| 20100168529 | Hyde et al. | Jul 2010 | A1 |
| 20100168602 | Hyde et al. | Jul 2010 | A1 |
| 20100174161 | Lynn | Jul 2010 | A1 |
| 20100174533 | Pakhomov | Jul 2010 | A1 |
| 20100177929 | Kurtz et al. | Jul 2010 | A1 |
| 20100179447 | Hunt | Jul 2010 | A1 |
| 20100185113 | Peot et al. | Jul 2010 | A1 |
| 20100189318 | Chang et al. | Jul 2010 | A1 |
| 20100191095 | Felblinger et al. | Jul 2010 | A1 |
| 20100191124 | Prokoski | Jul 2010 | A1 |
| 20100191139 | Jacquin et al. | Jul 2010 | A1 |
| 20100191305 | Imran et al. | Jul 2010 | A1 |
| 20100195770 | Ricci et al. | Aug 2010 | A1 |
| 20100196396 | Szentirmai et al. | Aug 2010 | A1 |
| 20100197610 | Lian et al. | Aug 2010 | A1 |
| 20100198090 | Hudson et al. | Aug 2010 | A1 |
| 20100198098 | Osorio et al. | Aug 2010 | A1 |
| 20100198101 | Song et al. | Aug 2010 | A1 |
| 20100201621 | Niikawa | Aug 2010 | A1 |
| 20100201780 | Bennett et al. | Aug 2010 | A1 |
| 20100204604 | Liley et al. | Aug 2010 | A1 |
| 20100204608 | Sugio et al. | Aug 2010 | A1 |
| 20100204614 | Lindquist et al. | Aug 2010 | A1 |
| 20100204748 | Lozano et al. | Aug 2010 | A1 |
| 20100204750 | Hargrove et al. | Aug 2010 | A1 |
| 20100217100 | LeBoeuf et al. | Aug 2010 | A1 |
| 20100217146 | Osvath | Aug 2010 | A1 |
| 20100217348 | DiLorenzo | Aug 2010 | A1 |
| 20100219820 | Skidmore et al. | Sep 2010 | A1 |
| 20100222640 | Anderson et al. | Sep 2010 | A1 |
| 20100222694 | Causevic | Sep 2010 | A1 |
| 20100224188 | John et al. | Sep 2010 | A1 |
| 20100228695 | Kaplan | Sep 2010 | A1 |
| 20100234705 | Lynn | Sep 2010 | A1 |
| 20100234752 | Sullivan et al. | Sep 2010 | A1 |
| 20100234753 | Ma | Sep 2010 | A1 |
| 20100241449 | Firminger et al. | Sep 2010 | A1 |
| 20100245093 | Kobetski et al. | Sep 2010 | A1 |
| 20100248275 | Jackowski et al. | Sep 2010 | A1 |
| 20100249573 | Marks | Sep 2010 | A1 |
| 20100249627 | Zhang et al. | Sep 2010 | A1 |
| 20100249635 | Van Der Reijden | Sep 2010 | A1 |
| 20100249636 | Pradeep et al. | Sep 2010 | A1 |
| 20100249638 | Liley | Sep 2010 | A1 |
| 20100258126 | Ujhazy et al. | Oct 2010 | A1 |
| 20100261977 | Seely | Oct 2010 | A1 |
| 20100261993 | van der Kouwe et al. | Oct 2010 | A1 |
| 20100262377 | Jensen | Oct 2010 | A1 |
| 20100268055 | Jung et al. | Oct 2010 | A1 |
| 20100268057 | Firminger et al. | Oct 2010 | A1 |
| 20100268108 | Firminger et al. | Oct 2010 | A1 |
| 20100274577 | Firminger et al. | Oct 2010 | A1 |
| 20100274578 | Firminger et al. | Oct 2010 | A1 |
| 20100280338 | Chou | Nov 2010 | A1 |
| 20100280372 | Poolman et al. | Nov 2010 | A1 |
| 20100280403 | Erdogmus et al. | Nov 2010 | A1 |
| 20100283972 | Plant et al. | Nov 2010 | A1 |
| 20100286549 | John et al. | Nov 2010 | A1 |
| 20100286747 | Sabesan et al. | Nov 2010 | A1 |
| 20100292752 | Bardakjian et al. | Nov 2010 | A1 |
| 20100293002 | Firminger et al. | Nov 2010 | A1 |
| 20100293115 | Seyed Momen | Nov 2010 | A1 |
| 20100298624 | Becker | Nov 2010 | A1 |
| 20100298735 | Suffin | Nov 2010 | A1 |
| 20100303101 | Lazar et al. | Dec 2010 | A1 |
| 20100305962 | Firminger et al. | Dec 2010 | A1 |
| 20100305963 | Firminger et al. | Dec 2010 | A1 |
| 20100312188 | Robertson et al. | Dec 2010 | A1 |
| 20100312579 | Firminger et al. | Dec 2010 | A1 |
| 20100318025 | John | Dec 2010 | A1 |
| 20100324441 | Hargrove et al. | Dec 2010 | A1 |
| 20100331649 | Chou | Dec 2010 | A1 |
| 20100331715 | Addison et al. | Dec 2010 | A1 |
| 20100331976 | Pesaran et al. | Dec 2010 | A1 |
| 20110004089 | Chou | Jan 2011 | A1 |
| 20110004115 | Shahaf et al. | Jan 2011 | A1 |
| 20110004412 | Shahaf et al. | Jan 2011 | A1 |
| 20110009715 | O'Reilly et al. | Jan 2011 | A1 |
| 20110009729 | Shin et al. | Jan 2011 | A1 |
| 20110009752 | Chen et al. | Jan 2011 | A1 |
| 20110009777 | Reichow et al. | Jan 2011 | A1 |
| 20110015467 | Dothie et al. | Jan 2011 | A1 |
| 20110015495 | Dothie et al. | Jan 2011 | A1 |
| 20110015501 | Lynn et al. | Jan 2011 | A1 |
| 20110015515 | deCharms | Jan 2011 | A1 |
| 20110015536 | Milgramm et al. | Jan 2011 | A1 |
| 20110015539 | deCharms | Jan 2011 | A1 |
| 20110026678 | Bonfiglio et al. | Feb 2011 | A1 |
| 20110028802 | Addison et al. | Feb 2011 | A1 |
| 20110028827 | Sitaram et al. | Feb 2011 | A1 |
| 20110028859 | Chian | Feb 2011 | A1 |
| 20110034821 | Ekpar | Feb 2011 | A1 |
| 20110034822 | Phillips et al. | Feb 2011 | A1 |
| 20110035231 | Firminger et al. | Feb 2011 | A1 |
| 20110038515 | Jacquin et al. | Feb 2011 | A1 |
| 20110039790 | Peyman | Feb 2011 | A1 |
| 20110040202 | Luo et al. | Feb 2011 | A1 |
| 20110040713 | Colman et al. | Feb 2011 | A1 |
| 20110043759 | Bushinsky | Feb 2011 | A1 |
| 20110046473 | Pradeep et al. | Feb 2011 | A1 |
| 20110046491 | Diamond | Feb 2011 | A1 |
| 20110046502 | Pradeep et al. | Feb 2011 | A1 |
| 20110046510 | Laufer et al. | Feb 2011 | A1 |
| 20110054272 | Derchak | Mar 2011 | A1 |
| 20110054279 | Reisfeld et al. | Mar 2011 | A1 |
| 20110054345 | Nagatani | Mar 2011 | A1 |
| 20110054562 | Gliner | Mar 2011 | A1 |
| 20110060423 | Bonfiglio et al. | Mar 2011 | A1 |
| 20110066005 | Rotenberg | Mar 2011 | A1 |
| 20110066041 | Pandia et al. | Mar 2011 | A1 |
| 20110066042 | Pandia et al. | Mar 2011 | A1 |
| 20110066053 | Yazicioglu | Mar 2011 | A1 |
| 20110074396 | Liao et al. | Mar 2011 | A1 |
| 20110077503 | Bonilha et al. | Mar 2011 | A1 |
| 20110077538 | Liu et al. | Mar 2011 | A1 |
| 20110077548 | Torch | Mar 2011 | A1 |
| 20110082360 | Fuchs et al. | Apr 2011 | A1 |
| 20110082381 | Uthman et al. | Apr 2011 | A1 |
| 20110087082 | Giftakis et al. | Apr 2011 | A1 |
| 20110087125 | Causevic | Apr 2011 | A1 |
| 20110092800 | Yoo et al. | Apr 2011 | A1 |
| 20110092834 | Yazicioglu et al. | Apr 2011 | A1 |
| 20110092839 | Alshaer et al. | Apr 2011 | A1 |
| 20110092882 | Firlik et al. | Apr 2011 | A1 |
| 20110096294 | Peyman | Apr 2011 | A1 |
| 20110098583 | Pandia et al. | Apr 2011 | A1 |
| 20110105859 | Popovic et al. | May 2011 | A1 |
| 20110105913 | Giftakis et al. | May 2011 | A1 |
| 20110105915 | Bauer et al. | May 2011 | A1 |
| 20110105938 | Hardt | May 2011 | A1 |
| 20110106206 | Schiff | May 2011 | A1 |
| 20110110868 | Akhtari et al. | May 2011 | A1 |
| 20110112379 | Li et al. | May 2011 | A1 |
| 20110112381 | Sun et al. | May 2011 | A1 |
| 20110112394 | Mishelevich | May 2011 | A1 |
| 20110112426 | Causevic | May 2011 | A1 |
| 20110112427 | Phillips et al. | May 2011 | A1 |
| 20110115624 | Tran | May 2011 | A1 |
| 20110118536 | Phillips et al. | May 2011 | A1 |
| 20110118618 | John et al. | May 2011 | A1 |
| 20110118619 | Burton et al. | May 2011 | A1 |
| 20110119212 | De Bruin et al. | May 2011 | A1 |
| 20110125046 | Burton et al. | May 2011 | A1 |
| 20110125048 | Causevic et al. | May 2011 | A1 |
| 20110125077 | Denison et al. | May 2011 | A1 |
| 20110125078 | Denison et al. | May 2011 | A1 |
| 20110125238 | Nofzinger | May 2011 | A1 |
| 20110129129 | Avinash et al. | Jun 2011 | A1 |
| 20110130643 | Derchak et al. | Jun 2011 | A1 |
| 20110130675 | Bibian et al. | Jun 2011 | A1 |
| 20110137372 | Makous et al. | Jun 2011 | A1 |
| 20110144520 | Causevic et al. | Jun 2011 | A1 |
| 20110144521 | Molnar et al. | Jun 2011 | A1 |
| 20110144522 | Sajda et al. | Jun 2011 | A1 |
| 20110150253 | Corona-Strauss et al. | Jun 2011 | A1 |
| 20110152710 | Kim et al. | Jun 2011 | A1 |
| 20110160543 | Parsey et al. | Jun 2011 | A1 |
| 20110160607 | John et al. | Jun 2011 | A1 |
| 20110160608 | Hargrove | Jun 2011 | A1 |
| 20110160795 | Osorio | Jun 2011 | A1 |
| 20110161011 | Hasson et al. | Jun 2011 | A1 |
| 20110162645 | John et al. | Jul 2011 | A1 |
| 20110162879 | Bunyan et al. | Jul 2011 | A1 |
| 20110166430 | Harris et al. | Jul 2011 | A1 |
| 20110170066 | Sugio et al. | Jul 2011 | A1 |
| 20110170067 | Sato et al. | Jul 2011 | A1 |
| 20110172500 | Van Dooren et al. | Jul 2011 | A1 |
| 20110172509 | Chance | Jul 2011 | A1 |
| 20110172553 | John et al. | Jul 2011 | A1 |
| 20110172725 | Wells et al. | Jul 2011 | A1 |
| 20110178359 | Hirschman et al. | Jul 2011 | A1 |
| 20110178441 | Tyler | Jul 2011 | A1 |
| 20110178442 | Mishelevich | Jul 2011 | A1 |
| 20110178581 | Haber et al. | Jul 2011 | A1 |
| 20110178784 | Sato et al. | Jul 2011 | A1 |
| 20110181422 | Tran | Jul 2011 | A1 |
| 20110182501 | Mercier et al. | Jul 2011 | A1 |
| 20110184305 | Liley | Jul 2011 | A1 |
| 20110184650 | Hymel | Jul 2011 | A1 |
| 20110190600 | McKenna et al. | Aug 2011 | A1 |
| 20110190846 | Ruffini et al. | Aug 2011 | A1 |
| 20110191350 | Zhang et al. | Aug 2011 | A1 |
| 20110196693 | Hargrove et al. | Aug 2011 | A1 |
| 20110207988 | Ruohonen et al. | Aug 2011 | A1 |
| 20110208094 | Mishelevich | Aug 2011 | A1 |
| 20110208539 | Lynn | Aug 2011 | A1 |
| 20110213200 | Mishelevich | Sep 2011 | A1 |
| 20110217240 | Ferris | Sep 2011 | A1 |
| 20110218405 | Avinash et al. | Sep 2011 | A1 |
| 20110218453 | Hirata et al. | Sep 2011 | A1 |
| 20110218456 | Graham et al. | Sep 2011 | A1 |
| 20110218950 | Mirowski et al. | Sep 2011 | A1 |
| 20110224503 | Cusimano Reaston et al. | Sep 2011 | A1 |
| 20110224569 | Isenhart et al. | Sep 2011 | A1 |
| 20110224570 | Causevic | Sep 2011 | A1 |
| 20110224571 | Pascual-Leone et al. | Sep 2011 | A1 |
| 20110224602 | Struijk et al. | Sep 2011 | A1 |
| 20110227813 | Haddick et al. | Sep 2011 | A1 |
| 20110230738 | Chance | Sep 2011 | A1 |
| 20110238685 | Garcia Molina et al. | Sep 2011 | A1 |
| 20110245709 | Greenwald | Oct 2011 | A1 |
| 20110251511 | Desain et al. | Oct 2011 | A1 |
| 20110251583 | Miyazawa et al. | Oct 2011 | A1 |
| 20110251985 | Waxman et al. | Oct 2011 | A1 |
| 20110256520 | Siefert | Oct 2011 | A1 |
| 20110257517 | Guttag et al. | Oct 2011 | A1 |
| 20110257519 | Bj?rnerud et al. | Oct 2011 | A1 |
| 20110263962 | Marks | Oct 2011 | A1 |
| 20110263968 | Quattrocki-Knight et al. | Oct 2011 | A1 |
| 20110263995 | Chen | Oct 2011 | A1 |
| 20110270074 | deCharms | Nov 2011 | A1 |
| 20110270095 | Bukhman | Nov 2011 | A1 |
| 20110270117 | Warwick et al. | Nov 2011 | A1 |
| 20110270579 | Watson et al. | Nov 2011 | A1 |
| 20110270914 | Jung et al. | Nov 2011 | A1 |
| 20110275927 | Wagner et al. | Nov 2011 | A1 |
| 20110282230 | Liley | Nov 2011 | A9 |
| 20110282234 | Ochs | Nov 2011 | A1 |
| 20110288400 | Russell et al. | Nov 2011 | A1 |
| 20110288424 | Kanai et al. | Nov 2011 | A1 |
| 20110288431 | Alshaer et al. | Nov 2011 | A1 |
| 20110289030 | Lu et al. | Nov 2011 | A1 |
| 20110295086 | Nakada et al. | Dec 2011 | A1 |
| 20110295142 | Chakravarthy et al. | Dec 2011 | A1 |
| 20110295143 | Leuthardt et al. | Dec 2011 | A1 |
| 20110295166 | Dalton | Dec 2011 | A1 |
| 20110295338 | Rickert et al. | Dec 2011 | A1 |
| 20110298702 | Sakata et al. | Dec 2011 | A1 |
| 20110298706 | Mann | Dec 2011 | A1 |
| 20110301436 | Teixeira | Dec 2011 | A1 |
| 20110301439 | Albert et al. | Dec 2011 | A1 |
| 20110301441 | Bandic et al. | Dec 2011 | A1 |
| 20110301448 | deCharms | Dec 2011 | A1 |
| 20110301486 | Van Hek et al. | Dec 2011 | A1 |
| 20110301487 | Abeyratne et al. | Dec 2011 | A1 |
| 20110301488 | Schuette et al. | Dec 2011 | A1 |
| 20110306845 | Osorio | Dec 2011 | A1 |
| 20110306846 | Osorio | Dec 2011 | A1 |
| 20110307029 | Hargrove | Dec 2011 | A1 |
| 20110307030 | John | Dec 2011 | A1 |
| 20110307079 | Oweiss et al. | Dec 2011 | A1 |
| 20110310238 | Koh et al. | Dec 2011 | A1 |
| 20110313268 | Kokones et al. | Dec 2011 | A1 |
| 20110313274 | Subbarao | Dec 2011 | A1 |
| 20110313308 | Zavoronkovs et al. | Dec 2011 | A1 |
| 20110313487 | Kokones et al. | Dec 2011 | A1 |
| 20110313760 | Ricci et al. | Dec 2011 | A1 |
| 20110319056 | Toy et al. | Dec 2011 | A1 |
| 20110319482 | Blower et al. | Dec 2011 | A1 |
| 20110319724 | Cox | Dec 2011 | A1 |
| 20110319785 | Snyder et al. | Dec 2011 | A1 |
| 20120003615 | Ochs | Jan 2012 | A1 |
| 20120004518 | D'Souza et al. | Jan 2012 | A1 |
| 20120004561 | John | Jan 2012 | A1 |
| 20120004564 | Daniel | Jan 2012 | A1 |
| 20120004579 | Luo et al. | Jan 2012 | A1 |
| 20120004749 | Abeyratne et al. | Jan 2012 | A1 |
| 20120010536 | Bolger et al. | Jan 2012 | A1 |
| 20120016218 | Lau et al. | Jan 2012 | A1 |
| 20120016252 | Melker et al. | Jan 2012 | A1 |
| 20120021394 | deCharms | Jan 2012 | A1 |
| 20120022336 | Teixeira | Jan 2012 | A1 |
| 20120022343 | Shastri et al. | Jan 2012 | A1 |
| 20120022350 | Teixeira | Jan 2012 | A1 |
| 20120022351 | Starr | Jan 2012 | A1 |
| 20120022365 | Mansfield | Jan 2012 | A1 |
| 20120022384 | Teixeira | Jan 2012 | A1 |
| 20120022392 | Leuthardt et al. | Jan 2012 | A1 |
| 20120022844 | Teixeira | Jan 2012 | A1 |
| 20120022884 | Chillemi | Jan 2012 | A1 |
| 20120023243 | Xu | Jan 2012 | A1 |
| 20120029320 | Watson et al. | Feb 2012 | A1 |
| 20120029378 | Low | Feb 2012 | A1 |
| 20120029379 | Sivadas | Feb 2012 | A1 |
| 20120035431 | Sun et al. | Feb 2012 | A1 |
| 20120035433 | Chance | Feb 2012 | A1 |
| 20120035765 | Sato et al. | Feb 2012 | A1 |
| 20120036004 | Pradeep et al. | Feb 2012 | A1 |
| 20120041279 | Freeman et al. | Feb 2012 | A1 |
| 20120041330 | Prichep et al. | Feb 2012 | A1 |
| 20120046531 | Hua | Feb 2012 | A1 |
| 20120046535 | Lin et al. | Feb 2012 | A1 |
| 20120046569 | Johnstone et al. | Feb 2012 | A1 |
| 20120046711 | Osorio | Feb 2012 | A1 |
| 20120046971 | Walker et al. | Feb 2012 | A1 |
| 20120052905 | Lim et al. | Mar 2012 | A1 |
| 20120053394 | Honeycutt | Mar 2012 | A1 |
| 20120053433 | Chamoun et al. | Mar 2012 | A1 |
| 20120053449 | Moses et al. | Mar 2012 | A1 |
| 20120053473 | Johnson et al. | Mar 2012 | A1 |
| 20120053476 | Hopenfeld | Mar 2012 | A1 |
| 20120053478 | Johnson et al. | Mar 2012 | A1 |
| 20120053479 | Hopenfeld | Mar 2012 | A1 |
| 20120053483 | Doidge et al. | Mar 2012 | A1 |
| 20120053491 | Nathan et al. | Mar 2012 | A1 |
| 20120053508 | Wu et al. | Mar 2012 | A1 |
| 20120059273 | Meggiolaro et al. | Mar 2012 | A1 |
| 20120065536 | Causevic et al. | Mar 2012 | A1 |
| 20120066393 | Tekwani | Mar 2012 | A1 |
| 20120071771 | Behar | Mar 2012 | A1 |
| 20120075168 | Osterhout et al. | Mar 2012 | A1 |
| 20120078115 | Lonky | Mar 2012 | A1 |
| 20120078327 | Sloan et al. | Mar 2012 | A1 |
| 20120078820 | Azam | Mar 2012 | A1 |
| 20120081666 | Kiderman et al. | Apr 2012 | A1 |
| 20120083700 | Osorio | Apr 2012 | A1 |
| 20120083701 | Osorio | Apr 2012 | A1 |
| 20120083708 | Rajdev et al. | Apr 2012 | A1 |
| 20120084480 | Reeves et al. | Apr 2012 | A1 |
| 20120084481 | Reeves et al. | Apr 2012 | A1 |
| 20120084542 | Reeves et al. | Apr 2012 | A1 |
| 20120084791 | Benedek et al. | Apr 2012 | A1 |
| 20120084792 | Benedek et al. | Apr 2012 | A1 |
| 20120088987 | Braun et al. | Apr 2012 | A1 |
| 20120088992 | Armitstead | Apr 2012 | A1 |
| 20120089004 | Hsu et al. | Apr 2012 | A1 |
| 20120089906 | Reeves et al. | Apr 2012 | A1 |
| 20120092156 | Tran | Apr 2012 | A1 |
| 20120092157 | Tran | Apr 2012 | A1 |
| 20120095352 | Tran | Apr 2012 | A1 |
| 20120095357 | Tran | Apr 2012 | A1 |
| 20120100514 | Desain et al. | Apr 2012 | A1 |
| 20120101387 | Ji et al. | Apr 2012 | A1 |
| 20120101401 | Faul et al. | Apr 2012 | A1 |
| 20120101402 | Nguyen | Apr 2012 | A1 |
| 20120101430 | Robertson et al. | Apr 2012 | A1 |
| 20120108909 | Slobounov et al. | May 2012 | A1 |
| 20120108918 | Jarvik et al. | May 2012 | A1 |
| 20120108995 | Pradeep et al. | May 2012 | A1 |
| 20120108997 | Guan et al. | May 2012 | A1 |
| 20120108998 | Molnar et al. | May 2012 | A1 |
| 20120108999 | Leininger et al. | May 2012 | A1 |
| 20120112909 | Baughman et al. | May 2012 | A1 |
| 20120116235 | Trumble et al. | May 2012 | A1 |
| 20120116559 | Davis et al. | May 2012 | A1 |
| 20120123232 | Najarian et al. | May 2012 | A1 |
| 20120123290 | Kidmose et al. | May 2012 | A1 |
| 20120125337 | Asanoi | May 2012 | A1 |
| 20120127426 | Backus et al. | May 2012 | A1 |
| 20120130204 | Basta et al. | May 2012 | A1 |
| 20120130228 | Zellers et al. | May 2012 | A1 |
| 20120130229 | Zellers et al. | May 2012 | A1 |
| 20120134548 | Rhoads et al. | May 2012 | A1 |
| 20120136242 | Qi et al. | May 2012 | A1 |
| 20120136274 | Burdea et al. | May 2012 | A1 |
| 20120136605 | Addison et al. | May 2012 | A1 |
| 20120143038 | Georgopoulos | Jun 2012 | A1 |
| 20120143074 | Shin et al. | Jun 2012 | A1 |
| 20120143075 | Tansey | Jun 2012 | A1 |
| 20120143104 | Tee et al. | Jun 2012 | A1 |
| 20120145152 | Lain et al. | Jun 2012 | A1 |
| 20120149042 | Jackowski et al. | Jun 2012 | A1 |
| 20120149997 | Diab et al. | Jun 2012 | A1 |
| 20120150262 | Gliner et al. | Jun 2012 | A1 |
| 20120150545 | Simon | Jun 2012 | A1 |
| 20120154633 | Rodriguez | Jun 2012 | A1 |
| 20120157804 | Rogers et al. | Jun 2012 | A1 |
| 20120157963 | Imran | Jun 2012 | A1 |
| 20120159656 | Gerber et al. | Jun 2012 | A1 |
| 20120163689 | Bottger et al. | Jun 2012 | A1 |
| 20120165624 | Diab et al. | Jun 2012 | A1 |
| 20120165631 | Diab et al. | Jun 2012 | A1 |
| 20120165899 | Gliner | Jun 2012 | A1 |
| 20120165904 | Lee et al. | Jun 2012 | A1 |
| 20120172682 | Linderman et al. | Jul 2012 | A1 |
| 20120172689 | Albert et al. | Jul 2012 | A1 |
| 20120172743 | Aguilar et al. | Jul 2012 | A1 |
| 20120176302 | Mangoubi et al. | Jul 2012 | A1 |
| 20120177233 | Kidmose et al. | Jul 2012 | A1 |
| 20120184826 | Keenan et al. | Jul 2012 | A1 |
| 20120190959 | Hayakawa et al. | Jul 2012 | A1 |
| 20120191000 | Adachi et al. | Jul 2012 | A1 |
| 20120191542 | Nurmi | Jul 2012 | A1 |
| 20120194781 | Agurok | Aug 2012 | A1 |
| 20120197092 | Luo et al. | Aug 2012 | A1 |
| 20120197153 | Kraus et al. | Aug 2012 | A1 |
| 20120197163 | Mishelevich | Aug 2012 | A1 |
| 20120200601 | Osterhout et al. | Aug 2012 | A1 |
| 20120203079 | McLaughlin | Aug 2012 | A1 |
| 20120203087 | McKenna et al. | Aug 2012 | A1 |
| 20120203130 | Bernhard | Aug 2012 | A1 |
| 20120203131 | DiLorenzo | Aug 2012 | A1 |
| 20120203133 | Jadidi | Aug 2012 | A1 |
| 20120203725 | Stoica | Aug 2012 | A1 |
| 20120209126 | Amos et al. | Aug 2012 | A1 |
| 20120209136 | Ma | Aug 2012 | A1 |
| 20120209139 | John | Aug 2012 | A1 |
| 20120210233 | Davis et al. | Aug 2012 | A1 |
| 20120212398 | Border et al. | Aug 2012 | A1 |
| 20120212399 | Border et al. | Aug 2012 | A1 |
| 20120212400 | Border et al. | Aug 2012 | A1 |
| 20120215114 | Gratton et al. | Aug 2012 | A1 |
| 20120219195 | Wu et al. | Aug 2012 | A1 |
| 20120219507 | Santosh et al. | Aug 2012 | A1 |
| 20120220843 | Diab et al. | Aug 2012 | A1 |
| 20120220889 | Sullivan et al. | Aug 2012 | A1 |
| 20120221075 | Bentwich | Aug 2012 | A1 |
| 20120221310 | Sarrafzadeh et al. | Aug 2012 | A1 |
| 20120226091 | Mishelevich | Sep 2012 | A1 |
| 20120226185 | Chung et al. | Sep 2012 | A1 |
| 20120226334 | Gardiner et al. | Sep 2012 | A1 |
| 20120229248 | Parshionikar et al. | Sep 2012 | A1 |
| 20120232327 | Lozano et al. | Sep 2012 | A1 |
| 20120232376 | Crevecoeur et al. | Sep 2012 | A1 |
| 20120232433 | Mishelevich | Sep 2012 | A1 |
| 20120235887 | Border et al. | Sep 2012 | A1 |
| 20120236030 | Border et al. | Sep 2012 | A1 |
| 20120238890 | Baker et al. | Sep 2012 | A1 |
| 20120242501 | Tran et al. | Sep 2012 | A1 |
| 20120245437 | Lovett et al. | Sep 2012 | A1 |
| 20120245450 | Lee et al. | Sep 2012 | A1 |
| 20120245464 | Tran | Sep 2012 | A1 |
| 20120245474 | Ofek et al. | Sep 2012 | A1 |
| 20120245481 | Blanco et al. | Sep 2012 | A1 |
| 20120245493 | Mishelevich | Sep 2012 | A1 |
| 20120249274 | Toda et al. | Oct 2012 | A1 |
| 20120250197 | Sullivan | Oct 2012 | A1 |
| 20120253141 | Addison et al. | Oct 2012 | A1 |
| 20120253168 | Hu et al. | Oct 2012 | A1 |
| 20120253219 | Suffin et al. | Oct 2012 | A1 |
| 20120253249 | Wilson | Oct 2012 | A1 |
| 20120253261 | Poletto et al. | Oct 2012 | A1 |
| 20120253434 | Nissila et al. | Oct 2012 | A1 |
| 20120256833 | Chiang | Oct 2012 | A1 |
| 20120262558 | Boger et al. | Oct 2012 | A1 |
| 20120265080 | Yu et al. | Oct 2012 | A1 |
| 20120265267 | Blum et al. | Oct 2012 | A1 |
| 20120265271 | Goetz | Oct 2012 | A1 |
| 20120271148 | Nelson | Oct 2012 | A1 |
| 20120271151 | Voilette et al. | Oct 2012 | A1 |
| 20120271190 | Mortensen et al. | Oct 2012 | A1 |
| 20120271376 | Kokones et al. | Oct 2012 | A1 |
| 20120271377 | Hagedorn et al. | Oct 2012 | A1 |
| 20120277545 | Teixeira | Nov 2012 | A1 |
| 20120277548 | Burton | Nov 2012 | A1 |
| 20120277618 | Giftakis et al. | Nov 2012 | A1 |
| 20120277816 | Zhang et al. | Nov 2012 | A1 |
| 20120283502 | Mishelevich et al. | Nov 2012 | A1 |
| 20120283604 | Mishelevich | Nov 2012 | A1 |
| 20120284012 | Rodriguez et al. | Nov 2012 | A1 |
| 20120289854 | Yamada et al. | Nov 2012 | A1 |
| 20120289869 | Tyler | Nov 2012 | A1 |
| 20120295589 | Alexander et al. | Nov 2012 | A1 |
| 20120296182 | Hornero Sánchez et al. | Nov 2012 | A1 |
| 20120296241 | Mishelevich | Nov 2012 | A1 |
| 20120296253 | Mathews et al. | Nov 2012 | A1 |
| 20120296476 | Cale et al. | Nov 2012 | A1 |
| 20120296569 | Shahaf et al. | Nov 2012 | A1 |
| 20120300972 | Rodriguez | Nov 2012 | A1 |
| 20120302842 | Kurtz et al. | Nov 2012 | A1 |
| 20120302845 | Lynn et al. | Nov 2012 | A1 |
| 20120302856 | Chang et al. | Nov 2012 | A1 |
| 20120302867 | Ichimura | Nov 2012 | A1 |
| 20120302894 | Diab et al. | Nov 2012 | A1 |
| 20120303548 | Johnson et al. | Nov 2012 | A1 |
| 20120310100 | Galen et al. | Dec 2012 | A1 |
| 20120310105 | Feingold et al. | Dec 2012 | A1 |
| 20120310106 | Cavuoto | Dec 2012 | A1 |
| 20120310107 | Doidge et al. | Dec 2012 | A1 |
| 20120310298 | Besio et al. | Dec 2012 | A1 |
| 20120316793 | Jung et al. | Dec 2012 | A1 |
| 20120321759 | Marinkovich et al. | Dec 2012 | A1 |
| 20120323132 | Warner et al. | Dec 2012 | A1 |
| 20120323229 | Zenzie et al. | Dec 2012 | A1 |
| 20120330109 | Tran | Dec 2012 | A1 |
| 20120330178 | Kraft et al. | Dec 2012 | A1 |
| 20120330869 | Durham | Dec 2012 | A1 |
| 20130006124 | Eyal et al. | Jan 2013 | A1 |
| 20130009783 | Tran | Jan 2013 | A1 |
| 20130011819 | Horseman | Jan 2013 | A1 |
| 20130012786 | Horseman | Jan 2013 | A1 |
| 20130012787 | Horseman | Jan 2013 | A1 |
| 20130012788 | Horseman | Jan 2013 | A1 |
| 20130012789 | Horseman | Jan 2013 | A1 |
| 20130012790 | Horseman | Jan 2013 | A1 |
| 20130012802 | Horseman | Jan 2013 | A1 |
| 20130012804 | deCharms | Jan 2013 | A1 |
| 20130012830 | Leininger et al. | Jan 2013 | A1 |
| 20130013327 | Horseman | Jan 2013 | A1 |
| 20130013667 | Serena | Jan 2013 | A1 |
| 20130023783 | Snyder et al. | Jan 2013 | A1 |
| 20130023951 | Greenspan | Jan 2013 | A1 |
| 20130030241 | Smith | Jan 2013 | A1 |
| 20130030257 | Nakata et al. | Jan 2013 | A1 |
| 20130033677 | MacDougall et al. | Feb 2013 | A1 |
| 20130035578 | Chiu et al. | Feb 2013 | A1 |
| 20130035579 | Le et al. | Feb 2013 | A1 |
| 20130035734 | Soler Fernandez et al. | Feb 2013 | A1 |
| 20130039498 | Adachi et al. | Feb 2013 | A1 |
| 20130039509 | Chuang et al. | Feb 2013 | A1 |
| 20130041235 | Rogers et al. | Feb 2013 | A1 |
| 20130041243 | Byrd et al. | Feb 2013 | A1 |
| 20130041281 | Park et al. | Feb 2013 | A1 |
| 20130044055 | Karmarkar et al. | Feb 2013 | A1 |
| 20130046151 | Bsoul et al. | Feb 2013 | A1 |
| 20130046193 | Guttag et al. | Feb 2013 | A1 |
| 20130046206 | Preminger | Feb 2013 | A1 |
| 20130046715 | Castermans et al. | Feb 2013 | A1 |
| 20130060110 | Lynn et al. | Mar 2013 | A1 |
| 20130060125 | Zeman et al. | Mar 2013 | A1 |
| 20130060158 | Perez-Velazquez et al. | Mar 2013 | A1 |
| 20130063434 | Miga et al. | Mar 2013 | A1 |
| 20130063550 | Ritchey et al. | Mar 2013 | A1 |
| 20130066183 | Jin et al. | Mar 2013 | A1 |
| 20130066184 | Nguyen et al. | Mar 2013 | A1 |
| 20130066350 | Mishelevich | Mar 2013 | A1 |
| 20130066391 | Hulvershorn et al. | Mar 2013 | A1 |
| 20130066392 | Simon et al. | Mar 2013 | A1 |
| 20130066394 | Saab | Mar 2013 | A1 |
| 20130066395 | Simon et al. | Mar 2013 | A1 |
| 20130069780 | Tran et al. | Mar 2013 | A1 |
| 20130070929 | Adachi et al. | Mar 2013 | A1 |
| 20130072292 | Sutton et al. | Mar 2013 | A1 |
| 20130072775 | Rogers et al. | Mar 2013 | A1 |
| 20130072780 | Espy et al. | Mar 2013 | A1 |
| 20130072807 | Tran | Mar 2013 | A1 |
| 20130076885 | Kobetski et al. | Mar 2013 | A1 |
| 20130079606 | McGonigle et al. | Mar 2013 | A1 |
| 20130079621 | Shoham et al. | Mar 2013 | A1 |
| 20130079647 | McGonigle et al. | Mar 2013 | A1 |
| 20130079656 | Dripps et al. | Mar 2013 | A1 |
| 20130079657 | Ochs et al. | Mar 2013 | A1 |
| 20130080127 | Shahaf et al. | Mar 2013 | A1 |
| 20130080489 | Ochs et al. | Mar 2013 | A1 |
| 20130085678 | Jung et al. | Apr 2013 | A1 |
| 20130094702 | Rodriguez | Apr 2013 | A1 |
| 20130095459 | Tran | Apr 2013 | A1 |
| 20130096391 | Osorio et al. | Apr 2013 | A1 |
| 20130096393 | Osorio et al. | Apr 2013 | A1 |
| 20130096394 | Gupta et al. | Apr 2013 | A1 |
| 20130096408 | He et al. | Apr 2013 | A1 |
| 20130096440 | Kiraly | Apr 2013 | A1 |
| 20130096441 | Osorio | Apr 2013 | A1 |
| 20130096453 | Chung et al. | Apr 2013 | A1 |
| 20130096454 | Jang et al. | Apr 2013 | A1 |
| 20130096575 | Olson | Apr 2013 | A1 |
| 20130096839 | Osorio et al. | Apr 2013 | A1 |
| 20130096840 | Osorio et al. | Apr 2013 | A1 |
| 20130097630 | Rodriguez | Apr 2013 | A1 |
| 20130102833 | John et al. | Apr 2013 | A1 |
| 20130102897 | Kalafut et al. | Apr 2013 | A1 |
| 20130109995 | Rothman et al. | May 2013 | A1 |
| 20130109996 | Turnbull et al. | May 2013 | A1 |
| 20130110616 | Bakalash et al. | May 2013 | A1 |
| 20130113816 | Sudarsky et al. | May 2013 | A1 |
| 20130116520 | Roham et al. | May 2013 | A1 |
| 20130116561 | Rothberg et al. | May 2013 | A1 |
| 20130116588 | Yazicioglu et al. | May 2013 | A1 |
| 20130118494 | Ujhazy et al. | May 2013 | A1 |
| 20130120246 | Schuette et al. | May 2013 | A1 |
| 20130123584 | Sun et al. | May 2013 | A1 |
| 20130123607 | Leuthardt et al. | May 2013 | A1 |
| 20130127708 | Jung et al. | May 2013 | A1 |
| 20130127980 | Haddick et al. | May 2013 | A1 |
| 20130130799 | Van Hulle et al. | May 2013 | A1 |
| 20130131438 | Brewer et al. | May 2013 | A1 |
| 20130131461 | Jorge et al. | May 2013 | A1 |
| 20130131537 | Tam | May 2013 | A1 |
| 20130131755 | Panken et al. | May 2013 | A1 |
| 20130137642 | Vavvas et al. | May 2013 | A1 |
| 20130137936 | Baker, Jr. et al. | May 2013 | A1 |
| 20130137938 | Peters | May 2013 | A1 |
| 20130138002 | Weng et al. | May 2013 | A1 |
| 20130138011 | Ang et al. | May 2013 | A1 |
| 20130138177 | DeRidder | May 2013 | A1 |
| 20130144106 | Phillips et al. | Jun 2013 | A1 |
| 20130144107 | Phillips et al. | Jun 2013 | A1 |
| 20130144108 | Phillips et al. | Jun 2013 | A1 |
| 20130144183 | John et al. | Jun 2013 | A1 |
| 20130150121 | Jeffery et al. | Jun 2013 | A1 |
| 20130150650 | Phillips et al. | Jun 2013 | A1 |
| 20130150651 | Phillips et al. | Jun 2013 | A1 |
| 20130150659 | Shaw et al. | Jun 2013 | A1 |
| 20130150702 | Hokari | Jun 2013 | A1 |
| 20130159041 | Jayaraman et al. | Jun 2013 | A1 |
| 20130165766 | Nishikawa et al. | Jun 2013 | A1 |
| 20130165804 | Johnson et al. | Jun 2013 | A1 |
| 20130165812 | Aksenova et al. | Jun 2013 | A1 |
| 20130167159 | Ricci et al. | Jun 2013 | A1 |
| 20130167360 | Masmanidis et al. | Jul 2013 | A1 |
| 20130172663 | Leonard | Jul 2013 | A1 |
| 20130172686 | Addison et al. | Jul 2013 | A1 |
| 20130172691 | Tran | Jul 2013 | A1 |
| 20130172716 | Lozano et al. | Jul 2013 | A1 |
| 20130172763 | Wheeler | Jul 2013 | A1 |
| 20130172767 | Dripps et al. | Jul 2013 | A1 |
| 20130172772 | Alshaer et al. | Jul 2013 | A1 |
| 20130172774 | Crowder et al. | Jul 2013 | A1 |
| 20130174047 | Sivakumar et al. | Jul 2013 | A1 |
| 20130177883 | Barnehama et al. | Jul 2013 | A1 |
| 20130178693 | Neuvonen et al. | Jul 2013 | A1 |
| 20130178718 | Tran et al. | Jul 2013 | A1 |
| 20130178733 | Langleben | Jul 2013 | A1 |
| 20130179087 | Garripoli | Jul 2013 | A1 |
| 20130182860 | Adachi et al. | Jul 2013 | A1 |
| 20130184516 | Genereux et al. | Jul 2013 | A1 |
| 20130184552 | Westermann et al. | Jul 2013 | A1 |
| 20130184558 | Gallant et al. | Jul 2013 | A1 |
| 20130184597 | Hopenfeld | Jul 2013 | A1 |
| 20130184603 | Rothman | Jul 2013 | A1 |
| 20130184728 | Mishelevich | Jul 2013 | A1 |
| 20130184786 | Goetz | Jul 2013 | A1 |
| 20130185144 | Pradeep et al. | Jul 2013 | A1 |
| 20130188854 | Bilgic et al. | Jul 2013 | A1 |
| 20130189663 | Tuchschmid et al. | Jul 2013 | A1 |
| 20130190577 | Brunner et al. | Jul 2013 | A1 |
| 20130190642 | Muesch et al. | Jul 2013 | A1 |
| 20130197321 | Wilson | Aug 2013 | A1 |
| 20130197322 | Tran | Aug 2013 | A1 |
| 20130197328 | Diab et al. | Aug 2013 | A1 |
| 20130197339 | Bardakjian et al. | Aug 2013 | A1 |
| 20130197401 | Sato et al. | Aug 2013 | A1 |
| 20130203019 | Nolen | Aug 2013 | A1 |
| 20130204085 | Alexander et al. | Aug 2013 | A1 |
| 20130204122 | Hendler et al. | Aug 2013 | A1 |
| 20130204150 | Similowski et al. | Aug 2013 | A1 |
| 20130208234 | Lewis | Aug 2013 | A1 |
| 20130211224 | Isenhart et al. | Aug 2013 | A1 |
| 20130211226 | Lee et al. | Aug 2013 | A1 |
| 20130211238 | DeCharms | Aug 2013 | A1 |
| 20130211276 | Luo et al. | Aug 2013 | A1 |
| 20130211291 | Tran | Aug 2013 | A1 |
| 20130217982 | Behzadi | Aug 2013 | A1 |
| 20130218043 | Yoshida | Aug 2013 | A1 |
| 20130218053 | Kaiser et al. | Aug 2013 | A1 |
| 20130218233 | Warschewske et al. | Aug 2013 | A1 |
| 20130221961 | Liu | Aug 2013 | A1 |
| 20130223709 | Wagner | Aug 2013 | A1 |
| 20130225940 | Fujita et al. | Aug 2013 | A1 |
| 20130225992 | Osorio | Aug 2013 | A1 |
| 20130226261 | Sparks et al. | Aug 2013 | A1 |
| 20130226464 | Marci et al. | Aug 2013 | A1 |
| 20130231574 | Tran | Sep 2013 | A1 |
| 20130231580 | Chen et al. | Sep 2013 | A1 |
| 20130231947 | Shusterman | Sep 2013 | A1 |
| 20130234823 | Kahn et al. | Sep 2013 | A1 |
| 20130237867 | Alexander et al. | Sep 2013 | A1 |
| 20130237874 | Zoicas | Sep 2013 | A1 |
| 20130238049 | Simon et al. | Sep 2013 | A1 |
| 20130238050 | Simon et al. | Sep 2013 | A1 |
| 20130238063 | Nofzinger | Sep 2013 | A1 |
| 20130242262 | Lewis | Sep 2013 | A1 |
| 20130245416 | Yarmush et al. | Sep 2013 | A1 |
| 20130245422 | D'arcy et al. | Sep 2013 | A1 |
| 20130245424 | deCharms | Sep 2013 | A1 |
| 20130245485 | Mashour et al. | Sep 2013 | A1 |
| 20130245486 | Simon et al. | Sep 2013 | A1 |
| 20130245711 | Simon et al. | Sep 2013 | A1 |
| 20130245712 | Simon et al. | Sep 2013 | A1 |
| 20130251641 | Akhtari et al. | Sep 2013 | A1 |
| 20130255586 | Gerashchenko | Oct 2013 | A1 |
| 20130259297 | Knudson | Oct 2013 | A1 |
| 20130260361 | Mutlu et al. | Oct 2013 | A1 |
| 20130260727 | Knudson et al. | Oct 2013 | A1 |
| 20130261490 | Truccolo et al. | Oct 2013 | A1 |
| 20130261506 | Mishelevich | Oct 2013 | A1 |
| 20130266163 | Morikawa et al. | Oct 2013 | A1 |
| 20130267760 | Jin | Oct 2013 | A1 |
| 20130267866 | Nakashima et al. | Oct 2013 | A1 |
| 20130267928 | Imran et al. | Oct 2013 | A1 |
| 20130274562 | Ghaffari et al. | Oct 2013 | A1 |
| 20130274580 | Madsen et al. | Oct 2013 | A1 |
| 20130274586 | Miyazaki et al. | Oct 2013 | A1 |
| 20130274625 | Sarma et al. | Oct 2013 | A1 |
| 20130275159 | Seely | Oct 2013 | A1 |
| 20130278492 | Stolarz et al. | Oct 2013 | A1 |
| 20130278631 | Border et al. | Oct 2013 | A1 |
| 20130279726 | Baughman et al. | Oct 2013 | A1 |
| 20130281759 | Hagedorn et al. | Oct 2013 | A1 |
| 20130281811 | Imran | Oct 2013 | A1 |
| 20130281879 | Raniere | Oct 2013 | A1 |
| 20130281890 | Mishelevich | Oct 2013 | A1 |
| 20130282339 | Ricci et al. | Oct 2013 | A1 |
| 20130289360 | Hyde et al. | Oct 2013 | A1 |
| 20130289364 | Colman et al. | Oct 2013 | A1 |
| 20130289385 | Lozano et al. | Oct 2013 | A1 |
| 20130289386 | Deisseroth et al. | Oct 2013 | A1 |
| 20130289401 | Colbaugh et al. | Oct 2013 | A1 |
| 20130289413 | Ochs et al. | Oct 2013 | A1 |
| 20130289417 | Grunwald et al. | Oct 2013 | A1 |
| 20130289424 | Brockway et al. | Oct 2013 | A1 |
| 20130289433 | Jin et al. | Oct 2013 | A1 |
| 20130293844 | Gross et al. | Nov 2013 | A1 |
| 20130295016 | Gerber et al. | Nov 2013 | A1 |
| 20130295898 | Kader | Nov 2013 | A1 |
| 20130300573 | Brown et al. | Nov 2013 | A1 |
| 20130303828 | Hargrove | Nov 2013 | A1 |
| 20130303934 | Collura | Nov 2013 | A1 |
| 20130304153 | Hargrove et al. | Nov 2013 | A1 |
| 20130304472 | Pakhomov | Nov 2013 | A1 |
| 20130308099 | Stack | Nov 2013 | A1 |
| 20130310422 | Brown et al. | Nov 2013 | A1 |
| 20130310660 | Zuckerman-Stark et al. | Nov 2013 | A1 |
| 20130310909 | Simon et al. | Nov 2013 | A1 |
| 20130311329 | Knudson et al. | Nov 2013 | A1 |
| 20130317380 | Liley et al. | Nov 2013 | A1 |
| 20130318546 | Kothuri et al. | Nov 2013 | A1 |
| 20130324880 | Adachi et al. | Dec 2013 | A1 |
| 20130325567 | Bradley et al. | Dec 2013 | A1 |
| 20130326333 | Hashmi | Dec 2013 | A1 |
| 20130338449 | Warwick et al. | Dec 2013 | A1 |
| 20130338459 | Lynn et al. | Dec 2013 | A1 |
| 20130338518 | Zoica | Dec 2013 | A1 |
| 20130338738 | Garcia Molina et al. | Dec 2013 | A1 |
| 20130338803 | Maoz et al. | Dec 2013 | A1 |
| 20130340775 | Juster et al. | Dec 2013 | A1 |
| 20130343584 | Bennett et al. | Dec 2013 | A1 |
| 20130343585 | Bennett et al. | Dec 2013 | A1 |
| 20130344465 | Dickinson et al. | Dec 2013 | A1 |
| 20130345522 | Sun et al. | Dec 2013 | A1 |
| 20130345523 | Diab et al. | Dec 2013 | A1 |
| 20130345524 | Meyer et al. | Dec 2013 | A1 |
| 20140000630 | Ford | Jan 2014 | A1 |
| 20140005518 | Ko et al. | Jan 2014 | A1 |
| 20140005988 | Brockway | Jan 2014 | A1 |
| 20140012061 | Song et al. | Jan 2014 | A1 |
| 20140012110 | Watson et al. | Jan 2014 | A1 |
| 20140012111 | Snyder et al. | Jan 2014 | A1 |
| 20140012133 | Sverdlik et al. | Jan 2014 | A1 |
| 20140012152 | Gentry et al. | Jan 2014 | A1 |
| 20140012153 | Greenwald | Jan 2014 | A1 |
| 20140018694 | Ang et al. | Jan 2014 | A1 |
| 20140018792 | Gang et al. | Jan 2014 | A1 |
| 20140019165 | Horseman | Jan 2014 | A1 |
| 20140020089 | Peter | Jan 2014 | A1 |
| 20140023999 | Greder | Jan 2014 | A1 |
| 20140024598 | Vavvas et al. | Jan 2014 | A1 |
| 20140025396 | Horseman | Jan 2014 | A1 |
| 20140025397 | Horseman | Jan 2014 | A1 |
| 20140031703 | Rayner et al. | Jan 2014 | A1 |
| 20140031889 | Mashiach | Jan 2014 | A1 |
| 20140031903 | Mashiach | Jan 2014 | A1 |
| 20140032466 | Kaplan | Jan 2014 | A1 |
| 20140038147 | Morrow | Feb 2014 | A1 |
| 20140039279 | Jarvik et al. | Feb 2014 | A1 |
| 20140039975 | Hill | Feb 2014 | A1 |
| 20140046208 | Sejdic et al. | Feb 2014 | A1 |
| 20140051044 | Badower et al. | Feb 2014 | A1 |
| 20140051960 | Badower et al. | Feb 2014 | A1 |
| 20140051961 | Badower et al. | Feb 2014 | A1 |
| 20140052213 | Osorio | Feb 2014 | A1 |
| 20140055284 | Tran et al. | Feb 2014 | A1 |
| 20140055746 | Nistico et al. | Feb 2014 | A1 |
| 20140057232 | Wetmore et al. | Feb 2014 | A1 |
| 20140058189 | Stubbeman | Feb 2014 | A1 |
| 20140058218 | Randlov et al. | Feb 2014 | A1 |
| 20140058219 | Kiraly | Feb 2014 | A1 |
| 20140058241 | Apparies et al. | Feb 2014 | A1 |
| 20140058292 | Alford et al. | Feb 2014 | A1 |
| 20140058528 | Contreras-Vidal et al. | Feb 2014 | A1 |
| 20140059566 | Benedek et al. | Feb 2014 | A1 |
| 20140062472 | Nishikawa | Mar 2014 | A1 |
| 20140066739 | He et al. | Mar 2014 | A1 |
| 20140066763 | Rothberg et al. | Mar 2014 | A2 |
| 20140067557 | van Niekerk et al. | Mar 2014 | A1 |
| 20140070958 | Foo | Mar 2014 | A1 |
| 20140072127 | Adachi et al. | Mar 2014 | A1 |
| 20140072130 | Adachi et al. | Mar 2014 | A1 |
| 20140073298 | Rossmann | Mar 2014 | A1 |
| 20140073863 | Engelbrecht et al. | Mar 2014 | A1 |
| 20140073864 | Engelbrecht et al. | Mar 2014 | A1 |
| 20140073866 | Engelbrecht et al. | Mar 2014 | A1 |
| 20140073870 | Engelbrecht et al. | Mar 2014 | A1 |
| 20140073875 | Engelbrecht et al. | Mar 2014 | A1 |
| 20140073876 | Rodriguez-Llorente et al. | Mar 2014 | A1 |
| 20140073877 | Wooder | Mar 2014 | A1 |
| 20140073878 | Engelbrecht et al. | Mar 2014 | A1 |
| 20140073898 | Engelbrecht et al. | Mar 2014 | A1 |
| 20140073948 | Engelbrecht et al. | Mar 2014 | A1 |
| 20140073949 | Engelbrecht et al. | Mar 2014 | A1 |
| 20140073951 | Engelbrecht et al. | Mar 2014 | A1 |
| 20140073953 | Engelbrecht et al. | Mar 2014 | A1 |
| 20140073954 | Engelbrecht et al. | Mar 2014 | A1 |
| 20140073955 | Engelbrecht et al. | Mar 2014 | A1 |
| 20140073956 | Engelbrecht et al. | Mar 2014 | A1 |
| 20140073960 | Rodriguez-Llorente et al. | Mar 2014 | A1 |
| 20140073961 | Rodriguez-Llorente et al. | Mar 2014 | A1 |
| 20140073963 | Engelbrecht et al. | Mar 2014 | A1 |
| 20140073965 | Engelbrecht et al. | Mar 2014 | A1 |
| 20140073966 | Engelbrecht et al. | Mar 2014 | A1 |
| 20140073967 | Engelbrecht et al. | Mar 2014 | A1 |
| 20140073968 | Engelbrecht et al. | Mar 2014 | A1 |
| 20140073969 | Zou et al. | Mar 2014 | A1 |
| 20140073974 | Engelbrecht | Mar 2014 | A1 |
| 20140073975 | Engelbrecht et al. | Mar 2014 | A1 |
| 20140074060 | Imran | Mar 2014 | A1 |
| 20140074179 | Heldman et al. | Mar 2014 | A1 |
| 20140074180 | Heldman et al. | Mar 2014 | A1 |
| 20140077612 | Onuma et al. | Mar 2014 | A1 |
| 20140077946 | Tran | Mar 2014 | A1 |
| 20140078049 | Parshionikar | Mar 2014 | A1 |
| 20140081114 | Shachar et al. | Mar 2014 | A1 |
| 20140081115 | Gu | Mar 2014 | A1 |
| 20140081117 | Kato et al. | Mar 2014 | A1 |
| 20140088341 | Altman et al. | Mar 2014 | A1 |
| 20140088377 | Manzke et al. | Mar 2014 | A1 |
| 20140089202 | Bond et al. | Mar 2014 | A1 |
| 20140089462 | Tekwani | Mar 2014 | A1 |
| 20140094710 | Sarma et al. | Apr 2014 | A1 |
| 20140094719 | Mishelevich | Apr 2014 | A1 |
| 20140094720 | Tyler | Apr 2014 | A1 |
| 20140096210 | Dabbiere | Apr 2014 | A1 |
| 20140098981 | Lunner et al. | Apr 2014 | A1 |
| 20140099623 | Amit et al. | Apr 2014 | A1 |
| 20140100467 | Baker et al. | Apr 2014 | A1 |
| 20140101084 | Li et al. | Apr 2014 | A1 |
| 20140104059 | Tran | Apr 2014 | A1 |
| 20140105436 | Adachi et al. | Apr 2014 | A1 |
| 20140106710 | Rodriguez | Apr 2014 | A1 |
| 20140107401 | Anderson et al. | Apr 2014 | A1 |
| 20140107464 | Aksenova et al. | Apr 2014 | A1 |
| 20140107519 | Musha et al. | Apr 2014 | A1 |
| 20140107520 | Hang et al. | Apr 2014 | A1 |
| 20140107521 | Galan | Apr 2014 | A1 |
| 20140107525 | Tass | Apr 2014 | A1 |
| 20140108842 | Frank et al. | Apr 2014 | A1 |
| 20140111335 | Kleiss et al. | Apr 2014 | A1 |
| 20140114165 | Walker et al. | Apr 2014 | A1 |
| 20140114205 | Braun et al. | Apr 2014 | A1 |
| 20140114207 | Patterson | Apr 2014 | A1 |
| 20140114242 | Eckle | Apr 2014 | A1 |
| 20140114889 | Dagum | Apr 2014 | A1 |
| 20140119621 | Uber | May 2014 | A1 |
| 20140121017 | Mandryk et al. | May 2014 | A1 |
| 20140121446 | Phillips et al. | May 2014 | A1 |
| 20140121476 | Tran et al. | May 2014 | A1 |
| 20140121554 | Sarma et al. | May 2014 | A1 |
| 20140121565 | Kim | May 2014 | A1 |
| 20140122255 | Snyder | May 2014 | A1 |
| 20140128762 | Han et al. | May 2014 | A1 |
| 20140128763 | Fadem | May 2014 | A1 |
| 20140128764 | Gandhi | May 2014 | A1 |
| 20140135642 | Ekpar | May 2014 | A1 |
| 20140135873 | An et al. | May 2014 | A1 |
| 20140135879 | Flint | May 2014 | A1 |
| 20140136585 | Brockway | May 2014 | A1 |
| 20140140567 | LeBoeuf et al. | May 2014 | A1 |
| 20140142448 | Bae et al. | May 2014 | A1 |
| 20140142654 | Simon et al. | May 2014 | A1 |
| 20140143064 | Tran | May 2014 | A1 |
| 20140146987 | Pontoppidan et al. | May 2014 | A1 |
| 20140148657 | Hendler et al. | May 2014 | A1 |
| 20140148715 | Alexander et al. | May 2014 | A1 |
| 20140148716 | Hopenfeld et al. | May 2014 | A1 |
| 20140148723 | Nierenberg et al. | May 2014 | A1 |
| 20140148726 | Wagner | May 2014 | A1 |
| 20140151563 | Rousso et al. | Jun 2014 | A1 |
| 20140152673 | Lynn et al. | Jun 2014 | A1 |
| 20140154647 | Nolen | Jun 2014 | A1 |
| 20140155706 | Kochs et al. | Jun 2014 | A1 |
| 20140155714 | Gavish | Jun 2014 | A1 |
| 20140155730 | Bansal et al. | Jun 2014 | A1 |
| 20140155952 | Lozano et al. | Jun 2014 | A1 |
| 20140156000 | Campin et al. | Jun 2014 | A1 |
| 20140159862 | Yang et al. | Jun 2014 | A1 |
| 20140160250 | Pomerantz et al. | Jun 2014 | A1 |
| 20140161412 | Chase et al. | Jun 2014 | A1 |
| 20140163328 | Geva et al. | Jun 2014 | A1 |
| 20140163330 | Horseman | Jun 2014 | A1 |
| 20140163331 | Horseman | Jun 2014 | A1 |
| 20140163332 | Horseman | Jun 2014 | A1 |
| 20140163333 | Horseman | Jun 2014 | A1 |
| 20140163335 | Horseman | Jun 2014 | A1 |
| 20140163336 | Horseman | Jun 2014 | A1 |
| 20140163337 | Horseman | Jun 2014 | A1 |
| 20140163368 | Rousso et al. | Jun 2014 | A1 |
| 20140163385 | Kelleher et al. | Jun 2014 | A1 |
| 20140163409 | Arndt | Jun 2014 | A1 |
| 20140163425 | Tran | Jun 2014 | A1 |
| 20140163897 | Lynn et al. | Jun 2014 | A1 |
| 20140164056 | Johnson et al. | Jun 2014 | A1 |
| 20140171749 | Chin et al. | Jun 2014 | A1 |
| 20140171757 | Kawato et al. | Jun 2014 | A1 |
| 20140171819 | Patterson | Jun 2014 | A1 |
| 20140171820 | Causevic | Jun 2014 | A1 |
| 20140174277 | Mann | Jun 2014 | A1 |
| 20140175261 | Addison et al. | Jun 2014 | A1 |
| 20140176944 | Addison et al. | Jun 2014 | A1 |
| 20140179980 | Phillips et al. | Jun 2014 | A1 |
| 20140179986 | Kelley | Jun 2014 | A1 |
| 20140180088 | Rothberg et al. | Jun 2014 | A1 |
| 20140180092 | Rothberg et al. | Jun 2014 | A1 |
| 20140180093 | Rothberg et al. | Jun 2014 | A1 |
| 20140180094 | Rothberg et al. | Jun 2014 | A1 |
| 20140180095 | Rothberg et al. | Jun 2014 | A1 |
| 20140180096 | Rothberg et al. | Jun 2014 | A1 |
| 20140180097 | Rothberg et al. | Jun 2014 | A1 |
| 20140180099 | Rothberg et al. | Jun 2014 | A1 |
| 20140180100 | Rothberg et al. | Jun 2014 | A1 |
| 20140180112 | Rothberg et al. | Jun 2014 | A1 |
| 20140180113 | Rothberg et al. | Jun 2014 | A1 |
| 20140180145 | Kanai et al. | Jun 2014 | A1 |
| 20140180153 | Zia et al. | Jun 2014 | A1 |
| 20140180160 | Brown et al. | Jun 2014 | A1 |
| 20140180161 | Bolger et al. | Jun 2014 | A1 |
| 20140180176 | Rothberg et al. | Jun 2014 | A1 |
| 20140180177 | Rothberg et al. | Jun 2014 | A1 |
| 20140180597 | Brown et al. | Jun 2014 | A1 |
| 20140184550 | Hennessey et al. | Jul 2014 | A1 |
| 20140187901 | Cui et al. | Jul 2014 | A1 |
| 20140187994 | Thornton | Jul 2014 | A1 |
| 20140188006 | Alshaer et al. | Jul 2014 | A1 |
| 20140188311 | Masson | Jul 2014 | A1 |
| 20140188770 | Agrafioti et al. | Jul 2014 | A1 |
| 20140193336 | Rousso et al. | Jul 2014 | A1 |
| 20140194702 | Tran | Jul 2014 | A1 |
| 20140194726 | Mishelevich et al. | Jul 2014 | A1 |
| 20140194758 | Korenberg | Jul 2014 | A1 |
| 20140194759 | Weiland et al. | Jul 2014 | A1 |
| 20140194768 | Nierenberg et al. | Jul 2014 | A1 |
| 20140194769 | Nierenberg et al. | Jul 2014 | A1 |
| 20140194780 | Alshaer et al. | Jul 2014 | A1 |
| 20140194793 | Nakata et al. | Jul 2014 | A1 |
| 20140195221 | Frank et al. | Jul 2014 | A1 |
| 20140198936 | Higgins et al. | Jul 2014 | A1 |
| 20140200414 | Osorio | Jul 2014 | A1 |
| 20140200432 | Banerji et al. | Jul 2014 | A1 |
| 20140201256 | Pinheiro et al. | Jul 2014 | A1 |
| 20140203797 | Stivoric et al. | Jul 2014 | A1 |
| 20140204025 | Niikawa | Jul 2014 | A1 |
| 20140204029 | Lopez et al. | Jul 2014 | A1 |
| 20140206981 | Nagasaka | Jul 2014 | A1 |
| 20140210709 | Alexander et al. | Jul 2014 | A1 |
| 20140211593 | Tyler et al. | Jul 2014 | A1 |
| 20140213937 | Bianchi et al. | Jul 2014 | A1 |
| 20140214330 | Iyer et al. | Jul 2014 | A1 |
| 20140214335 | Siefert | Jul 2014 | A1 |
| 20140221779 | Schoonover et al. | Aug 2014 | A1 |
| 20140221855 | McCaffrey | Aug 2014 | A1 |
| 20140221866 | Quy | Aug 2014 | A1 |
| 20140222612 | Knudson et al. | Aug 2014 | A1 |
| 20140223462 | Aimone et al. | Aug 2014 | A1 |
| 20140226131 | Lopez et al. | Aug 2014 | A1 |
| 20140228649 | Rayner et al. | Aug 2014 | A1 |
| 20140228651 | Causevic et al. | Aug 2014 | A1 |
| 20140228653 | Kiraly | Aug 2014 | A1 |
| 20140228701 | Chizeck et al. | Aug 2014 | A1 |
| 20140228702 | Shahaf et al. | Aug 2014 | A1 |
| 20140232516 | Stivoric et al. | Aug 2014 | A1 |
| 20140235965 | Tran | Aug 2014 | A1 |
| 20140236039 | Strokova Aksenova et al. | Aug 2014 | A1 |
| 20140236077 | Robertson et al. | Aug 2014 | A1 |
| 20140237073 | Schiff | Aug 2014 | A1 |
| 20140243608 | Hunt | Aug 2014 | A1 |
| 20140243614 | Rothberg et al. | Aug 2014 | A1 |
| 20140243621 | Weng et al. | Aug 2014 | A1 |
| 20140243628 | Ochs et al. | Aug 2014 | A1 |
| 20140243647 | Clark et al. | Aug 2014 | A1 |
| 20140243652 | Pashko | Aug 2014 | A1 |
| 20140243694 | Baker et al. | Aug 2014 | A1 |
| 20140243714 | Ward et al. | Aug 2014 | A1 |
| 20140244514 | Rodriguez et al. | Aug 2014 | A1 |
| 20140245191 | Serena | Aug 2014 | A1 |
| 20140249360 | Jaeger et al. | Sep 2014 | A1 |
| 20140249429 | Tran | Sep 2014 | A1 |
| 20140249445 | Deadwyler et al. | Sep 2014 | A1 |
| 20140249447 | Sereno et al. | Sep 2014 | A1 |
| 20140257047 | Sillay et al. | Sep 2014 | A1 |
| 20140257073 | Machon et al. | Sep 2014 | A1 |
| 20140257128 | Moxon et al. | Sep 2014 | A1 |
| 20140257147 | John et al. | Sep 2014 | A1 |
| 20140257833 | Williams | Sep 2014 | A1 |
| 20140258110 | Davis et al. | Sep 2014 | A1 |
| 20140266696 | Addison et al. | Sep 2014 | A1 |
| 20140266787 | Tran | Sep 2014 | A1 |
| 20140269441 | Hyde et al. | Sep 2014 | A1 |
| 20140269442 | Hyde et al. | Sep 2014 | A1 |
| 20140269443 | Hyde et al. | Sep 2014 | A1 |
| 20140270438 | Declerck et al. | Sep 2014 | A1 |
| 20140271483 | Satchi-Fainaro et al. | Sep 2014 | A1 |
| 20140273924 | Hyde et al. | Sep 2014 | A1 |
| 20140273934 | Hyde et al. | Sep 2014 | A1 |
| 20140273935 | Hyde et al. | Sep 2014 | A1 |
| 20140273937 | Hyde et al. | Sep 2014 | A1 |
| 20140273939 | Hyde et al. | Sep 2014 | A1 |
| 20140273940 | Hyde et al. | Sep 2014 | A1 |
| 20140273947 | Hyde et al. | Sep 2014 | A1 |
| 20140274056 | Hyde et al. | Sep 2014 | A1 |
| 20140274078 | Hyde et al. | Sep 2014 | A1 |
| 20140275741 | Vandenbelt et al. | Sep 2014 | A1 |
| 20140275807 | Redei | Sep 2014 | A1 |
| 20140275851 | Amble et al. | Sep 2014 | A1 |
| 20140275886 | Teixeira | Sep 2014 | A1 |
| 20140275889 | Addison et al. | Sep 2014 | A1 |
| 20140275891 | Muehlemann et al. | Sep 2014 | A1 |
| 20140276013 | Muehlemann et al. | Sep 2014 | A1 |
| 20140276014 | Khanicheh et al. | Sep 2014 | A1 |
| 20140276090 | Breed | Sep 2014 | A1 |
| 20140276123 | Yang | Sep 2014 | A1 |
| 20140276130 | Mirelman et al. | Sep 2014 | A1 |
| 20140276181 | Sun et al. | Sep 2014 | A1 |
| 20140276183 | Badower | Sep 2014 | A1 |
| 20140276187 | Iasemidis et al. | Sep 2014 | A1 |
| 20140276702 | Mckay et al. | Sep 2014 | A1 |
| 20140276944 | Farritor et al. | Sep 2014 | A1 |
| 20140277292 | Steel | Sep 2014 | A1 |
| 20140277582 | Leuthardt et al. | Sep 2014 | A1 |
| 20140278786 | Liu-Qiu-Yan | Sep 2014 | A1 |
| 20140279341 | Bhardwaj et al. | Sep 2014 | A1 |
| 20140279475 | Castrechini et al. | Sep 2014 | A1 |
| 20140279541 | Castrechini et al. | Sep 2014 | A1 |
| 20140279746 | De Bruin et al. | Sep 2014 | A1 |
| 20140282772 | Chen et al. | Sep 2014 | A1 |
| 20140288381 | Faarbaek et al. | Sep 2014 | A1 |
| 20140288614 | Hagedorn et al. | Sep 2014 | A1 |
| 20140288667 | Oxley | Sep 2014 | A1 |
| 20140288953 | Lynn et al. | Sep 2014 | A1 |
| 20140289172 | Rothman et al. | Sep 2014 | A1 |
| 20140296646 | Wingeier et al. | Oct 2014 | A1 |
| 20140296655 | Akhbardeh et al. | Oct 2014 | A1 |
| 20140296724 | Guttag et al. | Oct 2014 | A1 |
| 20140296733 | Omurtag et al. | Oct 2014 | A1 |
| 20140296750 | Einav et al. | Oct 2014 | A1 |
| 20140297397 | Bakalash et al. | Oct 2014 | A1 |
| 20140300532 | Karkkainen et al. | Oct 2014 | A1 |
| 20140303424 | Glass | Oct 2014 | A1 |
| 20140303425 | Pilla et al. | Oct 2014 | A1 |
| 20140303428 | Berka et al. | Oct 2014 | A1 |
| 20140303453 | Seely et al. | Oct 2014 | A1 |
| 20140303454 | Clifton et al. | Oct 2014 | A1 |
| 20140303486 | Baumgartner et al. | Oct 2014 | A1 |
| 20140303508 | Plotnik-Peleg et al. | Oct 2014 | A1 |
| 20140303511 | Sajda et al. | Oct 2014 | A1 |
| 20140304122 | Rhoads et al. | Oct 2014 | A1 |
| 20140304773 | Woods et al. | Oct 2014 | A1 |
| 20140307878 | Osborne et al. | Oct 2014 | A1 |
| 20140309484 | Chang | Oct 2014 | A1 |
| 20140309614 | Frei et al. | Oct 2014 | A1 |
| 20140309943 | Grundlehner et al. | Oct 2014 | A1 |
| 20140313303 | Davis et al. | Oct 2014 | A1 |
| 20140313488 | Kiderman et al. | Oct 2014 | A1 |
| 20140315169 | Bohbot | Oct 2014 | A1 |
| 20140316191 | de Zambotti et al. | Oct 2014 | A1 |
| 20140316192 | de Zambotti et al. | Oct 2014 | A1 |
| 20140316217 | Purdon et al. | Oct 2014 | A1 |
| 20140316221 | Rothman | Oct 2014 | A1 |
| 20140316230 | Denison et al. | Oct 2014 | A1 |
| 20140316235 | Davis et al. | Oct 2014 | A1 |
| 20140316248 | deCharms | Oct 2014 | A1 |
| 20140316278 | Addison et al. | Oct 2014 | A1 |
| 20140320808 | Kiderman et al. | Oct 2014 | A1 |
| 20140320817 | Kiderman et al. | Oct 2014 | A1 |
| 20140321682 | Kofod-Hansen et al. | Oct 2014 | A1 |
| 20140323455 | Vavvas | Oct 2014 | A1 |
| 20140323849 | Deisseroth et al. | Oct 2014 | A1 |
| 20140323899 | Silberstein | Oct 2014 | A1 |
| 20140323900 | Bibian et al. | Oct 2014 | A1 |
| 20140324118 | Simon et al. | Oct 2014 | A1 |
| 20140327881 | Kiderman et al. | Nov 2014 | A1 |
| 20140328487 | Hiroe | Nov 2014 | A1 |
| 20140330093 | Pedro | Nov 2014 | A1 |
| 20140330102 | Zbrzeski et al. | Nov 2014 | A1 |
| 20140330157 | Snook | Nov 2014 | A1 |
| 20140330159 | Costa et al. | Nov 2014 | A1 |
| 20140330268 | Palti et al. | Nov 2014 | A1 |
| 20140330334 | Errico et al. | Nov 2014 | A1 |
| 20140330335 | Errico et al. | Nov 2014 | A1 |
| 20140330336 | Errico et al. | Nov 2014 | A1 |
| 20140330394 | Leuthardt et al. | Nov 2014 | A1 |
| 20140330404 | Abdelghani et al. | Nov 2014 | A1 |
| 20140330580 | Grima et al. | Nov 2014 | A1 |
| 20140333529 | Kim et al. | Nov 2014 | A1 |
| 20140335489 | DeCharms | Nov 2014 | A1 |
| 20140336473 | Greco | Nov 2014 | A1 |
| 20140336489 | Angotzi et al. | Nov 2014 | A1 |
| 20140336547 | Tass et al. | Nov 2014 | A1 |
| 20140340084 | Alon | Nov 2014 | A1 |
| 20140342818 | Smith et al. | Nov 2014 | A1 |
| 20140343397 | Kim et al. | Nov 2014 | A1 |
| 20140343399 | Posse | Nov 2014 | A1 |
| 20140343408 | Tolkowsky | Nov 2014 | A1 |
| 20140343882 | Taulu et al. | Nov 2014 | A1 |
| 20140347265 | Aimone et al. | Nov 2014 | A1 |
| 20140347491 | Connor | Nov 2014 | A1 |
| 20140348183 | Kim et al. | Nov 2014 | A1 |
| 20140350353 | Connor | Nov 2014 | A1 |
| 20140350380 | Eidelberg | Nov 2014 | A1 |
| 20140350431 | Hagedorn | Nov 2014 | A1 |
| 20140350436 | Nathan et al. | Nov 2014 | A1 |
| 20140350634 | Grill et al. | Nov 2014 | A1 |
| 20140350864 | Fang et al. | Nov 2014 | A1 |
| 20140354278 | Subbarao | Dec 2014 | A1 |
| 20140357507 | Umansky et al. | Dec 2014 | A1 |
| 20140357932 | Lozano | Dec 2014 | A1 |
| 20140357935 | Ilmoniemi et al. | Dec 2014 | A1 |
| 20140357962 | Harrington et al. | Dec 2014 | A1 |
| 20140358025 | Parhi et al. | Dec 2014 | A1 |
| 20140358067 | Deisseroth et al. | Dec 2014 | A1 |
| 20140362346 | Leinonen et al. | Dec 2014 | A1 |
| 20140364721 | Lee et al. | Dec 2014 | A1 |
| 20140364746 | Addison et al. | Dec 2014 | A1 |
| 20140368601 | deCharms | Dec 2014 | A1 |
| 20140369537 | Pontoppidan et al. | Dec 2014 | A1 |
| 20140369550 | Davis et al. | Dec 2014 | A1 |
| 20140370479 | Gazzaley | Dec 2014 | A1 |
| 20140371516 | Tsai et al. | Dec 2014 | A1 |
| 20140371544 | Wu et al. | Dec 2014 | A1 |
| 20140371573 | Komoto et al. | Dec 2014 | A1 |
| 20140371599 | Wu et al. | Dec 2014 | A1 |
| 20140371611 | Kim | Dec 2014 | A1 |
| 20140378809 | Weitnauer et al. | Dec 2014 | A1 |
| 20140378810 | Davis et al. | Dec 2014 | A1 |
| 20140378815 | Huang et al. | Dec 2014 | A1 |
| 20140378830 | Li | Dec 2014 | A1 |
| 20140378941 | Su et al. | Dec 2014 | A1 |
| 20140379620 | Sarrafzadeh et al. | Dec 2014 | A1 |
| 20150000025 | Clements | Jan 2015 | A1 |
| 20150002815 | Gross et al. | Jan 2015 | A1 |
| 20150003698 | Davis et al. | Jan 2015 | A1 |
| 20150003699 | Davis et al. | Jan 2015 | A1 |
| 20150005592 | Osorio | Jan 2015 | A1 |
| 20150005594 | Chamoun et al. | Jan 2015 | A1 |
| 20150005640 | Davis et al. | Jan 2015 | A1 |
| 20150005644 | Rhoads | Jan 2015 | A1 |
| 20150005646 | Balakrishnan et al. | Jan 2015 | A1 |
| 20150005660 | Kraus et al. | Jan 2015 | A1 |
| 20150005680 | Lipani | Jan 2015 | A1 |
| 20150005840 | Pal et al. | Jan 2015 | A1 |
| 20150005841 | Pal et al. | Jan 2015 | A1 |
| 20150006186 | Davis et al. | Jan 2015 | A1 |
| 20150008916 | Le Prado et al. | Jan 2015 | A1 |
| 20150011866 | Baumgartner | Jan 2015 | A1 |
| 20150011877 | Baumgartner | Jan 2015 | A1 |
| 20150011907 | Purdon et al. | Jan 2015 | A1 |
| 20150012111 | Contreras-Vidal et al. | Jan 2015 | A1 |
| 20150012426 | Purves et al. | Jan 2015 | A1 |
| 20150016618 | Adachi et al. | Jan 2015 | A1 |
| 20150016664 | Rodriguez | Jan 2015 | A1 |
| 20150016674 | Cho et al. | Jan 2015 | A1 |
| 20150017115 | Satchi-Fainaro et al. | Jan 2015 | A1 |
| 20150018665 | Jasanoff et al. | Jan 2015 | A1 |
| 20150018699 | Zeng et al. | Jan 2015 | A1 |
| 20150018702 | Galloway et al. | Jan 2015 | A1 |
| 20150018705 | Barlow et al. | Jan 2015 | A1 |
| 20150018706 | Segal | Jan 2015 | A1 |
| 20150018758 | John | Jan 2015 | A1 |
| 20150018905 | Nofzinger et al. | Jan 2015 | A1 |
| 20150019266 | Stempora | Jan 2015 | A1 |
| 20150024356 | Hillyer et al. | Jan 2015 | A1 |
| 20150025351 | Govari | Jan 2015 | A1 |
| 20150025408 | Wingeier et al. | Jan 2015 | A1 |
| 20150025422 | Tyler | Jan 2015 | A1 |
| 20150025610 | Wingeier et al. | Jan 2015 | A1 |
| 20150025917 | Stempora | Jan 2015 | A1 |
| 20150026446 | Kim et al. | Jan 2015 | A1 |
| 20150029087 | Klappert et al. | Jan 2015 | A1 |
| 20150030220 | Cho et al. | Jan 2015 | A1 |
| 20150032017 | Babaeizadeh et al. | Jan 2015 | A1 |
| 20150033056 | Frank et al. | Jan 2015 | A1 |
| 20150033245 | Klappert et al. | Jan 2015 | A1 |
| 20150033258 | Klappert et al. | Jan 2015 | A1 |
| 20150033259 | Klappert et al. | Jan 2015 | A1 |
| 20150033262 | Klappert et al. | Jan 2015 | A1 |
| 20150033266 | Klappert et al. | Jan 2015 | A1 |
| 20150033363 | Pinsky et al. | Jan 2015 | A1 |
| 20150035745 | Ou-Yang et al. | Feb 2015 | A1 |
| 20150035959 | Amble et al. | Feb 2015 | A1 |
| 20150038804 | Younes | Feb 2015 | A1 |
| 20150038812 | Ayaz et al. | Feb 2015 | A1 |
| 20150038822 | Wingeier et al. | Feb 2015 | A1 |
| 20150038869 | Simon et al. | Feb 2015 | A1 |
| 20150039066 | Wingeier et al. | Feb 2015 | A1 |
| 20150039110 | Abeyratne et al. | Feb 2015 | A1 |
| 20150039710 | Feghali | Feb 2015 | A1 |
| 20150040139 | Frank et al. | Feb 2015 | A1 |
| 20150042477 | Kobetski et al. | Feb 2015 | A1 |
| 20150044138 | Lansbergen et al. | Feb 2015 | A1 |
| 20150045007 | Cash | Feb 2015 | A1 |
| 20150045606 | Hagedorn et al. | Feb 2015 | A1 |
| 20150045686 | Lynn | Feb 2015 | A1 |
| 20150051663 | Hagedorn | Feb 2015 | A1 |
| 20150054731 | Mun et al. | Feb 2015 | A1 |
| 20150057512 | Kapoor | Feb 2015 | A1 |
| 20150058611 | Reeves et al. | Feb 2015 | A1 |
| 20150065813 | Wochlik et al. | Mar 2015 | A1 |
| 20150065838 | Wingeier et al. | Mar 2015 | A1 |
| 20150065839 | Farah et al. | Mar 2015 | A1 |
| 20150065845 | Takiguchi | Mar 2015 | A1 |
| 20150069846 | Hokari | Mar 2015 | A1 |
| 20150071600 | Azam | Mar 2015 | A1 |
| 20150072394 | Deisseroth et al. | Mar 2015 | A1 |
| 20150072728 | Rodriguez et al. | Mar 2015 | A1 |
| 20150073237 | Osorio | Mar 2015 | A1 |
| 20150073249 | Musha | Mar 2015 | A1 |
| 20150073294 | Zhang et al. | Mar 2015 | A1 |
| 20150073306 | Abeyratne et al. | Mar 2015 | A1 |
| 20150073505 | Errico et al. | Mar 2015 | A1 |
| 20150073907 | Purves et al. | Mar 2015 | A1 |
| 20150079949 | Vishwanath | Mar 2015 | A1 |
| 20150080671 | Christensen et al. | Mar 2015 | A1 |
| 20150080695 | Rogers et al. | Mar 2015 | A1 |
| 20150080703 | Reiman | Mar 2015 | A1 |
| 20150080746 | Bleich et al. | Mar 2015 | A1 |
| 20150080753 | Miyazaki et al. | Mar 2015 | A1 |
| 20150080985 | Yun et al. | Mar 2015 | A1 |
| 20150081226 | Baki | Mar 2015 | A1 |
| 20150081299 | Jasinschi et al. | Mar 2015 | A1 |
| 20150087931 | Banerjee et al. | Mar 2015 | A1 |
| 20150088024 | Sackellares et al. | Mar 2015 | A1 |
| 20150088093 | Goetz | Mar 2015 | A1 |
| 20150088120 | Garcia et al. | Mar 2015 | A1 |
| 20150088224 | Goldwasser et al. | Mar 2015 | A1 |
| 20150091730 | Kangas et al. | Apr 2015 | A1 |
| 20150091791 | Segal | Apr 2015 | A1 |
| 20150092050 | Cho et al. | Apr 2015 | A1 |
| 20150092949 | Adachi et al. | Apr 2015 | A1 |
| 20150092983 | Nguyen et al. | Apr 2015 | A1 |
| 20150093729 | Plans et al. | Apr 2015 | A1 |
| 20150094914 | Abreu | Apr 2015 | A1 |
| 20150096564 | Cosnek | Apr 2015 | A1 |
| 20150099941 | Tran | Apr 2015 | A1 |
| 20150099946 | Sahin | Apr 2015 | A1 |
| 20150099959 | Bonmassar et al. | Apr 2015 | A1 |
| 20150099962 | Weiss et al. | Apr 2015 | A1 |
| 20150103360 | Addison et al. | Apr 2015 | A1 |
| 20150105111 | Rodriguez | Apr 2015 | A1 |
| 20150105631 | Tran et al. | Apr 2015 | A1 |
| 20150105641 | Austin et al. | Apr 2015 | A1 |
| 20150105701 | Mayer et al. | Apr 2015 | A1 |
| 20150105837 | Aguilar Domingo | Apr 2015 | A1 |
| 20150105844 | Tass et al. | Apr 2015 | A1 |
| 20150112153 | Nahum | Apr 2015 | A1 |
| 20150112222 | Sun et al. | Apr 2015 | A1 |
| 20150112403 | Ruffini et al. | Apr 2015 | A1 |
| 20150112409 | Hagedorn | Apr 2015 | A1 |
| 20150112899 | Dagum | Apr 2015 | A1 |
| 20150119652 | Hyde et al. | Apr 2015 | A1 |
| 20150119658 | Osorio | Apr 2015 | A1 |
| 20150119689 | Pascual-Leone et al. | Apr 2015 | A1 |
| 20150119698 | Eyal et al. | Apr 2015 | A1 |
| 20150119743 | Maksym et al. | Apr 2015 | A1 |
| 20150119745 | Similowski et al. | Apr 2015 | A1 |
| 20150119746 | Conradsen | Apr 2015 | A1 |
| 20150120007 | Guez et al. | Apr 2015 | A1 |
| 20150121474 | Korkishko et al. | Apr 2015 | A1 |
| 20150123653 | Nagasaka | May 2015 | A1 |
| 20150123984 | Kim et al. | May 2015 | A1 |
| 20150124220 | Gross et al. | May 2015 | A1 |
| 20150126281 | Lewis | May 2015 | A1 |
| 20150126821 | Kempfner et al. | May 2015 | A1 |
| 20150126845 | Jin et al. | May 2015 | A1 |
| 20150126848 | Baker et al. | May 2015 | A1 |
| 20150126873 | Connor | May 2015 | A1 |
| 20150126892 | Kim et al. | May 2015 | A1 |
| 20150131159 | Lewis | May 2015 | A1 |
| 20150133811 | Suzuki et al. | May 2015 | A1 |
| 20150133812 | deCharms | May 2015 | A1 |
| 20150133830 | Dirks et al. | May 2015 | A1 |
| 20150134264 | Tansey | May 2015 | A1 |
| 20150135309 | Karmarkar et al. | May 2015 | A1 |
| 20150137988 | Gravenstein et al. | May 2015 | A1 |
| 20150138089 | Angerbauer et al. | May 2015 | A1 |
| 20150140528 | Sikstrom et al. | May 2015 | A1 |
| 20150141529 | Hargrove | May 2015 | A1 |
| 20150141773 | Einav et al. | May 2015 | A1 |
| 20150141789 | Knight et al. | May 2015 | A1 |
| 20150141794 | Foo | May 2015 | A1 |
| 20150142082 | Simon et al. | May 2015 | A1 |
| 20150145676 | Adhikari et al. | May 2015 | A1 |
| 20150148619 | Berg et al. | May 2015 | A1 |
| 20150148621 | Sier | May 2015 | A1 |
| 20150148700 | Mhuircheartaigh et al. | May 2015 | A1 |
| 20150150122 | Son et al. | May 2015 | A1 |
| 20150150473 | Knight et al. | Jun 2015 | A1 |
| 20150150475 | Varcoe | Jun 2015 | A1 |
| 20150150753 | Racette | Jun 2015 | A1 |
| 20150151142 | Tyler et al. | Jun 2015 | A1 |
| 20150153477 | Wikelski et al. | Jun 2015 | A1 |
| 20150154721 | Thompson | Jun 2015 | A1 |
| 20150154764 | Xie et al. | Jun 2015 | A1 |
| 20150154889 | Tuchschmid et al. | Jun 2015 | A1 |
| 20150157235 | Jelen et al. | Jun 2015 | A1 |
| 20150157255 | Nduka | Jun 2015 | A1 |
| 20150157266 | Machon et al. | Jun 2015 | A1 |
| 20150157271 | Zhang | Jun 2015 | A1 |
| 20150161738 | Stempora | Jun 2015 | A1 |
| 20150162802 | Horseman et al. | Jun 2015 | A1 |
| 20150163345 | Cornaby et al. | Jun 2015 | A1 |
| 20150164349 | Gopalakrishnan et al. | Jun 2015 | A1 |
| 20150164362 | Morrow | Jun 2015 | A1 |
| 20150164375 | Schindhelm et al. | Jun 2015 | A1 |
| 20150164404 | Euliano et al. | Jun 2015 | A1 |
| 20150164431 | Terry et al. | Jun 2015 | A1 |
| 20150165239 | Mishelevich | Jun 2015 | A1 |
| 20150174362 | Panova et al. | Jun 2015 | A1 |
| 20150174403 | Pal et al. | Jun 2015 | A1 |
| 20150174418 | Tyler et al. | Jun 2015 | A1 |
| 20150177529 | Zhao et al. | Jun 2015 | A1 |
| 20150178388 | Winnemoeller et al. | Jun 2015 | A1 |
| 20150178631 | Thomas et al. | Jun 2015 | A1 |
| 20150178978 | Durand et al. | Jun 2015 | A1 |
| 20150181840 | Tupin, Jr. et al. | Jul 2015 | A1 |
| 20150182417 | Nagatani | Jul 2015 | A1 |
| 20150182753 | Harris et al. | Jul 2015 | A1 |
| 20150185482 | Lewis | Jul 2015 | A1 |
| 20150185506 | Lewis | Jul 2015 | A1 |
| 20150186923 | Gurumoorthy et al. | Jul 2015 | A1 |
| 20150190062 | Han et al. | Jul 2015 | A1 |
| 20150190070 | Bonmassar et al. | Jul 2015 | A1 |
| 20150190077 | Kim et al. | Jul 2015 | A1 |
| 20150190085 | Nathan et al. | Jul 2015 | A1 |
| 20150190094 | Lee et al. | Jul 2015 | A1 |
| 20150190636 | Simon et al. | Jul 2015 | A1 |
| 20150190637 | Simon et al. | Jul 2015 | A1 |
| 20150190650 | George | Jul 2015 | A1 |
| 20150192532 | Clevenson et al. | Jul 2015 | A1 |
| 20150192776 | Lee et al. | Jul 2015 | A1 |
| 20150195482 | Wise | Jul 2015 | A1 |
| 20150196213 | Pandia et al. | Jul 2015 | A1 |
| 20150196249 | Brown et al. | Jul 2015 | A1 |
| 20150196800 | Macri et al. | Jul 2015 | A1 |
| 20150199010 | Coleman et al. | Jul 2015 | A1 |
| 20150200046 | Park et al. | Jul 2015 | A1 |
| 20150201879 | Hargrove | Jul 2015 | A1 |
| 20150202330 | Yang et al. | Jul 2015 | A1 |
| 20150202447 | Afshar et al. | Jul 2015 | A1 |
| 20150203822 | Tremolada et al. | Jul 2015 | A1 |
| 20150205482 | Johnson et al. | Jul 2015 | A1 |
| 20150206051 | McIntosh et al. | Jul 2015 | A1 |
| 20150206174 | Barnett et al. | Jul 2015 | A1 |
| 20150208940 | Addison et al. | Jul 2015 | A1 |
| 20150208975 | Ghajar | Jul 2015 | A1 |
| 20150208994 | Rapoport | Jul 2015 | A1 |
| 20150212168 | Shah et al. | Jul 2015 | A1 |
| 20150212830 | Reeves et al. | Jul 2015 | A1 |
| 20150213012 | Marvit et al. | Jul 2015 | A1 |
| 20150213019 | Marvit et al. | Jul 2015 | A1 |
| 20150213020 | Marvit et al. | Jul 2015 | A1 |
| 20150213191 | Abdelghani et al. | Jul 2015 | A1 |
| 20150213722 | Nypl et al. | Jul 2015 | A1 |
| 20150215412 | Marvit et al. | Jul 2015 | A1 |
| 20150216436 | Bosl et al. | Aug 2015 | A1 |
| 20150216439 | Muraskin et al. | Aug 2015 | A1 |
| 20150216468 | Vidal-Naquet et al. | Aug 2015 | A1 |
| 20150216762 | Oohashi et al. | Aug 2015 | A1 |
| 20150217082 | Kang et al. | Aug 2015 | A1 |
| 20150219729 | Takahashi | Aug 2015 | A1 |
| 20150219732 | Diamond et al. | Aug 2015 | A1 |
| 20150220486 | Karakonstantis et al. | Aug 2015 | A1 |
| 20150220830 | Li et al. | Aug 2015 | A1 |
| 20150223683 | Davidovics et al. | Aug 2015 | A1 |
| 20150223721 | De Ridder | Aug 2015 | A1 |
| 20150223731 | Sahin | Aug 2015 | A1 |
| 20150223743 | Pathangay et al. | Aug 2015 | A1 |
| 20150223905 | Karmarkar et al. | Aug 2015 | A1 |
| 20150226813 | Yu et al. | Aug 2015 | A1 |
| 20150227193 | Frank et al. | Aug 2015 | A1 |
| 20150227702 | Krishna et al. | Aug 2015 | A1 |
| 20150227844 | Frank et al. | Aug 2015 | A1 |
| 20150227922 | Filler | Aug 2015 | A1 |
| 20150230719 | Berg et al. | Aug 2015 | A1 |
| 20150230744 | Faubert et al. | Aug 2015 | A1 |
| 20150230750 | McDarby et al. | Aug 2015 | A1 |
| 20150231330 | Lozano et al. | Aug 2015 | A1 |
| 20150231395 | Saab | Aug 2015 | A1 |
| 20150231405 | Okada | Aug 2015 | A1 |
| 20150231408 | Williams et al. | Aug 2015 | A1 |
| 20150234477 | Abovitz et al. | Aug 2015 | A1 |
| 20150235088 | Abovitz et al. | Aug 2015 | A1 |
| 20150235134 | Guan et al. | Aug 2015 | A1 |
| 20150235370 | Abovitz et al. | Aug 2015 | A1 |
| 20150235441 | Abovitz et al. | Aug 2015 | A1 |
| 20150235447 | Abovitz et al. | Aug 2015 | A1 |
| 20150238104 | Tass | Aug 2015 | A1 |
| 20150238106 | Lappalainen et al. | Aug 2015 | A1 |
| 20150238112 | Park et al. | Aug 2015 | A1 |
| 20150238137 | Eyal et al. | Aug 2015 | A1 |
| 20150241705 | Abovitz et al. | Aug 2015 | A1 |
| 20150241916 | Choi et al. | Aug 2015 | A1 |
| 20150241959 | Abovitz et al. | Aug 2015 | A1 |
| 20150242120 | Rodriguez | Aug 2015 | A1 |
| 20150242575 | Abovitz et al. | Aug 2015 | A1 |
| 20150242608 | Kim et al. | Aug 2015 | A1 |
| 20150242943 | Abovitz et al. | Aug 2015 | A1 |
| 20150243100 | Abovitz et al. | Aug 2015 | A1 |
| 20150243105 | Abovitz et al. | Aug 2015 | A1 |
| 20150243106 | Abovitz et al. | Aug 2015 | A1 |
| 20150245800 | Sorensen et al. | Sep 2015 | A1 |
| 20150246238 | Moses et al. | Sep 2015 | A1 |
| 20150247723 | Abovitz et al. | Sep 2015 | A1 |
| 20150247921 | Rothberg et al. | Sep 2015 | A1 |
| 20150247975 | Abovitz et al. | Sep 2015 | A1 |
| 20150247976 | Abovitz et al. | Sep 2015 | A1 |
| 20150248167 | Turbell et al. | Sep 2015 | A1 |
| 20150248169 | Abovitz et al. | Sep 2015 | A1 |
| 20150248170 | Abovitz et al. | Sep 2015 | A1 |
| 20150248470 | Coleman et al. | Sep 2015 | A1 |
| 20150248615 | Parra et al. | Sep 2015 | A1 |
| 20150248651 | Akutagawa et al. | Sep 2015 | A1 |
| 20150248764 | Keskin et al. | Sep 2015 | A1 |
| 20150248765 | Criminisi et al. | Sep 2015 | A1 |
| 20150248787 | Abovitz et al. | Sep 2015 | A1 |
| 20150248788 | Abovitz et al. | Sep 2015 | A1 |
| 20150248789 | Abovitz et al. | Sep 2015 | A1 |
| 20150248791 | Abovitz et al. | Sep 2015 | A1 |
| 20150248792 | Abovitz et al. | Sep 2015 | A1 |
| 20150248793 | Abovitz et al. | Sep 2015 | A1 |
| 20150250393 | Tran | Sep 2015 | A1 |
| 20150250401 | Tveit | Sep 2015 | A1 |
| 20150250415 | Leininger et al. | Sep 2015 | A1 |
| 20150253391 | Toda et al. | Sep 2015 | A1 |
| 20150253410 | Warfield et al. | Sep 2015 | A1 |
| 20150256593 | Kelani et al. | Sep 2015 | A1 |
| 20150256956 | Jensen et al. | Sep 2015 | A1 |
| 20150257104 | Choi et al. | Sep 2015 | A1 |
| 20150257645 | Bae et al. | Sep 2015 | A1 |
| 20150257673 | Lawrence et al. | Sep 2015 | A1 |
| 20150257674 | Jordan et al. | Sep 2015 | A1 |
| 20150257697 | Sepah | Sep 2015 | A1 |
| 20150257700 | Fu | Sep 2015 | A1 |
| 20150257712 | Sarrafzadeh et al. | Sep 2015 | A1 |
| 20150261003 | Morifuji et al. | Sep 2015 | A1 |
| 20150262016 | Rothblatt | Sep 2015 | A1 |
| 20150264028 | Kim et al. | Sep 2015 | A1 |
| 20150264492 | Laudanski et al. | Sep 2015 | A1 |
| 20150265164 | Gopalakrishnan et al. | Sep 2015 | A1 |
| 20150265207 | Wu et al. | Sep 2015 | A1 |
| 20150265679 | Miller et al. | Sep 2015 | A1 |
| 20150268483 | Lewis | Sep 2015 | A1 |
| 20150269825 | Tran | Sep 2015 | A1 |
| 20150272461 | Morimoto et al. | Oct 2015 | A1 |
| 20150272465 | Ishii | Oct 2015 | A1 |
| 20150272496 | Klappert et al. | Oct 2015 | A1 |
| 20150272508 | Chiouchang et al. | Oct 2015 | A1 |
| 20150272510 | Chin | Oct 2015 | A1 |
| 20150272652 | Ghaffari et al. | Oct 2015 | A1 |
| 20150277560 | Beaty | Oct 2015 | A1 |
| 20150278980 | Sinclair | Oct 2015 | A1 |
| 20150282705 | Avital | Oct 2015 | A1 |
| 20150282730 | Knight et al. | Oct 2015 | A1 |
| 20150282749 | Zand et al. | Oct 2015 | A1 |
| 20150282755 | Deriche et al. | Oct 2015 | A1 |
| 20150282760 | Badower et al. | Oct 2015 | A1 |
| 20150283019 | Feingold | Oct 2015 | A1 |
| 20150283393 | Schmidt | Oct 2015 | A1 |
| 20150287403 | Holzer Zaslansky et al. | Oct 2015 | A1 |
| 20150289065 | Jensen et al. | Oct 2015 | A1 |
| 20150289217 | Ban et al. | Oct 2015 | A1 |
| 20150289779 | Fischl et al. | Oct 2015 | A1 |
| 20150289813 | Lipov | Oct 2015 | A1 |
| 20150289929 | Toth et al. | Oct 2015 | A1 |
| 20150290420 | Nofzinger | Oct 2015 | A1 |
| 20150290453 | Tyler et al. | Oct 2015 | A1 |
| 20150290454 | Tyler et al. | Oct 2015 | A1 |
| 20150293004 | Adolphi et al. | Oct 2015 | A1 |
| 20150293592 | Cheong et al. | Oct 2015 | A1 |
| 20150294074 | Kawato et al. | Oct 2015 | A1 |
| 20150296288 | Anastas | Oct 2015 | A1 |
| 20150297106 | Pasley et al. | Oct 2015 | A1 |
| 20150297108 | Chase et al. | Oct 2015 | A1 |
| 20150297109 | Garten et al. | Oct 2015 | A1 |
| 20150297139 | Toth | Oct 2015 | A1 |
| 20150297141 | Siegel et al. | Oct 2015 | A1 |
| 20150297444 | Tass | Oct 2015 | A1 |
| 20150297719 | Deisseroth et al. | Oct 2015 | A1 |
| 20150297893 | Kokones et al. | Oct 2015 | A1 |
| 20150302543 | Weaver et al. | Oct 2015 | A1 |
| 20150304048 | Kim et al. | Oct 2015 | A1 |
| 20150304101 | Gupta et al. | Oct 2015 | A1 |
| 20150305685 | Shahaf et al. | Oct 2015 | A1 |
| 20150305686 | Coleman et al. | Oct 2015 | A1 |
| 20150305689 | Gourmelon et al. | Oct 2015 | A1 |
| 20150305799 | Trieu | Oct 2015 | A1 |
| 20150305800 | Trieu | Oct 2015 | A1 |
| 20150305801 | Trieu | Oct 2015 | A1 |
| 20150306057 | Goodenowe | Oct 2015 | A1 |
| 20150306340 | Giap et al. | Oct 2015 | A1 |
| 20150306390 | Zalay et al. | Oct 2015 | A1 |
| 20150306391 | Wu et al. | Oct 2015 | A1 |
| 20150309563 | Connor | Oct 2015 | A1 |
| 20150309582 | Gupta | Oct 2015 | A1 |
| 20150310862 | Dauphin et al. | Oct 2015 | A1 |
| 20150313496 | Connor | Nov 2015 | A1 |
| 20150313498 | Coleman et al. | Nov 2015 | A1 |
| 20150313535 | Alshaer et al. | Nov 2015 | A1 |
| 20150313539 | Connor | Nov 2015 | A1 |
| 20150313540 | Deuchar et al. | Nov 2015 | A1 |
| 20150313903 | During | Nov 2015 | A1 |
| 20150313949 | Cutillo | Nov 2015 | A1 |
| 20150313971 | Haslett et al. | Nov 2015 | A1 |
| 20150315554 | Shekdar et al. | Nov 2015 | A1 |
| 20150317447 | Helleputte et al. | Nov 2015 | A1 |
| 20150317796 | Schett et al. | Nov 2015 | A1 |
| 20150320591 | Smith et al. | Nov 2015 | A1 |
| 20150323986 | Frank et al. | Nov 2015 | A1 |
| 20150324544 | Maslowski et al. | Nov 2015 | A1 |
| 20150324568 | Publicover et al. | Nov 2015 | A1 |
| 20150324692 | Ritchey et al. | Nov 2015 | A1 |
| 20150325151 | Tuchschmid et al. | Nov 2015 | A1 |
| 20150327813 | Fu | Nov 2015 | A1 |
| 20150327837 | Qi et al. | Nov 2015 | A1 |
| 20150328330 | Satchi-Fainaro et al. | Nov 2015 | A1 |
| 20150331929 | El-Saban et al. | Nov 2015 | A1 |
| 20150335240 | Kiderman et al. | Nov 2015 | A1 |
| 20150335281 | Scroggins | Nov 2015 | A1 |
| 20150335288 | Toth et al. | Nov 2015 | A1 |
| 20150335292 | Mittal | Nov 2015 | A1 |
| 20150335294 | Witcher et al. | Nov 2015 | A1 |
| 20150335295 | Park et al. | Nov 2015 | A1 |
| 20150335876 | Jeffery et al. | Nov 2015 | A1 |
| 20150335877 | Jeffery et al. | Nov 2015 | A1 |
| 20150338915 | Publicover et al. | Nov 2015 | A1 |
| 20150338917 | Steiner et al. | Nov 2015 | A1 |
| 20150339363 | Moldoveanu et al. | Nov 2015 | A1 |
| 20150342478 | Galen et al. | Dec 2015 | A1 |
| 20150342493 | Hardt | Dec 2015 | A1 |
| 20150343242 | Tyler et al. | Dec 2015 | A1 |
| 20150347734 | Beigi | Dec 2015 | A1 |
| 20150350794 | Pontoppidan | Dec 2015 | A1 |
| 20150350820 | Son et al. | Dec 2015 | A1 |
| 20150351655 | Coleman | Dec 2015 | A1 |
| 20150351690 | Toth et al. | Dec 2015 | A1 |
| 20150351695 | Cronin | Dec 2015 | A1 |
| 20150351698 | Cronin | Dec 2015 | A1 |
| 20150351701 | Moxon et al. | Dec 2015 | A1 |
| 20150352085 | During | Dec 2015 | A1 |
| 20150358316 | Cronin | Dec 2015 | A1 |
| 20150358526 | Cronin | Dec 2015 | A1 |
| 20150359431 | Bakalash et al. | Dec 2015 | A1 |
| 20150359441 | Giovangrandi et al. | Dec 2015 | A1 |
| 20150359450 | Lee et al. | Dec 2015 | A1 |
| 20150359452 | Giovangrandi et al. | Dec 2015 | A1 |
| 20150359467 | Tran | Dec 2015 | A1 |
| 20150359482 | Garcia Molina et al. | Dec 2015 | A1 |
| 20150359486 | Kovacs et al. | Dec 2015 | A1 |
| 20150359492 | Giovangrandi et al. | Dec 2015 | A1 |
| 20150360039 | Lempka et al. | Dec 2015 | A1 |
| 20150363986 | Hoyos et al. | Dec 2015 | A1 |
| 20150366482 | Lee | Dec 2015 | A1 |
| 20150366497 | Cavuoto et al. | Dec 2015 | A1 |
| 20150366503 | Sjaaheim et al. | Dec 2015 | A1 |
| 20150366504 | Connor | Dec 2015 | A1 |
| 20150366516 | Dripps et al. | Dec 2015 | A1 |
| 20150366518 | Sampson | Dec 2015 | A1 |
| 20150366656 | Wortz et al. | Dec 2015 | A1 |
| 20150366659 | Wortz et al. | Dec 2015 | A1 |
| 20150367133 | Schiff et al. | Dec 2015 | A1 |
| 20150369864 | Marlow et al. | Dec 2015 | A1 |
| 20150370320 | Connor | Dec 2015 | A1 |
| 20150370325 | Jarosiewicz et al. | Dec 2015 | A1 |
| 20150374250 | Hatano et al. | Dec 2015 | A1 |
| 20150374285 | Chang et al. | Dec 2015 | A1 |
| 20150374292 | Wyeth et al. | Dec 2015 | A1 |
| 20150374300 | Najarian et al. | Dec 2015 | A1 |
| 20150375006 | Denison et al. | Dec 2015 | A1 |
| 20150379370 | Clifton et al. | Dec 2015 | A1 |
| 20150380009 | Chang et al. | Dec 2015 | A1 |
| 20160000348 | Kitajo et al. | Jan 2016 | A1 |
| 20160000354 | Hagedorn et al. | Jan 2016 | A1 |
| 20160000383 | Lee et al. | Jan 2016 | A1 |
| 20160001065 | Wingeier et al. | Jan 2016 | A1 |
| 20160001096 | Mishelevich | Jan 2016 | A1 |
| 20160001098 | Wingeier et al. | Jan 2016 | A1 |
| 20160004298 | Mazed et al. | Jan 2016 | A1 |
| 20160005176 | Nguyen et al. | Jan 2016 | A1 |
| 20160005229 | Lee et al. | Jan 2016 | A1 |
| 20160005235 | Fateh | Jan 2016 | A1 |
| 20160005320 | deCharms et al. | Jan 2016 | A1 |
| 20160007849 | Krueger | Jan 2016 | A1 |
| 20160007899 | Durkee et al. | Jan 2016 | A1 |
| 20160007915 | Berka et al. | Jan 2016 | A1 |
| 20160007918 | Badower et al. | Jan 2016 | A1 |
| 20160008489 | Korzus | Jan 2016 | A1 |
| 20160008568 | Attia et al. | Jan 2016 | A1 |
| 20160008598 | McLaughlin et al. | Jan 2016 | A1 |
| 20160008620 | Stubbeman | Jan 2016 | A1 |
| 20160008632 | Wetmore et al. | Jan 2016 | A1 |
| 20160012011 | Llinas et al. | Jan 2016 | A1 |
| 20160012583 | Cales et al. | Jan 2016 | A1 |
| 20160012749 | Connor | Jan 2016 | A1 |
| 20160014224 | Tekwani | Jan 2016 | A1 |
| 20160015281 | McKenna et al. | Jan 2016 | A1 |
| 20160015289 | Simon et al. | Jan 2016 | A1 |
| 20160015673 | Goodenowe | Jan 2016 | A1 |
| 20160019434 | Caldwell | Jan 2016 | A1 |
| 20160019693 | Silbersweig et al. | Jan 2016 | A1 |
| 20160022141 | Mittal et al. | Jan 2016 | A1 |
| 20160022156 | Kovacs et al. | Jan 2016 | A1 |
| 20160022164 | Brockway et al. | Jan 2016 | A1 |
| 20160022165 | Sackellares et al. | Jan 2016 | A1 |
| 20160022167 | Simon | Jan 2016 | A1 |
| 20160022168 | Luczak et al. | Jan 2016 | A1 |
| 20160022206 | Simon et al. | Jan 2016 | A1 |
| 20160022207 | Roberts et al. | Jan 2016 | A1 |
| 20160022981 | Wingeier et al. | Jan 2016 | A1 |
| 20160023016 | Bonmassar et al. | Jan 2016 | A1 |
| 20160026913 | Moon et al. | Jan 2016 | A1 |
| 20160027293 | Esteller et al. | Jan 2016 | A1 |
| 20160027342 | Ben-Haim | Jan 2016 | A1 |
| 20160027423 | Deuel et al. | Jan 2016 | A1 |
| 20160029883 | Cox | Feb 2016 | A1 |
| 20160029896 | Lee et al. | Feb 2016 | A1 |
| 20160029917 | Baker et al. | Feb 2016 | A1 |
| 20160029918 | Baker et al. | Feb 2016 | A1 |
| 20160029946 | Simon et al. | Feb 2016 | A1 |
| 20160029947 | Girouard et al. | Feb 2016 | A1 |
| 20160029950 | Chang et al. | Feb 2016 | A1 |
| 20160029958 | Le et al. | Feb 2016 | A1 |
| 20160029959 | Le et al. | Feb 2016 | A1 |
| 20160029965 | Simon | Feb 2016 | A1 |
| 20160029998 | Brister et al. | Feb 2016 | A1 |
| 20160030666 | Lozano et al. | Feb 2016 | A1 |
| 20160030702 | Yang | Feb 2016 | A1 |
| 20160030834 | Brown et al. | Feb 2016 | A1 |
| 20160038037 | Kovacs | Feb 2016 | A1 |
| 20160038038 | Kovacs | Feb 2016 | A1 |
| 20160038042 | Mulligan et al. | Feb 2016 | A1 |
| 20160038043 | Mulligan et al. | Feb 2016 | A1 |
| 20160038049 | Geva et al. | Feb 2016 | A1 |
| 20160038069 | Stack | Feb 2016 | A1 |
| 20160038091 | Krishnaswamy et al. | Feb 2016 | A1 |
| 20160038469 | During | Feb 2016 | A1 |
| 20160038559 | Palmer et al. | Feb 2016 | A1 |
| 20160038770 | Tyler et al. | Feb 2016 | A1 |
| 20160042123 | Meyer et al. | Feb 2016 | A1 |
| 20160044460 | Cornaby et al. | Feb 2016 | A1 |
| 20160045128 | Sitt et al. | Feb 2016 | A1 |
| 20160045150 | Leininger et al. | Feb 2016 | A1 |
| 20160045756 | Phillips et al. | Feb 2016 | A1 |
| 20160048659 | Pereira et al. | Feb 2016 | A1 |
| 20160048948 | Bajic | Feb 2016 | A1 |
| 20160048965 | Stehle et al. | Feb 2016 | A1 |
| 20160051161 | Labyt et al. | Feb 2016 | A1 |
| 20160051162 | Durand et al. | Feb 2016 | A1 |
| 20160051187 | Damadian | Feb 2016 | A1 |
| 20160051195 | Pang et al. | Feb 2016 | A1 |
| 20160051793 | Gibson-Horn | Feb 2016 | A1 |
| 20160051812 | Montgomery, Jr. et al. | Feb 2016 | A1 |
| 20160054568 | Lewis | Feb 2016 | A1 |
| 20160054569 | Lewis | Feb 2016 | A1 |
| 20160055236 | Frank et al. | Feb 2016 | A1 |
| 20160055304 | Russell et al. | Feb 2016 | A1 |
| 20160055415 | Baxi | Feb 2016 | A1 |
| 20160055842 | DeFranks et al. | Feb 2016 | A1 |
| 20160058301 | Shusterman | Mar 2016 | A1 |
| 20160058304 | Emblem et al. | Mar 2016 | A1 |
| 20160058322 | Brister et al. | Mar 2016 | A1 |
| 20160058354 | Phan et al. | Mar 2016 | A1 |
| 20160058366 | Choi et al. | Mar 2016 | A1 |
| 20160058376 | Baek et al. | Mar 2016 | A1 |
| 20160058392 | Hasson et al. | Mar 2016 | A1 |
| 20160058673 | Francis | Mar 2016 | A1 |
| 20160060926 | Kim et al. | Mar 2016 | A1 |
| 20160062459 | Publicover et al. | Mar 2016 | A1 |
| 20160062596 | Lee et al. | Mar 2016 | A1 |
| 20160062807 | Reeves et al. | Mar 2016 | A1 |
| 20160063207 | Schmidt | Mar 2016 | A1 |
| 20160063611 | Davis et al. | Mar 2016 | A1 |
| 20160063883 | Jeyanandarajan | Mar 2016 | A1 |
| 20160065557 | Hwang et al. | Mar 2016 | A1 |
| 20160065724 | Lee et al. | Mar 2016 | A1 |
| 20160065840 | Kim et al. | Mar 2016 | A1 |
| 20160066788 | Tran et al. | Mar 2016 | A1 |
| 20160066828 | Phan et al. | Mar 2016 | A1 |
| 20160066838 | DeCharms | Mar 2016 | A1 |
| 20160067494 | Lipani | Mar 2016 | A1 |
| 20160070334 | Frank et al. | Mar 2016 | A1 |
| 20160070436 | Thomas et al. | Mar 2016 | A1 |
| 20160071390 | Sales et al. | Mar 2016 | A1 |
| 20160073886 | Connor | Mar 2016 | A1 |
| 20160073916 | Aksenova et al. | Mar 2016 | A1 |
| 20160073947 | Anderson | Mar 2016 | A1 |
| 20160074661 | Lipani | Mar 2016 | A1 |
| 20160074749 | Choi | Mar 2016 | A1 |
| 20160077547 | Aimone et al. | Mar 2016 | A1 |
| 20160078366 | Kaplan | Mar 2016 | A1 |
| 20160078657 | McCord | Mar 2016 | A1 |
| 20160078780 | Alexander et al. | Mar 2016 | A1 |
| 20160081577 | Sridhar et al. | Mar 2016 | A1 |
| 20160081613 | Braun et al. | Mar 2016 | A1 |
| 20160081616 | Li | Mar 2016 | A1 |
| 20160081623 | Lunner | Mar 2016 | A1 |
| 20160081625 | Kim et al. | Mar 2016 | A1 |
| 20160081793 | Galstian et al. | Mar 2016 | A1 |
| 20160082180 | Toth et al. | Mar 2016 | A1 |
| 20160082319 | Macri et al. | Mar 2016 | A1 |
| 20160084925 | Le Prado et al. | Mar 2016 | A1 |
| 20160085302 | Publicover et al. | Mar 2016 | A1 |
| 20160086622 | Yamamoto | Mar 2016 | A1 |
| 20160087603 | Ricci et al. | Mar 2016 | A1 |
| 20160089031 | Hu | Mar 2016 | A1 |
| 20160095838 | Satchi-Fainaro et al. | Apr 2016 | A1 |
| 20160097824 | Fujii et al. | Apr 2016 | A1 |
| 20160100769 | Kim et al. | Apr 2016 | A1 |
| 20160101260 | Austin et al. | Apr 2016 | A1 |
| 20160103322 | Hall, Jr. | Apr 2016 | A1 |
| 20160103487 | Crawford et al. | Apr 2016 | A1 |
| 20160103963 | Mishra | Apr 2016 | A1 |
| 20160104006 | Son et al. | Apr 2016 | A1 |
| 20160106331 | Zorick et al. | Apr 2016 | A1 |
| 20160106344 | Nazari | Apr 2016 | A1 |
| 20160106950 | Vasapollo | Apr 2016 | A1 |
| 20160107309 | Walsh et al. | Apr 2016 | A1 |
| 20160109851 | Tsang | Apr 2016 | A1 |
| 20160109954 | Harris et al. | Apr 2016 | A1 |
| 20160109959 | Hec | Apr 2016 | A1 |
| 20160112022 | Butts | Apr 2016 | A1 |
| 20160112684 | Connor | Apr 2016 | A1 |
| 20160113517 | Lee et al. | Apr 2016 | A1 |
| 20160113539 | Sinharay et al. | Apr 2016 | A1 |
| 20160113545 | Kim et al. | Apr 2016 | A1 |
| 20160113567 | Osvath et al. | Apr 2016 | A1 |
| 20160113587 | Kothe et al. | Apr 2016 | A1 |
| 20160116472 | Ay | Apr 2016 | A1 |
| 20160116553 | Kim et al. | Apr 2016 | A1 |
| 20160117829 | Yoon et al. | Apr 2016 | A1 |
| 20160119726 | Pontoppidan et al. | Apr 2016 | A1 |
| 20160120048 | Seo et al. | Apr 2016 | A1 |
| 20160120428 | Yoshida et al. | May 2016 | A1 |
| 20160120432 | Sridhar et al. | May 2016 | A1 |
| 20160120433 | Hughes et al. | May 2016 | A1 |
| 20160120434 | Park et al. | May 2016 | A1 |
| 20160120436 | Silberstein | May 2016 | A1 |
| 20160120437 | Graham et al. | May 2016 | A1 |
| 20160120457 | Wu et al. | May 2016 | A1 |
| 20160120464 | Lau et al. | May 2016 | A1 |
| 20160120474 | Connor | May 2016 | A1 |
| 20160120480 | Turnbull et al. | May 2016 | A1 |
| 20160121074 | Ashby | May 2016 | A1 |
| 20160125228 | Son et al. | May 2016 | A1 |
| 20160125572 | Yoo et al. | May 2016 | A1 |
| 20160128589 | Tabib-Azar | May 2016 | A1 |
| 20160128596 | Morshed et al. | May 2016 | A1 |
| 20160128597 | Lin et al. | May 2016 | A1 |
| 20160128629 | Crow et al. | May 2016 | A1 |
| 20160128632 | Wiebe et al. | May 2016 | A1 |
| 20160128864 | Nofzinger et al. | May 2016 | A1 |
| 20160129249 | Yun et al. | May 2016 | A1 |
| 20160131723 | Nagasaka | May 2016 | A1 |
| 20160132189 | Choi et al. | May 2016 | A1 |
| 20160132654 | Rothman et al. | May 2016 | A1 |
| 20160133052 | Choi et al. | May 2016 | A1 |
| 20160135691 | Dripps et al. | May 2016 | A1 |
| 20160135727 | Osorio | May 2016 | A1 |
| 20160135748 | Lin et al. | May 2016 | A1 |
| 20160135754 | Marshall et al. | May 2016 | A1 |
| 20160139215 | Fujii | May 2016 | A1 |
| 20160140834 | Tran | May 2016 | A1 |
| 20160140887 | Kim | May 2016 | A1 |
| 20160140975 | Kamamoto et al. | May 2016 | A1 |
| 20160142252 | Garg et al. | May 2016 | A1 |
| 20160142407 | Chun et al. | May 2016 | A1 |
| 20160143540 | Gencer et al. | May 2016 | A1 |
| 20160143541 | He et al. | May 2016 | A1 |
| 20160143554 | Lim et al. | May 2016 | A1 |
| 20160143560 | Grunwald et al. | May 2016 | A1 |
| 20160143574 | Jones et al. | May 2016 | A1 |
| 20160143582 | Connor | May 2016 | A1 |
| 20160143594 | Moorman et al. | May 2016 | A1 |
| 20160144173 | Wallbridge et al. | May 2016 | A1 |
| 20160144175 | Simon et al. | May 2016 | A1 |
| 20160147301 | Iwasaki et al. | May 2016 | A1 |
| 20160148077 | Cox et al. | May 2016 | A1 |
| 20160148400 | Bajic | May 2016 | A1 |
| 20160148531 | Bleich et al. | May 2016 | A1 |
| 20160150582 | Jung et al. | May 2016 | A1 |
| 20160150955 | Kiderman et al. | Jun 2016 | A1 |
| 20160150988 | Prerau et al. | Jun 2016 | A1 |
| 20160151014 | Ujhazy et al. | Jun 2016 | A1 |
| 20160151018 | Machon et al. | Jun 2016 | A1 |
| 20160151628 | Simon et al. | Jun 2016 | A1 |
| 20160156575 | Jeong et al. | Jun 2016 | A1 |
| 20160156682 | Jeon et al. | Jun 2016 | A1 |
| 20160157742 | Huang et al. | Jun 2016 | A1 |
| 20160157773 | Baek et al. | Jun 2016 | A1 |
| 20160157777 | Attal et al. | Jun 2016 | A1 |
| 20160157828 | Sumi et al. | Jun 2016 | A1 |
| 20160158553 | Panken et al. | Jun 2016 | A1 |
| 20160162016 | Lee et al. | Jun 2016 | A1 |
| 20160162652 | Siekmeier | Jun 2016 | A1 |
| 20160164813 | Anderson et al. | Jun 2016 | A1 |
| 20160164949 | Grimstrup et al. | Jun 2016 | A1 |
| 20160165852 | Goldfain | Jun 2016 | A1 |
| 20160165853 | Goldfain | Jun 2016 | A1 |
| 20160166169 | Badower et al. | Jun 2016 | A1 |
| 20160166197 | Venkatraman et al. | Jun 2016 | A1 |
| 20160166199 | Sun et al. | Jun 2016 | A1 |
| 20160166207 | Falconer | Jun 2016 | A1 |
| 20160166208 | Girouard et al. | Jun 2016 | A1 |
| 20160166219 | Majewski et al. | Jun 2016 | A1 |
| 20160167672 | Krueger | Jun 2016 | A1 |
| 20160168137 | Van Leyen et al. | Jun 2016 | A1 |
| 20160170996 | Frank et al. | Jun 2016 | A1 |
| 20160170998 | Frank et al. | Jun 2016 | A1 |
| 20160171514 | Frank et al. | Jun 2016 | A1 |
| 20160174099 | Goldfain | Jun 2016 | A1 |
| 20160174862 | Yu et al. | Jun 2016 | A1 |
| 20160174863 | Foerster et al. | Jun 2016 | A1 |
| 20160174867 | Hatano et al. | Jun 2016 | A1 |
| 20160174907 | Colman et al. | Jun 2016 | A1 |
| 20160175557 | Tass | Jun 2016 | A1 |
| 20160175607 | Deisseroth et al. | Jun 2016 | A1 |
| 20160176053 | Rognini et al. | Jun 2016 | A1 |
| 20160178392 | Goldfain | Jun 2016 | A1 |
| 20160180054 | Luo et al. | Jun 2016 | A1 |
| 20160183812 | Zhang et al. | Jun 2016 | A1 |
| 20160183828 | Ouyang et al. | Jun 2016 | A1 |
| 20160183861 | Hayes et al. | Jun 2016 | A1 |
| 20160183881 | Keenan et al. | Jun 2016 | A1 |
| 20160184029 | Peng et al. | Jun 2016 | A1 |
| 20160184599 | Segal | Jun 2016 | A1 |
| 20160191269 | Niruyi et al. | Jun 2016 | A1 |
| 20160191517 | Bae et al. | Jun 2016 | A1 |
| 20160192166 | deCharms | Jun 2016 | A1 |
| 20160192841 | Inagaki et al. | Jul 2016 | A1 |
| 20160192842 | Inagaki | Jul 2016 | A1 |
| 20160192847 | Inagaki | Jul 2016 | A1 |
| 20160192879 | Yamashita | Jul 2016 | A1 |
| 20160193442 | Adamczyk et al. | Jul 2016 | A1 |
| 20160193499 | Kim et al. | Jul 2016 | A1 |
| 20160196185 | Gu et al. | Jul 2016 | A1 |
| 20160196393 | Avinash et al. | Jul 2016 | A1 |
| 20160196635 | Cho et al. | Jul 2016 | A1 |
| 20160196758 | Causevic et al. | Jul 2016 | A1 |
| 20160198950 | Gross et al. | Jul 2016 | A1 |
| 20160198963 | Addison et al. | Jul 2016 | A1 |
| 20160198966 | Uematsu et al. | Jul 2016 | A1 |
| 20160198968 | Plenz et al. | Jul 2016 | A1 |
| 20160198973 | Fukuda et al. | Jul 2016 | A1 |
| 20160199241 | Rapoport | Jul 2016 | A1 |
| 20160199577 | Hyde et al. | Jul 2016 | A1 |
| 20160202755 | Connor | Jul 2016 | A1 |
| 20160203597 | Chang et al. | Jul 2016 | A1 |
| 20160203726 | Hibbs et al. | Jul 2016 | A1 |
| 20160204937 | Edwards et al. | Jul 2016 | A1 |
| 20160205450 | Gartseev et al. | Jul 2016 | A1 |
| 20160205489 | Jabri | Jul 2016 | A1 |
| 20160206241 | Cho et al. | Jul 2016 | A1 |
| 20160206380 | Sparks et al. | Jul 2016 | A1 |
| 20160206581 | Wittkowski | Jul 2016 | A1 |
| 20160206871 | Weisend | Jul 2016 | A1 |
| 20160206877 | Hargrove | Jul 2016 | A1 |
| 20160206880 | Koubeissi | Jul 2016 | A1 |
| 20160210552 | Kasabov et al. | Jul 2016 | A1 |
| 20160210872 | Roberts et al. | Jul 2016 | A1 |
| 20160212708 | Kim et al. | Jul 2016 | A1 |
| 20160213261 | Fleischer et al. | Jul 2016 | A1 |
| 20160213276 | Gadot et al. | Jul 2016 | A1 |
| 20160213314 | Zuckerman-Stark et al. | Jul 2016 | A1 |
| 20160213317 | Richardson et al. | Jul 2016 | A1 |
| 20160213354 | Levin et al. | Jul 2016 | A1 |
| 20160216760 | Trutna et al. | Jul 2016 | A1 |
| 20160219000 | Park et al. | Jul 2016 | A1 |
| 20160219345 | Knight et al. | Jul 2016 | A1 |
| 20160220133 | Inagaki | Aug 2016 | A1 |
| 20160220134 | Inagaki | Aug 2016 | A1 |
| 20160220136 | Schultz | Aug 2016 | A1 |
| 20160220163 | Yamada et al. | Aug 2016 | A1 |
| 20160220166 | Thornton | Aug 2016 | A1 |
| 20160220439 | Wojciechowski et al. | Aug 2016 | A1 |
| 20160220821 | O'Connell et al. | Aug 2016 | A1 |
| 20160220836 | Parks | Aug 2016 | A1 |
| 20160220837 | Jin | Aug 2016 | A1 |
| 20160220850 | Tyler | Aug 2016 | A1 |
| 20160222073 | Deisseroth et al. | Aug 2016 | A1 |
| 20160223622 | Yu et al. | Aug 2016 | A1 |
| 20160223627 | Shah et al. | Aug 2016 | A1 |
| 20160224757 | Melkonyan | Aug 2016 | A1 |
| 20160224803 | Frank et al. | Aug 2016 | A1 |
| 20160226542 | Tran et al. | Aug 2016 | A1 |
| 20160228019 | Grunwald et al. | Aug 2016 | A1 |
| 20160228028 | Van Der Kooi et al. | Aug 2016 | A1 |
| 20160228029 | Ware | Aug 2016 | A1 |
| 20160228059 | Badower | Aug 2016 | A1 |
| 20160228064 | Jung et al. | Aug 2016 | A1 |
| 20160228418 | During | Aug 2016 | A1 |
| 20160228640 | Pindado et al. | Aug 2016 | A1 |
| 20160228702 | Kempe et al. | Aug 2016 | A1 |
| 20160228705 | Crowder et al. | Aug 2016 | A1 |
| 20160231401 | Wang et al. | Aug 2016 | A1 |
| 20160232625 | Akutagawa et al. | Aug 2016 | A1 |
| 20160232811 | Connor | Aug 2016 | A9 |
| 20160235323 | Tadi et al. | Aug 2016 | A1 |
| 20160235324 | Mershin et al. | Aug 2016 | A1 |
| 20160235341 | Choi et al. | Aug 2016 | A1 |
| 20160235351 | Intrator | Aug 2016 | A1 |
| 20160235352 | DiLorenzo | Aug 2016 | A1 |
| 20160235359 | Cho et al. | Aug 2016 | A1 |
| 20160235980 | Berman et al. | Aug 2016 | A1 |
| 20160235983 | Berman et al. | Aug 2016 | A1 |
| 20160238673 | Honkura | Aug 2016 | A1 |
| 20160239084 | Connor | Aug 2016 | A1 |
| 20160239966 | Parsey et al. | Aug 2016 | A1 |
| 20160239968 | Parsey et al. | Aug 2016 | A1 |
| 20160240212 | Wilson et al. | Aug 2016 | A1 |
| 20160240765 | Washington et al. | Aug 2016 | A1 |
| 20160242645 | Muller | Aug 2016 | A1 |
| 20160242659 | Yamashita et al. | Aug 2016 | A1 |
| 20160242665 | Galloway et al. | Aug 2016 | A1 |
| 20160242669 | Muraskin et al. | Aug 2016 | A1 |
| 20160242670 | Suzuki et al. | Aug 2016 | A1 |
| 20160242690 | Principe et al. | Aug 2016 | A1 |
| 20160242699 | Das et al. | Aug 2016 | A1 |
| 20160245670 | Nelson et al. | Aug 2016 | A1 |
| 20160245766 | Nelson et al. | Aug 2016 | A1 |
| 20160247064 | Yoo et al. | Aug 2016 | A1 |
| 20160248434 | Govari | Aug 2016 | A1 |
| 20160248994 | Liu | Aug 2016 | A1 |
| 20160249826 | Derchak | Sep 2016 | A1 |
| 20160249841 | Gerber et al. | Sep 2016 | A1 |
| 20160249857 | Choi et al. | Sep 2016 | A1 |
| 20160249864 | Kang et al. | Sep 2016 | A1 |
| 20160250189 | Vavvas et al. | Sep 2016 | A1 |
| 20160250355 | Macknik | Sep 2016 | A1 |
| 20160250473 | Alberts et al. | Sep 2016 | A1 |
| 20160256063 | Friedman et al. | Sep 2016 | A1 |
| 20160256086 | Byrd et al. | Sep 2016 | A1 |
| 20160256105 | Boyle et al. | Sep 2016 | A1 |
| 20160256108 | Yun et al. | Sep 2016 | A1 |
| 20160256112 | Brockway et al. | Sep 2016 | A1 |
| 20160256118 | Iyer et al. | Sep 2016 | A1 |
| 20160256130 | Hamilton et al. | Sep 2016 | A1 |
| 20160257957 | Greenberg et al. | Sep 2016 | A1 |
| 20160259905 | Park et al. | Sep 2016 | A1 |
| 20160260216 | Wu et al. | Sep 2016 | A1 |
| 20160262608 | Krueger | Sep 2016 | A1 |
| 20160262664 | Linderman | Sep 2016 | A1 |
| 20160262680 | Martucci et al. | Sep 2016 | A1 |
| 20160262685 | Wagner et al. | Sep 2016 | A1 |
| 20160262695 | Zhang et al. | Sep 2016 | A1 |
| 20160262703 | MacCallum | Sep 2016 | A1 |
| 20160262704 | Min et al. | Sep 2016 | A1 |
| 20160265952 | Hwang | Sep 2016 | A1 |
| 20160267809 | deCharms et al. | Sep 2016 | A1 |
| 20160269999 | Hwang | Sep 2016 | A1 |
| 20160270656 | Samec et al. | Sep 2016 | A1 |
| 20160270723 | Deisseroth et al. | Sep 2016 | A1 |
| 20160271475 | Jeffery et al. | Sep 2016 | A1 |
| 20160274660 | Publicover et al. | Sep 2016 | A1 |
| 20160275536 | Anderson | Sep 2016 | A1 |
| 20160278651 | Lu et al. | Sep 2016 | A1 |
| 20160278653 | Clark et al. | Sep 2016 | A1 |
| 20160278662 | Brister et al. | Sep 2016 | A1 |
| 20160278672 | Cho et al. | Sep 2016 | A1 |
| 20160278687 | Xia | Sep 2016 | A1 |
| 20160278697 | John et al. | Sep 2016 | A1 |
| 20160278713 | Shoaran et al. | Sep 2016 | A1 |
| 20160278736 | Hamilton et al. | Sep 2016 | A1 |
| 20160279267 | Deisseroth et al. | Sep 2016 | A1 |
| 20160282113 | Lee | Sep 2016 | A1 |
| 20160282941 | Aksenova et al. | Sep 2016 | A1 |
| 20160287117 | Breakspear et al. | Oct 2016 | A1 |
| 20160287118 | Sarma et al. | Oct 2016 | A1 |
| 20160287120 | Sun et al. | Oct 2016 | A1 |
| 20160287142 | Han et al. | Oct 2016 | A1 |
| 20160287157 | Simpson | Oct 2016 | A1 |
| 20160287162 | Bardakjian et al. | Oct 2016 | A1 |
| 20160287166 | Tran | Oct 2016 | A1 |
| 20160287169 | Kortelainen et al. | Oct 2016 | A1 |
| 20160287308 | Grant et al. | Oct 2016 | A1 |
| 20160287334 | Grant et al. | Oct 2016 | A1 |
| 20160287436 | Wingeier et al. | Oct 2016 | A1 |
| 20160287869 | Errico et al. | Oct 2016 | A1 |
| 20160287871 | Bardakjian et al. | Oct 2016 | A1 |
| 20160287895 | Deisseroth et al. | Oct 2016 | A1 |
| 20160296157 | Girouard | Oct 2016 | A1 |
| 20160296746 | Wingeier et al. | Oct 2016 | A1 |
| 20160299568 | Segal | Oct 2016 | A1 |
| 20160300252 | Frank et al. | Oct 2016 | A1 |
| 20160300352 | Raj | Oct 2016 | A1 |
| 20160302683 | Lawrence et al. | Oct 2016 | A1 |
| 20160302704 | Lynn et al. | Oct 2016 | A9 |
| 20160302709 | Mossbridge | Oct 2016 | A1 |
| 20160302711 | Frank et al. | Oct 2016 | A1 |
| 20160302720 | John et al. | Oct 2016 | A1 |
| 20160302737 | Watson et al. | Oct 2016 | A1 |
| 20160303396 | Deisseroth et al. | Oct 2016 | A9 |
| 20160303397 | Hirschman et al. | Oct 2016 | A1 |
| 20160303402 | Tyler | Oct 2016 | A1 |
| 20160306844 | Frank et al. | Oct 2016 | A1 |
| 20160306942 | Rapaka et al. | Oct 2016 | A1 |
| 20160307380 | Ho et al. | Oct 2016 | A1 |
| 20160310031 | Sarkar | Oct 2016 | A1 |
| 20160310070 | Sabesan | Oct 2016 | A1 |
| 20160310071 | Kim | Oct 2016 | A1 |
| 20160310698 | Schoonover et al. | Oct 2016 | A1 |
| 20160310838 | Poisner et al. | Oct 2016 | A1 |
| 20160313408 | Hatano et al. | Oct 2016 | A1 |
| 20160313417 | Kawabata et al. | Oct 2016 | A1 |
| 20160313418 | Fujii et al. | Oct 2016 | A1 |
| 20160313798 | Connor | Oct 2016 | A1 |
| 20160316288 | Mendez Estrada | Oct 2016 | A1 |
| 20160317056 | Moon et al. | Nov 2016 | A1 |
| 20160317060 | Connor | Nov 2016 | A1 |
| 20160317077 | Sillay | Nov 2016 | A1 |
| 20160317383 | Stanfield et al. | Nov 2016 | A1 |
| 20160317834 | Kirk et al. | Nov 2016 | A1 |
| 20160320210 | Nelson et al. | Nov 2016 | A1 |
| 20160320930 | Byrd et al. | Nov 2016 | A1 |
| 20160321742 | Phillips et al. | Nov 2016 | A1 |
| 20160323431 | Gaw | Nov 2016 | A1 |
| 20160324445 | Kim et al. | Nov 2016 | A1 |
| 20160324457 | Dagum | Nov 2016 | A1 |
| 20160324465 | Osvath et al. | Nov 2016 | A1 |
| 20160324478 | Goldstein | Nov 2016 | A1 |
| 20160324580 | Esterberg | Nov 2016 | A1 |
| 20160324677 | Hyde et al. | Nov 2016 | A1 |
| 20160324942 | Lester et al. | Nov 2016 | A1 |
| 20160331264 | Helms-Tillery et al. | Nov 2016 | A1 |
| 20160331307 | Purdon et al. | Nov 2016 | A1 |
| 20160331925 | Kelley | Nov 2016 | A1 |
| 20160334475 | Ueno | Nov 2016 | A1 |
| 20160334866 | Mazed et al. | Nov 2016 | A9 |
| 20160337857 | Carron et al. | Nov 2016 | A1 |
| 20160338608 | Nagasaka et al. | Nov 2016 | A1 |
| 20160338634 | Neu et al. | Nov 2016 | A1 |
| 20160338644 | Connor | Nov 2016 | A1 |
| 20160338798 | Vora et al. | Nov 2016 | A1 |
| 20160338825 | Wortz et al. | Nov 2016 | A1 |
| 20160339243 | Wingeier et al. | Nov 2016 | A1 |
| 20160339300 | Todasco | Nov 2016 | A1 |
| 20160341684 | Choi | Nov 2016 | A1 |
| 20160342241 | Chung et al. | Nov 2016 | A1 |
| 20160342644 | Stolarz et al. | Nov 2016 | A1 |
| 20160344569 | Chun et al. | Nov 2016 | A1 |
| 20160345895 | Loetsch et al. | Dec 2016 | A1 |
| 20160345901 | Connor | Dec 2016 | A1 |
| 20160345911 | Leuthardt et al. | Dec 2016 | A1 |
| 20160346530 | Jeffery et al. | Dec 2016 | A1 |
| 20160346542 | Simon et al. | Dec 2016 | A1 |
| 20160349841 | Beaty | Dec 2016 | A1 |
| 20160354003 | Baker et al. | Dec 2016 | A1 |
| 20160354027 | Benson et al. | Dec 2016 | A1 |
| 20160357003 | Hauger et al. | Dec 2016 | A1 |
| 20160357256 | Siefert | Dec 2016 | A1 |
| 20160358091 | Stolarz et al. | Dec 2016 | A1 |
| 20160358092 | Stolarz et al. | Dec 2016 | A1 |
| 20160360100 | Kim et al. | Dec 2016 | A1 |
| 20160360965 | Tran | Dec 2016 | A1 |
| 20160360970 | Tzvieli et al. | Dec 2016 | A1 |
| 20160360990 | Altshuler et al. | Dec 2016 | A1 |
| 20160360992 | Guger et al. | Dec 2016 | A1 |
| 20160361021 | Salehizadeh et al. | Dec 2016 | A1 |
| 20160361027 | Jang et al. | Dec 2016 | A1 |
| 20160361041 | Barsimantov et al. | Dec 2016 | A1 |
| 20160361532 | Wingeier et al. | Dec 2016 | A1 |
| 20160361534 | Weisend | Dec 2016 | A9 |
| 20160361546 | Salam et al. | Dec 2016 | A1 |
| 20160361602 | Lagree | Dec 2016 | A1 |
| 20160363483 | Tzvieli et al. | Dec 2016 | A1 |
| 20160364586 | Todeschini | Dec 2016 | A1 |
| 20160366462 | Klappert et al. | Dec 2016 | A1 |
| 20160367138 | Kim et al. | Dec 2016 | A1 |
| 20160367186 | Freeman et al. | Dec 2016 | A1 |
| 20160367195 | Park et al. | Dec 2016 | A1 |
| 20160367198 | Chon et al. | Dec 2016 | A1 |
| 20160367204 | Won et al. | Dec 2016 | A1 |
| 20160367619 | Vavvas et al. | Dec 2016 | A1 |
| 20160370774 | Lamti et al. | Dec 2016 | A1 |
| 20160371387 | Serena | Dec 2016 | A1 |
| 20160371721 | Bogdon et al. | Dec 2016 | A1 |
| 20160374581 | Jensen | Dec 2016 | A1 |
| 20160374594 | Garcia Molina et al. | Dec 2016 | A1 |
| 20160374616 | Mullins et al. | Dec 2016 | A1 |
| 20160374618 | Giovangrandi | Dec 2016 | A1 |
| 20160378608 | Kong et al. | Dec 2016 | A1 |
| 20160378965 | Choe et al. | Dec 2016 | A1 |
| 20160381621 | Kim et al. | Dec 2016 | A1 |
| 20170000324 | Samec et al. | Jan 2017 | A1 |
| 20170000325 | Samec et al. | Jan 2017 | A1 |
| 20170000326 | Samec et al. | Jan 2017 | A1 |
| 20170000329 | Samec et al. | Jan 2017 | A1 |
| 20170000330 | Samec et al. | Jan 2017 | A1 |
| 20170000331 | Samec et al. | Jan 2017 | A1 |
| 20170000332 | Samec et al. | Jan 2017 | A1 |
| 20170000333 | Samec et al. | Jan 2017 | A1 |
| 20170000334 | Samec et al. | Jan 2017 | A1 |
| 20170000335 | Samec et al. | Jan 2017 | A1 |
| 20170000337 | Samec et al. | Jan 2017 | A1 |
| 20170000340 | Samec et al. | Jan 2017 | A1 |
| 20170000341 | Samec et al. | Jan 2017 | A1 |
| 20170000342 | Samec et al. | Jan 2017 | A1 |
| 20170000343 | Samec et al. | Jan 2017 | A1 |
| 20170000345 | Samec et al. | Jan 2017 | A1 |
| 20170000404 | Leininger et al. | Jan 2017 | A1 |
| 20170000422 | Moturu et al. | Jan 2017 | A1 |
| 20170000454 | Samec et al. | Jan 2017 | A1 |
| 20170000683 | Samec et al. | Jan 2017 | A1 |
| 20170000970 | Garcia Molina et al. | Jan 2017 | A1 |
| 20170001016 | De Ridder | Jan 2017 | A1 |
| 20170001032 | Samec et al. | Jan 2017 | A1 |
| 20170003741 | Ding | Jan 2017 | A1 |
| 20170003742 | Ding | Jan 2017 | A1 |
| 20170006217 | Ding | Jan 2017 | A1 |
| 20170006931 | Guez et al. | Jan 2017 | A1 |
| 20170007111 | Samec et al. | Jan 2017 | A1 |
| 20170007115 | Samec et al. | Jan 2017 | A1 |
| 20170007116 | Samec et al. | Jan 2017 | A1 |
| 20170007122 | Samec et al. | Jan 2017 | A1 |
| 20170007123 | Samec et al. | Jan 2017 | A1 |
| 20170007165 | Jain et al. | Jan 2017 | A1 |
| 20170007173 | Adamczyk et al. | Jan 2017 | A1 |
| 20170007182 | Samec et al. | Jan 2017 | A1 |
| 20170007450 | Samec et al. | Jan 2017 | A1 |
| 20170007799 | Samec et al. | Jan 2017 | A1 |
| 20170007843 | Samec et al. | Jan 2017 | A1 |
| 20170010469 | Samec et al. | Jan 2017 | A1 |
| 20170010470 | Samec et al. | Jan 2017 | A1 |
| 20170010647 | Frank et al. | Jan 2017 | A1 |
| 20170010677 | Roh et al. | Jan 2017 | A1 |
| 20170011178 | Hendrickson et al. | Jan 2017 | A1 |
| 20170011210 | Cheong et al. | Jan 2017 | A1 |
| 20170013562 | Lim et al. | Jan 2017 | A1 |
| 20170014037 | Coppola et al. | Jan 2017 | A1 |
| 20170014080 | Macia Barber et al. | Jan 2017 | A1 |
| 20170014083 | Diab et al. | Jan 2017 | A1 |
| 20170017083 | Samec et al. | Jan 2017 | A1 |
| 20170020388 | Kiderman et al. | Jan 2017 | A1 |
| 20170020434 | Walker et al. | Jan 2017 | A1 |
| 20170020447 | Grossman et al. | Jan 2017 | A1 |
| 20170020454 | Keteyian et al. | Jan 2017 | A1 |
| 20170020627 | Tesar et al. | Jan 2017 | A1 |
| 20170021158 | Wingeier et al. | Jan 2017 | A1 |
| 20170021161 | De Ridder | Jan 2017 | A1 |
| 20170027467 | Hagedorn | Feb 2017 | A1 |
| 20170027517 | Le et al. | Feb 2017 | A9 |
| 20170027521 | Geva et al. | Feb 2017 | A1 |
| 20170027539 | Uber | Feb 2017 | A1 |
| 20170027651 | Esterberg | Feb 2017 | A1 |
| 20170027812 | Hyde et al. | Feb 2017 | A1 |
| 20170028563 | Hemken | Feb 2017 | A1 |
| 20170031440 | Randolph | Feb 2017 | A1 |
| 20170031441 | Muller et al. | Feb 2017 | A1 |
| 20170032098 | Ghorbanian et al. | Feb 2017 | A1 |
| 20170032221 | Wu et al. | Feb 2017 | A1 |
| 20170032527 | Murthy et al. | Feb 2017 | A1 |
| 20170032584 | Moran et al. | Feb 2017 | A1 |
| 20170034638 | Anastas | Feb 2017 | A1 |
| 20170035309 | Kang et al. | Feb 2017 | A1 |
| 20170035317 | Jung et al. | Feb 2017 | A1 |
| 20170035344 | Tzvieli et al. | Feb 2017 | A1 |
| 20170035392 | Grunwald et al. | Feb 2017 | A1 |
| 20170039045 | Abrahami et al. | Feb 2017 | A1 |
| 20170039591 | Knight et al. | Feb 2017 | A1 |
| 20170039706 | Mikhno et al. | Feb 2017 | A1 |
| 20170041205 | Rangel et al. | Feb 2017 | A1 |
| 20170041699 | Mackellar et al. | Feb 2017 | A1 |
| 20170042418 | Leinonen et al. | Feb 2017 | A1 |
| 20170042430 | Kovacs | Feb 2017 | A1 |
| 20170042439 | Yeow et al. | Feb 2017 | A1 |
| 20170042444 | Bardy et al. | Feb 2017 | A1 |
| 20170042469 | Prerau et al. | Feb 2017 | A1 |
| 20170042474 | Widge et al. | Feb 2017 | A1 |
| 20170042475 | Verghese et al. | Feb 2017 | A1 |
| 20170042476 | Reiman | Feb 2017 | A1 |
| 20170042485 | Chung et al. | Feb 2017 | A1 |
| 20170042827 | Margel et al. | Feb 2017 | A1 |
| 20170043160 | Goodall et al. | Feb 2017 | A1 |
| 20170043166 | Choi et al. | Feb 2017 | A1 |
| 20170043167 | Widge et al. | Feb 2017 | A1 |
| 20170045601 | Akhtari | Feb 2017 | A1 |
| 20170046052 | Lee et al. | Feb 2017 | A1 |
| 20170048626 | Jensen et al. | Feb 2017 | A1 |
| 20170049395 | Cao | Feb 2017 | A1 |
| 20170049524 | Olson | Feb 2017 | A1 |
| 20170052170 | Shekdar et al. | Feb 2017 | A1 |
| 20170053082 | Pereira et al. | Feb 2017 | A1 |
| 20170053088 | Walker et al. | Feb 2017 | A1 |
| 20170053461 | Pal et al. | Feb 2017 | A1 |
| 20170053513 | Savolainen et al. | Feb 2017 | A1 |
| 20170053665 | Quatieri, Jr. et al. | Feb 2017 | A1 |
| 20170055839 | Levinson et al. | Mar 2017 | A1 |
| 20170055868 | Hatakeyama | Mar 2017 | A1 |
| 20170055898 | Bandyopadhyay et al. | Mar 2017 | A1 |
| 20170055900 | Jain et al. | Mar 2017 | A1 |
| 20170055913 | Bandyopadhyay et al. | Mar 2017 | A1 |
| 20170056363 | Goodenowe | Mar 2017 | A1 |
| 20170056467 | Deisseroth et al. | Mar 2017 | A1 |
| 20170056642 | Moffitt et al. | Mar 2017 | A1 |
| 20170056655 | Lineaweaver | Mar 2017 | A1 |
| 20170060298 | Hwang et al. | Mar 2017 | A1 |
| 20170061034 | Ritchey et al. | Mar 2017 | A1 |
| 20170061760 | Lee et al. | Mar 2017 | A1 |
| 20170064434 | Campbell et al. | Mar 2017 | A1 |
| 20170065199 | Meisel | Mar 2017 | A1 |
| 20170065218 | Leininger et al. | Mar 2017 | A1 |
| 20170065229 | Howard | Mar 2017 | A1 |
| 20170065349 | Ourselin et al. | Mar 2017 | A1 |
| 20170065379 | Cowburn et al. | Mar 2017 | A1 |
| 20170065792 | Bonvallet | Mar 2017 | A1 |
| 20170065816 | Wingeier et al. | Mar 2017 | A1 |
| 20170066806 | Deisseroth et al. | Mar 2017 | A1 |
| 20170068920 | Dow et al. | Mar 2017 | A1 |
| 20170068921 | Dow et al. | Mar 2017 | A1 |
| 20170069306 | Asaei et al. | Mar 2017 | A1 |
| 20170071495 | Denison et al. | Mar 2017 | A1 |
| 20170071521 | Mestha et al. | Mar 2017 | A1 |
| 20170071523 | Jain et al. | Mar 2017 | A1 |
| 20170071529 | Haugland et al. | Mar 2017 | A1 |
| 20170071532 | Greco | Mar 2017 | A1 |
| 20170071537 | Jain et al. | Mar 2017 | A1 |
| 20170071546 | Jain et al. | Mar 2017 | A1 |
| 20170071551 | Jain et al. | Mar 2017 | A1 |
| 20170071552 | Harpe et al. | Mar 2017 | A1 |
| 20170076520 | Ho et al. | Mar 2017 | A1 |
| 20170078883 | Rodriguez | Mar 2017 | A1 |
| 20170079538 | Liang et al. | Mar 2017 | A1 |
| 20170079543 | Sadeghian-Motahar | Mar 2017 | A1 |
| 20170079588 | Ghaffari et al. | Mar 2017 | A1 |
| 20170079589 | Ghaffari et al. | Mar 2017 | A1 |
| 20170079596 | Teixeira | Mar 2017 | A1 |
| 20170080050 | Deisseroth et al. | Mar 2017 | A1 |
| 20170080256 | Kim et al. | Mar 2017 | A1 |
| 20170080320 | Smith | Mar 2017 | A1 |
| 20170080332 | Poisner et al. | Mar 2017 | A1 |
| 20170083312 | Pindado et al. | Mar 2017 | A1 |
| 20170085547 | De Aguiar et al. | Mar 2017 | A1 |
| 20170085855 | Roberts et al. | Mar 2017 | A1 |
| 20170086672 | Tran | Mar 2017 | A1 |
| 20170086695 | Mullins et al. | Mar 2017 | A1 |
| 20170086727 | Dagum | Mar 2017 | A1 |
| 20170086729 | Bruno | Mar 2017 | A1 |
| 20170086763 | Verma et al. | Mar 2017 | A1 |
| 20170087330 | Kahn et al. | Mar 2017 | A1 |
| 20170087367 | Weisend | Mar 2017 | A1 |
| 20170087453 | Poisner et al. | Mar 2017 | A1 |
| 20170090475 | Choi et al. | Mar 2017 | A1 |
| 20170091418 | Chen et al. | Mar 2017 | A1 |
| 20170091532 | Son et al. | Mar 2017 | A1 |
| 20170091567 | Wang et al. | Mar 2017 | A1 |
| 20170093848 | Poisner et al. | Mar 2017 | A1 |
| 20170094385 | Lee et al. | Mar 2017 | A1 |
| 20170095157 | Tzvieli et al. | Apr 2017 | A1 |
| 20170095174 | Fokas et al. | Apr 2017 | A1 |
| 20170095199 | Kranck | Apr 2017 | A1 |
| 20170095383 | Li et al. | Apr 2017 | A1 |
| 20170095670 | Ghaffari et al. | Apr 2017 | A1 |
| 20170095721 | Bleich et al. | Apr 2017 | A1 |
| 20170099479 | Browd et al. | Apr 2017 | A1 |
| 20170099713 | Perez et al. | Apr 2017 | A1 |
| 20170100051 | Honkura | Apr 2017 | A1 |
| 20170100540 | Hyde et al. | Apr 2017 | A1 |
| 20170102767 | Kim et al. | Apr 2017 | A1 |
| 20170103440 | Xing et al. | Apr 2017 | A1 |
| 20170103668 | Chatterjee et al. | Apr 2017 | A1 |
| 20170104787 | Myron | Apr 2017 | A1 |
| 20170104928 | Chase et al. | Apr 2017 | A1 |
| 20170105647 | Duffy | Apr 2017 | A1 |
| 20170107575 | Umansky et al. | Apr 2017 | A1 |
| 20170108926 | Moon et al. | Apr 2017 | A1 |
| 20170112379 | Swiston et al. | Apr 2017 | A1 |
| 20170112403 | Doidge et al. | Apr 2017 | A1 |
| 20170112427 | Simon et al. | Apr 2017 | A1 |
| 20170112446 | Dagum | Apr 2017 | A1 |
| 20170112577 | Bonutti et al. | Apr 2017 | A1 |
| 20170112671 | Goldstein | Apr 2017 | A1 |
| 20170113046 | Fried et al. | Apr 2017 | A1 |
| 20170113056 | Stocco et al. | Apr 2017 | A1 |
| 20170113057 | Goodall et al. | Apr 2017 | A1 |
| 20170115742 | Xing et al. | Apr 2017 | A1 |
| 20170119270 | Juan et al. | May 2017 | A1 |
| 20170119271 | Leuthardt et al. | May 2017 | A1 |
| 20170119994 | Argaman | May 2017 | A1 |
| 20170120041 | Wenger et al. | May 2017 | A1 |
| 20170120043 | John | May 2017 | A1 |
| 20170120066 | Phillips et al. | May 2017 | A1 |
| 20170127946 | Levinson et al. | May 2017 | A1 |
| 20170127975 | Bozkurt | May 2017 | A1 |
| 20170128006 | Seo et al. | May 2017 | A1 |
| 20170128015 | Rogers et al. | May 2017 | A1 |
| 20170131293 | Haslett et al. | May 2017 | A1 |
| 20170132816 | Aston et al. | May 2017 | A1 |
| 20170132861 | Ho et al. | May 2017 | A1 |
| 20170133009 | Cho et al. | May 2017 | A1 |
| 20170133576 | Marcus et al. | May 2017 | A1 |
| 20170133577 | Cybart et al. | May 2017 | A1 |
| 20170135594 | Hartings et al. | May 2017 | A1 |
| 20170135597 | Mann | May 2017 | A1 |
| 20170135604 | Kent et al. | May 2017 | A1 |
| 20170135626 | Singer | May 2017 | A1 |
| 20170135629 | Kent et al. | May 2017 | A1 |
| 20170135631 | Zuckerman-Stark et al. | May 2017 | A1 |
| 20170135633 | Connor | May 2017 | A1 |
| 20170135640 | Gunasekar et al. | May 2017 | A1 |
| 20170136240 | Mogul | May 2017 | A1 |
| 20170136264 | Hyde et al. | May 2017 | A1 |
| 20170136265 | Hyde et al. | May 2017 | A1 |
| 20170139484 | Todeschini | May 2017 | A1 |
| 20170140124 | Sehgal et al. | May 2017 | A1 |
| 20170142656 | Hong et al. | May 2017 | A1 |
| 20170143231 | Ostberg et al. | May 2017 | A1 |
| 20170143249 | Davis et al. | May 2017 | A1 |
| 20170143255 | Babaeizadeh et al. | May 2017 | A1 |
| 20170143257 | Kent et al. | May 2017 | A1 |
| 20170143259 | Kent et al. | May 2017 | A1 |
| 20170143266 | Kovacs et al. | May 2017 | A1 |
| 20170143267 | Kovacs et al. | May 2017 | A1 |
| 20170143268 | Kovacs et al. | May 2017 | A1 |
| 20170143273 | Osorio et al. | May 2017 | A1 |
| 20170143280 | Kent et al. | May 2017 | A1 |
| 20170143282 | Kovacs et al. | May 2017 | A1 |
| 20170143442 | Tesar et al. | May 2017 | A1 |
| 20170143960 | Kent et al. | May 2017 | A1 |
| 20170143963 | Osorio | May 2017 | A1 |
| 20170143986 | Deisseroth et al. | May 2017 | A1 |
| 20170146386 | Wiard et al. | May 2017 | A1 |
| 20170146387 | Wiard et al. | May 2017 | A1 |
| 20170146390 | Kovacs | May 2017 | A1 |
| 20170146391 | Kovacs et al. | May 2017 | A1 |
| 20170146615 | Wolf et al. | May 2017 | A1 |
| 20170146801 | Stempora | May 2017 | A1 |
| 20170147578 | Hecht et al. | May 2017 | A1 |
| 20170147754 | Kovacs | May 2017 | A1 |
| 20170148213 | Thomas et al. | May 2017 | A1 |
| 20170148240 | Kovacs et al. | May 2017 | A1 |
| 20170148340 | Popa-Simil et al. | May 2017 | A1 |
| 20170148592 | Tabib-Azir | May 2017 | A1 |
| 20170149945 | Lee et al. | May 2017 | A1 |
| 20170150896 | Lu et al. | Jun 2017 | A9 |
| 20170150897 | Komaki | Jun 2017 | A1 |
| 20170150898 | Liu et al. | Jun 2017 | A1 |
| 20170150916 | Osorio | Jun 2017 | A1 |
| 20170150925 | Jung | Jun 2017 | A1 |
| 20170151435 | Deadwyler et al. | Jun 2017 | A1 |
| 20170151436 | Flaherty et al. | Jun 2017 | A1 |
| 20170154167 | Ovtchinnikov | Jun 2017 | A1 |
| 20170156593 | Ferber et al. | Jun 2017 | A1 |
| 20170156606 | Ferber et al. | Jun 2017 | A1 |
| 20170156655 | Austin et al. | Jun 2017 | A1 |
| 20170156662 | Goodall et al. | Jun 2017 | A1 |
| 20170156674 | Hochman | Jun 2017 | A1 |
| 20170157435 | Choi | Jun 2017 | A1 |
| 20170160360 | Deisseroth et al. | Jun 2017 | A1 |
| 20170160703 | Heo et al. | Jun 2017 | A1 |
| 20170162072 | Horseman et al. | Jun 2017 | A1 |
| 20170164293 | Hwang | Jun 2017 | A1 |
| 20170164861 | Cahan et al. | Jun 2017 | A1 |
| 20170164862 | Dolev et al. | Jun 2017 | A1 |
| 20170164876 | Hyde et al. | Jun 2017 | A1 |
| 20170164878 | Connor | Jun 2017 | A1 |
| 20170164893 | Narayan et al. | Jun 2017 | A1 |
| 20170164894 | Yoo et al. | Jun 2017 | A1 |
| 20170164901 | Shusterman | Jun 2017 | A1 |
| 20170165020 | Martel | Jun 2017 | A1 |
| 20170165481 | Menon | Jun 2017 | A1 |
| 20170168121 | Yu et al. | Jun 2017 | A1 |
| 20170168568 | Petrov | Jun 2017 | A1 |
| 20170169176 | Abiola | Jun 2017 | A1 |
| 20170169295 | Park et al. | Jun 2017 | A1 |
| 20170169714 | Lin et al. | Jun 2017 | A1 |
| 20170171441 | Kearns et al. | Jun 2017 | A1 |
| 20170172414 | Nierenberg et al. | Jun 2017 | A1 |
| 20170172445 | Dang et al. | Jun 2017 | A1 |
| 20170172446 | Kuzum et al. | Jun 2017 | A1 |
| 20170172499 | Yoo | Jun 2017 | A1 |
| 20170172501 | Badower et al. | Jun 2017 | A1 |
| 20170172520 | Kannan et al. | Jun 2017 | A1 |
| 20170172527 | Uber | Jun 2017 | A1 |
| 20170173262 | Veltz | Jun 2017 | A1 |
| 20170173326 | Bloch et al. | Jun 2017 | A1 |
| 20170173391 | Wiebe et al. | Jun 2017 | A1 |
| 20170174180 | Hoyos et al. | Jun 2017 | A1 |
| 20170175280 | Dang et al. | Jun 2017 | A1 |
| 20170177023 | Simon et al. | Jun 2017 | A1 |
| 20170178001 | Anderson et al. | Jun 2017 | A1 |
| 20170178340 | Schadewaldt et al. | Jun 2017 | A1 |
| 20170180558 | Li et al. | Jun 2017 | A1 |
| 20170180882 | Lunner et al. | Jun 2017 | A1 |
| 20170181252 | Wouhaybi et al. | Jun 2017 | A1 |
| 20170181693 | Kim et al. | Jun 2017 | A1 |
| 20170182176 | Satchi-Fainaro et al. | Jun 2017 | A1 |
| 20170185149 | Oluwafemi et al. | Jun 2017 | A1 |
| 20170185150 | Yang et al. | Jun 2017 | A1 |
| 20170185714 | Halter et al. | Jun 2017 | A1 |
| 20170185762 | Chang et al. | Jun 2017 | A1 |
| 20170188862 | Kale et al. | Jul 2017 | A1 |
| 20170188865 | Nierenberg et al. | Jul 2017 | A1 |
| 20170188866 | Kale et al. | Jul 2017 | A1 |
| 20170188868 | Kale et al. | Jul 2017 | A1 |
| 20170188869 | Kale et al. | Jul 2017 | A1 |
| 20170188870 | Hilty | Jul 2017 | A1 |
| 20170188872 | Hughes et al. | Jul 2017 | A1 |
| 20170188905 | Lee et al. | Jul 2017 | A1 |
| 20170188916 | Wang et al. | Jul 2017 | A1 |
| 20170188922 | Lee et al. | Jul 2017 | A1 |
| 20170188932 | Singer et al. | Jul 2017 | A1 |
| 20170188933 | Huggins et al. | Jul 2017 | A1 |
| 20170188947 | Connor | Jul 2017 | A1 |
| 20170188992 | O'Brien et al. | Jul 2017 | A1 |
| 20170189640 | Sadwick | Jul 2017 | A1 |
| 20170189691 | De Ridder | Jul 2017 | A1 |
| 20170190765 | El-Agnaf | Jul 2017 | A1 |
| 20170193314 | Kim et al. | Jul 2017 | A1 |
| 20170193831 | Walter et al. | Jul 2017 | A1 |
| 20170196497 | Ray et al. | Jul 2017 | A1 |
| 20170196501 | Watson et al. | Jul 2017 | A1 |
| 20170196503 | Narayan et al. | Jul 2017 | A1 |
| 20170196519 | Miller et al. | Jul 2017 | A1 |
| 20170197081 | Charlesworth et al. | Jul 2017 | A1 |
| 20170198017 | Deisseroth et al. | Jul 2017 | A1 |
| 20170199251 | Fujii et al. | Jul 2017 | A1 |
| 20170201619 | Cohen et al. | Jul 2017 | A1 |
| 20170202474 | Banerjee et al. | Jul 2017 | A1 |
| 20170202475 | Leuthardt | Jul 2017 | A1 |
| 20170202476 | Desain et al. | Jul 2017 | A1 |
| 20170202518 | Furman et al. | Jul 2017 | A1 |
| 20170202633 | Liu | Jul 2017 | A1 |
| 20170203154 | Solinsky | Jul 2017 | A1 |
| 20170205259 | Jang et al. | Jul 2017 | A1 |
| 20170206654 | Shiroishi et al. | Jul 2017 | A1 |
| 20170206691 | Harrises et al. | Jul 2017 | A1 |
| 20170206913 | Nahman et al. | Jul 2017 | A1 |
| 20170209043 | Gross et al. | Jul 2017 | A1 |
| 20170209044 | Ito et al. | Jul 2017 | A1 |
| 20170209053 | Pantelopoulos et al. | Jul 2017 | A1 |
| 20170209062 | Iwasaki et al. | Jul 2017 | A1 |
| 20170209083 | Zarandi et al. | Jul 2017 | A1 |
| 20170209094 | Derchak et al. | Jul 2017 | A1 |
| 20170209225 | Wu | Jul 2017 | A1 |
| 20170209389 | Toth et al. | Jul 2017 | A1 |
| 20170209737 | Tadi et al. | Jul 2017 | A1 |
| 20170212188 | Kikitsu et al. | Jul 2017 | A1 |
| 20170213311 | Sinclair | Jul 2017 | A1 |
| 20170214786 | Lee et al. | Jul 2017 | A1 |
| 20170215011 | Goldstein | Jul 2017 | A1 |
| 20170215757 | Gil Da Costa et al. | Aug 2017 | A1 |
| 20170216393 | Vavvas et al. | Aug 2017 | A1 |
| 20170221121 | Davis et al. | Aug 2017 | A1 |
| 20170221463 | Lenhert | Aug 2017 | A1 |
| 20170238831 | Cho et al. | Aug 2017 | A1 |
| 20170243023 | Lee et al. | Aug 2017 | A1 |
| 20170243203 | Bond et al. | Aug 2017 | A1 |
| 20170244702 | Jwa et al. | Aug 2017 | A1 |
| 20170245145 | Choi et al. | Aug 2017 | A1 |
| 20170249009 | Parshionikar | Aug 2017 | A1 |
| 20170251945 | Nick et al. | Sep 2017 | A1 |
| 20170255981 | Van Niekerk et al. | Sep 2017 | A1 |
| 20170258319 | Weffers-Albu et al. | Sep 2017 | A1 |
| 20170258390 | Howard | Sep 2017 | A1 |
| 20170259167 | Cook et al. | Sep 2017 | A1 |
| 20170262943 | Akutagawa et al. | Sep 2017 | A1 |
| 20170265807 | Stopek | Sep 2017 | A1 |
| 20170270636 | Shtukater | Sep 2017 | A1 |
| 20170272699 | Stopek | Sep 2017 | A1 |
| 20170272842 | Touma et al. | Sep 2017 | A1 |
| 20170276956 | Morifuji et al. | Sep 2017 | A1 |
| 20170281001 | Stopek | Oct 2017 | A1 |
| 20170293846 | Zyglowicz et al. | Oct 2017 | A1 |
| 20170300654 | Stein et al. | Oct 2017 | A1 |
| 20170300998 | Knudson et al. | Oct 2017 | A1 |
| 20170304587 | Santostasi et al. | Oct 2017 | A1 |
| 20170304623 | Tandon | Oct 2017 | A1 |
| 20170308172 | Niikawa | Oct 2017 | A1 |
| 20170309152 | Dinkins | Oct 2017 | A1 |
| 20170311023 | Chen et al. | Oct 2017 | A1 |
| 20170311097 | Nielsen et al. | Oct 2017 | A1 |
| 20170311832 | Barthelemy et al. | Nov 2017 | A1 |
| 20170311837 | Wei | Nov 2017 | A1 |
| 20170311878 | Wu et al. | Nov 2017 | A1 |
| 20170312622 | Ishihara | Nov 2017 | A1 |
| 20170316707 | Lawrenson et al. | Nov 2017 | A1 |
| 20170319109 | Skelton et al. | Nov 2017 | A1 |
| 20170319815 | Nofzinger et al. | Nov 2017 | A1 |
| 20170319817 | Morishima | Nov 2017 | A1 |
| 20170323073 | Westermann et al. | Nov 2017 | A1 |
| 20170329401 | Mitchell | Nov 2017 | A1 |
| 20170330248 | Gomariz et al. | Nov 2017 | A1 |
| 20170331563 | Tyler et al. | Nov 2017 | A1 |
| 20170332964 | Attal et al. | Nov 2017 | A1 |
| 20170333729 | Olcese | Nov 2017 | A1 |
| 20170337834 | Shindi | Nov 2017 | A1 |
| 20170344991 | Mark et al. | Nov 2017 | A1 |
| 20170345239 | Ho et al. | Nov 2017 | A9 |
| 20170346851 | Drake | Nov 2017 | A1 |
| 20170347181 | Campbell et al. | Nov 2017 | A1 |
| 20170347906 | Intrator | Dec 2017 | A1 |
| 20170347947 | Liang et al. | Dec 2017 | A1 |
| 20170347948 | Thein et al. | Dec 2017 | A1 |
| 20170352233 | Rivaud et al. | Dec 2017 | A1 |
| 20170354327 | Kiderman et al. | Dec 2017 | A1 |
| 20170360360 | Alqurashi | Dec 2017 | A1 |
| 20170360363 | Fonseca et al. | Dec 2017 | A1 |
| 20170367606 | Lee | Dec 2017 | A1 |
| 20170367610 | Girouard | Dec 2017 | A1 |
| 20170367651 | Tzvieli et al. | Dec 2017 | A1 |
| 20170368348 | Le Van Quyen et al. | Dec 2017 | A1 |
| 20170371421 | Parshionikar | Dec 2017 | A1 |
| 20180000255 | Youngblood et al. | Jan 2018 | A1 |
| 20180004287 | Yoo et al. | Jan 2018 | A1 |
| 20180005442 | Mullins | Jan 2018 | A1 |
| 20180009417 | Hoyos et al. | Jan 2018 | A1 |
| 20180011676 | Han et al. | Jan 2018 | A1 |
| 20180011689 | Motamedi et al. | Jan 2018 | A1 |
| 20180012009 | Furman et al. | Jan 2018 | A1 |
| 20180014130 | Lunner et al. | Jan 2018 | A1 |
| 20180014741 | Chou | Jan 2018 | A1 |
| 20180025368 | Frank et al. | Jan 2018 | A1 |
| 20180027176 | Agell et al. | Jan 2018 | A1 |
| 20180027347 | Osborne et al. | Jan 2018 | A1 |
| 20180032103 | Eskilsson et al. | Feb 2018 | A1 |
| 20180034855 | Myron | Feb 2018 | A1 |
| 20180042513 | Connor | Feb 2018 | A1 |
| 20180042523 | Sales et al. | Feb 2018 | A1 |
| 20180046248 | San Agustin Lopez et al. | Feb 2018 | A1 |
| 20180047216 | Mullins | Feb 2018 | A1 |
| 20180056026 | Harkness et al. | Mar 2018 | A1 |
| 20180068581 | Skorheim et al. | Mar 2018 | A1 |
| 20180070823 | Blackwell et al. | Mar 2018 | A1 |
| 20180075364 | Stolarz et al. | Mar 2018 | A1 |
| 20180081430 | Konz | Mar 2018 | A1 |
| 20180081439 | Daniels | Mar 2018 | A1 |
| 20180088678 | Komaki et al. | Mar 2018 | A1 |
| 20180089531 | Geva et al. | Mar 2018 | A1 |
| 20180092557 | Bickford et al. | Apr 2018 | A1 |
| 20180092566 | Guger et al. | Apr 2018 | A1 |
| 20180092600 | Simons et al. | Apr 2018 | A1 |
| 20180093092 | Howard | Apr 2018 | A1 |
| 20180095532 | Cheng et al. | Apr 2018 | A1 |
| 20180098710 | Gavas et al. | Apr 2018 | A1 |
| 20180098908 | Chien | Apr 2018 | A1 |
| 20180103859 | Provenzano | Apr 2018 | A1 |
| 20180103867 | Stephens et al. | Apr 2018 | A1 |
| 20180103917 | Kim et al. | Apr 2018 | A1 |
| 20180108191 | Ho et al. | Apr 2018 | A9 |
| 20180108192 | Ho et al. | Apr 2018 | A1 |
| 20180110960 | Youngblood et al. | Apr 2018 | A1 |
| 20180110991 | Molnar et al. | Apr 2018 | A1 |
| 20180113509 | Kim et al. | Apr 2018 | A1 |
| 20180113669 | Szeto | Apr 2018 | A1 |
| 20180115808 | Buga | Apr 2018 | A1 |
| 20180116543 | Miller et al. | May 2018 | A1 |
| 20180125356 | Yamada | May 2018 | A1 |
| 20180125386 | Lim et al. | May 2018 | A1 |
| 20180125405 | Yamada | May 2018 | A1 |
| 20180125406 | Yamada | May 2018 | A1 |
| 20180133431 | Malchano et al. | May 2018 | A1 |
| 20180133504 | Malchano et al. | May 2018 | A1 |
| 20180133507 | Malchano et al. | May 2018 | A1 |
| 20180139518 | Touma et al. | May 2018 | A1 |
| 20180140249 | Frohlich | May 2018 | A1 |
| 20180146879 | Fadem et al. | May 2018 | A9 |
| 20180146916 | Howard et al. | May 2018 | A1 |
| 20180150762 | Stolarz et al. | May 2018 | A1 |
| 20180154104 | Gerdes et al. | Jun 2018 | A1 |
| 20180157336 | Harris et al. | Jun 2018 | A1 |
| 20180157379 | Sivakumar et al. | Jun 2018 | A1 |
| 20180158133 | Davis et al. | Jun 2018 | A1 |
| 20180160982 | Laszlo et al. | Jun 2018 | A1 |
| 20180165593 | Stolarz et al. | Jun 2018 | A1 |
| 20180166157 | Firminger et al. | Jun 2018 | A1 |
| 20180168905 | Goodall et al. | Jun 2018 | A1 |
| 20180169411 | Goodall et al. | Jun 2018 | A1 |
| 20180169412 | Goodall et al. | Jun 2018 | A1 |
| 20180173220 | Wang et al. | Jun 2018 | A1 |
| 20180177393 | Muniraju | Jun 2018 | A1 |
| 20180177451 | Sahin | Jun 2018 | A1 |
| 20180182161 | Chaudhari et al. | Jun 2018 | A1 |
| 20180184002 | Thukral et al. | Jun 2018 | A1 |
| 20180184964 | Simon et al. | Jul 2018 | A1 |
| 20180189678 | Gupta et al. | Jul 2018 | A1 |
| 20180190376 | Hill et al. | Jul 2018 | A1 |
| 20180192936 | Widge et al. | Jul 2018 | A1 |
| 20180193589 | McLaughlin et al. | Jul 2018 | A1 |
| 20180196511 | Chae | Jul 2018 | A1 |
| 20180196512 | Kim et al. | Jul 2018 | A1 |
| 20180197636 | Firminger et al. | Jul 2018 | A1 |
| 20180214020 | Ohlendorf et al. | Aug 2018 | A1 |
| 20180214028 | Zhang et al. | Aug 2018 | A1 |
| 20180214768 | Macri et al. | Aug 2018 | A1 |
| 20180217666 | Gil Da Costa et al. | Aug 2018 | A1 |
| 20180219729 | Garg et al. | Aug 2018 | A1 |
| 20180220957 | Fuerst et al. | Aug 2018 | A1 |
| 20180221620 | Metzger | Aug 2018 | A1 |
| 20180228423 | Intrator | Aug 2018 | A1 |
| 20180232507 | Zizi et al. | Aug 2018 | A1 |
| 20180234479 | Lilienthal et al. | Aug 2018 | A1 |
| 20180234847 | Rodriguez | Aug 2018 | A1 |
| 20180236202 | Weiss et al. | Aug 2018 | A1 |
| 20180242902 | Martinmaki et al. | Aug 2018 | A1 |
| 20180246570 | Coleman et al. | Aug 2018 | A1 |
| 20180250494 | Hanbury | Sep 2018 | A1 |
| 20180256094 | Russell et al. | Sep 2018 | A1 |
| 20180260801 | Chiarella et al. | Sep 2018 | A1 |
| 20180263562 | Laplante-Levesque et al. | Sep 2018 | A1 |
| 20180271362 | Palczewski et al. | Sep 2018 | A1 |
| 20180275747 | Campbell | Sep 2018 | A1 |
| 20180276833 | Yoon et al. | Sep 2018 | A1 |
| 20180278984 | Aimone et al. | Sep 2018 | A1 |
| 20180279902 | Liu | Oct 2018 | A1 |
| 20180279939 | Madsen et al. | Oct 2018 | A1 |
| 20180279960 | Li et al. | Oct 2018 | A1 |
| 20180284886 | Mardanbegi et al. | Oct 2018 | A1 |
| 20180289310 | Girouard et al. | Oct 2018 | A1 |
| 20180289318 | Howard | Oct 2018 | A1 |
| 20180292902 | Min | Oct 2018 | A1 |
| 20180296112 | Girouard et al. | Oct 2018 | A1 |
| 20180299953 | Selker et al. | Oct 2018 | A1 |
| 20180301061 | Paudyal et al. | Oct 2018 | A1 |
| 20180303370 | Kanayama et al. | Oct 2018 | A1 |
| 20180303805 | During | Oct 2018 | A1 |
| 20180310851 | Das et al. | Nov 2018 | A1 |
| 20180310855 | Connor | Nov 2018 | A1 |
| 20180311462 | Garcia Molina | Nov 2018 | A1 |
| 20180317794 | Mackellar et al. | Nov 2018 | A1 |
| 20180317795 | Couser | Nov 2018 | A1 |
| 20180321700 | Kwak et al. | Nov 2018 | A1 |
| 20180321898 | Okubo et al. | Nov 2018 | A1 |
| 20180324516 | Campbell et al. | Nov 2018 | A1 |
| 20180328917 | Ilan | Nov 2018 | A1 |
| 20180333585 | Gaddam et al. | Nov 2018 | A1 |
| 20180333587 | Howard | Nov 2018 | A1 |
| 20180338068 | Weaver et al. | Nov 2018 | A1 |
| 20180341328 | Agell et al. | Nov 2018 | A1 |
| 20180341848 | Breuer et al. | Nov 2018 | A1 |
| 20180343219 | Anderson et al. | Nov 2018 | A1 |
| 20180344969 | Stoneman et al. | Dec 2018 | A1 |
| 20180348764 | Zhang et al. | Dec 2018 | A1 |
| 20180352326 | Restuccia et al. | Dec 2018 | A1 |
| 20180364810 | Parshionikar | Dec 2018 | A1 |
| 20180368717 | Soulet De Brugiere et al. | Dec 2018 | A1 |
| 20180368722 | Lunner et al. | Dec 2018 | A1 |
| 20180368755 | Garcia Molina et al. | Dec 2018 | A1 |
| 20180369847 | Kihm et al. | Dec 2018 | A1 |
| 20180373272 | Kihm et al. | Dec 2018 | A1 |
| 20190001039 | Heide et al. | Jan 2019 | A1 |
| 20190004325 | Connor | Jan 2019 | A1 |
| 20190008992 | Kihm et al. | Jan 2019 | A1 |
| 20190011612 | Mastrangelo et al. | Jan 2019 | A1 |
| 20190012758 | Sinclair et al. | Jan 2019 | A1 |
| 20190013960 | Sadwick | Jan 2019 | A1 |
| 20190020554 | Lilienthal et al. | Jan 2019 | A1 |
| 20190020610 | Park et al. | Jan 2019 | A1 |
| 20190026871 | Han et al. | Jan 2019 | A1 |
| 20190029528 | Tzvieli et al. | Jan 2019 | A1 |
| 20190029587 | Walker et al. | Jan 2019 | A1 |
| 20190029595 | Sekitani et al. | Jan 2019 | A1 |
| 20190030278 | Kremer | Jan 2019 | A1 |
| 20190033914 | Aimone et al. | Jan 2019 | A1 |
| 20190033968 | Segal | Jan 2019 | A1 |
| 20190034164 | Motamedi et al. | Jan 2019 | A1 |
| 20190037067 | Cohen et al. | Jan 2019 | A1 |
| 20190043154 | Lawrence | Feb 2019 | A1 |
| 20190046119 | Oxley | Feb 2019 | A1 |
| 20190053731 | Moon et al. | Feb 2019 | A1 |
| 20190053756 | Ayers et al. | Feb 2019 | A1 |
| 20190053766 | Mijovic et al. | Feb 2019 | A1 |
| 20190054899 | Hoyos et al. | Feb 2019 | A1 |
| 20190056438 | Jaroch | Feb 2019 | A1 |
| 20190059771 | Fu | Feb 2019 | A1 |
| 20190060602 | Tran et al. | Feb 2019 | A1 |
| 20190070386 | Raut et al. | Mar 2019 | A1 |
| 20190073029 | Filatov et al. | Mar 2019 | A1 |
| 20190073044 | Komaki et al. | Mar 2019 | A1 |
| 20190073605 | Keller | Mar 2019 | A1 |
| 20190077409 | Zandi et al. | Mar 2019 | A1 |
| 20190079580 | Ura et al. | Mar 2019 | A1 |
| 20190082990 | Poltorak | Mar 2019 | A1 |
| 20190082991 | Barthelemy et al. | Mar 2019 | A1 |
| 20190083212 | Cowburn et al. | Mar 2019 | A1 |
| 20190086919 | Zhang et al. | Mar 2019 | A1 |
| 20190097430 | Bae et al. | Mar 2019 | A1 |
| 20190099076 | Fujikado et al. | Apr 2019 | A1 |
| 20190099104 | Macri et al. | Apr 2019 | A1 |
| 20190099467 | Vavvas et al. | Apr 2019 | A1 |
| 20190101985 | Sajda et al. | Apr 2019 | A1 |
| 20190103034 | Walter et al. | Apr 2019 | A1 |
| 20190107888 | Sereshkeh et al. | Apr 2019 | A1 |
| 20190108191 | Frank et al. | Apr 2019 | A1 |
| 20190110726 | Chatterjee et al. | Apr 2019 | A1 |
| 20190113973 | Coleman et al. | Apr 2019 | A1 |
| 20190117062 | Yeo et al. | Apr 2019 | A1 |
| 20190117933 | Couser | Apr 2019 | A1 |
| 20190121682 | Adiletta et al. | Apr 2019 | A1 |
| 20190126033 | Pradeep | May 2019 | A1 |
| 20190130353 | Fenty et al. | May 2019 | A1 |
| 20190130750 | Cole et al. | May 2019 | A1 |
| 20190130777 | Dey et al. | May 2019 | A1 |
| 20190133445 | Eteminan et al. | May 2019 | A1 |
| 20190142349 | Schorey et al. | May 2019 | A1 |
| 20190143073 | Grossman | May 2019 | A1 |
| 20190146580 | Baugh et al. | May 2019 | A1 |
| 20190151337 | Tsuruda et al. | May 2019 | A1 |
| 20190158717 | Nomura et al. | May 2019 | A1 |
| 20190159675 | Sengupta et al. | May 2019 | A1 |
| 20190159715 | Mishra Ramanathan et al. | May 2019 | A1 |
| 20190167179 | Arzy | Jun 2019 | A1 |
| 20190167370 | Olson | Jun 2019 | A1 |
| 20190174237 | Lunner et al. | Jun 2019 | A1 |
| 20190174238 | Lunner et al. | Jun 2019 | A1 |
| 20190336724 | Li | Nov 2019 | A1 |
| Number | Date | Country |
|---|---|---|
| 102458242 | May 2012 | CN |
| 104605844 | May 2015 | CN |
| 0483698 | May 1992 | EP |
| 1090583 | Apr 2001 | EP |
| 1304073 | Apr 2003 | EP |
| 1304073 | Sep 2003 | EP |
| 1776922 | Apr 2007 | EP |
| 4582509 | Apr 2007 | JP |
| 4699694 | Apr 2007 | JP |
| 4801839 | Apr 2007 | JP |
| 4829231 | Apr 2007 | JP |
| 100895297 | Apr 2007 | KR |
| 2563433 | Sep 2015 | RU |
| WO2000025668 | Sep 2015 | WO |
| WO2001087153 | Sep 2015 | WO |
| WO2015143031 | Sep 2015 | WO |
| Entry |
|---|
| English TranslationRU2065297 (see attached) (Year: 1996) (Year: 1996). |
| U.S. Appl. No. 10/009,644, filed Jun. 26, 2018, Aimone et al. |
| U.S. Appl. No. 10/016,156, filed Jul. 10, 2018, Klin et al. |
| U.S. Appl. No. 10/019,060, filed Jul. 10, 2018, Cash. |
| U.S. Appl. No. 10/026,138, filed Jul. 17, 2018, Sinclair. |
| U.S. Appl. No. 10/029,067, filed Jul. 24, 2018, Gerdes et al. |
| U.S. Appl. No. 10/031,580, filed Jul. 24, 2018, Cruz-Hernandez. |
| U.S. Appl. No. 10/037,636, filed Jul. 31, 2018, Ho et al. |
| U.S. Appl. No. 10/039,445, filed Aug. 7, 2018, Torch. |
| U.S. Appl. No. 10/039,682, filed Aug. 7, 2018, Einav et al. |
| U.S. Appl. No. 10/042,038, filed Aug. 7, 2018, Lord. |
| U.S. Appl. No. 10/042,993, filed Aug. 7, 2018, Beigi. |
| U.S. Appl. No. 10/052,023, filed Aug. 21, 2018, Horseman. |
| U.S. Appl. No. 10/052,057, filed Aug. 21, 2018, Klin et al. |
| U.S. Appl. No. 10/052,066, filed Aug. 21, 2018, Rogers et al. |
| U.S. Appl. No. 10/052,452, filed Aug. 21, 2018, Schoonover et al. |
| U.S. Appl. No. 10/058,285, filed Aug. 28, 2018, Horseman. |
| U.S. Appl. No. 10/064,578, filed Sep. 4, 2018, Garcia Molina et al. |
| U.S. Appl. No. 10/068,373, filed Sep. 4, 2018, Lee et al. |
| U.S. Appl. No. 10/073,519, filed Sep. 11, 2018, Mun et al. |
| U.S. Appl. No. 10/074,224, filed Sep. 11, 2018, Ho et al. |
| U.S. Appl. No. 10/075,581, filed Sep. 11, 2018, Cohen et al. |
| U.S. Appl. No. 10/075,896, filed Sep. 11, 2018, Kim et al. |
| U.S. Appl. No. 10/079,788, filed Sep. 18, 2018, Park et al. |
| U.S. Appl. No. 10/080,506, filed Sep. 25, 2018, Fu. |
| U.S. Appl. No. 10/086,268, filed Oct. 2, 2018, Ishihara. |
| U.S. Appl. No. 10/089,074, filed Oct. 2, 2018, Motamedi et al. |
| U.S. Appl. No. 10/095,191, filed Oct. 9, 2018, Heo et al. |
| U.S. Appl. No. 10/108,783, filed Oct. 23, 2018, Horseman. |
| U.S. Appl. No. 10/109,056, filed Oct. 23, 2018, Nguyen et al. |
| U.S. Appl. No. 10/110,805, filed Oct. 23, 2018, Pomerantz et al. |
| U.S. Appl. No. 10/111,603, filed Oct. 30, 2018, Macri et al. |
| U.S. Appl. No. 10/111,615, filed Oct. 30, 2018, Russell et al. |
| U.S. Appl. No. 10/113,913, filed Oct. 30, 2018, Tzvieli et al. |
| U.S. Appl. No. 10/120,413, filed Nov. 6, 2018, Aimone et al. |
| U.S. Appl. No. 10/123,133, filed Nov. 6, 2018, Pontoppidan et al. |
| U.S. Appl. No. 10/123,134, filed Nov. 6, 2018, Jensen et al. |
| U.S. Appl. No. 10/126,816, filed Nov. 13, 2018, Segal. |
| U.S. Appl. No. 10/129,325, filed Nov. 13, 2018, Kelani et al. |
| U.S. Appl. No. 10/130,278, filed Nov. 20, 2018, Jordan et al. |
| U.S. Appl. No. 10/130,279, filed Nov. 20, 2018, Moon et al. |
| U.S. Appl. No. 10/130,766, filed Nov. 20, 2018, Bibian et al. |
| U.S. Appl. No. 10/130,788, filed Nov. 20, 2018, Garcia Molina et al. |
| U.S. Appl. No. 10/131,322, filed Nov. 20, 2018, Hoyos et al. |
| U.S. Appl. No. 10/136,856, filed Nov. 27, 2018, Tzvieli et al. |
| U.S. Appl. No. 10/136,862, filed Nov. 27, 2018, Chafe et al. |
| U.S. Appl. No. 10/137,363, filed Nov. 27, 2018, Parshionikar. |
| U.S. Appl. No. 10/143,415, filed Dec. 4, 2018, Girouard et al. |
| U.S. Appl. No. 10/149,161, filed Dec. 4, 2018, Choi et al. |
| U.S. Appl. No. 10/149,884, filed Dec. 11, 2018, Vavvas et al. |
| U.S. Appl. No. 10/149,958, filed Dec. 11, 2018, Tran et al. |
| U.S. Appl. No. 10/152,957, filed Dec. 11, 2018, Lenhert. |
| U.S. Appl. No. 10/154,333, filed Dec. 11, 2018, Campbell et al. |
| U.S. Appl. No. 10/154,815, filed Dec. 18, 2018, Al-Ali et al. |
| U.S. Appl. No. 10/156,888, filed Dec. 18, 2018, Lee et al. |
| U.S. Appl. No. 10/162,707, filed Dec. 25, 2018, Kong et al. |
| U.S. Appl. No. 10/165,949, filed Jan. 1, 2019, Tzvieli et al. |
| U.S. Appl. No. 10/165,977, filed Jan. 1, 2019, Wu et al. |
| U.S. Appl. No. 10/166,091, filed Jan. 1, 2019, Cowburn et al. |
| U.S. Appl. No. 10/168,704, filed Jan. 1, 2019, Zhang et al. |
| U.S. Appl. No. 10/168,772, filed Jan. 1, 2019, Kim et al. |
| U.S. Appl. No. 10/168,793, filed Jan. 1, 2019, Komaki et al. |
| U.S. Appl. No. 10/169,712, filed Jan. 1, 2019, Stolarz et al. |
| U.S. Appl. No. 10/173,059, filed Jan. 8, 2019, Wallbridge et al. |
| U.S. Appl. No. 10/176,894, filed Jan. 8, 2019, Park et al. |
| U.S. Appl. No. 10/180,339, filed Jan. 15, 2019, Long et al. |
| U.S. Appl. No. 10/182,736, filed Jan. 22, 2019, Coleman et al. |
| U.S. Appl. No. 10/185,147, filed Jan. 22, 2019, Lewis. |
| U.S. Appl. No. 10/186,014, filed Jan. 22, 2019, Cho et al. |
| U.S. Appl. No. 10/188,307, filed Jan. 29, 2019, Henson et al. |
| U.S. Appl. No. 10/191,545, filed Jan. 29, 2019, Laszlo et al. |
| U.S. Appl. No. 10/191,558, filed Jan. 29, 2019, Parshionikar. |
| U.S. Appl. No. 10/192,173, filed Jan. 29, 2019, Stephens et al. |
| U.S. Appl. No. 10/195,455, filed Feb. 5, 2019, Stubbeman. |
| U.S. Appl. No. 10/198,068, filed Feb. 5, 2019, Holz et al. |
| U.S. Appl. No. 10/198,505, filed Feb. 5, 2019, Frank et al. |
| U.S. Appl. No. 10/203,751, filed Feb. 12, 2019, Keskin et al. |
| U.S. Appl. No. 10/204,251, filed Feb. 12, 2019, Fenty III et al. |
| U.S. Appl. No. 10/206,625, filed Feb. 19, 2019, Horseman. |
| U.S. Appl. No. 10/209,779, filed Feb. 19, 2019, Roh et al. |
| U.S. Appl. No. 10/212,593, filed Feb. 19, 2019, Rodriguez. |
| U.S. Appl. No. 10/213,156, filed Feb. 26, 2019, Min et al. |
| U.S. Appl. No. 10/219,736, filed Mar. 5, 2019, Davis et al. |
| U.S. Appl. No. 10/223,633, filed Mar. 5, 2019, Breuer et al. |
| U.S. Appl. No. 10/223,710, filed Mar. 5, 2019, Purves et al. |
| U.S. Appl. No. 10/226,209, filed Mar. 12, 2019, Girouard. |
| U.S. Appl. No. 10/227,063, filed Mar. 12, 2019, Abreu. |
| U.S. Appl. No. 10/231,650, filed Mar. 19, 2019, Skelton et al. |
| U.S. Appl. No. 10/231,673, filed Mar. 19, 2019, Jain et al. |
| U.S. Appl. No. 10/234,942, filed Mar. 19, 2019, Connor. |
| U.S. Appl. No. 10/244,033, filed Mar. 26, 2019, Grimstrup et al. |
| U.S. Appl. No. 10/254,785, filed Apr. 9, 2019, Simon et al. |
| U.S. Appl. No. 10/257,177, filed Apr. 9, 2019, Hwang et al. |
| U.S. Appl. No. 10/257,555, filed Apr. 9, 2019, Chen et al. |
| U.S. Appl. No. 10/258,243, filed Apr. 16, 2019, LeBoeuf et al. |
| U.S. Appl. No. 10/258,291, filed Apr. 16, 2019, Coleman et al. |
| U.S. Appl. No. 10/258,798, filed Apr. 16, 2019, Panken et al. |
| U.S. Appl. No. 10/261,947, filed Apr. 16, 2019, Frank et al. |
| U.S. Appl. No. 10/262,356, filed Apr. 16, 2019, Davis et al. |
| U.S. Appl. No. 10/264,019, filed Apr. 16, 2019, Myron. |
| U.S. Appl. No. 10/264,990, filed Apr. 23, 2019, Pasley et al. |
| U.S. Appl. No. 10/265,527, filed Apr. 23, 2019, Lim et al. |
| U.S. Appl. No. 10/271,087, filed Apr. 23, 2019, Klappert et al. |
| U.S. Appl. No. 10/275,027, filed Apr. 30, 2019, Segal. |
| U.S. Appl. No. 10/279,192, filed May 7, 2019, Malchano et al. |
| U.S. Appl. No. 10/285,634, filed May 14, 2019, Jain et al. |
| U.S. Appl. No. 10/290,225, filed May 14, 2019, Danyluk et al. |
| U.S. Appl. No. 10/291,977, filed May 14, 2019, Mackellar et al. |
| U.S. Appl. No. 10/292,613, filed May 21, 2019, Hatakeyama. |
| U.S. Appl. No. 10/293,177, filed May 21, 2019, Malchano et al. |
| U.S. Appl. No. 10/299,210, filed May 21, 2019, Kim et al. |
| U.S. Appl. No. 10/300,240, filed May 28, 2019, Weiss et al. |
| U.S. Appl. No. 10/303,258, filed May 28, 2019, Todeschini. |
| U.S. Appl. No. 10/303,971, filed May 28, 2019, Geva et al. |
| U.S. Appl. No. 10/303,988, filed May 28, 2019, Long et al. |
| U.S. Appl. No. 10/307,085, filed Jun. 4, 2019, Sales et al. |
| U.S. Appl. No. 10/307,104, filed Jun. 4, 2019, Horseman. |
| U.S. Appl. No. 10/307,611, filed Jun. 4, 2019, Malchano et al. |
| U.S. Appl. No. 10/314,508, filed Jun. 11, 2019, Desain et al. |
| U.S. Appl. No. 10/319,471, filed Jun. 11, 2019, Firminger et al. |
| Number | Date | Country | |
|---|---|---|---|
| 20200368491 A1 | Nov 2020 | US |
| Number | Date | Country | |
|---|---|---|---|
| 62862656 | Jun 2019 | US | |
| 62852877 | May 2019 | US |
